0001757073-22-000091.txt : 20221103 0001757073-22-000091.hdr.sgml : 20221103 20221103162046 ACCESSION NUMBER: 0001757073-22-000091 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 99 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221103 DATE AS OF CHANGE: 20221103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Envista Holdings Corp CENTRAL INDEX KEY: 0001757073 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 832206728 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39054 FILM NUMBER: 221358360 BUSINESS ADDRESS: STREET 1: 200 S. KRAEMER BLVD., BLDG. E CITY: BREA STATE: CA ZIP: 92821 BUSINESS PHONE: 714-516-7774 MAIL ADDRESS: STREET 1: 200 S. KRAEMER BLVD., BLDG. E CITY: BREA STATE: CA ZIP: 92821 FORMER COMPANY: FORMER CONFORMED NAME: DH Dental Holding Corp. DATE OF NAME CHANGE: 20181025 10-Q 1 nvst-20220930.htm 10-Q nvst-20220930
false2022Q3--12-310001757073http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member0.047586200017570732022-01-012022-09-3000017570732022-10-28xbrli:shares00017570732022-09-30iso4217:USD00017570732021-12-31iso4217:USDxbrli:shares00017570732022-07-022022-09-3000017570732021-07-032021-10-0100017570732021-01-012021-10-010001757073us-gaap:CommonStockMember2021-12-310001757073us-gaap:AdditionalPaidInCapitalMember2021-12-310001757073us-gaap:RetainedEarningsMember2021-12-310001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001757073us-gaap:ParentMember2021-12-310001757073us-gaap:NoncontrollingInterestMember2021-12-3100017570732021-01-012021-12-310001757073us-gaap:AdditionalPaidInCapitalMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001757073us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001757073us-gaap:ParentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:CommonStockMember2021-12-310001757073us-gaap:AdditionalPaidInCapitalMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2021-12-310001757073us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001757073us-gaap:ParentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:NoncontrollingInterestMember2021-12-310001757073us-gaap:NoncontrollingInterestMember2022-01-012022-04-010001757073us-gaap:AdditionalPaidInCapitalMember2022-01-012022-04-010001757073us-gaap:ParentMember2022-01-012022-04-010001757073us-gaap:RetainedEarningsMember2022-01-012022-04-010001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-04-010001757073us-gaap:CommonStockMember2022-04-010001757073us-gaap:AdditionalPaidInCapitalMember2022-04-010001757073us-gaap:RetainedEarningsMember2022-04-010001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-010001757073us-gaap:ParentMember2022-04-010001757073us-gaap:NoncontrollingInterestMember2022-04-010001757073us-gaap:AdditionalPaidInCapitalMember2022-04-022022-07-010001757073us-gaap:ParentMember2022-04-022022-07-010001757073us-gaap:RetainedEarningsMember2022-04-022022-07-010001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-022022-07-010001757073us-gaap:CommonStockMember2022-07-010001757073us-gaap:AdditionalPaidInCapitalMember2022-07-010001757073us-gaap:RetainedEarningsMember2022-07-010001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-010001757073us-gaap:ParentMember2022-07-010001757073us-gaap:AdditionalPaidInCapitalMember2022-07-022022-09-300001757073us-gaap:ParentMember2022-07-022022-09-300001757073us-gaap:RetainedEarningsMember2022-07-022022-09-300001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-022022-09-300001757073us-gaap:CommonStockMember2022-09-300001757073us-gaap:AdditionalPaidInCapitalMember2022-09-300001757073us-gaap:RetainedEarningsMember2022-09-300001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001757073us-gaap:ParentMember2022-09-300001757073us-gaap:CommonStockMember2020-12-310001757073us-gaap:AdditionalPaidInCapitalMember2020-12-310001757073us-gaap:RetainedEarningsMember2020-12-310001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001757073us-gaap:ParentMember2020-12-310001757073us-gaap:NoncontrollingInterestMember2020-12-310001757073us-gaap:AdditionalPaidInCapitalMember2021-01-012021-04-020001757073us-gaap:ParentMember2021-01-012021-04-020001757073us-gaap:RetainedEarningsMember2021-01-012021-04-020001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-04-020001757073us-gaap:CommonStockMember2021-04-020001757073us-gaap:AdditionalPaidInCapitalMember2021-04-020001757073us-gaap:RetainedEarningsMember2021-04-020001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-020001757073us-gaap:ParentMember2021-04-020001757073us-gaap:NoncontrollingInterestMember2021-04-020001757073us-gaap:AdditionalPaidInCapitalMember2021-04-032021-07-020001757073us-gaap:ParentMember2021-04-032021-07-020001757073us-gaap:RetainedEarningsMember2021-04-032021-07-020001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-032021-07-020001757073us-gaap:CommonStockMember2021-07-020001757073us-gaap:AdditionalPaidInCapitalMember2021-07-020001757073us-gaap:RetainedEarningsMember2021-07-020001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-020001757073us-gaap:ParentMember2021-07-020001757073us-gaap:NoncontrollingInterestMember2021-07-020001757073us-gaap:AdditionalPaidInCapitalMember2021-07-032021-10-010001757073us-gaap:ParentMember2021-07-032021-10-010001757073us-gaap:RetainedEarningsMember2021-07-032021-10-010001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-032021-10-010001757073us-gaap:CommonStockMember2021-10-010001757073us-gaap:AdditionalPaidInCapitalMember2021-10-010001757073us-gaap:RetainedEarningsMember2021-10-010001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-10-010001757073us-gaap:ParentMember2021-10-010001757073us-gaap:NoncontrollingInterestMember2021-10-0100017570732020-12-3100017570732021-10-01nvst:segment0001757073nvst:OsteogenicsBiomedicalIncMember2022-07-052022-07-050001757073nvst:CarestreamDentalTechnologyMember2022-04-202022-04-200001757073nvst:CarestreamDentalTechnologyMember2022-04-200001757073nvst:OsteogenicsBiomedicalIncMember2022-07-050001757073nvst:CarestreamDentalTechnologyMember2022-01-012022-09-300001757073nvst:OsteogenicsBiomedicalIncMember2022-01-012022-09-300001757073nvst:OsteogenicsBiomedicalIncCarestreamDentalTechnologyMember2022-07-022022-09-300001757073nvst:OsteogenicsBiomedicalIncCarestreamDentalTechnologyMember2022-01-012022-09-300001757073us-gaap:DiscontinuedOperationsDisposedOfBySaleMembernvst:PlamencaMember2021-12-310001757073us-gaap:DiscontinuedOperationsDisposedOfBySaleMembernvst:PlamencaMember2022-01-012022-09-300001757073us-gaap:DiscontinuedOperationsDisposedOfBySaleMembernvst:PlamencaMember2022-07-022022-09-300001757073us-gaap:DiscontinuedOperationsDisposedOfBySaleMembernvst:PlamencaMember2021-07-032021-10-010001757073us-gaap:DiscontinuedOperationsDisposedOfBySaleMembernvst:PlamencaMember2021-01-012021-10-010001757073us-gaap:LandAndLandImprovementsMember2022-09-300001757073us-gaap:LandAndLandImprovementsMember2021-12-310001757073us-gaap:BuildingAndBuildingImprovementsMember2022-09-300001757073us-gaap:BuildingAndBuildingImprovementsMember2021-12-310001757073us-gaap:MachineryAndEquipmentMember2022-09-300001757073us-gaap:MachineryAndEquipmentMember2021-12-310001757073us-gaap:ConstructionInProgressMember2022-09-300001757073us-gaap:ConstructionInProgressMember2021-12-310001757073nvst:SpecialtyProductsandTechnologiesMember2021-12-310001757073nvst:EquipmentandConsumablesMember2021-12-310001757073nvst:SpecialtyProductsandTechnologiesMember2022-01-012022-09-300001757073nvst:EquipmentandConsumablesMember2022-01-012022-09-300001757073nvst:SpecialtyProductsandTechnologiesMember2022-09-300001757073nvst:EquipmentandConsumablesMember2022-09-300001757073nvst:EuroTermLoanDue2024Member2022-09-30iso4217:EUR0001757073nvst:USTermLoanDue2024Member2019-09-200001757073nvst:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2022-09-300001757073nvst:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2022-07-022022-09-300001757073nvst:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2021-10-010001757073nvst:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2021-07-032021-10-010001757073us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2022-09-300001757073us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2022-07-022022-09-300001757073us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2021-10-010001757073us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2021-07-032021-10-010001757073us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2022-09-300001757073us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2022-07-022022-09-300001757073us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2021-10-010001757073us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2021-07-032021-10-010001757073nvst:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2022-01-012022-09-300001757073nvst:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2021-01-012021-10-010001757073us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2022-01-012022-09-300001757073us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2021-01-012021-10-010001757073us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2022-01-012022-09-300001757073us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2021-01-012021-10-010001757073us-gaap:LongTermDebtMember2022-09-300001757073us-gaap:LongTermDebtMember2021-12-310001757073us-gaap:FairValueInputsLevel1Member2022-09-300001757073us-gaap:FairValueInputsLevel2Member2022-09-300001757073us-gaap:FairValueInputsLevel3Member2022-09-300001757073us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Member2021-12-310001757073us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2021-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMember2021-12-310001757073us-gaap:InterestRateSwapMember2021-12-310001757073us-gaap:FairValueInputsLevel1Memberus-gaap:CurrencySwapMember2021-12-310001757073us-gaap:CurrencySwapMemberus-gaap:FairValueInputsLevel2Member2021-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:CurrencySwapMember2021-12-310001757073us-gaap:CurrencySwapMember2021-12-310001757073us-gaap:FairValueInputsLevel1Member2021-12-310001757073us-gaap:FairValueInputsLevel2Member2021-12-310001757073us-gaap:FairValueInputsLevel3Member2021-12-310001757073us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300001757073us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-09-300001757073us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001757073us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001757073us-gaap:InterestRateSwapMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300001757073us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:InterestRateSwapMember2022-09-300001757073us-gaap:InterestRateSwapMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001757073us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:InterestRateSwapMember2021-12-310001757073us-gaap:CurrencySwapMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300001757073us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CurrencySwapMember2022-09-300001757073us-gaap:CurrencySwapMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001757073us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CurrencySwapMember2021-12-310001757073nvst:USTermLoanDue2024Member2022-09-300001757073nvst:USTermLoanDue2024Member2021-12-310001757073nvst:EuroTermLoanDue2024Member2021-12-310001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2020-05-210001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2022-09-300001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2021-12-310001757073us-gaap:RevolvingCreditFacilityMember2022-09-300001757073us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2022-09-300001757073us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-12-310001757073us-gaap:OtherDebtSecuritiesMember2022-09-300001757073us-gaap:OtherDebtSecuritiesMember2021-12-3100017570732019-09-202019-09-200001757073nvst:USTermLoanDue2024Member2019-09-202019-09-200001757073nvst:EuroTermLoanDue2024Member2019-09-202019-09-200001757073nvst:EuroTermLoanDue2024Member2019-09-200001757073us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2019-09-202019-09-200001757073nvst:EuroTermLoanDue2024Member2021-02-092021-02-090001757073us-gaap:RevolvingCreditFacilityMember2019-09-202019-09-200001757073us-gaap:RevolvingCreditFacilityMember2021-06-152021-06-150001757073us-gaap:RevolvingCreditFacilityMember2021-06-15xbrli:pure0001757073us-gaap:RevolvingCreditFacilityMemberus-gaap:StandbyLettersOfCreditMember2022-09-300001757073us-gaap:RevolvingCreditFacilityMember2021-12-310001757073us-gaap:LondonInterbankOfferedRateLIBORMembernvst:CreditFacilityMembersrt:MinimumMember2022-01-012022-09-300001757073us-gaap:LondonInterbankOfferedRateLIBORMembersrt:MaximumMembernvst:CreditFacilityMember2022-01-012022-09-300001757073us-gaap:BaseRateMembersrt:MinimumMember2022-01-012022-09-300001757073srt:MaximumMemberus-gaap:BaseRateMember2022-01-012022-09-300001757073srt:MinimumMember2022-01-012022-09-300001757073srt:MaximumMember2022-01-012022-09-300001757073nvst:USTermLoanDue2024Member2022-01-012022-09-300001757073nvst:USTermLoanDue2024Member2021-01-012021-12-310001757073nvst:EuroTermLoanDue2024Member2022-01-012022-09-300001757073nvst:EuroTermLoanDue2024Member2021-01-012021-12-310001757073nvst:A2.375ConvertibleSeniorNotesOverAllotmentOptionMemberus-gaap:ConvertibleDebtMember2020-05-210001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2020-05-212020-05-210001757073srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:ConvertibleDebtMember2021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2022-01-012022-09-300001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2021-01-012021-12-31nvst:tradingDay0001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2022-07-022022-09-300001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2021-07-032021-10-010001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2021-01-012021-10-010001757073nvst:A2.375ConvertibleSeniorNotesCappedCallsMemberus-gaap:ConvertibleDebtMember2020-05-212020-05-210001757073nvst:A2.375ConvertibleSeniorNotesCappedCallsMemberus-gaap:ConvertibleDebtMember2020-05-210001757073us-gaap:AccumulatedTranslationAdjustmentMember2022-07-010001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-010001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-010001757073us-gaap:AccumulatedTranslationAdjustmentMember2022-07-022022-09-300001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-022022-09-300001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-022022-09-300001757073us-gaap:AccumulatedTranslationAdjustmentMember2022-09-300001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-09-300001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-300001757073us-gaap:AccumulatedTranslationAdjustmentMember2021-07-020001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-07-020001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-07-020001757073us-gaap:AccumulatedTranslationAdjustmentMember2021-07-032021-10-010001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-07-032021-10-010001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-07-032021-10-010001757073us-gaap:AccumulatedTranslationAdjustmentMember2021-10-010001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-10-010001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-10-010001757073us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001757073us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-09-300001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-09-300001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-09-300001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300001757073us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001757073us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-10-010001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-10-010001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-10-010001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-10-010001757073nvst:SpecialtyProductsandTechnologiesMembersrt:NorthAmericaMember2022-07-022022-09-300001757073srt:NorthAmericaMembernvst:EquipmentandConsumablesMember2022-07-022022-09-300001757073srt:NorthAmericaMember2022-07-022022-09-300001757073nvst:SpecialtyProductsandTechnologiesMembersrt:NorthAmericaMember2021-07-032021-10-010001757073srt:NorthAmericaMembernvst:EquipmentandConsumablesMember2021-07-032021-10-010001757073srt:NorthAmericaMember2021-07-032021-10-010001757073nvst:SpecialtyProductsandTechnologiesMembernvst:WesternEuropeMember2022-07-022022-09-300001757073nvst:WesternEuropeMembernvst:EquipmentandConsumablesMember2022-07-022022-09-300001757073nvst:WesternEuropeMember2022-07-022022-09-300001757073nvst:SpecialtyProductsandTechnologiesMembernvst:WesternEuropeMember2021-07-032021-10-010001757073nvst:WesternEuropeMembernvst:EquipmentandConsumablesMember2021-07-032021-10-010001757073nvst:WesternEuropeMember2021-07-032021-10-010001757073nvst:SpecialtyProductsandTechnologiesMembernvst:OtherDevelopedMarketsMember2022-07-022022-09-300001757073nvst:OtherDevelopedMarketsMembernvst:EquipmentandConsumablesMember2022-07-022022-09-300001757073nvst:OtherDevelopedMarketsMember2022-07-022022-09-300001757073nvst:SpecialtyProductsandTechnologiesMembernvst:OtherDevelopedMarketsMember2021-07-032021-10-010001757073nvst:OtherDevelopedMarketsMembernvst:EquipmentandConsumablesMember2021-07-032021-10-010001757073nvst:OtherDevelopedMarketsMember2021-07-032021-10-010001757073nvst:SpecialtyProductsandTechnologiesMembernvst:HighGrowthMarketsMember2022-07-022022-09-300001757073nvst:HighGrowthMarketsMembernvst:EquipmentandConsumablesMember2022-07-022022-09-300001757073nvst:HighGrowthMarketsMember2022-07-022022-09-300001757073nvst:SpecialtyProductsandTechnologiesMembernvst:HighGrowthMarketsMember2021-07-032021-10-010001757073nvst:HighGrowthMarketsMembernvst:EquipmentandConsumablesMember2021-07-032021-10-010001757073nvst:HighGrowthMarketsMember2021-07-032021-10-010001757073nvst:SpecialtyProductsandTechnologiesMember2022-07-022022-09-300001757073nvst:EquipmentandConsumablesMember2022-07-022022-09-300001757073nvst:SpecialtyProductsandTechnologiesMember2021-07-032021-10-010001757073nvst:EquipmentandConsumablesMember2021-07-032021-10-010001757073nvst:SpecialtyProductsandTechnologiesMembersrt:NorthAmericaMember2022-01-012022-09-300001757073srt:NorthAmericaMembernvst:EquipmentandConsumablesMember2022-01-012022-09-300001757073srt:NorthAmericaMember2022-01-012022-09-300001757073nvst:SpecialtyProductsandTechnologiesMembersrt:NorthAmericaMember2021-01-012021-10-010001757073srt:NorthAmericaMembernvst:EquipmentandConsumablesMember2021-01-012021-10-010001757073srt:NorthAmericaMember2021-01-012021-10-010001757073nvst:SpecialtyProductsandTechnologiesMembernvst:WesternEuropeMember2022-01-012022-09-300001757073nvst:WesternEuropeMembernvst:EquipmentandConsumablesMember2022-01-012022-09-300001757073nvst:WesternEuropeMember2022-01-012022-09-300001757073nvst:SpecialtyProductsandTechnologiesMembernvst:WesternEuropeMember2021-01-012021-10-010001757073nvst:WesternEuropeMembernvst:EquipmentandConsumablesMember2021-01-012021-10-010001757073nvst:WesternEuropeMember2021-01-012021-10-010001757073nvst:SpecialtyProductsandTechnologiesMembernvst:OtherDevelopedMarketsMember2022-01-012022-09-300001757073nvst:OtherDevelopedMarketsMembernvst:EquipmentandConsumablesMember2022-01-012022-09-300001757073nvst:OtherDevelopedMarketsMember2022-01-012022-09-300001757073nvst:SpecialtyProductsandTechnologiesMembernvst:OtherDevelopedMarketsMember2021-01-012021-10-010001757073nvst:OtherDevelopedMarketsMembernvst:EquipmentandConsumablesMember2021-01-012021-10-010001757073nvst:OtherDevelopedMarketsMember2021-01-012021-10-010001757073nvst:SpecialtyProductsandTechnologiesMembernvst:HighGrowthMarketsMember2022-01-012022-09-300001757073nvst:HighGrowthMarketsMembernvst:EquipmentandConsumablesMember2022-01-012022-09-300001757073nvst:HighGrowthMarketsMember2022-01-012022-09-300001757073nvst:SpecialtyProductsandTechnologiesMembernvst:HighGrowthMarketsMember2021-01-012021-10-010001757073nvst:HighGrowthMarketsMembernvst:EquipmentandConsumablesMember2021-01-012021-10-010001757073nvst:HighGrowthMarketsMember2021-01-012021-10-010001757073nvst:SpecialtyProductsandTechnologiesMember2021-01-012021-10-010001757073nvst:EquipmentandConsumablesMember2021-01-012021-10-010001757073nvst:ConsumablesMember2022-07-022022-09-300001757073nvst:ConsumablesMember2021-07-032021-10-010001757073nvst:ConsumablesMember2022-01-012022-09-300001757073nvst:ConsumablesMember2021-01-012021-10-010001757073nvst:EquipmentSalesMember2022-07-022022-09-300001757073nvst:EquipmentSalesMember2021-07-032021-10-010001757073nvst:EquipmentSalesMember2022-01-012022-09-300001757073nvst:EquipmentSalesMember2021-01-012021-10-0100017570732022-10-012022-09-300001757073us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembernvst:LargestCustomerMember2022-07-022022-09-300001757073us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembernvst:LargestCustomerMember2022-01-012022-09-300001757073us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembernvst:LargestCustomerMember2021-01-012021-10-010001757073us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembernvst:LargestCustomerMember2021-07-032021-10-010001757073us-gaap:EmployeeSeveranceMember2021-12-310001757073us-gaap:FacilityClosingMember2021-12-310001757073us-gaap:EmployeeSeveranceMember2022-01-012022-09-300001757073us-gaap:FacilityClosingMember2022-01-012022-09-300001757073us-gaap:EmployeeSeveranceMember2022-09-300001757073us-gaap:FacilityClosingMember2022-09-300001757073us-gaap:AllOtherSegmentsMember2022-07-022022-09-300001757073us-gaap:AllOtherSegmentsMember2021-07-032021-10-010001757073us-gaap:AllOtherSegmentsMember2022-01-012022-09-300001757073us-gaap:AllOtherSegmentsMember2021-01-012021-10-010001757073us-gaap:CostOfSalesMember2022-07-022022-09-300001757073us-gaap:CostOfSalesMember2021-07-032021-10-010001757073us-gaap:CostOfSalesMember2022-01-012022-09-300001757073us-gaap:CostOfSalesMember2021-01-012021-10-010001757073us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-022022-09-300001757073us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-07-032021-10-010001757073us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-09-300001757073us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-10-010001757073us-gaap:StockCompensationPlanMember2022-07-022022-09-300001757073us-gaap:StockCompensationPlanMember2021-07-032021-10-010001757073us-gaap:StockCompensationPlanMember2022-01-012022-09-300001757073us-gaap:StockCompensationPlanMember2021-01-012021-10-01nvst:Segment0001757073nvst:SpecialtyProductsandTechnologiesMemberus-gaap:OperatingSegmentsMember2022-07-022022-09-300001757073nvst:SpecialtyProductsandTechnologiesMemberus-gaap:OperatingSegmentsMember2021-07-032021-10-010001757073nvst:SpecialtyProductsandTechnologiesMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001757073nvst:SpecialtyProductsandTechnologiesMemberus-gaap:OperatingSegmentsMember2021-01-012021-10-010001757073nvst:EquipmentandConsumablesMemberus-gaap:OperatingSegmentsMember2022-07-022022-09-300001757073nvst:EquipmentandConsumablesMemberus-gaap:OperatingSegmentsMember2021-07-032021-10-010001757073nvst:EquipmentandConsumablesMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001757073nvst:EquipmentandConsumablesMemberus-gaap:OperatingSegmentsMember2021-01-012021-10-010001757073us-gaap:CorporateNonSegmentMember2022-07-022022-09-300001757073us-gaap:CorporateNonSegmentMember2021-07-032021-10-010001757073us-gaap:CorporateNonSegmentMember2022-01-012022-09-300001757073us-gaap:CorporateNonSegmentMember2021-01-012021-10-010001757073nvst:SpecialtyProductsandTechnologiesMemberus-gaap:OperatingSegmentsMember2022-09-300001757073nvst:SpecialtyProductsandTechnologiesMemberus-gaap:OperatingSegmentsMember2021-12-310001757073nvst:EquipmentandConsumablesMemberus-gaap:OperatingSegmentsMember2022-09-300001757073nvst:EquipmentandConsumablesMemberus-gaap:OperatingSegmentsMember2021-12-310001757073us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberus-gaap:MaterialReconcilingItemsMember2022-09-300001757073us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberus-gaap:MaterialReconcilingItemsMember2021-12-310001757073us-gaap:CorporateNonSegmentMember2022-09-300001757073us-gaap:CorporateNonSegmentMember2021-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________
FORM 10-Q
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2022
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from         to         
    
Commission File Number: 001-39054
nvst-20220930_g1.jpg
ENVISTA HOLDINGS CORPORATION
(Exact name of Registrant as specified in its charter)
Delaware83-2206728
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number)
200 S. Kraemer Blvd., Building E92821-6208
Brea,California
(Address of Principal Executive Offices)(Zip Code)
Registrant’s telephone number, including area code: 714-817-7000
Securities Registered Pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common stock, $0.01 par valueNVSTNew York Stock Exchange
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.     Yes   ☒     No  ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).     Yes   ☒     No  ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer☒ Accelerated Filer☐
Non-accelerated Filer☐ Smaller Reporting company☐
Emerging Growth Company☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes   ☐     No  ☒
The number of shares of common stock outstanding as of October 28, 2022, was 163,045,022.



TABLE OF CONTENTS
PART I. FINANCIAL INFORMATION
PAGE
Item 1.
Item 2.
Item 3.
Item 4.
PART II. OTHER INFORMATION
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.



PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
ENVISTA HOLDINGS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
($ in millions, except share amounts)
As of
September 30, 2022December 31, 2021
ASSETS
Current assets:
Cash and cash equivalents$568.5 $1,073.6 
Trade accounts receivable, less allowance for credit losses of $16.8 and $20.7, respectively
392.2 331.9 
Inventories, net291.3 263.8 
Prepaid expenses and other current assets114.0 154.3 
Assets held for sale— 12.2 
Total current assets1,366.0 1,835.8 
Property, plant and equipment, net277.2 264.1 
Operating lease right-of-use assets132.1 128.1 
Other long-term assets173.2 167.8 
Goodwill3,399.6 3,132.0 
Other intangible assets, net1,063.8 1,046.4 
Total assets$6,411.9 $6,574.2 
LIABILITIES AND EQUITY
Current liabilities:
Short-term debt$579.3 $432.4 
Trade accounts payable190.0 185.8 
Accrued expenses and other liabilities462.5 562.3 
Operating lease liabilities26.5 23.7 
Liabilities held for sale— 4.0 
Total current liabilities1,258.3 1,208.2 
Operating lease liabilities123.4 120.4 
Other long-term liabilities220.7 304.2 
Long-term debt851.6 883.4 
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at September 30, 2022 and December 31, 2021
— — 
Common stock - $0.01 par value, 500.0 million shares authorized; 163.6 million shares issued and 163.0 million shares outstanding at September 30, 2022; 162.0 million shares issued and 161.6 million outstanding at December 31, 2021
1.6 1.6 
Additional paid-in capital3,689.6 3,732.6 
Retained earnings657.9 466.9 
Accumulated other comprehensive loss(391.2)(143.5)
Total Envista stockholders’ equity3,957.9 4,057.6 
Noncontrolling interests— 0.4 
Total stockholders’ equity3,957.9 4,058.0 
Total liabilities and stockholders’ equity$6,411.9 $6,574.2 
See the accompanying Notes to the Condensed Consolidated Financial Statements.
1

ENVISTA HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
($ and shares in millions, except per share amounts)
 Three Months EndedNine Months Ended
 September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Sales$631.1 $607.3 $1,908.3 $1,857.1 
Cost of sales266.4 251.0 799.7 773.8 
Gross profit364.7 356.3 1,108.6 1,083.3 
Operating expenses:
Selling, general and administrative264.2 250.6 801.9 747.5 
Research and development26.0 24.0 75.5 75.7 
Operating profit74.5 81.7 231.2 260.1 
Nonoperating income (expense):
Other income0.3 0.2 0.9 0.8 
Interest expense, net(11.6)(12.0)(23.9)(43.6)
Income before income taxes63.2 69.9 208.2 217.3 
Income tax expense (benefit)13.6 (10.3)43.7 (3.7)
Income from continuing operations, net of tax 49.6 80.2 164.5 221.0 
(Loss) income from discontinued operations, net of tax (Note 3)(2.0)12.7 5.1 33.7 
Net income$47.6 $92.9 $169.6 $254.7 
Earnings per share:
Earnings from continuing operations - basic$0.30 $0.50 $1.01 $1.37 
Earnings from continuing operations - diluted$0.28 $0.45 $0.92 $1.25 
(Loss) earnings from discontinued operations - basic$(0.01)$0.08 $0.03 $0.21 
(Loss) earnings from discontinued operations - diluted$(0.01)$0.07 $0.03 $0.19 
Earnings - basic$0.29 $0.58 $1.04 $1.58 
Earnings - diluted$0.27 $0.52 $0.95 $1.43 *
Average common stock and common equivalent shares outstanding:
Basic163.1 161.5 162.7 161.1 
Diluted176.9 178.1 178.4 177.5 
* Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.
See the accompanying Notes to the Condensed Consolidated Financial Statements.
2

ENVISTA HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)
($ in millions)
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Net income$47.6 $92.9 $169.6 $254.7 
Other comprehensive (loss) income, net of income taxes:
Foreign currency translation adjustments(116.6)(25.0)(249.1)(64.3)
Cash flow hedge adjustments(0.2)1.1 1.7 3.6 
Pension plan adjustments(0.1)0.2 (0.3)(0.1)
Total other comprehensive loss, net of income taxes(116.9)(23.7)(247.7)(60.8)
Comprehensive (loss) income $(69.3)$69.2 $(78.1)$193.9 
See the accompanying Notes to the Condensed Consolidated Financial Statements.
3


ENVISTA HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (Unaudited)
 ($ in millions)
Nine Months Ended September 30, 2022
Common StockAdditional Paid-in CapitalRetained EarningsAccumulated Other
Comprehensive Loss		Total
Envista
Equity		Noncontrolling Interests
Balance, December 31, 2021$1.6 $3,732.6 $466.9 $(143.5)$4,057.6 $0.4 
Cumulative effect of adjustment related to change in accounting principle. (Note 13)— (77.8)21.4 — (56.4)— 
Balance, January 1, 20221.6 3,654.8 488.3 (143.5)4,001.2 0.4 
Change in noncontrolling interest— — — — — (0.4)
Common stock-based award activity— 13.1 — — 13.1 — 
Net income— — 74.9 — 74.9 — 
Other comprehensive loss— — — (58.3)(58.3)— 
Balance, April 1, 20221.6 3,667.9 563.2 (201.8)4,030.9 — 
Common stock-based award activity— 10.5 — — 10.5 — 
Net income— — 47.1 — 47.1 — 
Other comprehensive loss— — — (72.5)(72.5)— 
Balance, July 1, 20221.6 3,678.4 610.3 (274.3)4,016.0 — 
Common stock-based award activity— 11.2 — — 11.2 — 
Net income— — 47.6 — 47.6 — 
Other comprehensive loss— — — (116.9)(116.9)— 
Balance, September 30, 2022$1.6 $3,689.6 $657.9 $(391.2)$3,957.9 $— 

4

Nine Months Ended October 1, 2021
Common StockAdditional Paid-in CapitalRetained EarningsAccumulated Other
Comprehensive Loss		Total
Envista
Equity		Noncontrolling Interests
Balance, December 31, 2020$1.6 $3,684.4 $126.4 $(91.8)$3,720.6 $0.4 
Common stock-based award activity— 6.7 — — 6.7 — 
Net income— — 71.7 — 71.7 — 
Other comprehensive loss— — — (52.1)(52.1)— 
Balance, April 2, 20211.6 3,691.1 198.1 (143.9)3,746.9 0.4 
Common stock-based award activity— 16.5 — — 16.5 — 
Net income— — 90.1 — 90.1 — 
Other comprehensive income— — — 15.0 15.0 — 
Balance, July 2, 20211.6 3,707.6 288.2 (128.9)3,868.5 0.4 
Common stock-based award activity— 9.0 — — 9.0 — 
Net income— — 92.9 — 92.9 — 
Other comprehensive loss— — — (23.7)(23.7)— 
Balance, October 1, 2021$1.6 $3,716.6 $381.1 $(152.6)$3,946.7 $0.4 
See the accompanying Notes to the Condensed Consolidated Financial Statements.

5

ENVISTA HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
($ in millions)
 Nine Months Ended
 September 30, 2022October 1, 2021
Cash flows from operating activities:
Net income $169.6 $254.7 
Noncash items:
Depreciation23.9 29.4 
Amortization78.2 62.6 
Allowance for credit losses3.8 4.2 
Stock-based compensation expense23.1 21.6 
Gain on sale of property, plant and equipment(1.1)(2.2)
Gain on sale of KaVo treatment unit and instrument business(8.9)— 
Restructuring charges5.5 0.3 
Impairment charges5.8 9.4 
Fair value of acquisition-related inventory7.7 — 
Amortization of right-of-use assets17.7 21.3 
Amortization of debt discount and issuance costs3.0 17.6 
Change in trade accounts receivable(76.5)(15.1)
Change in inventories(35.9)(67.1)
Change in trade accounts payable11.3 (39.9)
Change in prepaid expenses and other assets(21.7)(23.4)
Change in accrued expenses and other liabilities(109.7)(18.7)
Change in operating lease liabilities(23.4)(29.1)
Net cash provided by operating activities72.4 225.6 
Cash flows from investing activities:
Acquisition, net of cash acquired(696.2)— 
Payments for additions to property, plant and equipment(58.8)(46.0)
Proceeds from sales of property, plant and equipment1.6 11.6 
Proceeds from sale of KaVo treatment unit and instrument business, net59.8 — 
Proceeds from the settlement of derivative financial instruments55.9 8.5 
All other investing activities, net(18.5)— 
Net cash used in investing activities(656.2)(25.9)
Cash flows from financing activities:
Proceeds from revolving line of credit124.0 — 
Repayment of revolving line of credit(54.0)— 
Proceeds from borrowing0.3 — 
Repayment of borrowing(0.5)(475.7)
Payment of debt issuance and other deferred financing costs— (2.3)
Proceeds from stock option exercises19.9 16.0 
Tax withholding payment related to net settlement of equity awards(8.9)(6.1)
6

All other financing activities— 0.7 
Net cash provided by (used in) financing activities80.8 (467.4)
Effect of exchange rate changes on cash and cash equivalents(2.1)17.6 
Net change in cash and cash equivalents(505.1)(250.1)
Beginning balance of cash and cash equivalents1,073.6 888.9 
Ending balance of cash and cash equivalents$568.5 $638.8 
Supplemental data:
Cash paid for interest$21.1 $26.1 
Cash paid for taxes$80.2 $65.6 
ROU assets obtained in exchange for operating lease obligations$29.6 $24.9 
See the accompanying Notes to the Condensed Consolidated Financial Statements.
7

ENVISTA HOLDINGS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
NOTE 1. BUSINESS AND BASIS OF PRESENTATION
Business Overview

The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services and is dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity.

The Company operates in two business segments: Specialty Products & Technologies and Equipment & Consumables.
The Company’s Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Company’s Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Basis of Presentation
All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the financial statements. All significant intercompany accounts and transactions between the businesses comprising the Company have been eliminated in the accompanying Condensed Consolidated Financial Statements.

The Condensed Consolidated Financial Statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The accompanying Condensed Consolidated Financial Statements contain all adjustments (consisting of only normal recurring adjustments and reclassifications to conform to current year presentation) necessary to present fairly the financial position of the Company as of September 30, 2022 and December 31, 2021, and its results of operations for the three and nine month periods ended September 30, 2022 and October 1, 2021 and cash flows for the nine month periods ended September 30, 2022 and October 1, 2021. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Consolidated and Combined Financial Statements and accompanying notes for the three years ended December 31, 2021, included in the Annual Report on Form 10-K filed by the Company with the SEC on February 24, 2022.

As discussed in Note 3, Discontinued Operations, on December 31, 2021, the Company completed the sale of its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.

Risks and Uncertainties

The Company is subject to risks and uncertainties as a result of the novel coronavirus (“COVID-19”) pandemic.

During the three and nine months ended September 30, 2022, notwithstanding improvement in many markets in which the Company operates due to a return to more normalized business operations, certain markets continue to be adversely impacted either directly attributable to COVID-19 or as a result of prior COVID-19 influenced policies. Late in the first quarter of 2022, the Chinese authorities instituted COVID-19-related lockdowns, shut-downs and restrictions in certain parts of China, specifically the Shanghai area, which impacted the Company’s operations in China. These restrictions were lifted in early June 2022, but the extent to which continuing effects from these restrictions, current localized restrictions throughout China under its zero-COVID policy, and any future restrictions may impact our operations remains uncertain.

8

The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the scope and duration of the pandemic, the rise of new variants, the extent and severity of the impact on the Company's customers, the measures that have been and may be taken to contain the virus (including its various mutations) and mitigate its impact, U.S. and foreign government actions to respond to the reduction in global economic activity, the ability of the Company to continue to manufacture and source its products and to find suitable alternative products at reasonable prices, the Company’s ability to continue to ship and deliver its products in a cost-effective and timely manner, uncertain demand, staffing shortages, the impact of the pandemic and associated economic downturn on the Company’s ability to access capital if and when needed and how quickly and to what extent normal economic and operating conditions can resume, all of which are uncertain and cannot be predicted. Even after the COVID-19 pandemic has further subsided, the Company may continue to experience materially adverse impacts on the Company’s financial condition and results of operations.

In addition, Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on the Company’s business, including impacting the Company’s ability to market and sell products in the affected regions, impacting its ability to enforce its intellectual property rights in Russia, creating disruptions in the global supply chain, and by potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise.

Accounting Standards Recently Adopted

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. The ASU is effective for public entities through December 31, 2022 and the adoption did not have an impact on the Company’s Condensed Consolidated Financial Statements.

NOTE 2. ACQUISITIONS
The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into new and attractive business areas. The Company has completed a number of acquisitions that have been accounted for as business combinations and have resulted in the recognition of goodwill in the Company’s Condensed Consolidated Financial Statements. Among other things, goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.

The Company makes an initial allocation of the purchase price at the date of acquisition based upon its understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains this information during due diligence and through other sources. For those assets and liabilities that were accounted for on a preliminary basis, the Company may up to 12 months after closing, refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The finalization of the acquisition valuation assessment, for the acquisitions listed below, may result in a change in the valuation of deferred taxes and goodwill, which could have a material impact on the Company’s financial statements.

During the nine months ended September 30, 2022, the Company completed the following acquisitions:

Osteogenics Biomedical Inc., Allotech LLC and OBI Biologics, Inc.
On July 5, 2022, the Company acquired all of the equity of Osteogenics Biomedical Inc., Allotech LLC and OBI Biologics, Inc. (together "Osteogenics") for total consideration of approximately $128.2 million, subject to certain customary adjustments as provided in the definitive agreement dated May 17, 2022. Osteogenics develops innovative regenerative solutions for periodontists, oral and maxillofacial surgeons, and clinicians involved in implant dentistry throughout the world, and is part of the Company’s Specialty Products & Technologies segment.

9

Carestream Dental Technology Parent Limited’s Intraoral Scanner Business
On April 20, 2022, the Company completed the acquisition of Carestream Dental Technology Parent Limited’s (“Carestream Dental”) intraoral scanner business (the “Intraoral Scanner Business”) for total consideration of $580.3 million, including contingent consideration of $7.5 million, and subject to certain customary adjustments as provided in the Stock and Asset Purchase Agreement dated December 21, 2021 and as subsequently amended by the closing agreement dated as of April 20, 2022. The Intraoral Scanner Business manufactures, markets, sells, commercializes, distributes, services, trains, supports, and maintains operations of intraoral scanners and software, and is part of the Company’s Equipment & Consumables segment. The Company purchased the Intraoral Scanner Business through the acquisition of certain assets and the assumption of certain liabilities as well as the acquisition of all of the equity of certain subsidiaries of Carestream Dental.

The following table summarizes the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates ($ in millions):

Osteogenics
July 5, 2022		Intraoral Scanner Business
April 20, 2022
Assets acquired:
   Cash$2.1 $2.7 
   Accounts receivable2.5 0.1 
   Inventories13.3 6.1 
   Intangible assets53.0 129.8 
   Property, plant and equipment— 0.3 
   Prepaids and Other Current Assets1.3 — 
   Goodwill77.5 370.6 
   Non-current deferred tax asset— 98.5 
   Operating lease right-of-use assets2.6 0.9 
   Other long-term assets4.9 0.2 
       Total assets acquired157.2 609.2 
Liabilities assumed:
   Accounts payable (4.1)(0.5)
   Accrued expenses and other liabilities (2.6)(27.9)
   Non-current deferred tax liability(14.4)— 
   Other long-term liabilities(5.8)— 
   Operating lease liabilities(2.1)(0.5)
       Total liabilities assumed(29.0)(28.9)
Total net assets acquired$128.2 $580.3 

The intangible assets acquired consist of trade name, developed technology, and customer relationships. The weighted average amortization period of the acquired intangible assets in the aggregate is 8 and 10 years for the Intraoral Scanner Business and Osteogenics, respectively.

The excess of the purchase price over the fair value assigned to the assets acquired and liabilities assumed represents the goodwill resulting from the acquisitions. Goodwill attributable to the acquisitions has been recorded as a non-current asset and is not amortized, but is subject to review at least on an annual basis for impairment. Goodwill recognized was primarily attributable to expected operating efficiencies and expansion opportunities in the businesses acquired. Goodwill is not deductible for income tax purposes. The pro forma impact of the acquisitions is not presented as the acquisitions were not considered material to the Company's Condensed Consolidated Financial Statements.

For the three and nine months ended September 30, 2022, legal, accounting, and other professional service costs associated with the acquisitions were $1.5 million and $13.4 million, respectively, and have been recorded as selling, general and administrative expense in the Condensed Consolidated Statements of Income.

10

NOTE 3. DISCONTINUED OPERATIONS
On December 31, 2021, the Company completed the sale of substantially all of the KaVo Treatment Unit and Instrument Business (the “Divestiture”) to planmeca Verwaltungs Gmbh, Germany (“Planmeca”), pursuant to the master sale and purchase agreement (the “Purchase Agreement”) among the Company, Planmeca, and Planmeca Oy, as guarantor. In accordance with the terms of the Purchase Agreement, the Company received cash consideration of $317.3 million upon closing on December 31, 2021. During the nine months ended September 30, 2022, the Company has received an additional $59.8 million related to an earnout payment and certain working capital adjustments.

On December 30, 2021, the Company entered into an amendment to the Purchase Agreement (the "Amendment"), providing that the transfer of net assets in Russia, China and Brazil (the "Relevant Jurisdictions") would be deferred until the purchaser had formed entities for such transfer of assets in each such Relevant Jurisdiction and the applicable asset transfer agreement could be executed and consummated (each such asset transfer, a "Deferred Local Closing"). Except for the implementation of the Deferred Local Closings and related matters regarding the assets in the Relevant Jurisdictions, the provisions, terms and conditions of the Purchase Agreement were not materially amended by the Amendment. The Amendment did not alter the preliminary purchase price that Planmeca paid to the Company upon the closing of the Divestiture and the Company recognized the applicable gain or loss at the time of each Relevant Jurisdiction’s applicable closing. At December 31, 2021, the Company recorded a liability of $10.8 million for the proceeds related to the Relevant Jurisdictions. All three Relevant Jurisdictions have closed as of September 30, 2022 and the related liability associated with the proceeds released.

The Company recognized a loss of $1.6 million and a gain of $5.7 million on the Divestiture during the three and nine months ended September 30, 2022, respectively, primarily related to the recognition of certain purchase price adjustments and the closing of the Relevant Jurisdictions.

In conjunction with the Divestiture, the Company entered into a customary transition services agreement, which requires support transition services to Planmeca throughout the applicable transition period.

For the three and nine months ended September 30, 2022, the Divestiture continued to meet the criteria to be classified as held for sale and to be presented as a discontinued operation. Accordingly, the Company reclassified the results of operations and financial position of the Divestiture to discontinued operations in its accompanying Condensed Consolidated Statements of Income and Condensed Consolidated Balance Sheets for all periods presented. The Company’s Condensed Consolidated Statements of Cash Flows for all periods presented include the financial results of the KaVo Treatment Unit and Instrument Business.

For the nine months ended October 1, 2021, balances represent activity for the entire Divestiture, while balances for the nine months ended September 30, 2022, represent activity for the remaining Relevant Jurisdictions.

The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):
December 31, 2021
ASSETS
Current assets:
Assets for relevant jurisdictions$12.2 
Current assets held for sale$12.2 
LIABILITIES AND EQUITY
Current liabilities:
Liabilities for relevant jurisdictions$4.0 
Current liabilities held for sale$4.0 
11


The operating results of the Divestiture are reflected in the Condensed Consolidated Statements of Income within income from discontinued operations, net of tax as follows ($ in millions):
 Three Months EndedNine Months Ended
 September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Sales$2.8 $102.5 $11.7 $302.0 
Cost of sales2.1 57.2 9.1 174.4 
Gross profit0.7 45.3 2.6 127.6 
Operating expenses:
Selling, general and administrative1.1 25.2 3.2 70.4 
Research and development— 3.8 — 12.5 
Operating (loss) profit(0.4)16.3 (0.6)44.7 
Income tax expense— 3.6 — 11.0 
(Loss) income from discontinued operations(0.4)12.7 (0.6)33.7 
(Loss) gain on sale of discontinued operations, net of tax(1.6)— 5.7 — 
Net (loss) income from discontinued operations$(2.0)$12.7 $5.1 $33.7 

Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):
Nine Months Ended
September 30, 2022October 1, 2021
Cash flows from operating activities
Depreciation and amortization1
$— $5.6 
Cash flows from investing activities:
Capital expenditures$— $4.2 
1 Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.

NOTE 4. CREDIT LOSSES

The allowance for credit losses is a valuation account deducted from accounts receivable to present the net amount expected to be collected. Accounts receivable are charged off against the allowance when management believes the uncollectibility of an accounts receivable balance is confirmed.

Management estimates the adequacy of the allowance by using relevant available information, from internal and external sources, relating to past events, current conditions and forecasts. Historical credit loss experience provides the basis for estimation of expected credit losses and is adjusted as necessary using the relevant information available. The allowance for credit losses is measured on a collective basis when similar risk characteristics exist. The Company has identified one portfolio segment based on the following risk characteristics: geographic regions, product lines, default rates and customer specific factors.

The factors used by management in its credit loss analysis are inherently subject to uncertainty. If actual results are not consistent with management’s estimates and assumptions, the allowance for credit losses may be overstated or understated and a charge or credit to net income (loss) may be required.

12

The rollforward of the allowance for credit losses is summarized as follows ($ in millions):

Balance at December 31, 2021$20.7 
Foreign currency translation(1.5)
Provision for credit losses3.8 
Write-offs charged against the allowance(3.3)
Recoveries(2.9)
Balance at September 30, 2022$16.8 

NOTE 5. INVENTORIES
The classes of inventory are summarized as follows ($ in millions):
September 30, 2022December 31, 2021
Finished goods$234.9 $214.3 
Work in process26.7 22.0 
Raw materials87.3 88.3 
Reserve for inventory obsolescence(57.6)(60.8)
Total$291.3 $263.8 

NOTE 6. PROPERTY, PLANT AND EQUIPMENT
The classes of property, plant and equipment are summarized as follows ($ in millions):
September 30, 2022December 31, 2021
Land and improvements$10.4 $10.7 
Buildings and improvements155.2 168.7 
Machinery, equipment and other assets353.2 354.5 
Construction in progress69.3 45.6 
Gross property, plant and equipment588.1 579.5 
Less: accumulated depreciation(310.9)(315.4)
Property, plant and equipment, net$277.2 $264.1 

NOTE 7. GOODWILL
The following is a rollforward of the Company’s goodwill by segment ($ in millions):
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Balance at December 31, 2021$2,029.7 $1,102.3 $3,132.0 
Acquisitions77.5 370.6 448.1 
Foreign currency translation(126.2)(54.3)(180.5)
Balance at September 30, 2022$1,981.0 $1,418.6 $3,399.6 

13

NOTE 8. ACCRUED EXPENSES AND OTHER LIABILITIES
Accrued expenses and other liabilities were as follows ($ in millions):
September 30, 2022December 31, 2021
CurrentNoncurrentCurrentNoncurrent
Compensation and benefits$145.1 $16.2 $188.9 $17.9 
Restructuring-related employee severance, benefits and other17.6 — 21.9 — 
Pension benefits5.6 37.3 5.6 41.7 
Taxes, income and other30.4 116.6 48.1 201.4 
Contract liabilities71.4 8.9 60.1 5.1 
Sales and product allowances81.9 1.1 75.4 1.2 
Loss contingencies8.0 29.1 8.4 30.3 
Derivative financial instruments— — 19.6 — 
Other102.5 11.5 134.3 6.6 
Total$462.5 $220.7 $562.3 $304.2 

NOTE 9.  HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The Company has foreign currency denominated long-term debt in the amount of €208.0 million. This senior unsecured term loan facility represents a partial hedge of the Company’s net investment in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The euro senior unsecured term loan facility is designated and qualifies as a non-derivative hedging instrument. Accordingly, the foreign currency translation of the euro senior unsecured term loan facility is recorded in accumulated other comprehensive loss in equity in the accompanying Condensed Consolidated Balance Sheets, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive loss in equity (see Note 14). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The euro senior unsecured term loan facility matures in September 2024. Refer to Note 13 for a further discussion of the above loan facility.

The Company has used cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts were agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. The Company maintained cross-currency swap derivative contracts with respect to its $650.0 million senior unsecured term loan facility. These contracts effectively converted the $650.0 million senior unsecured term loan facility to an obligation denominated in euros and partially offset the impact of changes in currency rates on foreign currency denominated net investments. During the three months ended September 30, 2022, the Company settled all of its cross-currency swap derivative contracts and as of September 30, 2022 did not have any cross-currency swap derivative contracts outstanding. The changes in the fair value of these instruments were recorded in accumulated other comprehensive loss in equity, in the accompanying Condensed Consolidated Balance Sheets, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that was also recorded in accumulated other comprehensive loss as reflected in Note 14. Any ineffective portions of net investment hedges were reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps was recorded in interest expense, net in the Company’s Condensed Consolidated Statements of Income consistent with the classification of interest expense attributable to the underlying debt.

The Company has also used interest rate swap derivative contracts to reduce its variability of cash flows related to interest payments with respect to its senior unsecured term loans. The interest rate swap contracts exchanged interest payments based on variable rates for interest payments based on fixed rates. During the three months ended September 30, 2022, the existing interest rate swap matured. As of September 30, 2022, the Company did not have any outstanding interest rate swap contracts. The changes in the fair value of these instruments were recorded in accumulated other comprehensive loss in equity (see Note 14). Any ineffective portions of the cash flow hedges were reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps was recorded in interest expense in the Company’s Condensed Consolidated Statements of Income consistent with the classification of interest expense attributable to the underlying debt.
14

The following table summarizes the notional values as of September 30, 2022 and October 1, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three and nine months ended September 30, 2022 and October 1, 2021 ($ in millions):

Three Months Ended
September 30, 2022		Three Months Ended
October 1, 2021
Notional AmountGain (Loss) Recognized in OCINotional AmountGain Recognized in OCI
Foreign currency denominated debt$203.9 $12.8 $241.2 $5.6 
Interest rate contract— (0.3)250.01.5
Foreign currency contracts— 14.4 650.0 14.1 
Total$203.9 $26.9 $1,141.2 $21.2 
Nine Months Ended
September 30, 2022		Nine Months Ended
October 1, 2021
Notional AmountGain Recognized in OCINotional AmountGain Recognized in OCI
Foreign currency denominated debt$203.9 $32.7 $241.2 $19.7 
Interest rate contracts— 2.2 250.0 4.8 
Foreign currency contracts— 68.5 650.0 33.1 
Total$203.9 $103.4 $1,141.2 $57.6 

Gains or losses related to the foreign currency contracts and foreign currency denominated debt were classified as foreign currency translation adjustments in the schedule of changes in OCI in Note 14, as these items were attributable to the Company’s hedges of its net investment in foreign operations. Gains or losses related to the interest rate contracts were classified as cash flow hedge adjustments in the schedule of changes in OCI in Note 14. The Company did not reclassify any deferred gains or losses related to net investment and cash flow hedges from accumulated other comprehensive loss to income during the three and nine months ended September 30, 2022 and October 1, 2021. In addition, the Company did not have any ineffectiveness related to net investment and cash flow hedges during the three and nine months ended September 30, 2022 and October 1, 2021. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in investing activities in the accompanying Condensed Consolidated Statements of Cash Flows.

The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified in the Company’s Condensed Consolidated Balance Sheets as follows ($ in millions):
September 30, 2022December 31, 2021
Derivative liabilities:
Accrued expenses and other liabilities$— $19.6 
Nonderivative hedging instruments:
Long-term debt$203.9 $236.5 
Amounts related to the Company’s derivatives expected to be reclassified from accumulated other comprehensive loss to net income during the next 12 months are not significant.

15

NOTE 10. FAIR VALUE MEASUREMENTS
Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows: Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation; and Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
September 30, 2022:
Liabilities:
Deferred compensation plans$— $14.8 $— $14.8 
Contingent consideration$— $— $6.0 $6.0 
December 31, 2021:
Liabilities:
Interest rate swap derivative contracts$— $2.2 $— $2.2 
Cross-currency swap derivative contracts$— $17.4 $— $17.4 
Deferred compensation plans$— $16.5 $— $16.5 
Derivative Instruments
The cross-currency swap derivative contracts were classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates and foreign currency current exchange rates and forward curves as inputs. The interest rate swap derivative contracts were classified as Level 2 in the fair value hierarchy as they were measured using the income approach with the relevant interest rates and forward curves as inputs. Refer to Note 9 for additional information.
Deferred Compensation Plans
Certain management employees of the Company participate in nonqualified deferred compensation programs that permit such employees to defer a portion of their compensation, on a pretax basis. All amounts deferred under this plan are unfunded, unsecured obligations and are presented as a component of the Company’s compensation and benefits accrual included in accrued expenses in the accompanying Condensed Consolidated Balance Sheets (refer to Note 8). Participants may choose among alternative earnings rates for the amounts they defer, which are primarily based on investment options within the Company’s 401(k) program. Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates on investment options within the Company’s 401(k) program. Amounts voluntarily deferred by employees into the Company stock fund and amounts contributed to participant accounts by the Company are deemed invested in the Company’s common stock and future distributions of such contributions will be made solely in shares of Company common stock, and therefore are not reflected in the above amounts.
16

Contingent Consideration
Contingent consideration represents a cash hold back intended to be used for certain liabilities related to the Company’s newly acquired Intraoral Scanner Business (as further discussed in Note 2). Contingent consideration was classified as Level 3 in the fair value hierarchy as the estimated fair value was measured using a probability weighted discounted cash flow model.
Fair Value of Financial Instruments
The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):
September 30, 2022December 31, 2021
 Carrying AmountFair ValueCarrying AmountFair Value
Liabilities:
Contingent consideration$6.0 $6.0 $— $— 
Interest rate swap derivative contracts$— $— $2.2 $2.2 
Cross-currency swap derivative contracts$— $— $17.4 $17.4 
Convertible senior notes due 2025$509.3 $854.5 $432.1 $1,162.5 
Long-term debt$851.6 $851.6 $883.4 $883.4 
The fair value of long-term debt approximates the carrying value as these borrowings are based on variable market rates. The fair value of the convertible senior notes due 2025 was determined based on the quoted bid price of the convertible senior notes in an over-the-counter market on September 30, 2022 and December 31, 2021. The convertible senior notes are considered as Level 2 of the fair value hierarchy. The fair values of cash and cash equivalents, which consist primarily of money market funds, time and demand deposits, trade accounts receivable, net and trade accounts payable approximate their carrying amounts due to the short-term maturities of these instruments.

NOTE 11. WARRANTY
The Company generally accrues estimated warranty costs at the time of sale. In general, manufactured products are warranted against defects in material and workmanship when properly used for their intended purpose, installed correctly and appropriately maintained. Warranty periods depend on the nature of the product and range from 90 days up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known.
The following is a rollforward of the Company’s accrued warranty liability ($ in millions):
Balance at December 31, 2021$9.4 
Accruals for warranties issued during the year11.0 
Settlements made(11.3)
Effect of foreign currency translation(0.8)
Balance at September 30, 2022$8.3 

NOTE 12. LITIGATION AND CONTINGENCIES
The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated.

17

The Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated and has accrued $37.1 million and $38.7 million as of September 30, 2022 and December 31, 2021, respectively, which are included in accrued liabilities in the Condensed Consolidated Balance Sheets. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated. In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's Condensed Consolidated Balance Sheets, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company’s results of operations and cash flows for that period.

NOTE 13. DEBT AND CREDIT FACILITIES
The components of the Company’s debt were as follows ($ in millions):
September 30, 2022December 31, 2021
Senior term loan facility due 2024 ($650.0 aggregate principal amount) (the “Term Loan Facility”), net of deferred debt issuance costs of $1.9 and $2.7, respectively
$648.1 $647.3 
Senior euro term loan facility due 2024 (€208.0 aggregate principal amount) (the “Euro Term Loan Facility”), net of deferred debt issuance costs of $0.3 and $0.5, respectively
203.5 236.1 
Convertible senior notes due 2025 ($517.5 aggregate principal amount), net of deferred debt issuance costs of $8.2 and $8.9, respectively, and unamortized discount of $0.0 and $76.5, respectively
509.3 432.1 
Revolving credit facility due 2024 ($750.0 aggregate borrowing capacity) (the Revolving Credit Facility)
70.0 — 
Other— 0.3 
Total debt1,430.9 1,315.8 
Less: current portion(579.3)(432.4)
Long-term debt$851.6 $883.4 
As of September 30, 2022 unamortized debt issuance costs totaled $10.4 million. As of December 31, 2021 unamortized debt issuance costs and discount totaled $88.6 million. Unamortized debt issuance costs and discount have been netted against their respective aggregate principal amounts of the related debt in the table above, and are being amortized to interest expense over the term of the respective debt.
Credit Agreement
On September 20, 2019, the Company entered into a credit agreement (the “Credit Agreement”) with a syndicate of banks under which Envista borrowed approximately $1.3 billion, consisting of the three-year $650.0 million Term Loan Facility and the three-year €600.0 million Euro Term Loan Facility (together with the Term Loan Facility, the “Term Loans”). The Credit Agreement also included the five-year, $250.0 million revolving credit facility (the “Revolving Credit Facility” and together with the Term Loans, the “Senior Credit Facilities”). Pursuant to the Separation Agreement, all of the net proceeds of the Term Loans were paid to Danaher as partial consideration for the Dental business Danaher transferred to Envista.

On February 9, 2021, in connection with an amendment to the Credit Agreement, the Company repaid $472.0 million of its Euro Term Loan Facility.

18

On June 15, 2021, the Company entered into an amended and restated credit agreement (the “Amended Credit Agreement”) with a syndicate of banks including Bank of America, N.A. as administrative agent (the “Administrative Agent”). The Amended Credit Agreement amends and restates the Company’s Credit Agreement, originally dated September 20, 2019 (as amended by Amendment No. 1 to Credit Agreement dated as of May 6, 2020, Amendment No. 2 to Credit Agreement dated as of May 19, 2020, and Amendment No. 3 to Credit Agreement dated as of February 9, 2021).

Under the Amended Credit Agreement: (a) the maturity date of the Company’s existing Term Loans has been extended to September 20, 2024, (b) the Revolving Credit Facility has been increased from $250.0 million to $750.0 million, (c) the Company may request further increases to the Revolving Credit Facility in an aggregate amount not to exceed $350.0 million, (d) the amount of cash and cash equivalents permitted to be netted in the definition of “Consolidated Funded Indebtedness” has been increased to up to the greater of (i) $250.0 million and (ii) 50% of Consolidated EBITDA as of the most recent measurement period, and (e) the floor on Eurocurrency rate loans applicable to the Revolving Credit Facility and the Term Loan Facility has been reduced to zero, in each case subject to and in accordance with the terms and conditions of the Amended Credit Agreement. The Company paid fees aggregating approximately $2.1 million in connection with the Amended Credit Agreement.

The Revolving Credit Facility includes an aggregate available borrowing capacity of $750.0 million with a $20.0 million sublimit for the issuance of standby letters of credit. The Revolving Credit Facility can be used for working capital and other general corporate purposes. As of September 30, 2022, the Company had $70.0 million of outstanding borrowings and $680.0 million of available aggregate undrawn borrowing capacity under the Revolving Credit Facility. At December 31, 2021 there were no borrowings outstanding under the Revolving Credit Facility. The interest rate for borrowings under the Revolving Credit Facility was 3.76% as of September 30, 2022.
Under the Senior Credit Facilities, borrowings bear interest as follows: (1) Eurocurrency Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to the London inter-bank offered (“LIBOR”) rate plus a margin of between 0.785% and 1.625%, depending on the Company’s Consolidated Leverage Ratio (as defined in the Amended Credit Agreement) as of the last day of the immediately preceding fiscal quarter; and (2) Base Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to (a) the highest of (i) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 0.50%, (ii) Bank of America’s “prime rate” as publicly announced from time to time and (iii) the Eurocurrency Rate (as defined in the Amended Credit Agreement) plus 1.0%, plus (b) a margin of between 0.00% and 0.625%, depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter. In no event will Eurocurrency Rate Loans or Base Rate Loans bear interest at a rate lower than 0.0%. In addition, the Company is required to pay a per annum facility fee of between 0.09% and 0.225% depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter and based on the aggregate commitments under the Revolving Credit Facility, whether drawn or not.
The interest rates for borrowings under the Term Loan Facility were 4.77% and 1.25% as of September 30, 2022 and December 31, 2021, respectively. The interest rate for borrowings under the Euro Term Loan Facility was 2.14% and 0.95% as of September 30, 2022 and December 31, 2021, respectively. Interest is payable quarterly for the Term Loans. The Amended Credit Agreement requires the Company to maintain a Consolidated Leverage Ratio of 3.75 to 1.00 or less and includes a provision that the maximum Consolidated Leverage Ratio will be increased to 4.25 to 1.00 for the four consecutive full fiscal quarters immediately following the consummation of any acquisition by the Company or any subsidiary of the Company in which the purchase price exceeds $100.0 million. The Amended Credit Agreement also requires the Company to maintain a Consolidated Interest Coverage Ratio (as defined in the Amended Credit Agreement) of at least 3.00 to 1.00. The Amended Credit Agreement contains customary representations, warranties, conditions precedent, events of default, indemnities and affirmative and negative covenants, including covenants that, among other things, limit or restrict the Company’s and/or the Company’s subsidiaries ability, subject to certain exceptions and qualifications, to incur liens or indebtedness, merge, consolidate or sell or otherwise transfer assets, make dividends or distributions, enter into transactions with the Company’s affiliates and use proceeds of the debt financing for other than permitted uses. The Amended Credit Agreement also contains customary events of default. Upon the occurrence and during the continuance of an event of default, the lenders may declare the outstanding advances and all other obligations under the Amended Credit Agreement immediately due and payable. The Company was in compliance with all of its debt covenants as of September 30, 2022.
19

Convertible Senior Notes (the “Notes”)

On May 21, 2020, the Company issued the Notes due on June 1, 2025, unless earlier repurchased, redeemed or converted. The aggregate principal amount, which includes the initial purchasers’ exercise in full of their option to purchase an additional $67.5 million principal amount of the Notes, was $517.5 million. The net proceeds from the issuance, after deducting purchasers’ discounts and estimated offering expenses, were $502.6 million. The Company used part of the net proceeds to pay for the capped call transactions (“Capped Calls”) as further described below. The Notes accrue interest at a rate of 2.375% per annum, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. The Notes have an initial conversion rate of 47.5862 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $21.01 per share of the Company’s common stock and is subject to adjustment upon the occurrence of specified events. The Notes are governed by an indenture dated as of May 21, 2020 (the “Indenture”) between the Company and Wilmington Trust, National Association, as trustee. The Indenture does not contain any financial covenants or any restrictions on the payment of dividends, the incurrence of senior debt or other indebtedness or the issuance or repurchase of the Company’s securities by the Company.

Prior to the adoption of ASU 2020-06, the Company separated the carrying amounts of the Notes and total issuance costs incurred into liability and equity components. For the Notes, the carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature, while the carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the Notes. Total issuance costs incurred were then allocated to the liability and equity components of the Notes based on their relative values.

Due to the Company’s adoption of ASU 2020-06 on January 1, 2022, the Notes and related issuance costs incurred are no longer required to be bifurcated into separate liability and equity components. This resulted in a $75.0 million increase to the carrying value of the Notes due 2025, comprised of unamortized discount of $76.5 million and deferred debt issuance costs of $1.5 million and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption of ASU 2020-06 resulted in a $21.4 million increase to retained earnings and a $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs.

As of September 30, 2022, the unamortized debt issuance costs on the Notes was $8.2 million and is being amortized over the term of the Notes.

The Notes are the Company’s senior, unsecured obligations and are (i) equal in right of payment with the Company’s existing and future senior, unsecured indebtedness; (ii) senior in right of payment to the Company’s existing and future indebtedness that is expressly subordinated to the Notes; (iii) effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and (iv) structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries.

Holders of the Notes may convert their Notes at any time on or after December 2, 2024 until the close of business on the second scheduled trading day preceding the maturity date. Holders of the Notes will also have the right to convert the Notes prior to December 2, 2024, but only upon the occurrence of specified events. In December 2021, the Company made the irrevocable election to settle all Notes conversions through combination settlement, satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash, shares of the Company’s common stock or a combination of both. If a fundamental change occurs prior to the maturity date, holders of the Notes may require the Company to repurchase all or a portion of their Notes for cash at a repurchase price equal to 100.0% of the principal amount plus any accrued and unpaid interest. In addition, if specific corporate events occur prior to the maturity date, the Company would increase the conversion rate for a holder who elects to convert its Notes in connection with such an event in certain circumstances. As of September 30, 2022 and December 31, 2021, the stock price exceeded 130% of the conversion price of $21.01 in 20 days of the final 30 trading days ended September 30, 2022 and December 31, 2021, which satisfied one of the conditions permitting early conversion by holders of the Notes, therefore, the Notes are classified as short-term debt.

20

The Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after June 1, 2023 and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding the redemption date, but only if the last reported sale price per share of the Company’s common stock exceeds 130.0% of the conversion price on (i) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such notice. In addition, calling any Note for redemption will constitute a “Make-Whole Fundamental Change” (as defined in the Indenture) with respect to that Note, in which case the conversion rate applicable to the conversion of that Note will be increased in certain circumstances if it is converted after it is called for redemption.

The following table sets forth total interest expense recognized related to the Notes ($ in millions):

Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Contractual interest expense
$3.1 $3.1 $9.2 $9.2 
Amortization of debt issuance costs
0.7 0.5 2.2 1.4 
Amortization of debt discount
— 4.9 — 14.2 
Total interest expense
$3.8 $8.5 $11.4 $24.8 

For the three and nine months ended September 30, 2022, the debt discount and debt issuance costs were amortized using an annual effective interest rate of 3.0%, to interest expense over the term of the Notes.

As of September 30, 2022 and December 31, 2021, the if-converted value of the Notes exceeded the outstanding principal amount by $290.5 million and $592.1 million, respectively.

Capped Call Transactions

In connection with the offering of the Notes, the Company entered into Capped Calls with certain counterparties. The Capped Calls each have an initial strike price of approximately $21.01 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have initial cap prices of $23.79 per share, subject to certain adjustments. The Capped Calls cover, subject to anti-dilution adjustments, 2.9 million shares of the Company's common stock. The Capped Calls are generally intended to reduce or offset the potential dilution from shares of common stock issued upon any conversion of the Notes with such reduction or offset, as the case may be, subject to a cap based on the cap price. As the Capped Call transactions are considered indexed to the Company's own stock and are considered equity classified, they are recorded in equity and are not accounted for as derivatives. The cost of $20.7 million incurred in connection with the Capped Calls was recorded as a reduction to additional paid-in capital.

NOTE 14. ACCUMULATED OTHER COMPREHENSIVE LOSS
The changes in accumulated other comprehensive loss by component are summarized below ($ in millions).
21

Foreign Currency Translation AdjustmentsUnrealized Loss on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Three Months Ended September 30, 2022
Balance, July 1, 2022$(272.1)$0.2 $(2.4)$(274.3)
Other comprehensive loss before reclassifications:
(Decrease) increase(109.9)(0.3)— (110.2)
Income tax impact(6.7)0.1 — (6.6)
Other comprehensive loss before reclassifications, net of income taxes(116.6)(0.2)— (116.8)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — (0.1)(0.1)
Income tax impact— — — — 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (0.1)(0.1)
Net current period other comprehensive loss, net of income taxes(116.6)(0.2)(0.1)(116.9)
Balance, September 30, 2022$(388.7)$— $(2.5)$(391.2)
Foreign Currency Translation AdjustmentsUnrealized Loss on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Three Months Ended October 1, 2021
Balance, July 2, 2021$(101.8)$(3.8)$(23.3)$(128.9)
Other comprehensive income before reclassifications:
(Decrease) increase(20.2)1.5 — (18.7)
Income tax impact(4.8)(0.4)— (5.2)
Other comprehensive (loss) income before reclassifications, net of income taxes(25.0)1.1 — (23.9)
Amounts reclassified from accumulated other comprehensive loss:
Decrease— — 0.2 0.2 
Income tax impact— — — — 
Amounts reclassified from accumulated other comprehensive income, net of income taxes— — 0.2 0.2 
Net current period other comprehensive (loss) income, net of income taxes(25.0)1.1 0.2 (23.7)
Balance, October 1, 2021$(126.8)$(2.7)$(23.1)$(152.6)
22

Foreign Currency Translation AdjustmentsUnrealized Loss on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Nine Months Ended September 30, 2022
Balance, December 31, 2021$(139.6)$(1.7)$(2.2)$(143.5)
Other comprehensive (loss) income before reclassifications:
(Decrease) increase(224.1)2.2 — (221.9)
Income tax impact(25.0)(0.5)— (25.5)
Other comprehensive (loss) income before reclassifications, net of income taxes(249.1)1.7 — (247.4)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — (0.3)(0.3)
Income tax impact— — — — 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (0.3)(0.3)
Net current period other comprehensive (loss) income, net of income taxes(249.1)1.7 (0.3)(247.7)
Balance, September 30, 2022$(388.7)$— $(2.5)$(391.2)
Foreign Currency Translation AdjustmentsUnrealized Loss on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Nine Months Ended October 1, 2021
Balance, December 31, 2020$(62.5)$(6.3)$(23.0)$(91.8)
Other comprehensive (loss) before reclassifications:
(Decrease) increase(51.2)4.8 — (46.4)
Income tax impact(13.1)(1.2)— (14.3)
Other comprehensive (loss) income before reclassifications, net of income taxes(64.3)3.6 — (60.7)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — — — 
Income tax impact— — (0.1)(0.1)
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (0.1)(0.1)
Net current period other comprehensive (loss) income, net of income taxes(64.3)3.6 (0.1)(60.8)
Balance, October 1, 2021$(126.8)$(2.7)$(23.1)$(152.6)


23

NOTE 15. REVENUE
The following table presents the Company’s revenues disaggregated by geographical region for the three and nine months ended September 30, 2022 and October 1, 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.
Three Months Ended September 30, 2022Three Months Ended October 1, 2021
Specialty Products & TechnologiesEquipment & ConsumablesTotalSpecialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$176.5 $163.5 $340.0 $165.4 $164.0 $329.4 
Western Europe77.7 23.6 101.3 76.7 27.0 103.7 
Other developed markets21.7 8.6 30.3 23.4 9.3 32.7 
Emerging markets119.5 40.0 159.5 97.9 43.6 141.5 
Total$395.4 $235.7 $631.1 $363.4 $243.9 $607.3 

Nine Months Ended September 30, 2022Nine Months Ended October 1, 2021
Specialty Products & TechnologiesEquipment & ConsumablesTotalSpecialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$535.3 $480.1 $1,015.4 $502.8 $491.9 $994.7 
Western Europe284.5 85.0 369.5 267.8 89.3 357.1 
Other developed markets69.1 29.2 98.3 74.2 31.1 105.3 
Emerging markets311.3 113.8 425.1 271.3 128.7 400.0 
Total$1,200.2 $708.1 $1,908.3 $1,116.1 $741.0 $1,857.1 

Sales by Major Product Group:
Three Months EndedNine Months Ended
($ in millions)September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Consumables$531.0 $493.7 $1,605.7 $1,541.6 
Equipment100.1 113.6 302.6 315.5 
Total$631.1 $607.3 $1,908.3 $1,857.1 
Consumable products include implants, regenerative solutions, prosthetics, orthodontic brackets, aligners and lab products from our Specialty Products & Technologies business segment and traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products from the Company’s Equipment & Consumables business segment. The Company’s equipment products include digital imaging systems, software and other visualization and magnification systems.

Remaining Performance Obligations
Remaining performance obligations include noncancelable purchase orders, extended warranty and service agreements and do not include revenue from contracts with customers with an original term of one year or less.
As of September 30, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $46.8 million and the Company expects to recognize revenue on the majority of this amount over the next 12 months.
24

Contract Liabilities
The Company often receives cash payments from customers in advance of the Company’s performance resulting in contract liabilities. These contract liabilities are classified as either current or long-term in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of September 30, 2022 and December 31, 2021, the contract liabilities were $80.3 million and $65.2 million, respectively, and are included within accrued expenses and other liabilities and other long-term liabilities in the accompanying Condensed Consolidated Balance Sheets. Revenue recognized during the nine months ended September 30, 2022 and October 1, 2021 that was included in the contract liability balance at December 31, 2021 and December 31, 2020 was $48.4 million and $34.4 million, respectively.
Significant Customers
Sales to the Company’s largest customer were 11% of sales for both the three and nine months ended September 30, 2022. Sales to the Company’s largest customer were 12% of sales for both the three and nine months ended October 1, 2021.

Seasonality

Based on historical experience, the Company generally has more sales in the second half of the calendar year than in the first half of the calendar year, with the first quarter typically having the lowest sales of the year. Based on historical customer buying patterns, the Company generally has more sales in the fourth quarter than in any other quarter of the year, driven in particular by capital spending in the Equipment & Consumables segment. As a result of this seasonality in sales, profitability in the Equipment & Consumables segment also tends to be higher in the second half of the year. There are no assurances that these historical trends will continue in the future and the ongoing COVID-19 pandemic may impact these trends.

NOTE 16. RESTRUCTURING ACTIVITIES AND RELATED IMPAIRMENTS
Restructuring Activities
The Company’s restructuring activities are undertaken as necessary to implement management’s strategy, streamline operations, take advantage of available capacity and resources, and ultimately achieve net cost reductions. These activities generally relate to the realignment of existing manufacturing capacity and closure of facilities and other exit or disposal activities, as it relates to executing the Company’s strategy, either in the normal course of business or pursuant to significant restructuring programs.
The related liability which is included in accrued liabilities in the Condensed Consolidated Balance Sheets is summarized below ($ in millions):
Employee Severance
and Related		Facility Exit
and Related		Total
Balance, December 31, 2021$21.4 $0.5 $21.9 
Costs incurred12.7 4.1 16.8 
Paid/settled(17.2)(3.9)(21.1)
Balance, September 30, 2022$16.9 $0.7 $17.6 

Restructuring related charges recorded for the three and nine months ended September 30, 2022 and October 1, 2021, by segment were as follows ($ in millions): 
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Specialty Products & Technologies$4.5 $8.2 $12.7 $15.2 
Equipment & Consumables4.2 0.1 12.6 4.5 
Other0.9 0.3 2.8 4.1 
Total$9.6 $8.6 $28.1 $23.8 
25

The restructuring related charges incurred during the three and nine months ended September 30, 2022 and October 1, 2021, are reflected in the following captions in the accompanying Condensed Consolidated Statements of Income ($ in millions):
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Cost of sales$3.4 $1.0 $10.0 $6.9 
Selling, general and administrative expenses6.2 7.6 18.1 16.9 
Total$9.6 $8.6 $28.1 $23.8 

NOTE 17. INCOME TAXES
The Company’s effective tax rates from continuing operations of 21.5% and 21.0% for the three and nine months ended September 30, 2022, respectively, are consistent with the U.S. federal statutory rate of 21.0%. The Company’s effective tax rates from continuing operations of (14.7)% and (1.7)% for the three and nine months ended October 1, 2021, respectively, differ from the U.S. federal statutory rate of 21.0%, primarily due to the Company’s geographical mix of earnings and certain non-recurring Swiss discrete tax benefits.

On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, the Company does not believe this legislation will have a material impact on its Condensed Consolidated Financial Statements.

NOTE 18.  EARNINGS PER SHARE
Earnings per share is calculated by dividing the applicable income by the weighted average number of shares of common stock outstanding for the applicable period. Diluted earnings per share is computed based on the weighted average number of common shares outstanding plus the effect of dilutive potential shares outstanding during the period using the treasury stock method. Dilutive potential common shares include employee equity options, non-vested shares and similar instruments granted by the Company and the assumed conversion impact of the Notes. The Company will settle any Notes conversions through a combination settlement by satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash or shares in the Company’s common stock or any combination thereof. As such, the Company uses the treasury stock method for the assumed conversion of the Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. As the Company will settle the principal amount of the Notes in cash upon conversion, the Notes do not have an impact on the Company's diluted earnings per share until the average share price of the Company’s common stock exceeds the conversion price of $21.01 per share in any applicable period. See the computation of earnings per share below for the dilutive impact of the Notes for the three and nine months ended September 30, 2022 and October 1, 2021.

In connection with the offering of the Notes, the Company entered into Capped Calls (see further discussion in Note 13), which are intended to reduce or offset the potential dilution from shares of common stock issued upon conversion of the Notes. However, this impact is not included when calculating potentially dilutive shares since their effect is anti-dilutive. The Capped Calls will mitigate dilution from the conversion of the Notes up to the Company’s common stock price of $23.79. If the Notes are converted at a price higher than $23.79 per share, the Capped Calls will no longer mitigate dilution from the conversion of the Notes.

26

The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Numerator:
Income from continuing operations, net of tax$49.6 $80.2 $164.5 $221.0 
(Loss) income from discontinued operations, net of tax$(2.0)$12.7 $5.1 $33.7 
Net income $47.6 $92.9 $169.6 $254.7 
Denominator:
Weighted-average common shares outstanding used in basic earnings (loss) per share163.1 161.5 162.7 161.1 
Incremental common shares from:
Assumed exercise of dilutive options and vesting of dilutive restricted stock units2.8 4.3 3.5 4.4 
Assumed conversion of the Notes11.0 12.3 12.2 12.0 
Weighted average common shares outstanding used in diluted earnings (loss) per share176.9 178.1 178.4 177.5 
Earnings per share:
Earnings from continuing operations - basic$0.30 $0.50 $1.01 $1.37 
Earnings from continuing operations - diluted$0.28 $0.45 $0.92 $1.25 
(Loss) earnings from discontinued operations - basic$(0.01)$0.08 $0.03 $0.21 
(Loss) earnings from discontinued operations - diluted$(0.01)$0.07 $0.03 $0.19 
Earnings - basic$0.29 $0.58 $1.04 $1.58 
Earnings - diluted$0.27 $0.52 $0.95 $1.43 *
* Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.

The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):

Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Stock-based awards1.9 1.4 1.5 1.2 
Total1.9 1.4 1.5 1.2 

NOTE 19. SEGMENT INFORMATION
The Company operates and reports its results in two separate business segments, the Specialty Products & Technologies and Equipment & Consumables segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income (expense) and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Inter-segment amounts are not significant and are eliminated to arrive at consolidated totals.

27

The Company’s Specialty Products & Technologies products include implants, regenerative products, prosthetics, orthodontic brackets, aligners and lab products. The Company’s Equipment & Consumables products include traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products, while the Company’s equipment products include digital imaging systems, software and other visualization and magnification systems.

On December 31, 2021, the Company completed the sale of its KaVo Treatment Unit and Instrument Business, which was part of the Company’s Equipment & Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business. Refer to Note 3 for more information on the Company’s discontinued operations.

Segment related information is shown below ($ in millions):
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Sales:
Specialty Products & Technologies$395.4 $363.4 $1,200.2 $1,116.1 
Equipment & Consumables235.7 243.9 708.1 741.0 
Total$631.1 $607.3 $1,908.3 $1,857.1 
Operating profit and reconciliation to income before taxes from continuing operations:
Specialty Products & Technologies$62.3 $61.5 $206.6 $211.6 
Equipment & Consumables44.7 45.4 120.4 131.0 
Other(32.5)(25.2)(95.8)(82.5)
Operating profit74.5 81.7 231.2 260.1 
Nonoperating income (expense):
   Other income0.3 0.2 0.9 0.8 
   Interest expense, net(11.6)(12.0)(23.9)(43.6)
Income before taxes from continuing operations$63.2 $69.9 $208.2 $217.3 
Identifiable assets:September 30, 2022December 31, 2021
Specialty Products & Technologies$3,395.9 $3,498.2 
Equipment & Consumables2,424.1 1,946.1 
Held for Sale— 12.2 
Other591.9 1,117.7 
Total$6,411.9 $6,574.2 
28

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with other information, including our Condensed Consolidated Financial Statements and related notes included in Part I, Item 1, Financial Information, of this Quarterly Report on Form 10-Q, our consolidated and combined financial statements appearing in our Annual Report on Form 10-K for the year ended December 31, 2021 (the “2021 10-K”), and Part II, Item 1A, Risk Factors, of this Quarterly Report on Form 10-Q. Unless the context otherwise requires, all references herein to the “Company,” “we,” “us” or “our,” or similar terms, refer to Envista Holdings Corporation and its consolidated subsidiaries.

Certain statements included or incorporated by reference in this Quarterly Report are “forward-looking statements” within the meaning of the U.S. federal securities laws. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding: the potential impacts of the COVID-19 pandemic on our business, financial condition, and results of operations; projections of revenue, expenses, profit, profit margins, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures; management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions and the integration thereof, divestitures, spin-offs, split-offs or other distributions, strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets we sell into; future regulatory approvals and the timing thereof; outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities; future foreign currency exchange rates and fluctuations in those rates; the anticipated timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that Envista intends or believes will or may occur in the future. Terminology such as “believe,” “anticipate,” “should,” “could,” “intend,” “will,” “plan,” “expect,” “estimate,” “project,” “target,” “may,” “possible,” “potential,” “forecast” and “positioned” and similar references to future periods are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words. Forward-looking statements are based on assumptions and assessments made by our management in light of their experience and perceptions of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. These forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, the following: the impact of the COVID-19 pandemic, including new variants of the virus, the pace of recovery in the markets in which we operate, global supply chain disruptions and potential staffing shortages, the conditions in the U.S. and global economy, the markets served by us and the financial markets, the impact of our debt obligations on our operations and liquidity, developments and uncertainties in trade policies and regulations, contractions or growth rates and cyclicality of markets we serve, fluctuations in inventory of our distributors and customers, loss of a key distributor, our relationships with and the performance of our channel partners, competition, our ability to develop and successfully market new products and services, the potential for improper conduct by our employees, agents or business partners, our compliance with applicable laws and regulations (including regulations relating to medical devices and the health care industry), the results of our clinical trials and perceptions thereof, penalties associated with any off-label marketing of our products, modifications to our products that require new marketing clearances or authorizations, our ability to effectively address cost reductions and other changes in the health care industry, our ability to successfully identify and consummate appropriate acquisitions and strategic investments, our ability to integrate the businesses we acquire and achieve the anticipated benefits of such acquisitions, contingent liabilities relating to acquisitions, investments and divestitures, security breaches or other disruptions of our information technology systems or violations of data privacy laws, our ability to adequately protect our intellectual property, the impact of our restructuring activities on our ability to grow, risks relating to currency exchange rates, changes in tax laws applicable to multinational companies, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, risks relating to product, service or software defects, risks relating to product manufacturing, commodity costs and surcharges, our ability to adjust purchases and manufacturing capacity to reflect market conditions, reliance on sole or limited sources of supply, the impact of regulation on demand for our products and services, labor matters, international economic, political, legal, compliance and business factors and disruptions relating to war, terrorism, climate change, widespread protests and civil unrest, man-made and natural disasters, public health issues and other events, the impact of inflation and increasing interest rates, and other risks and uncertainties set forth under “Item 1A. Risk Factors” in the 2021 10-K and this Quarterly Report on Form 10-Q.

Forward-looking statements are not guarantees of future performance and actual results may differ materially from the results, developments and business decisions contemplated by our forward-looking statements. Accordingly, you should not place undue reliance on any such forward-looking statements. Forward-looking statements contained herein speak only as of the date of this Quarterly Report. Except to the extent required by applicable law, we do not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

29

BASIS OF PRESENTATION
The accompanying Condensed Consolidated Financial Statements present our historical financial position, results of operations, changes in stockholders’ equity and cash flows in accordance with GAAP.
Sale of the KaVo Treatment Unit and Instrument Business
On December 31, 2021, we completed the Divestiture to Planmeca, pursuant to the Purchase Agreement among us, Planmeca, and Planmeca Oy, as guarantor. In accordance with the terms of the Purchase Agreement, we received cash consideration of $317.3 million upon closing on December 31, 2021. During the nine months ended September 30, 2022, we received an additional $59.8 million related to an earnout payment and certain working capital adjustments. We recognized a loss of $1.6 million and a gain of $5.7 million on the Divestiture during the three and nine months ended September 30, 2022, respectively, due primarily to the recognition of certain purchase price adjustments.
The Divestiture was part of our strategy to structurally improve our long-term margins and represented a strategic shift with a major effect on our operations and financial results as described in ASC 205-20. The sale met the criteria to be accounted for as a discontinued operation. Accordingly, we have applied discontinued operations treatment for the Divestiture as required by ASC 205-20. In accordance with ASC 205-20, we reclassified the Divestiture to assets and liabilities held for sale on our Condensed Consolidated Balance Sheets as of December 31, 2021 and reclassified the financial results of the Divestiture in our Condensed Consolidated Statements of Income for all periods presented. Our Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and October 1, 2021 include the financial results of the KaVo Treatment Unit and Instrument Business. We also revised our discussion and presentation of operating and financial results to be reflective of our continuing operations as required by ASC 205-20. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.

With the sale of the KaVo Treatment Unit and Instrument business, we continue to make significant progress toward our long-term goal of re-calibrating our product portfolio to higher growth and higher margin segments. The Divestiture shifts our revenue mix from approximately 50% each for the Specialty Products & Technology and Equipment & Consumables segments to approximately 60% for the Specialty Products & Technology segment and approximately 40% for the Equipment & Consumables segment. The Specialty Products & Technology segment is a higher growth and higher margin business than the Equipment & Consumables segment. The Divestiture was a strategic shift that will allow us to focus more on higher value and higher margin consumables, imaging, and digital workflow solutions.

OVERVIEW
General
We provide products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. With leading brand names, innovative technology and significant market positions, we are a leading worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services, and are dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity. Our research and development, manufacturing, sales, distribution, service and administrative facilities are located in more than 30 countries across North America, Asia, Europe, the Middle East and Latin America.
We operate in two business segments: Specialty Products & Technologies and Equipment & Consumables. Our Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Our Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
30

For both the three and nine months ended September 30, 2022, sales derived from customers outside of the United States were 49.7% and 50.8%, respectively, compared to the three and nine months ended October 1, 2021, of 49.8% and 50.6%, respectively. As a global provider of dental consumables, equipment and services, our operations are affected by worldwide, regional and industry-specific economic and political factors. Given the broad range of dental products, software and services provided and geographies served, we do not use any indices other than general economic trends to predict our overall outlook. Our individual businesses monitor key competitors and customers, including to the extent possible their sales, to gauge relative performance and the outlook for the future.
As a result of our geographic and product line diversity, we face a variety of opportunities and challenges, including rapid technological development in most of our served markets, the expansion and evolution of opportunities in emerging markets, trends and costs associated with a global labor force, consolidation of our competitors and increasing regulation. We operate in a highly competitive business environment in most markets, and our long-term growth and profitability will depend in particular on our ability to expand our business in emerging geographies and market segments, identify, consummate and integrate appropriate acquisitions, develop innovative and differentiated new products and services, expand and improve the effectiveness of our sales force, continue to reduce costs and improve operating efficiency and quality and effectively address the demands of an increasingly regulated global environment. We are making significant investments to address the rapid pace of technological change in our served markets and to globalize our manufacturing, research and development and customer-facing resources (particularly in emerging markets and our dental implant business) in order to be responsive to our customers throughout the world and improve the efficiency of our operations.

Key Trends and Conditions Affecting Our Results of Operations
There have been no material changes to the key trends and conditions affecting our results of operations that were disclosed in our 2021 10-K, except as follows:

COVID-19

The extent of the impact of the COVID-19 pandemic on our business is highly uncertain and difficult to predict because of the dynamic and evolving nature of the situation. During the three and nine months ended September 30, 2022, notwithstanding improvement in many markets in which we operate due to a return to more normalized business operations, certain markets continue to be adversely impacted either directly attributable to COVID-19 or as a result of prior COVID-19 influenced policies. Late in the first quarter of 2022, the Chinese authorities instituted COVID-19-related lockdowns, shut-downs and restrictions in certain parts of China, specifically the Shanghai area, which impacted our operations in China. These restrictions were lifted in early June 2022, but the extent to which continuing effects from these restrictions, current localized restrictions throughout China under its zero-COVID policy, and any future restrictions may impact our operations remains uncertain.

The severity of the impact of the COVID-19 pandemic on our business will depend on a number of factors, including, but not limited to, the scope and duration of the pandemic, the rise of new variants, the extent and severity of the impact on our customers, the measures that have been and may be taken to contain the virus (including its various mutations) and mitigate its impact, U.S. and foreign government actions to respond to the reduction in global economic activity, our ability to continue to manufacture and source our products and to find suitable alternative products at reasonable prices, our ability to continue to ship and deliver our products in a cost-effective and timely manner, uncertain demand, staffing shortages, the impact of the pandemic and associated economic downturn on our ability to access capital if and when needed and how quickly and to what extent normal economic and operating conditions can continue, all of which are uncertain and cannot be predicted. Even after the COVID-19 pandemic has further subsided, we may continue to experience materially adverse impacts on our financial condition and results of operations.

For additional information on the risks of COVID-19 to our business, please refer to the “Item 1A. Risk Factors—Risks Related to COVID-19” section of our 2021 10-K.





31


Russia-Ukraine Conflict
Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on our business, including our ability to market and sell products in the affected regions, impacting our ability to enforce our intellectual property rights in Russia, creating disruptions in the global supply chain, and potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise. Russia’s invasion of Ukraine did not have a material impact on our financial position or results of operations as of and for the three and nine months ended September 30, 2022.

Foreign Currency Exchange Rates
On a period-over-period basis, currency exchange rates negatively impacted reported sales by 4.1% and 3.2% for the three and nine months ended September 30, 2022, respectively, compared to the comparable period of 2021, primarily due to the strength of the U.S. dollar against most major currencies. Any future strengthening of the U.S. dollar against major currencies would negatively impact our sales and results of operations for the remainder of the year, and any weakening of the U.S. dollar against major currencies would positively impact our sales and results of operations for the remainder of the year.

General Economic Conditions

In addition to industry-specific factors, we, like other businesses, face challenges related to global economic conditions, including rising inflation, increasing interest rates, slowing economic growth, and continuing supply chain disruptions. Dental costs are largely out-of-pocket for the consumer and thus utilization rates can vary significantly depending on economic growth. While many of our products are considered necessary by patients regardless of the economic environment, certain products and services that support discretionary dental procedures may be more susceptible to changes in economic conditions.

Acquisitions
Our growth strategy contemplates future acquisitions. Our operations and results can be affected by the rate and extent to which appropriate acquisition opportunities are available, acquired businesses are effectively integrated and anticipated synergies or cost savings are achieved. During the nine months ended September 30, 2022, we completed two acquisitions.

On July 5, 2022, we completed our purchase of Osteogenics for total consideration of approximately $128.2 million, subject to certain customary adjustments as provided in the definitive agreement dated May 17, 2022. Osteogenics develops innovative regenerative solutions for periodontists, oral and maxillofacial surgeons, and clinicians involved in implant dentistry throughout the world, and is part of our Specialty Products & Technologies segment.

On April 20, 2022, we completed our acquisition of the Intraoral Scanner Business for total consideration of approximately $580.3 million. The Intraoral Scanner Business manufactures, markets, sells, commercializes, distributes, services, trains, supports, and maintains operations of intraoral scanners and software, and is part of our Equipment & Consumables segment.

For the three and nine months ended September 30, 2022, the revenue and earnings of these two acquisitions were not material to the Condensed Consolidated Statements of Income.

Envista Business Systems
Throughout this discussion, references to sales volume refer to the impact of both price and unit sales and references to productivity improvements generally refer to improved cost-efficiencies resulting from the ongoing application of Envista Business Systems (“EBS”). We believe our deep-rooted commitment to EBS helps drive our market leadership and differentiates us in the dental products industry. EBS encompasses not only lean tools and processes, but also methods for driving growth, innovation and leadership. Within the EBS framework, we pursue a number of ongoing strategic initiatives relating to customer insight generation, product development and commercialization, efficient sourcing, and improvement in manufacturing and back-office support, all with a focus on continually improving quality, delivery, cost, growth and innovation.
32

Non-GAAP Measures
References to the non-GAAP measure of core sales (also referred to as core revenues or sales/revenues from existing businesses) refer to sales calculated according to GAAP, but excluding:
•sales from acquired businesses for one year from the acquisition date;
•sales from discontinued products; and
•the impact of currency translation.
Sales from discontinued products includes major brands or major products that we have made the decision to discontinue as part of a portfolio restructuring. Discontinued brands or products consist of those which we (1) are no longer manufacturing, (2) are no longer investing in the research or development of, and (3) expect to discontinue all significant sales of within one year from the decision date. The portion of sales attributable to discontinued brands or products is calculated as the net decline of the applicable discontinued brand or product from period-to-period.
The portion of sales attributable to currency translation is calculated as the difference between:
•the period-to-period change in sales; and
•the period-to-period change in sales after applying current period foreign exchange rates to the prior year period.
Core sales growth should be considered in addition to, and not as a replacement for or superior to, sales, and may not be comparable to similarly titled measures reported by other companies. We believe that reporting the non-GAAP financial measure of core sales growth provides useful information to investors by helping identify underlying growth trends in our on-going business and facilitating comparisons of our sales performance with our performance in prior and future periods and to our peers. We also use core sales growth to measure our operating and financial performance. We exclude sales from discontinued products because discontinued products do not have a continuing contribution to operations and management believes that excluding such items provides investors with a means of evaluating our on-going operations and facilitates comparisons to our peers. We exclude the effect of currency translation from core sales because currency translation is not under our control, is subject to volatility and can obscure underlying business trends.
33

RESULTS OF OPERATIONS
All comparisons, variances, increases or decreases discussed below are for the three and nine months ended September 30, 2022, compared to the three and nine months ended October 1, 2021.
Three Months Ended
($ in millions)September 30, 2022October 1, 2021% Change
Sales$631.1 100.0%$607.3 100.0%3.9 %
Cost of sales266.4 42.2%251.0 41.3%6.1 %
Gross profit364.7 57.8%356.3 58.7%2.4 %
Operating costs:
Selling, general and administrative (“SG&A”) expenses264.2 41.9%250.6 41.3%5.4 %
Research and development (“R&D”) expenses26.0 4.1%24.0 4.0%8.3 %
Operating profit74.5 11.8%81.7 13.5%(8.8)%
Nonoperating income (expense):
Other income0.3 —%0.2 —%50.0 %
Interest expense, net(11.6)(1.8)%(12.0)(2.0)%(3.3)%
Income before income taxes63.2 10.0%69.9 11.5%(9.6)%
Income tax expense (benefit)13.6 2.2%(10.3)(1.7)%(232.0)%
Income from continuing operations49.6 7.9%80.2 13.2%(38.2)%
(Loss) income from discontinued operations, net of tax(2.0)(0.3)%12.7 2.1%(115.7)%
Net income $47.6 7.5%$92.9 15.3%(48.8)%
Effective tax rate from continuing operations21.5 %(14.7)%
Nine Months Ended
($ in millions)September 30, 2022October 1, 2021% Change
Sales$1,908.3 100.0%$1,857.1 100.0%2.8 %
Cost of sales799.7 41.9%773.8 41.7%3.3 %
Gross profit1,108.6 58.1%1,083.3 58.3%2.3 %
Operating costs:
SG&A expenses801.9 42.0%747.5 40.3%7.3 %
R&D expenses75.5 4.0%75.7 4.1%(0.3)%
Operating profit231.2 12.1%260.1 14.0%(11.1)%
Nonoperating income (expense):
Other income0.9 —%0.8 —%12.5 %
Interest expense, net(23.9)(1.3)%(43.6)(2.3)%(45.2)%
Income before income taxes208.2 10.9%217.3 11.7%(4.2)%
Income tax expense (benefit)43.7 2.3%(3.7)(0.2)%(1,281.1)%
Income from continuing operations164.5 8.6%221.0 11.9%(25.6)%
Income from discontinued operations, net of tax5.1 0.3%33.7 1.8%(84.9)%
Net income $169.6 8.9%$254.7 13.7%(33.4)%
Effective tax rate from continuing operations21.0 %(1.7)%
34

GAAP Reconciliation
Sales and Core Sales Growth
% Change Three Month Period Ended September 30, 2022 vs. Comparable 2021 Period% Change Nine Month Period Ended September 30, 2022 vs. Comparable 2021 Period
Total sales growth (GAAP)3.9 %2.8 %
Plus the impact of:
Acquisition(3.1)%(1.3)%
Currency exchange rates 4.1 %3.2 %
Core sales growth (non-GAAP)4.9 %4.7 %
Sales and core sales growth for the three months ended September 30, 2022 increased 3.9% and 4.9%, respectively, compared to the comparable period in 2021. Price positively impacted sales growth by 1.6% on a period-over-period basis, combined with an overall sales increase of 3.3% due primarily to higher volume. Sales in developed markets increased due to strong growth in Western Europe. Sales in emerging markets increased primarily due to China and the continued recovery from the COVID-19 pandemic.
Sales and core sales growth for the nine months ended September 30, 2022 increased 2.8% and 4.7%, respectively, compared to the comparable period in 2021. Price positively impacted sales growth by 1.9% on a period-over-period basis, combined with an overall sales increase of 2.8% due primarily to higher volume. Sales in developed markets increased primarily due to strong growth in Western Europe combined with a modest increase in North America. Sales in emerging markets increased primarily due to continued recovery from the COVID-19 pandemic, partially offset by a decrease in China due to localized pandemic related lockdowns.

COST OF SALES AND GROSS PROFIT
Three Months EndedNine Months Ended
($ in millions)September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Sales$631.1 $607.3 $1,908.3 $1,857.1 
Cost of sales266.4 251.0 799.7 773.8 
Gross profit$364.7 $356.3 $1,108.6 $1,083.3 
Gross profit margin57.8 %58.7 %58.1 %58.3 %
The increase in cost of sales during the three months ended September 30, 2022, as compared to the comparable period in 2021, was primarily due to higher sales, the unfavorable impact from foreign exchange rates, the amortization of the fair value adjustments related to acquired inventory as part of our acquisitions, and unfavorable material price variances due in part to inflation.
The increase in cost of sales during the nine months ended September 30, 2022, as compared to the comparable period in 2021, was primarily due to higher sales, the unfavorable impact from foreign exchange rates, the amortization of the fair value adjustments related to acquired inventory as part of our acquisitions, and unfavorable material price variances due in part to inflation, partially offset by favorable incremental period-over-period savings associated with productivity improvements.
The decrease in gross profit margin percentage during the three months ended September 30, 2022, as compared to the comparable period in 2021, was primarily due to the unfavorable impact from foreign exchange rates, the amortization of the fair value adjustments related to acquired inventory as part of our acquisitions, unfavorable material price variances due in part to inflation, and unfavorable product mix, partially offset by higher sales volume and price.
35

The decrease in gross profit margin percentage during the nine months ended September 30, 2022, as compared to the comparable period in 2021, was primarily due to the unfavorable impact from foreign exchange rates, the amortization of the fair value adjustments related to acquired inventory as part of our acquisitions, unfavorable material price variances due in part to inflation, and unfavorable product mix, partially offset by higher sales volume and price, and favorable incremental period-over-period savings associated with productivity improvements.
OPERATING EXPENSES
Three Months EndedNine Months Ended
($ in millions)September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Sales$631.1 $607.3 $1,908.3 $1,857.1 
Selling, general and administrative expenses$264.2 $250.6 $801.9 $747.5 
Research and development expenses$26.0 $24.0 $75.5 $75.7 
SG&A as a % of sales41.9 %41.3 %42.0 %40.3 %
R&D as a % of sales4.1 %4.0 %4.0 %4.1 %
The increase in SG&A expenses as a percentage of sales for the three months ended September 30, 2022 as compared to the comparable period of 2021, was primarily due to higher sales and marketing expenses and acquisition related costs, partially offset by higher sales volume.
The increase in SG&A expenses as a percentage of sales for the nine months ended September 30, 2022 as compared to the comparable periods of 2021, was primarily due to higher sales and marketing expenses, compensation spend, and acquisition related costs, partially offset by higher sales volume.
R&D expenses as a percentage of sales for the three and nine months ended September 30, 2022, were consistent with the comparable periods in 2021.
OPERATING PROFIT
Operating profit margin was 11.8% for the three months ended September 30, 2022, as compared to an operating margin of 13.5% for the comparable period in 2021. The decrease in operating profit margin was primarily due to higher sales and marketing expenses and acquisition related expenses, the amortization of the fair value adjustments related to acquired inventory as part of our acquisitions, unfavorable material price variances due in part to inflation and unfavorable product mix, partially offset by higher sales volume and price.
Operating profit margin was 12.1% for the nine months ended September 30, 2022, as compared to an operating margin of 14.0% for the comparable period in 2021. The decrease in operating profit margin was primarily due to higher sales and marketing expenses, compensation spend, and acquisition related expenses, the amortization of the fair value adjustments related to acquired inventory as part of our acquisitions, unfavorable material price variances due in part to inflation, and unfavorable product mix, partially offset by higher sales volume, price and favorable incremental period-over-period savings associated with productivity improvements.
OTHER INCOME
Net periodic benefit costs included in other income, were $0.3 million and $0.2 million for the three months ended September 30, 2022 and October 1, 2021, respectively. Net periodic benefit costs included in other income were $0.9 million and $0.8 million for the nine months ended September 30, 2022 and October 1, 2021, respectively.

36

INTEREST COSTS AND FINANCING
Interest costs were $11.6 million and $12.0 million for the three months ended September 30, 2022 and October 1, 2021, respectively. For the three months ended September 30, 2022, interest costs were consistent with the comparable period of 2021 as a result of higher rates, offset by the absence of accretive interest expense related to the convertible debt discount as a result of adopting ASU 2020-06.

Interest costs were $23.9 million and $43.6 million for the nine months ended September 30, 2022 and October 1, 2021, respectively. The decrease in interest expense for the nine months ended September 30, 2022 as compared to the comparable periods of 2021 was primarily due to overall lower debt outstanding related to the amendment to the Credit Agreement and the $472.0 million partial repayment of the Euro term loan in February 2021, and the absence of accretive interest expense related to the convertible debt discount as a result of adopting ASU 2020-06, partially offset by higher interest rates.

Refer to Note 13 for a further discussion of the convertible debt instrument.

INCOME TAXES
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Effective tax rate from continuing operations21.5 %(14.7)%21.0 %(1.7)%

Our effective tax rate from continuing operations of 21.5% and 21.0% for the three and nine months ended September 30, 2022, respectively, was higher compared to the comparable periods in 2021 primarily due to the Company’s geographical mix of earnings and certain Swiss discrete tax benefits in 2021 not recurring in 2022.

On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on our current analysis of the provisions, we do not believe this legislation will have a material impact on our Condensed Consolidated Financial Statements.

COMPREHENSIVE INCOME (LOSS)
For the three months ended September 30, 2022, comprehensive loss was $69.3 million as compared to comprehensive income of $69.2 million for the comparable period of 2021. For the nine months ended September 30, 2022, comprehensive loss was $78.1 million as compared to comprehensive income of $193.9 million for the comparable period of 2021. The decrease for the three and nine months ended September 30, 2022, was primarily due to lower net income generated in the current period, combined with higher foreign currency translation losses.
RESULTS OF OPERATIONS - BUSINESS SEGMENTS
Specialty Products & Technologies
Our Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products.
Specialty Products & Technologies Selected Financial Data
Three Months EndedNine Months Ended
($ in millions)September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Sales$395.4 $363.4 $1,200.2 $1,116.1 
Operating profit$62.3 $61.5 $206.6 $211.6 
Operating profit as a % of sales15.8 %16.9 %17.2 %19.0 %
37

Sales and Core Sales Growth
% Change Three Month Period Ended September 30, 2022 vs. Comparable 2021 Period% Change Nine Month Period Ended September 30, 2022 vs. Comparable 2021 Period
Total sales growth (GAAP)8.8 %7.5 %
Plus the impact of:
Acquisitions(2.3)%(0.7)%
Currency exchange rates 4.8 %3.9 %
Core sales growth (non-GAAP)11.3 %10.7 %
Sales
Sales and core sales growth for the three months ended September 30, 2022 increased 8.8% and 11.3%, respectively, compared to the comparable period in 2021. Sales growth increased due to higher volume and stronger demand for implant systems and orthodontic products.
Sales and core sales growth for the nine months ended September 30, 2022 increased 7.5% and 10.7%, respectively, compared to the comparable period in 2021. Sales growth increased by 9.8% due to higher volume as demand improved for implant systems and orthodontic products, combined with an increase in sales price which impacted sales growth by 0.9% on a period-over-period basis.
Sales in developed markets, for both the three and nine months ended September 30, 2022, increased primarily due to an increase in North America and Western Europe and well as sales in emerging markets, primarily due to reduced impact of COVID-19 measures. Additionally, sales for both the three and nine months ended September 30, 2022, were also positively impacted by the acquisition of Osteogenics.
Operating Profit

Operating profit margin was 15.8% for the three months ended September 30, 2022, as compared to an operating profit margin of 16.9% for the comparable period of 2021. The decrease in operating profit margin for the three month period was primarily due to higher sales and marketing expenses, and an unfavorable product mix, partially offset by higher sales volume.
Operating profit margin was 17.2% for the nine months ended September 30, 2022, as compared to an operating profit margin of 19.0% for the comparable period of 2021. The decrease in operating profit margin for the nine month period was primarily due to higher sales and marketing expenses, compensation spend, unfavorable product mix, and the unfavorable price variances due in part to inflation, partially offset by higher sales volume and price.
EQUIPMENT & CONSUMABLES
Our Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Equipment & Consumables Selected Financial Data
Three Months EndedNine Months Ended
($ in millions)September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Sales$235.7 $243.9 $708.1 $741.0 
Operating profit$44.7 45.4 $120.4 $131.0 
Operating profit as a % of sales19.0 %18.6 %17.0 %17.7 %
38

Sales and Core Sales Growth
% Change Three Month Period Ended September 30, 2022 vs. Comparable 2021 Period% Change Nine Month Period Ended September 30, 2022 vs. Comparable 2021 Period
Total sales growth (GAAP)(3.4)%(4.4)%
Plus the impact of:
Acquisition(4.2)%(2.1)%
Currency exchange rates 2.9 %2.3 %
Core sales growth (non-GAAP)(4.7)%(4.2)%
Sales
Sales and core sales growth for the three months ended September 30, 2022 decreased 3.4% and 4.7%, respectively, compared to the comparable period in 2021. Price positively impacted sales growth by 3.8% on a period-over-period basis, while sales decreased by 8.5% due to lower demand for our imaging products, offset by higher demand for our infection prevention products and restorative and endodontic solutions.
Sales and core sales growth for the nine months ended September 30, 2022 decreased 4.4% and 4.2%, respectively, compared to the comparable period in 2021. Price positively impacted sales growth by 3.3% on a period-over-period basis, while sales decreased by 7.5% due to lower demand for our imaging products and infection prevention products, offset by increased demand in our restorative and endodontic solutions.
Sales in developed markets, for both three and nine months ended September 30, 2022, decreased primarily due to a decrease in North America and Western Europe combined with the decrease in sales in emerging markets. Sales for both the three and nine months ended September 30, 2022, were positively impacted by the acquisition of our new Intraoral Scanner Business.
Operating Profit
Operating profit margin was 19.0% for the three months ended September 30, 2022, as compared to an operating profit margin of 18.6% for the comparable period of 2021. The increase in operating profit margin was primarily due to higher sales price, favorable product mix and favorable incremental period-over-period savings associated with productivity improvements, partially offset by lower sales volumes, higher restructuring spend, amortization of intangibles, and the unfavorable incremental material price variances due in part to inflation.
Operating profit margin was 17.0% for the nine months ended September 30, 2022, as compared to an operating profit margin of 17.7% for the comparable period of 2021. The decrease in operating profit margin was primarily due to lower sales volume, higher compensation and restructuring spend, amortization of intangibles, and the unfavorable incremental material price variances due in part to inflation, partially offset by favorable product mix, higher prices and favorable incremental period-over-period savings associated with productivity improvements.
LIQUIDITY AND CAPITAL RESOURCES
We assess our liquidity in terms of our ability to generate cash to fund our operating and investing activities. We continue to generate substantial cash from operating activities and believe that our operating cash flow and other sources of liquidity are sufficient to allow us to manage our capital structure on a short-term and long-term basis and continue investing in existing businesses and consummating strategic acquisitions.
Following is an overview of our cash flows and liquidity:
39

Overview of Cash Flows and Liquidity
 Nine Months Ended
 September 30, 2022October 1, 2021
Net cash provided by operating activities$72.4 $225.6 
Acquisitions, net of cash acquired$(696.2)$— 
Payments for additions to property, plant and equipment(58.8)(46.0)
Proceeds from sales of property, plant and equipment1.6 11.6 
Proceeds from sale of KaVo treatment unit and instrument business59.8 — 
Proceeds from the settlement of derivative financial instruments55.9 8.5 
All other investing activities, net(18.5)— 
Net cash used in investing activities$(656.2)$(25.9)
Proceeds from revolving line of credit124.0 — 
Repayment of revolving line of credit(54.0)— 
Proceeds from borrowings0.3 — 
Repayment of borrowings(0.5)(475.7)
Payment of debt issuance and other deferred financing costs— (2.3)
Proceeds from stock option exercises19.9 16.0 
Tax withholding payment related to net settlement of equity awards(8.9)(6.1)
All other financing activities— 0.7 
Net cash provided by (used in) financing activities$80.8 $(467.4)

Operating Activities
Cash flows from operating activities can fluctuate significantly from period-to-period due to working capital needs and the timing of payments for income taxes, restructuring activities, pension funding and other items impacting reported cash flows.

Net cash provided by operating activities was $72.4 million during the nine months ended September 30, 2022, as compared to net cash provided by operating activities of $225.6 million for the comparable period of 2021, primarily due to lower net income and higher payments during 2022, including higher incentive compensation payout and transaction costs associated with acquisitions.

Investing Activities
Cash flows relating to investing activities consist primarily of cash used for capital expenditures and acquisitions. Capital expenditures are made primarily for increasing capacity, replacing equipment, supporting new product development and improving information technology systems.

Net cash used in investing activities was $656.2 million for the nine months ended September 30, 2022, as compared to net cash used in investing activities of $25.9 million for the comparable period in 2021, primarily due to the acquisitions of Osteogenics and the Intraoral Scanner Business, and higher purchases of property, plant and equipment, partially offset by proceeds from the earnout and sale of the KaVo Treatment Unit and Instrument Business and the settlement of derivative financial instruments.

Financing Activities and Indebtedness
Cash flows relating to financing activities consist primarily of cash flows associated with debt borrowings and the issuance of common stock.

40

Net cash provided by financing activities was $80.8 million during the nine months ended September 30, 2022 and consists of $124.0 million of proceeds from borrowings under the Revolving Credit Facility, offset by repayments of $54.0 million, and other net proceeds from equity awards. Net cash used in financing activities was $467.4 million during the nine months ended October 1, 2021 and is primarily related to the February 2021 repayment of $472.0 million of the Euro Term Loan Facility in connection with an amendment to the Credit Agreement.

For a description of our outstanding debt as of September 30, 2022, refer to Note 13 to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

We intend to satisfy any short-term liquidity needs that are not met through operating cash flow and available cash primarily through our Revolving Credit Facility.

Cash and Cash Requirements

As of September 30, 2022, we held $568.5 million of cash and cash equivalents that were held on deposit with financial institutions. Of this amount, $91.6 million was held within the United States and $476.9 million was held outside of the United States. We will continue to have cash requirements to support working capital needs, capital expenditures and acquisitions, pay interest and service debt, pay taxes and any related interest or penalties, fund our restructuring activities and pension plans as required and support other business needs. We generally intend to use our revolving credit facility, available cash and internally generated funds to meet these cash requirements, but in the event that additional liquidity is required, particularly in connection with acquisitions, we may need to enter into new credit facilities or access the capital markets. We may also access the capital markets from time to time to take advantage of favorable interest rate environments or other market conditions. However, there is no guarantee that we will be able to obtain alternative sources of financing on commercially reasonable terms or at all. See “Item 1A. Risk Factors—Risks Related to Our Business” in our 2021 10-K.

While repatriation of some cash held outside the United States may be restricted by local laws, most of our foreign cash could be repatriated to the United States. Following enactment of the Tax Cut and Jobs Act of 2017 (“TCJA”) and the associated transition tax, in general, repatriation of cash to the United States can be completed with no incremental U.S. tax; however, repatriation of cash could subject us to non-U.S. jurisdictional taxes on distributions. The cash that our non-U.S. subsidiaries hold for indefinite reinvestment is generally used to finance foreign operations and investments, including acquisitions. The income taxes, if any, applicable to such earnings including basis differences in our foreign subsidiaries are not readily determinable.

As of September 30, 2022, we believe that we have sufficient sources of liquidity to satisfy our cash needs over the next 12 months and beyond, including our cash needs in the United States.

There were no material changes to our contractual obligations during the three and nine months ended September 30, 2022. For a description of our remaining contractual obligations, such as leases see “Item 8. Financial Statements and Supplementary Data - Notes to Condensed Consolidated Financial Statements - “Note 8. Leases” in the 2021 10-K.

Off-Balance Sheet Arrangements

There were no material changes to the Company’s off-balance sheet arrangements described in the 2021 10-K that would have a material impact on the Company’s Condensed Consolidated Financial Statements.
Debt Financing Transactions

For a description of our outstanding debt as of September 30, 2022, refer to Note 13 to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Sale of the KaVo Treatment Unit and Instrument Business
The proceeds from the Divestiture will allow us to continue our product portfolio transformation with a disciplined approach to capital deployment.

41

CRITICAL ACCOUNTING ESTIMATES

There were no material changes to our critical accounting estimates described in the 2021 10-K that have had a material impact on our Condensed Consolidated Financial Statements.

The extent of the impact of the COVID-19 pandemic on our business is highly uncertain and difficult to predict. If actual results are not consistent with management’s estimates and assumptions used for valuation allowances, contingencies, potential impairments, revenue recognition and income taxes, the related account balances may be overstated or understated and a charge or credit to net income may be required.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Quantitative and qualitative disclosures about market risk appear in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Qualitative and Quantitative Disclosures About Market Risk,” in our 2021 10-K. There were no material changes to this information reported in our 2021 10-K during the quarter ended September 30, 2022.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our President and Chief Executive Officer, and Senior Vice President and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this report. Based on such evaluation, our President and Chief Executive Officer, and Senior Vice President and Chief Financial Officer, have concluded that, as of the end of such period, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
42

PART II. Other Information
Item 1. Legal Proceedings

There have been no material changes to legal proceedings from our 2021 10-K. For additional information regarding legal proceedings, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Legal Proceedings” in our 2021 10-K.

Item 1A. Risk Factors

You should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2021 10-K and in Part II, “Item 1A. Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended April 1, 2022 (“Q1 10-Q”), which could materially affect our business, financial position, or future results of operations. The risks described in our 2021 10-K and Q1 10-Q, are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial position, or future results of operations.

The risk factor set forth below updates, and should be read together with, the risk factors described in our 2021 10-K and Q1 10-Q.

Conditions in the global economy, the particular markets we serve and the financial markets may adversely affect our business and financial statements.

Our business is sensitive to general economic conditions. Sustained inflation, rising interest rates, slower global economic growth, continuing supply chain disruptions, geopolitical tensions, actual or anticipated default on sovereign debt, volatility in the currency and credit markets, high levels of unemployment or underemployment, reduced levels of capital expenditures, changes or anticipation of potential changes in government trade, fiscal, tax and monetary policies, changes in capital requirements for financial institutions, government deficit reduction and budget negotiation dynamics, sequestration, austerity measures, social or political unrest, the impact of the COVID-19 pandemic and other challenges that affect the global economy may adversely affect us and our distributors, customers and suppliers. Our success also depends upon the continued strength of the markets we serve. In many markets, dental reimbursement is largely out of pocket for the consumer and thus utilization rates can vary significantly depending on economic growth. While many of our products are considered necessary by patients regardless of the economic environment, certain products and services that support discretionary dental procedures may be susceptible to changes in economic conditions. The above factors can have the effect of:

•reducing demand for our products and services (in this Quarterly Report, references to products and services also includes software), limiting the financing available to our customers and suppliers, increasing order cancellations and resulting in longer sales cycles and slower adoption of new technologies;
•increasing the difficulty in collecting accounts receivable and the risk of excess and obsolete inventories;
•increasing price competition in our served markets;
•supply interruptions, which could disrupt our ability to produce our products;
•increasing the risk of impairment of goodwill and other long-lived assets, and the risk that we may not be able to fully recover the value of other assets such as real estate and tax assets;
•increasing the risk that counterparties to our contractual arrangements will become insolvent or otherwise unable to fulfill their contractual obligations which, in addition to increasing the risks identified above, could result in preference actions against us; and
•adversely impacting market sizes.

There can be no assurance that the capital markets will be available to us or that the lenders participating in our credit facilities will be able to provide financing in accordance with their contractual obligations. If growth in the global economy or in any of the markets we serve slows for a significant period, if there is significant deterioration in the global economy or such markets or if improvements in the global economy do not benefit the markets we serve, our business and financial statements could be adversely affected.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities
43


None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

EXHIBIT INDEX
Exhibit
Number		Description
3.1
3.2
10.3
10.4
31.1
31.2
32.1
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
44

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ENVISTA HOLDINGS CORPORATION
Date: November 3, 2022
By:/s/ Howard H. Yu
Howard H. Yu
Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

45
 EX-10.3 2 ace-thirdsapaamendmentexec.htm EX-10.3 Document

Exhibit 10.3













THIRD AMENDMENT AGREEMENT
to the Master Sale and Purchase Agreement relating to
the assets and companies comprising the
KaVo Dental Business

KIRKLAND & ELLIS INTERNATIONAL LLP

Third Amendment Agreement
This amendment agreement (the "Agreement") is entered into on 28 July 2022 by and between
(1)Envista Holdings Corporation, a corporation organized under the laws of Delaware, USA, registered with the Delaware Register (Secretary of State) under 7034624 with business address 200 S. Kraemer Blvd. Bldg. E, Brea, California 92821, United States of America
– the "Seller Parent" –
(2)planmeca Verwaltungs GmbH, a limited liability company organized under the laws of Germany, registered with the commercial register of the local court of Hamburg under HRB 160729 with business address Hermannstraße 13, 20095 Hamburg, Germany
– the "Purchaser" –
and
(3)Planmeca Oy, a stock corporation incorporated under the laws of Finland, registered with the Finnish trade register (kaupparekisteri) under business ID 0112773-2 with business address Asentajankatu 6, 00880 Helsinki, Finland
– the "Guarantor" –
– the Seller Parent, the Purchaser and the Guarantor are hereinafter collectively referred to as the "Parties" and individually as a "Party" –



    2 / 6

RECITALS
(A)WHEREAS, the Parties entered into a certain master sale and purchase agreement relating to the assets and companies comprising the KaVo Dental Business on 6 and 7 September 2021 (roll of deeds no. H 3751/21 of the notary public Sebastian Herrler, Munich, Germany) (the "Initial SAPA"), as amended, inter alia, by a first amendment agreement dated 30 December 2021 (roll of deeds no. H 5806/21 of the notary public Sebastian Herrler, Munich, Germany) (the "First SAPA Amendment") and by a second amendment agreement dated 30 April 2022 (the "Second SAPA Amendment"). The Initial SAPA as amended by the First SAPA Amendment, the Second SAPA Amendment and as further amended from time to time shall be referred to as the "SAPA". All capitalized terms used but not defined herein shall have the meaning ascribed to them in the SAPA.
(B)WHEREAS, in the course of setting up the Final Closing Date Statements, it has become apparent that the allocation of the Preliminary Purchase Price for the Entire Sold Assets relating to France, Italy, Sweden and Germany ("Affected Countries") deviates from the original estimates as agreed between the Parties in Exhibit 2.1 of the Second SPA Amendment. The total Preliminary Purchase Price has, however, not changed.
(C)WHEREAS, the Purchaser expects according to current estimates and information that the Deferred Local Closings in Brazil and China can be implemented by 30 September 2022 at the latest and the Parties intend to fix this date as the definitive Final Closing Date for these countries.
(D)WHEREAS, against this background, the Parties further intend to replace Exhibit 2.1 of the Second SAPA Amendment and amend the Final Closing Date for the Deferred Local Closings in Brazil and China in accordance with the terms of this Agreement.
NOW, THEREFORE, the Parties agree as follows:
1Amendment of the Allocation of the Preliminary Purchase Price
1.1The Parties agree that the allocation of the Purchase Price under the SAPA shall be as set forth in Exhibit 1 replacing Exhibit 2.1 of the Second SAPA Amendment.
1.2The Seller Parent shall ensure that each of the respective Asset Sellers in the Affected Countries, and the Purchaser shall ensure that each of the respective Asset Purchasers in the Affected Countries, enters into a certain amendment agreement to the respective local Asset Transfer Agreements reflecting the Preliminary Purchase Price allocated to the respective Affected Countries pursuant to Exhibit 1.
2Amendment of the Final Closing Date for Brazil and China
2.1The Parties agree that the Final Closing Date for Brazil and China shall be no later than 30 September 2022.
2.2The Parties agree to discuss in good faith to extend the Final Closing Date for Brazil and China, respectively, in case of a delay to implement the respective Deferred Asset Purchaser
3 / 5

as a result of unexpected constraints of the local authorities or circumstances similar to that, it being understood that this shall not create an obligation for the Seller Parent to actually agree on such extension.
3Miscellaneous
3.1For the avoidance of doubt, except for the implementation of the amendments made by this Agreement, all remaining provisions, terms and conditions of the SAPA shall not be amended by this Agreement and remain in full force and effect.
3.2The amendments made by this Agreement are made strictly on the basis of the terms of this Agreement and without prejudice to the rights of the Parties under the SAPA. Nothing in this Agreement shall be deemed to constitute a waiver of rights under the SAPA.
3.3Sections 29 (Confidentiality), 31.1 (Notices), 30.2 (Process Agent) and 30.4 (Entire Agreement) through 30.10 (Severability) of the Initial SAPA shall apply to this Agreement mutatis mutandis.
[Signature pages follow.]

4 / 5

Envista Holdings Corporation,
represented by
Signature:   /s/ Dr. Tamara Zehentbauer                            
Name:Dr. Tamara Zehentbauer
Position:Acting by virtue of power of attorney from Envista Holdings Corporation dated 28 July 2021
planmeca Verwaltungs GmbH,
represented by
Signature: /s/ Markus Maier                                               
Name:Mr. Markus Maier
Position:Acting by virtue of power of attorney from planmeca Verwaltungs GmbH dated 21 December 2021
Planmeca Oy,
represented by
Signature:  /s/ Markus Maier                                              
Name:Mr. Markus Maier
Position:Acting by virtue of power of attorney from Planmeca Oy dated 21 December 2021
5 / 5
 EX-10.4 3 ace-fourthspaamendmentrecl.htm EX-10.4 Document


Exhibit 10.4














FOURTH AMENDMENT AGREEMENT
to the Master Sale and Purchase Agreement relating to
the assets and companies comprising the
KaVo Dental Business


Fourth Amendment Agreement
entered into on 30 September 2022 between
(1)Envista Holdings Corporation, a corporation organized under the laws of Delaware, USA, registered with the Delaware Register (Secretary of State) under 7034624 with business address 200 S. Kraemer Blvd. Bldg. E, Brea, California 92821, United States of America
– the "Seller Parent" –
(2)planmeca Verwaltungs GmbH, a limited liability company organized under the laws of Germany, registered with the commercial register of the local court of Hamburg under HRB 160729 with business address Hermannstraße 13, 20095 Hamburg, Germany
– the "Purchaser" –
(3)Planmeca Oy, a stock corporation incorporated under the laws of Finland, registered with the Finnish trade register (kaupparekisteri) under business ID 0112773-2 with business address Asentajankatu 6, 00880 Helsinki, Finland
– the "Guarantor" –

– the Seller Parent, the Purchaser and the Guarantor are hereinafter collectively referred to as the "Parties" and individually as a "Party" –



    2 / 10

RECITALS
(A)WHEREAS, the Parties entered into a certain master sale and purchase agreement relating to the assets and companies comprising the KaVo Dental Business dated 6th and 7th September 2021 (roll of deeds no. H 3751/21 of the notary public Sebastian Herrler, Munich, Germany) (the "Initial SAPA") as amended by a first amendment agreement dated 30 December 2021 (roll of deeds no. H 5806/21 of the notary public Sebastian Herrler, Munich, Germany) (the "First SAPA Amendment"), by a second amendment agreement dated 30 April 2022 (the "Second SAPA Amendment") and by a third amendment agreement dated 29 July and 3 August 2022 (the "Third SAPA Amendment", and together with the First SAPA Amendment and the Second SAPA Amendment the "SAPA Amendment Agreements"). The Initial SAPA as amended by the First SAPA Amendment, the Second SAPA Amendment, the Third SAPA Amendment and as further amended from time to time shall be referred to as the "SAPA". All capitalized terms used but not defined herein shall have the meaning ascribed to them in the SAPA.
(B)WHEREAS, Closing of the transactions contemplated under the SAPA has occurred on 31 December 2021, except for certain Deferred Local Closings in the Relevant Jurisdictions as agreed in the First SAPA Amendment. The Deferred Local Closing in Russia has occurred on 30 April 2022.
(C)WHEREAS, the only pending local closings are thus the Deferred Local Closings in Brazil and China ("Pending Local Closing(s)").
(D)WHEREAS, it is agreed between the Parties that all (i) inventories and (ii) receivables and possibly further positions comprised by the Sold Assets Brazil (as defined below) to be transferred in Brazil will most likely be transferred to a third party acquirer not being part of Purchaser's corporate group.
(E)WHEREAS, the Seller Parent has received from the Purchaser Revised Closing Date Statements on 29 May 2022 and the Seller Parent has issued an objection notice in relation to the Revised Closing Date Statements to the Purchaser on 10 June 2022.
(F)WHEREAS, while the Parties had laid out their initial intentions for the payment mechanics of the Deferred Local Closing in Section 2.2 of the First SAPA Amendment, the Parties now intend to agree on the (i) Final Closing Date Statements (which shall be subject to a further adjustment as laid out in this Agreement), (ii) allocation of  the relevant portion of the Preliminary Purchase Price only to the Entire Sold Assets in Brazil, China and Germany and (iii) payment procedures with regard to the adjustment and payment of the Final Local Purchase Price Brazil (as defined below) and the Final Local Purchase Price China (as defined below).
3 /9

NOW, THEREFORE, the Parties agree as follows:
1Final Closing Date Statements
Irrespective of section 15.4 of the Initial SAPA and irrespective of any previous discussions between the Parties, the Parties agree that the Closing Date Statements as attached to this Agreement as Exhibit 1 shall - subject to the Post Final Adjustment Rules (as defined below) - become final and binding on the Parties and therefore shall be deemed the Final Closing Date Statements.
2Sold Assets regarding Brazil and China
2.1As regards the Entire Sold Assets relating to Brazil ("Sold Assets Brazil"), the Sold Assets Brazil with value as of the date of actual transfer and assumption shall be relevant for the sale and transfer of the respective Sold Assets and for the assumption of the respective Assumed Liabilities, Assumed Agreements and transfer of the Business Employees. The Parties assume that, as of 31 July 2022, the purchase price for all Sold Assets, Assumed Liabilities (except for the Transferred Litigation), Assumed Agreements and Transferred Employees that need to be transferred according to the relevant provisions of the SAPA in Brazil amounts to USD 2,475,598.00 of the Preliminary Purchase Price with respect to the Sold Assets Brazil ("Allocated Purchase Price Brazil"), provided that the Allocated Purchase Price Brazil shall be comprised as follows: (i) an amount of USD 1,684,735.00 will be allocated to the respective Fixed Assets and Current Assets and an amount of USD 790,863.00 will be allocated to the receivables as set forth in Section 8.1.2 of the Initial SAPA (to the extent not excluded pursuant to Section 8.2 of the Initial SAPA) and (ii) an amount of USD 0.00 will be allocated to the respective Assumed Liabilities, excluding any liabilities allocated to the Transferred Litigation. For the avoidance of doubt, Section 9.5 of the Initial SAPA shall apply for the Transferred Litigation.
2.2As regards the Entire Sold Assets relating to China ("Sold Assets China"), the Sold Assets China with value as of the date of actual transfer and assumption shall be relevant for the sale and transfer of the respective Sold Assets and for the assumption of the respective Assumed Liabilities, Assumed Agreements and transfer of the Business Employees. The Parties assume that, as of 31 December 2021, all Sold Assets, Assumed Liabilities, Assumed Agreements and Transferred Employees that need to be transferred according to the relevant provisions of the SAPA in China amounts to USD 309,253 with respect to the Sold Assets China based on such current estimate of the respective part of the Entire Sold Assets ("Allocated Purchase Price China").
2.3The Parties agree that the allocation of the Purchase Price under the SAPA shall be updated in a new Exhibit once the Deferred Closing in Brazil and China has occurred and such new Exhibit shall replace Exhibit 1 of the Third SAPA Amendment, provided that the Seller Parent shall ensure that the Share Seller in Germany, and the Purchaser itself enter into a certain amendment agreement to the KaVo Dental Share Sale and Transfer Agreement for Germany reflecting the Preliminary Purchase Price allocated to Germany pursuant to such new Exhibit, which shall, for the avoidance of doubt, not result in any additional payments between the Share Seller in Germany and the Share Purchaser in Germany.
4 /9

3Post Final Adjustment on the Final Closing Date Statements
3.1As regards the Pending Local Closings and considering the current estimates of the Sold Assets Brazil and the Sold Assets China, the Parties agree as follows (the "Post Final Adjustment Rules"):
3.1.1All figures contained in the Final Closing Date Statements relating to Brazil and/or China shall be deemed not to be final, but to be subject to a final adjustment made after the respective Pending Local Closing has occurred.
3.1.2Regarding the Pending Local Closings, Section 15 of the Initial SAPA (including, for avoidance of doubt, also Section 15.4 of the Initial SAPA) shall apply mutatis mutandis, whereas Seller Parent shall procure that a detailed list outlining the Sold Assets Brazil ("Transferred Assets Brazil") and/or the Sold Assets China ("Transferred Assets China", and together with the "Transferred Assets Brazil", the "Transferred Assets Pending Closings") with a valuation of such date of the Transferred Assets Pending Closings in USD, considering an exchange rate, if necessary, as of 31 December 2021, will be prepared within thirty (30) Business Days following the respective Pending Local Closing and the Parties will, without undermining any of the rights granted to one of the Parties according to Section 15 of the Initial SAPA, use their best efforts to mutually agree on the calculation and amount of the respective purchase price for the Sold Assets Brazil and/or the Sold Assets China.
3.1.3For clarification purposes: If a Pending Local Closing does not occur on one specific date but is carried out successively, the Transferred Assets Pending Closings will be comprised by such valuation considering their USD-value at the time of transfer to the respective Asset Purchaser (or, with respect to the Sold Assets Brazil, any other third party the Parties had agreed on in writing). For the avoidance of doubt, this also applies to the Transferred Assets Brazil, which may be transferred to a third party acquirer not being part of Purchaser's corporate group. The Parties agree that, in case the Sold Assets Brazil are transferred to a third party and such third party rejects and/or refuses transfer of some of the Sold Assets Brazil to it, the Purchaser remains liable for and shall pay to the Seller Parent the full purchase price for the Transferred Assets Brazil.
3.2The final purchase price of the Entire Sold Assets in Brazil as of the date of actual transfer and assumption of the Sold Assets Brazil as determined pursuant to Section 3.1 above (as the case may be, after the rights pursuant to Section 15 of the Initial SAPA have been exercised mutatis mutandis) shall be the "Final Local Purchase Price Brazil". The final purchase price in relation to the Entire Sold Assets in China as of the date of actual transfer and assumption of the Sold Assets China as determined pursuant to Section 3.1 above (as the case may be, after the rights pursuant to Section 15 of the Initial SAPA have been exercised mutatis mutandis) shall be the "Final Local Purchase Price China".

5 /9

3.3If the Final Local Purchase Price Brazil or the Final Local Purchase Price China, as the case may be, is (i) higher than the Allocated Purchase Price Brazil or the Allocated Purchase Price China, as the case may be, the Purchaser shall pay to the Seller Parent an amount equal to the respective excess amount, or (ii) lower than the Allocated Purchase Price Brazil or Allocated Purchase Price China, as the case may be, the Seller Parent shall pay to the Purchaser an amount equal to the respective shortfall.
4Payment Modalities, No Double Dip or Windfall Profit
4.1The Parties acknowledge that the (Preliminary) Purchase Price as well as any adjustment payment to the Preliminary Purchase Price resulting from the adjustment pursuant to Section 14 of the Initial SAPA shall be made between the Seller Parent and the Purchaser. In case that local law requires for any payment to be made between the respective Asset Seller in Brazil and/or China and the respective Asset Purchaser (or, with respect to the Sold Assets Brazil, the potential third party purchaser) in Brazil and/or China in connection with the Pending Local Closings, this shall not result in any additional payment to the (Preliminary) Purchase Price already paid, any double dip or other windfall profit and, the Parties mutually agree that:
4.1.1any payment obligation, if any, directly between the respective Asset Seller in Brazil and/or China and the respective Asset Purchaser (or, with respect to the Sold Assets Brazil, the potential third party purchaser) in Brazil and/or China, shall, if required, be calculated and executed in the respective local currency and shall be executed, unless otherwise agreed between the respective Asset Seller in Brazil and/or China and the respective Asset Purchaser in Brazil and/or China, within fifteen (15) Business Days after the Local Closing Date in accordance with the terms of this Agreement; and
4.1.2in case any local payment is made with respect to the Sold Assets Brazil or the Sold Assets China (for clarification: irrespective whether made by Purchaser, an Asset Purchaser or any third party purchaser with respect to the Sold Brazilian Assets and irrespective whether received by the respective Asset Seller or any other Affiliate(s) of the Seller Parent) (each a "Local Payment"), the Seller Parent undertakes to pay to the Purchaser, in USD (and, if the respective Local Payment is not performed in USD, based on the exchange rate published by Bloomberg as of the respective date of such respective Local Payment, an amount equal to any amount received by such payment within fifteen (15) Business Days after receipt of the respective amount of such payment. For the avoidance of doubt, with this provision the Parties intend to agree on a refund of any payments that would lead to a double dip or windfall profit relating to the Purchase Price.





6 /9

4.2For the avoidance of doubt, except for the clarifications made with respect to the allocation of the portions of the Preliminary Purchase Price to Brazil, China and Germany and the clarifications regarding payment modalities with respect to the Pending Local Closings, and as specifically varied and modified by this Agreement and the SAPA Amendment Agreements, all remaining provisions, terms and conditions of the SAPA shall not be amended by this Agreement and remain in full force and effect, in particular, the amount of the Preliminary Purchase Price shall not be adjusted by this Agreement.
4.3All payments under or in connection with this Agreement shall be made by irrevocable wire transfer of immediately available funds, free of bank and other charges. Any such payment shall be deemed made only upon the irrevocable and unconditional crediting of the amount payable (without deduction of any costs or charges) to the relevant bank account of the receiving Party.
5Sales Process in Brazil
5.1The Purchaser shall, with the consent of the Seller Parent, have the right to sell, transfer and assign the Sold Assets Brazil to a third-party purchaser and the Seller Parent intends, at its sole discretion, to arrange for the Asset Seller in Brazil to execute the documentation required to be executed to reflect the sale, transfer and assignment of the Sold Assets Brazil to a third-party purchaser provided that (i) the Purchaser shall remain liable to the Seller Parent for the purchase price payment with respect to the acquisition and transfer of the respective Sold Assets and for the assumption of the respective Assumed Liabilities, Assumed Agreements and transfer of the Business Employees in Brazil in accordance with the Initial SAPA and (ii) the Purchaser shall indemnify and hold harmless the Seller Parent for any claims made by the third-party purchaser against the Seller Parent or the Asset Seller in Brazil from, in connection with or arising out of the sale of the Sold Assets Brazil and/or the Sold Assets Brazil.
5.2The Parties agree that the sale, transfer and/or assignment of the Sold Assets and the respective Assumed Liabilities, Assumed Agreements and the Business Employees in Brazil to a third party by the Seller Parent, and/or the respective Asset Seller of the Sold Assets Brazil, shall also fulfill the obligations by the Seller Parent, and/or the respective Asset Seller of the Sold Assets Brazil, towards the Purchaser with respect to the Sold Assets Brazil under the SAPA; as well as, correspondingly, the respective obligations by the Purchaser (excluding with respect to the liabilities allocated to the Transferred Litigation, it being understood that, for the avoidance of doubt, Section 9.5 of the Initial SAPA shall remain to apply for the Transferred Litigation) towards the Seller Parent.





7 /9

6Miscellaneous
6.1To the extent legally permissible, the Purchaser shall bear all transfer Taxes, stamp duties, fees, registration duties and other charges in connection with any regulatory requirements and other charges and costs payable in connection with the execution of this Agreement and the consummation of the transaction contemplated hereby. Seller Parent and Purchaser shall each bear their own costs and expenses in connection with the preparation, conclusion and performance of this Agreement including any professional fees, charges and expenses of their respective advisors.
6.2Sections 8.4 through 8.7 of the First SAPA Amendment shall apply to this Agreement mutatis mutandis.
[Signature pages follow.]

8 /9

Envista Holdings Corporation,
represented by
Signature:/s/ Dr. Sebastian Hafele                             
Name:Dr. Sebastian Häfele
Position:Acting by virtue of power of attorney from Envista Holdings Corporation dated 28 July 2021
planmeca Verwaltungs GmbH,
represented by
Signature:/s/ Markus Maier                                                
Name:Mr. Markus Maier
Position:Acting by virtue of power of attorney from planmeca Verwaltungs GmbH dated 21 December 2021
Planmeca Oy,
represented by
Signature: /s/ Markus Maier                                               
Name:Mr. Markus Maier
Position:Acting by virtue of power of attorney from Planmeca Oy dated 21 December 2021
9 /9
 EX-31.1 4 exhibit3119302022.htm EX-31.1 Document

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Amir Aghdaei, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of Envista Holdings Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 3, 2022
/s/ Amir Aghdaei
                                Amir Aghdaei
President and Chief Executive Officer


 EX-31.2 5 exhibit3129302022.htm EX-31.2 Document

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Howard H. Yu, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of Envista Holdings Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 3, 2022
/s/ Howard H. Yu
                                Howard H. Yu
Senior Vice President and Chief Financial Officer


 EX-32.1 6 exhibit3219302022.htm EX-32.1 Document

Exhibit 32.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Amir Aghdaei, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Envista Holdings Corporation for the period ended September 30, 2022, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Envista Holdings Corporation as of and for the periods presented in the Report.
Date: November 3, 2022
/s/ Amir Aghdaei
Amir Aghdaei
President and Chief Executive Officer
I, Howard H. Yu, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Envista Holdings Corporation for the period ended September 30, 2022, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Envista Holdings Corporation as of and for the periods presented in the Report.
Date: November 3, 2022
/s/ Howard H. Yu
Howard H. Yu
Senior Vice President and Chief Financial Officer


 EX-101.SCH 7 nvst-20220930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Condensed Consolidated Statements of Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Business And Basis Of Presentation link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Credit Losses link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Property, Plant And Equipment link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Accrued Expenses And Other Liabilities link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Hedging Transactions And Derivative Financial Instruments link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Warranty link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Litigation And Contingencies link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Debt And Credit Facilities link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Accumulated Other Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Restructuring Activities And Related Impairments link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Business And Basis Of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Discontinued Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Credit Losses (Tables) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Property, Plant And Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Accrued Expenses And Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Warranty (Tables) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Debt And Credit Facilities (Tables) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Restructuring Activities And Related Impairments (Tables) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - Business And Basis Of Presentation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - Acquisitions - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - Acquisitions - Fair Values of Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - Discontinued Operations - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - Discontinued Operations - Carrying Amount of Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - Discontinued Operations - Operating Results (Details) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - Credit Losses - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - Credit Losses - Allowance for Credit Losses (Details) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - Inventories - Summary (Details) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - Property, Plant And Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 0000055 - Disclosure - Goodwill - Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - Accrued Expenses And Other Liabilities - Summary (Details) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000058 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 0000059 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 0000060 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 0000061 - Disclosure - Fair Value Measurements - Fair Value of Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 0000062 - Disclosure - Warranty - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000063 - Disclosure - Warranty - Warranty Accrual (Details) link:presentationLink link:calculationLink link:definitionLink 0000064 - Disclosure - Litigation And Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000065 - Disclosure - Debt And Credit Facilities - Components Of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000066 - Disclosure - Debt And Credit Facilities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000067 - Disclosure - Debt And Credit Facilities - Interest Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000068 - Disclosure - Accumulated Other Comprehensive Loss - Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 0000069 - Disclosure - Revenue - Disaggregation by Revenue Type and Geographical Region (Details) link:presentationLink link:calculationLink link:definitionLink 0000070 - Disclosure - Revenue - Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 0000070 - Disclosure - Revenue - Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 0000071 - Disclosure - Revenue - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000072 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details) link:presentationLink link:calculationLink link:definitionLink 0000073 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details) link:presentationLink link:calculationLink link:definitionLink 0000074 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details) link:presentationLink link:calculationLink link:definitionLink 0000075 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000076 - Disclosure - Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000077 - Disclosure - Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000078 - Disclosure - Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000079 - Disclosure - Segment Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000080 - Disclosure - Segment Information - Segment Results (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 nvst-20220930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 nvst-20220930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 nvst-20220930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Business Acquisition [Axis] Business Acquisition [Axis] Amounts reclassified from accumulated other comprehensive loss, net of income taxes Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Gain Recognized in OCI Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments US term loan due 2024 US Term Loan Due 2024 [Member] US Term Loan Due 2024 Total borrowings under term loan Total Borrowings under Term Loan Total Borrowings under Term Loan Allowance for credit losses Accounts Receivable, Credit Loss Expense (Reversal) ASSETS Disposal Group, Including Discontinued Operation, Assets [Abstract] Current assets: Disposal Group, Including Discontinued Operation, Assets, Current [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Preferred shares outstanding (in shares) Preferred Stock, Shares Outstanding Payments of debt restructuring costs Payments of Debt Restructuring Costs Acquisitions Business Combinations Policy [Policy Text Block] Other Other Segments [Member] Convertible debt, consecutive trading days (in trading days) Debt Instrument, Convertible, Threshold Consecutive Trading Days Rate in excess of Eurocurrency rate Rate in excess of Eurocurrency rate Rate in excess of Eurocurrency rate Debt Instrument [Axis] Debt Instrument [Axis] Gross property, plant and equipment Property, Plant and Equipment, Gross Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Revolving credit facility maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Prepaids and Other Current Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Balance at beginning of year Balance at end of year Restructuring Reserve Foreign currency contracts Foreign Exchange Contract [Member] Additional paid-in capital Additional Paid in Capital (Loss) income from discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax Sales Disposal Group, Including Discontinued Operation, Revenue Fair Value Measurement [Domain] Fair Value Measurement [Domain] Margin spread of variable interest rate Debt Instrument, Basis Spread on Variable Rate Credit facility Credit Facility [Member] Credit Facility [Member] All other investing activities, net Payments for (Proceeds from) Other Investing Activities Statistical Measurement [Domain] Statistical Measurement [Domain] Depreciation Depreciation Contractual interest expense Interest Expense, Debt, Excluding Amortization Interest rate Debt Instrument, Interest Rate, Stated Percentage Contingency provision on the ratio of indebtedness to net capital Ratio of Indebtedness to Net Capital, Contingency Provision Ratio of Indebtedness to Net Capital, Contingency Provision Derivative instruments, gain (loss) Derivative Instruments, Gain (Loss) [Table Text Block] Repayment of debt Repayments of Debt Operating expenses: Disposal Group, Including Discontinued Operation, Operating Expenses [Abstract] Disposal Group, Including Discontinued Operation, Operating Expenses Cash paid for taxes Income Taxes Paid Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Osteogenics Biomedical Inc & Carestream Dental Technology Osteogenics Biomedical Inc & Carestream Dental Technology [Member] Osteogenics Biomedical Inc & Carestream Dental Technology Net income Net income Net Income (Loss) Attributable to Parent Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of diluted (loss) income per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Western Europe Western Europe [Member] Western Europe [Member] Equity Component [Domain] Equity Component [Domain] Loss contingencies Loss Contingency, Accrual, Noncurrent Interest coverage ratio (at least) Interest Coverage Ratio Interest Coverage Ratio Numerator: Earnings Per Share Reconciliation [Abstract] Redemption price Debt Instrument, Redemption Price, Percentage Standby letters of credit Standby Letters of Credit [Member] Convertible debt, stock price trigger (in USD per share) Debt Instrument, Convertible, Stock Price Trigger LIABILITIES AND EQUITY Disposal Group, Including Discontinued Operation, Liabilities [Abstract] Supplemental data: Supplemental Cash Flow Information [Abstract] Earnings from continuing operations - diluted (in USD per share) Income (Loss) from Continuing Operations, Per Diluted Share Derivative Instrument [Axis] Derivative Instrument [Axis] Number of business segments (in segments) Number of operating segments (in segments) Number of Operating Segments Goodwill [Line Items] Goodwill [Line Items] Accrued expenses and other [Abstract] Accrued expenses and other [Abstract] Accrued expenses and other [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Line of credit facility, outstanding borrowings Long-Term Line of Credit Entity Address, State or Province Entity Address, State or Province Quoted Prices in Active Market (Level 1) Fair Value, Inputs, Level 1 [Member] Schedule of notional amounts of outstanding derivative positions Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Assumed conversion of the Notes (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities Liabilities for relevant jurisdictions Disposal Group, Including Discontinued Operations, Liability For Relevant Jurisdiction Proceeds, Current Disposal Group, Including Discontinued Operations, Liability For Relevant Jurisdiction Proceeds, Current Cash flows from operating activities Disposal Group, Including Discontinued Operation, Cash Flows from Discontinued Operations [Abstract] Disposal Group, Including Discontinued Operation, Cash Flows from Discontinued Operations New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Operating lease liabilities Operating Lease, Liability, Current The components of accrued expenses and other liabilities Other Liabilities [Table Text Block] Noncash items: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Proceeds from sale of KaVo treatment unit and instrument business, net Proceeds from Divestiture of Businesses Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Operating expenses: Costs and Expenses [Abstract] Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Recoveries Accounts Receivable, Allowance for Credit Loss, Recovery Long-term debt Long-term debt Long-Term Debt, Excluding Current Maturities Geographical [Axis] Geographical [Axis] Plamenca Plamenca [Member] Plamenca Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Settlements made Standard and Extended Product Warranty Accrual, Decrease for Payments Derivative financial instruments Derivative Liability, Current Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Costs incurred Restructuring Costs and Asset Impairment Charges Revolving Credit Facility Revolving Credit Facility [Member] Gross profit Disposal Group, Including Discontinued Operation, Gross Profit (Loss) Schedule of Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] (Loss) earnings from discontinued operations - basic (in USD per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share Loss contingencies Loss Contingency, Accrual, Current Preferred shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type Largest customer Largest Customer [Member] Largest Customer Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Restructuring Type [Axis] Restructuring Type [Axis] Segments [Axis] Segments [Axis] Debt And Credit Facilities Debt Disclosure [Text Block] Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Cash and cash equivalent threshold Debt Instrument, Covenant, Cash and Cash Equivalent Threshold Debt Instrument, Covenant, Cash and Cash Equivalent Threshold Accrued expenses and other liabilities Other Liabilities Disclosure [Text Block] Consolidation Items [Domain] Consolidation Items [Domain] Revenue Benchmark Revenue Benchmark [Member] Document Period End Date Document Period End Date Specialty Products & Technologies Specialty Products and Technologies [Member] Specialty Products and Technologies Total net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Schedule of accumulated other comprehensive income (loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Total assets Identifiable assets Assets Write-offs charged against the allowance Accounts Receivable, Allowance for Credit Loss, Writeoff Debt Disclosure [Abstract] Debt Disclosure [Abstract] Earnings per share: Earnings Per Share [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Interest rate swap derivative contracts Interest rate swap derivative contracts Interest Rate Swap [Member] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Restructuring-related employee severance, benefits and other Restructuring Reserve, Noncurrent Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Long-term debt Fair value of notes Long-Term Debt, Fair Value Total interest expense Interest Expense, Debt Compensation and benefits Employee-related Liabilities, Current Revolving credit facility due 2024 Line of Credit [Member] Credit Losses Credit Loss, Financial Instrument [Text Block] Gain on sale of KaVo treatment unit and instrument business Gain (Loss) on Disposition of Business Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Segments [Domain] Segments [Domain] Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Amortization of debt discount and issuance costs Amortization of Debt Issuance Costs and Discounts Earnings Per Share Earnings Per Share [Text Block] Customer [Axis] Customer [Axis] Current Other Liabilities, Current [Abstract] Deferred compensation plans Deferred Compensation Liability, Classified, Noncurrent Provision for credit losses Accounts Receivable, Credit Loss Expense (Reversal), Adjusted for Discontinued Operations Accounts Receivable, Credit Loss Expense (Reversal), Adjusted for Discontinued Operations Liabilities assumed: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract] Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill Schedule of derivative instruments in statement of financial position, fair value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Other comprehensive (loss) income before reclassifications, net of income taxes Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Derivative Contract [Domain] Derivative Contract [Domain] Finished goods Inventory, Finished Goods, Gross Net investment hedging Net Investment Hedging [Member] Gross profit Gross Profit Entity Registrant Name Entity Registrant Name Long-term debt Nonderivative Hedging Instruments Nonderivative Hedging Instruments Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Euro term loan due 2024 Euro Term Loan Due 2024 [Member] Euro Term Loan Due 2024 Foreign currency translation Goodwill, Foreign Currency Translation Gain (Loss) Equipment & Consumables Equipment and Consumables [Member] Equipment and Consumables Foreign Currency Translation Adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Entity Address, City or Town Entity Address, City or Town 2.375% convertible senior notes, capped calls 2.375% Convertible Senior Notes, Capped Calls [Member] 2.375% Convertible Senior Notes, Capped Calls [Member] Unrealized Loss on Cash Flow Hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Total stockholders’ equity Balance, beginning of period Balance, end of period Stockholders' equity Increase (decrease) in stockholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Minimum Minimum [Member] Convertible debt, conversion ratio Debt Instrument, Convertible, Conversion Ratio Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Product warranty period Product Warranty Period Product Warranty Period Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Restructuring charges Inventory Write-down (Loss) earnings from discontinued operations - diluted (in USD per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Income tax impact Other Comprehensive Income (Loss) before Reclassifications, Tax Debt issuance and deferred financing costs Debt Issuance Costs, Net Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Fair Value Measurements Fair Value Disclosures [Text Block] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Amortization Amortization of Other Deferred Charges Operating lease liabilities Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation Trading Symbol Trading Symbol Entity File Number Entity File Number Income tax impact Reclassification from AOCI, Current Period, Tax Trade accounts payable Accounts Payable, Trade, Current Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Contract liabilities Contract with Customer, Liability, Noncurrent Research and development Research and Development Expense Disposal Group Classification [Axis] Disposal Group Classification [Axis] Effective tax rate Effective Income Tax Rate Reconciliation, Percent Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Acquisitions Business Combination Disclosure [Text Block] Other comprehensive (loss) income, net of income taxes: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Raw materials Inventory, Raw Materials, Gross Change in trade accounts payable Increase (Decrease) in Accounts Payable LIBOR London Interbank Offered Rate (LIBOR) [Member] Concentration risk percentage Concentration Risk, Percentage Beginning balance Ending balance Standard and Extended Product Warranty Accrual Income Taxes Income Tax Disclosure [Text Block] Income from continuing operations, net of tax Income from continuing operations, net of tax Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Credit Facility [Domain] Credit Facility [Domain] Rollforward and Carrying Value Of Goodwill Schedule of Goodwill [Table Text Block] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Earnings - basic (in USD per share) Earnings Per Share, Basic Increase Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Liability for proceeds related to the Relevant Jurisdictions Disposal Group, Including Discontinued Operation, Liabilities Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Other Corporate, Non-Segment [Member] Unrealized Pension Costs Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Land and improvements Land and Land Improvements [Member] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Total Envista stockholders’ equity Stockholders' Equity Attributable to Parent Hedging Transactions and Derivative Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Entity Interactive Data Current Entity Interactive Data Current Pension benefits Liability, Pension and Other Postretirement and Postemployment Benefits, Current Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Retained Earnings Retained Earnings [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Common Stock Common Stock [Member] Number of reportable segments (in segments) Number of Reportable Segments 2.375% convertible senior notes over allotment option 2.375% Convertible Senior Notes Over Allotment Option [Member] 2.375% Convertible Senior Notes Over Allotment Option [Member] Contingent consideration Business Combination, Contingent Consideration, Liability Statement [Table] Statement [Table] Schedule of Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Document Quarterly Report Document Quarterly Report Discontinued Operations and Disposal Groups [Abstract] Discontinued Operations and Disposal Groups [Abstract] Current assets: Assets, Current [Abstract] Other developed markets Other Developed Markets [Member] Other developed markets [Member] Operating lease liabilities Operating Lease, Liability, Noncurrent Statistical Measurement [Axis] Statistical Measurement [Axis] Retained earnings Retained Earnings (Accumulated Deficit) Disposal Group Name [Axis] Disposal Group Name [Axis] Proceeds from issuance of convertible senior notes Proceeds from Convertible Debt Trade accounts receivable, less allowance for credit losses of $16.8 and $20.7, respectively Accounts Receivable, after Allowance for Credit Loss, Current Convertible senior notes due 2025 Convertible Debt, Fair Value Disclosures Equity Components [Axis] Equity Components [Axis] EBITDA threshold Debt Instrument, Covenant, Percentage Of Earnings Before Taxes, Threshold Debt Instrument, Covenant, Percentage Of Earnings Before Taxes, Threshold Document Fiscal Year Focus Document Fiscal Year Focus Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Consideration Disposal Group, Including Discontinued Operation, Consideration Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Variable Rate Variable Rate [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Selling, general and administrative Selling, General and Administrative Expense Goodwill Goodwill Disclosure [Text Block] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Loss Comprehensive Income (Loss) Note [Text Block] Sales and product allowances Sales And Product Allowances, Noncurrent Sales And Product Allowances, Noncurrent Compensation and benefits Due to Employees, Noncurrent Proceeds from the settlement of derivative financial instruments Proceeds from Derivative Instrument, Investing Activities Type of Restructuring [Domain] Type of Restructuring [Domain] Document Transition Report Document Transition Report Foreign currency denominated debt Foreign Currency Denominated Debt [Member] Foreign Currency Denominated debt [Member] Local Phone Number Local Phone Number Emerging markets High-Growth Markets [Member] The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which includes Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). Operating profit Operating profit (loss) Operating Income (Loss) Change in inventories Increase (Decrease) in Inventories Accounting Standards Recently Adopted New Accounting Pronouncements, Policy [Policy Text Block] Unamortized discount (premium), net Debt Instrument, Unamortized Discount (Premium), Net Line of credit facility, available borrowing capacity Line of Credit Facility, Current Borrowing Capacity Discontinued operations disposed of by sale Discontinued Operations, Disposed of by Sale [Member] Change in prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Goodwill Beginning balance Ending balance Goodwill Income tax expense Discontinued Operation, Tax Effect of Discontinued Operation Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Convertible debt, capped calls (in shares) Debt Instrument, Convertible, Capped Calls, Shares Debt Instrument, Convertible, Capped Calls, Shares Income tax expense (benefit) Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Net deferred tax liability Deferred Income Tax Liabilities, Net Warranty accrual Schedule of Product Warranty Liability [Table Text Block] Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Income Statement [Abstract] Income Statement [Abstract] Hedging Relationship [Axis] Hedging Relationship [Axis] Credit Loss [Abstract] Number of portfolio segments (in segments) Number Of Portfolio Segments Number Of Portfolio Segments Additional Paid-in Capital Additional Paid-in Capital [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Document Fiscal Period Focus Document Fiscal Period Focus Adjusted balance Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Earnings per share: Earnings Per Share, Basic [Abstract] Cost of sales Cost of Goods and Services Sold Derivative [Line Items] Derivative [Line Items] Diluted (in shares) Weighted average common shares outstanding used in diluted earnings (loss) per share (in shares) Weighted Average Number of Shares Outstanding, Diluted Accrued expenses and other liabilities Derivative Liability Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Osteogenics Biomedical Inc Osteogenics Biomedical Inc [Member] Osteogenics Biomedical Inc Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Buildings and improvements Building and Building Improvements [Member] Increase limit of revolving credit facility Debt Instrument, Accordion Feature, Increase Limit Debt Instrument, Accordion Feature, Increase Limit Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Base Rate Base Rate [Member] Debt issuance costs Debt Issuance Costs, Gross Contingency provision, purchase price in excess of $100 million Contingency Provision, Purchase Price in Excess of $100 million Contingency Provision, Purchase Price in Excess of $100 million Common stock - $0.01 par value, 500.0 million shares authorized; 163.6 million shares issued and 163.0 million shares outstanding at September 30, 2022; 162.0 million shares issued and 161.6 million outstanding at December 31, 2021 Common Stock, Value, Issued Carrying Amount Reported Value Measurement [Member] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Accruals for warranties issued during the year Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Conversion price (in USD per share) Debt Instrument, Convertible, Conversion Price Schedule of antidilutive securities excluded from computation of earnings per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Assets acquired: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract] Schedule of financial assets and liabilities at carrying and fair value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Operating segments Operating Segments [Member] Convertible Debt Convertible Debt [Member] Non-current deferred tax asset Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Cost of sales Disposal Group, Including Discontinued Operation, Costs of Goods Sold Warranty Product Warranty Disclosure [Text Block] Preferred shares authorized (in shares) Preferred Stock, Shares Authorized Impairment charges Impairment of Intangible Assets, Finite-Lived Beginning balance of cash and cash equivalents Ending balance of cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Current liabilities: Liabilities, Current [Abstract] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Proceeds from stock option exercises Proceeds from Stock Options Exercised Proceeds from borrowing Proceeds from Short-Term Debt, Maturing in Three Months or Less Common stock, shares issued (in shares) Common Stock, Shares, Issued Liabilities held for sale Current liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities, Current Contract liabilities Contract with Customer, Liability, Current Total Envista Equity Parent [Member] Income Statement Location [Domain] Income Statement Location [Domain] Acquisition costs Business Combination, Acquisition Related Costs Facility Exit and Related Facility Closing [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Amendment Flag Amendment Flag Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Capital expenditures Capital Expenditure, Discontinued Operations Gain (loss) on disposal (Loss) gain on sale of discontinued operations, net of tax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax If-converted value in excess of principal Debt Instrument, Convertible, If-converted Value in Excess of Principal Term loan Debt Instrument, Face Amount Total other comprehensive loss, net of income taxes Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax Proceeds from revolving line of credit Proceeds from Long-Term Lines of Credit Comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Acquisitions Goodwill, Acquired During Period Assets for relevant jurisdictions Disposal Group, Including Discontinued Operation, Asset For Relevant Jurisdiction Proceeds, Current Disposal Group, Including Discontinued Operation, Asset For Relevant Jurisdiction Proceeds, Current Cash flows from investing activities: Disposal Group, Including Discontinued Operation, Cash Flows From Investing Activities [Abstract] Disposal Group, Including Discontinued Operation, Cash Flows From Investing Activities Restructuring-related employee severance, benefits and other Restructuring Reserve, Current Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Segment results Schedule of Segment Reporting Information, by Segment [Table Text Block] Construction in progress Construction in Progress [Member] Entity Current Reporting Status Entity Current Reporting Status Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Accrued expenses and other liabilities Total Other Liabilities, Current Non-current deferred tax liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Other long-term assets Other Assets, Noncurrent (Loss) income from discontinued operations, net of tax (Note 3) (Loss) income from discontinued operations, net of tax Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Paid/settled Payments for Restructuring Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Employee Severance and Related Employee Severance [Member] Effect of foreign currency translation Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss) Fair Values of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Derivative [Table] Derivative [Table] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Unamortized debt issuance costs and discount Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Change in operating lease liabilities Operating Lease, Payments Long-term debt Long-Term Debt [Member] Pension plan adjustments Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Long-term Debt Total debt Total debt Long-Term Debt Other income Other Nonoperating Income (Expense) Balance Sheet Location [Axis] Balance Sheet Location [Axis] Restructuring Activities And Related Impairments Restructuring and Related Activities Disclosure [Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Research and development Disposal Group, Including Discontinued Operation, Research And Development Expense Disposal Group, Including Discontinued Operation, Research And Development Expense Taxes, income and other Accrued Income Taxes, Current Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Maximum Maximum [Member] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Senior unsecured revolving credit facility Senior Unsecured Revolving Credit Facility Senior Unsecured Revolving Credit Facility Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Stock-based awards Share-Based Payment Arrangement [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Work in process Inventory, Work in Process, Gross Total current assets Assets, Current Revenue recognized Contract with Customer, Liability, Revenue Recognized Business Acquisition [Line Items] Business Acquisition [Line Items] Change in noncontrolling interest Noncontrolling Interest, Period Increase (Decrease) Entity Small Business Entity Small Business Measurement Basis [Axis] Measurement Basis [Axis] Cash flow hedge adjustments Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent Amortization of right-of-use assets Operating Lease, Right-of-Use Asset, Amortization Expense Expected timing of satisfaction Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Accrued expenses and other liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Convertible debt, trading days (in trading days) Debt Instrument, Convertible, Threshold Trading Days Property, Plant And Equipment Property, Plant and Equipment Disclosure [Text Block] Amortization of debt discount Amortization of Debt Discount (Premium) Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Change in trade accounts receivable Increase (Decrease) in Accounts Receivable Fair value of acquisition-related inventory Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Short-term debt Short-Term Debt Title of 12(b) Security Title of 12(b) Security Business and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Debt Instrument [Line Items] Debt Instrument [Line Items] Business Combination and Asset Acquisition [Abstract] Equipment Equipment Sales [Member] Equipment Sales [Member] Payment of debt issuance and other deferred financing costs Payments of Debt Issuance Costs Segment Information Segment Reporting Disclosure [Text Block] Litigation And Contingencies Commitments Contingencies and Guarantees [Text Block] Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Consumables Consumables [Member] Consumables [Member] LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Fair Value Estimate of Fair Value Measurement [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Average common stock and common equivalent shares outstanding: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Inventories, net Total Inventory, Net Costs incurred Restructuring Charges Unamortized discount Debt Instrument, Unamortized Discount Other Other Accrued Liabilities, Noncurrent Threshold percentage of stock price trigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Earnings from continuing operations - basic (in USD per share) Income (Loss) from Continuing Operations, Per Basic Share Leverage ratio Ratio of Indebtedness to Net Capital Hedging Relationship [Domain] Hedging Relationship [Domain] Entity Filer Category Entity Filer Category Basic (in shares) Weighted-average common shares outstanding used in basic earnings per share (in shares) Weighted Average Number of Shares Outstanding, Basic Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Accrual for legal matters Loss Contingency Accrual Operating lease right-of-use assets Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right Of Use Asset Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right Of Use Asset Liabilities: Liabilities, Fair Value Disclosure [Abstract] Commitments and contingencies Commitments and Contingencies Security Exchange Name Security Exchange Name Convertible senior notes due 2025 2.375% convertible senior notes 2.375% Convertible Senior Notes [Member] 2.375% Convertible Senior Notes [Member] Carestream Dental Technology Carestream Dental Technology [Member] Carestream Dental Technology Weighted-average useful life of acquired intangible assets Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Notional Amount Derivative, Notional Amount Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at September 30, 2022 and December 31, 2021 Preferred Stock, Value, Issued Assets held for sale Current assets held for sale Disposal Group, Including Discontinued Operation, Assets, Current Held for sale Segment Reconciling Items [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Other long-term liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Sales Revenue from Contract with Customer, Excluding Assessed Tax Operating (loss) profit Disposal Group, Including Discontinued Operation, Operating Income (Loss) Less: current portion Debt, Current Cover [Abstract] Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Allowance for credit losses Beginning balance Ending balance Accounts Receivable, Allowance for Credit Loss Revenue Revenue from Contract with Customer [Text Block] Segment Reporting [Abstract] Segment Reporting [Abstract] Noncontrolling Interests Noncontrolling Interest [Member] Depreciation and amortization Depreciation and Amortization, Discontinued Operations Tax withholding payment related to net settlement of equity awards Payment, Tax Withholding, Share-Based Payment Arrangement Total liabilities and stockholders’ equity Liabilities and Equity Debt instrument, term Debt Instrument, Term Amortization of debt issuance costs Amortization of Debt Issuance Costs Goodwill [Roll Forward] Goodwill [Roll Forward] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Repayment of revolving line of credit Repayments of Long-Term Lines of Credit Assumed exercise of dilutive options and vesting of dilutive restricted stock units (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Disposal Group Name [Domain] Disposal Group Name [Domain] Acquisition, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Held for Sale Disposal Group, Including Discontinued Operation, Assets Earnings - diluted (in USD per share) Earnings Per Share, Diluted Other intangible assets, net Intangible Assets, Net (Excluding Goodwill) Selling, general and administrative Disposal Group, Including Discontinued Operation, General and Administrative Expense Proceeds from sales of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Gain on sale of property, plant and equipment Gain (Loss) on Disposition of Property Plant Equipment Common stock-based award activity APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Consolidation Items [Axis] Consolidation Items [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current Customer Concentration Risk Customer Concentration Risk [Member] Taxes, income and other Accrued Income Taxes, Noncurrent Current liabilities: Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Sales and product allowances Sales And Product Allowances, Current Sales And Product Allowances, Current Discontinued Operations Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Noncurrent Other Liabilities, Noncurrent [Abstract] Facility fee Line of Credit Facility, Commitment Fee Percentage Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss [Table Text Block] Nonoperating income (expense): Nonoperating Income (Expense) [Abstract] (Decrease) increase before reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Net (loss) income from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Entity Address, Address Line One Entity Address, Address Line One All other financing activities Proceeds from (Payments for) Other Financing Activities Contract liability Contract with Customer, Liability Product and Service [Axis] Product and Service [Axis] Other long-term assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Pension benefits Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent Interest expense, net Interest Expense Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Dilution threshold (in USD per share) Derivative, Cap Price, Dilution Threshold Derivative, Cap Price, Dilution Threshold Credit Facility [Axis] Credit Facility [Axis] Reserve for inventory obsolescence Inventory Valuation Reserves Inventories Inventory Disclosure [Text Block] Foreign currency translation Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation Components of debt Schedule of Long-Term Debt Instruments [Table Text Block] Equity [Abstract] Equity [Abstract] Machinery, equipment and other assets Machinery and Equipment [Member] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Entity Tax Identification Number Entity Tax Identification Number Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Schedule of disaggregation of revenue by geographical region and type Disaggregation of Revenue [Table Text Block] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward] Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] Loan facility interest rates Debt Instrument, Interest Rate During Period Cross-currency swap derivative contracts Cross-currency swap derivative contracts Currency Swap [Member] Net change in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Repayment of borrowing Repayments of Short-Term Debt, Maturing in Three Months or Less Schedule of restructuring reserve by type of cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Restructuring and related costs Restructuring and Related Costs [Table Text Block] Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Consideration transferred Business Combination, Consideration Transferred Other Other Accrued Liabilities, Current Change in accrued expenses and other liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities City Area Code City Area Code Convertible debt expense, capped calls Debt Instrument, Convertible, Capped Calls, Expense Debt Instrument, Convertible, Capped Calls, Expense ASSETS Assets [Abstract] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Other Other Debt Obligations [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Variable Rate [Axis] Variable Rate [Axis] Other long-term liabilities Total Other Liabilities, Noncurrent Interest rate contracts Interest Rate Contract [Member] North America North America [Member] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Payments for additions to property, plant and equipment Payments to Acquire Property, Plant, and Equipment Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Proceeds from sale of KaVo treatment unit and instrument business, net Proceeds from Divestiture of Businesses, Net of Cash Divested Schedule of earnings per share, basic and diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Line of credit facility, interest rate Line of Credit Facility, Interest Rate at Period End ROU assets obtained in exchange for operating lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Cost of sales Cost of Sales [Member] Components of note interest expense Convertible Debt [Table Text Block] Customer [Domain] Customer [Domain] Rate in excess of Federal funds rate Prime Rate Prime Rate Derivative financial instruments Derivative Liability, Noncurrent Accounting Standards Update [Extensible List] Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member] EX-101.PRE 11 nvst-20220930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 12 nvst-20220930_g1.jpg GRAPHIC begin 644 nvst-20220930_g1.jpg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end XML 13 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover Page - shares
 9 Months Ended
Sep. 30, 2022
Oct. 28, 2022
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2022  
Document Transition Report false  
Entity File Number 001-39054  
Entity Registrant Name ENVISTA HOLDINGS CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 83-2206728  
Entity Address, Address Line One 200 S. Kraemer Blvd., Building E  
Entity Address, City or Town Brea,  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92821-6208  
City Area Code 714  
Local Phone Number 817-7000  
Title of 12(b) Security Common stock, $0.01 par value  
Trading Symbol NVST  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   163,045,022
Amendment Flag false  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --12-31  
Entity Central Index Key 0001757073  
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 568.5 $ 1,073.6
Trade accounts receivable, less allowance for credit losses of $16.8 and $20.7, respectively 392.2 331.9
Inventories, net 291.3 263.8
Prepaid expenses and other current assets 114.0 154.3
Assets held for sale 0.0 12.2
Total current assets 1,366.0 1,835.8
Property, plant and equipment, net 277.2 264.1
Operating lease right-of-use assets 132.1 128.1
Other long-term assets 173.2 167.8
Goodwill 3,399.6 3,132.0
Other intangible assets, net 1,063.8 1,046.4
Total assets 6,411.9 6,574.2
Current liabilities:    
Short-term debt 579.3 432.4
Trade accounts payable 190.0 185.8
Accrued expenses and other liabilities 462.5 562.3
Operating lease liabilities 26.5 23.7
Liabilities held for sale 0.0 4.0
Total current liabilities 1,258.3 1,208.2
Operating lease liabilities 123.4 120.4
Other long-term liabilities 220.7 304.2
Long-term debt 851.6 883.4
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at September 30, 2022 and December 31, 2021 0.0 0.0
Common stock - $0.01 par value, 500.0 million shares authorized; 163.6 million shares issued and 163.0 million shares outstanding at September 30, 2022; 162.0 million shares issued and 161.6 million outstanding at December 31, 2021 1.6 1.6
Additional paid-in capital 3,689.6 3,732.6
Retained earnings 657.9 466.9
Accumulated other comprehensive loss (391.2) (143.5)
Total Envista stockholders’ equity 3,957.9 4,057.6
Noncontrolling interests 0.0 0.4
Total stockholders’ equity 3,957.9 4,058.0
Total liabilities and stockholders’ equity $ 6,411.9 $ 6,574.2
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Allowance for credit losses $ 16.8 $ 20.7
Preferred stock, par value (in USD per share) $ 0.01 $ 0.01
Preferred shares authorized (in shares) 15,000,000 15,000,000
Preferred shares issued (in shares) 0 0
Preferred shares outstanding (in shares) 0 0
Common stock, par value (in USD per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 163,600,000 162,000,000
Common stock, shares outstanding (in shares) 163,000,000 161,600,000
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Income Statement [Abstract]        
Sales $ 631.1 $ 607.3 $ 1,908.3 $ 1,857.1
Cost of sales 266.4 251.0 799.7 773.8
Gross profit 364.7 356.3 1,108.6 1,083.3
Operating expenses:        
Selling, general and administrative 264.2 250.6 801.9 747.5
Research and development 26.0 24.0 75.5 75.7
Operating profit 74.5 81.7 231.2 260.1
Nonoperating income (expense):        
Other income 0.3 0.2 0.9 0.8
Interest expense, net (11.6) (12.0) (23.9) (43.6)
Income before income taxes 63.2 69.9 208.2 217.3
Income tax expense (benefit) 13.6 (10.3) 43.7 (3.7)
Income from continuing operations, net of tax 49.6 80.2 164.5 221.0
(Loss) income from discontinued operations, net of tax (Note 3) (2.0) 12.7 5.1 33.7
Net income $ 47.6 $ 92.9 $ 169.6 $ 254.7
Earnings per share:        
Earnings from continuing operations - basic (in USD per share) $ 0.30 $ 0.50 $ 1.01 $ 1.37
Earnings from continuing operations - diluted (in USD per share) 0.28 0.45 0.92 1.25
(Loss) earnings from discontinued operations - basic (in USD per share) (0.01) 0.08 0.03 0.21
(Loss) earnings from discontinued operations - diluted (in USD per share) (0.01) 0.07 0.03 0.19
Earnings - basic (in USD per share) 0.29 0.58 1.04 1.58
Earnings - diluted (in USD per share) [1] $ 0.27 $ 0.52 $ 0.95 $ 1.43
Average common stock and common equivalent shares outstanding:        
Basic (in shares) 163.1 161.5 162.7 161.1
Diluted (in shares) 176.9 178.1 178.4 177.5
[1] * Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Statement of Comprehensive Income [Abstract]        
Net income $ 47.6 $ 92.9 $ 169.6 $ 254.7
Other comprehensive (loss) income, net of income taxes:        
Foreign currency translation adjustments (116.6) (25.0) (249.1) (64.3)
Cash flow hedge adjustments (0.2) 1.1 1.7 3.6
Pension plan adjustments (0.1) 0.2 (0.3) (0.1)
Total other comprehensive loss, net of income taxes (116.9) (23.7) (247.7) (60.8)
Comprehensive (loss) income $ (69.3) $ 69.2 $ (78.1) $ 193.9
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Total Envista Equity
Total Envista Equity
Adjustment
Total Envista Equity
Adjusted balance
Common Stock
Common Stock
Adjusted balance
Additional Paid-in Capital
Additional Paid-in Capital
Adjustment
Additional Paid-in Capital
Adjusted balance
Retained Earnings
Retained Earnings
Adjustment
Retained Earnings
Adjusted balance
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Adjusted balance
Noncontrolling Interests
Noncontrolling Interests
Adjusted balance
Balance, beginning of period at Dec. 31, 2020   $ 3,720.6     $ 1.6   $ 3,684.4     $ 126.4     $ (91.8)   $ 0.4  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common stock-based award activity   6.7         6.7                  
Net income   71.7               71.7            
Other comprehensive loss   (52.1)                     (52.1)      
Balance, end of period at Apr. 02, 2021   3,746.9     1.6   3,691.1     198.1     (143.9)   0.4  
Balance, beginning of period at Dec. 31, 2020   3,720.6     1.6   3,684.4     126.4     (91.8)   0.4  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income $ 254.7                              
Other comprehensive loss $ (60.8)                       (60.8)      
Balance, end of period at Oct. 01, 2021   3,946.7     1.6   3,716.6     381.1     (152.6)   0.4  
Balance, beginning of period at Dec. 31, 2020   3,720.6     1.6   3,684.4     126.4     (91.8)   0.4  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06 [Member]                              
Balance, end of period at Dec. 31, 2021 $ 4,058.0 4,057.6 $ (56.4) $ 4,001.2 1.6 $ 1.6 3,732.6 $ (77.8) $ 3,654.8 466.9 $ 21.4 $ 488.3 (143.5) $ (143.5) 0.4 $ 0.4
Balance, beginning of period at Apr. 02, 2021   3,746.9     1.6   3,691.1     198.1     (143.9)   0.4  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common stock-based award activity   16.5         16.5                  
Net income   90.1               90.1            
Other comprehensive loss   15.0                     15.0      
Balance, end of period at Jul. 02, 2021   3,868.5     1.6   3,707.6     288.2     (128.9)   0.4  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common stock-based award activity   9.0         9.0                  
Net income 92.9 92.9               92.9            
Other comprehensive loss (23.7) (23.7)                     (23.7)      
Balance, end of period at Oct. 01, 2021   3,946.7     1.6   3,716.6     381.1     (152.6)   0.4  
Balance, beginning of period at Dec. 31, 2021 4,058.0 4,057.6 (56.4) 4,001.2 1.6 1.6 3,732.6 (77.8) 3,654.8 466.9 21.4 488.3 (143.5) (143.5) 0.4 0.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Change in noncontrolling interest                             (0.4)  
Common stock-based award activity   13.1         13.1                  
Net income   74.9               74.9            
Other comprehensive loss   (58.3)                     (58.3)      
Balance, end of period at Apr. 01, 2022   4,030.9     1.6   3,667.9     563.2     (201.8)   0.0  
Balance, beginning of period at Dec. 31, 2021 4,058.0 4,057.6 $ (56.4) $ 4,001.2 1.6 $ 1.6 3,732.6 $ (77.8) $ 3,654.8 466.9 $ 21.4 $ 488.3 (143.5) $ (143.5) 0.4 $ 0.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 169.6                              
Other comprehensive loss (247.7)                       (247.7)      
Balance, end of period at Sep. 30, 2022 3,957.9 3,957.9     1.6   3,689.6     657.9     (391.2)      
Balance, beginning of period at Apr. 01, 2022   4,030.9     1.6   3,667.9     563.2     (201.8)   $ 0.0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common stock-based award activity   10.5         10.5                  
Net income   47.1               47.1            
Other comprehensive loss   (72.5)                     (72.5)      
Balance, end of period at Jul. 01, 2022   4,016.0     1.6   3,678.4     610.3     (274.3)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common stock-based award activity   11.2         11.2                  
Net income 47.6 47.6               47.6            
Other comprehensive loss (116.9) (116.9)                     (116.9)      
Balance, end of period at Sep. 30, 2022 $ 3,957.9 $ 3,957.9     $ 1.6   $ 3,689.6     $ 657.9     $ (391.2)      
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Cash flows from operating activities:    
Net income $ 169.6 $ 254.7
Noncash items:    
Depreciation 23.9 29.4
Amortization 78.2 62.6
Allowance for credit losses 3.8 4.2
Stock-based compensation expense 23.1 21.6
Gain on sale of property, plant and equipment (1.1) (2.2)
Gain on sale of KaVo treatment unit and instrument business (8.9) 0.0
Restructuring charges 5.5 0.3
Impairment charges 5.8 9.4
Fair value of acquisition-related inventory 7.7 0.0
Amortization of right-of-use assets 17.7 21.3
Amortization of debt discount and issuance costs 3.0 17.6
Change in trade accounts receivable (76.5) (15.1)
Change in inventories (35.9) (67.1)
Change in trade accounts payable 11.3 (39.9)
Change in prepaid expenses and other assets (21.7) (23.4)
Change in accrued expenses and other liabilities (109.7) (18.7)
Change in operating lease liabilities (23.4) (29.1)
Net cash provided by operating activities 72.4 225.6
Cash flows from investing activities:    
Acquisition, net of cash acquired (696.2) 0.0
Payments for additions to property, plant and equipment (58.8) (46.0)
Proceeds from sales of property, plant and equipment 1.6 11.6
Proceeds from sale of KaVo treatment unit and instrument business, net 59.8 0.0
Proceeds from the settlement of derivative financial instruments 55.9 8.5
All other investing activities, net (18.5) 0.0
Net cash used in investing activities (656.2) (25.9)
Cash flows from financing activities:    
Proceeds from revolving line of credit 124.0 0.0
Repayment of revolving line of credit (54.0) 0.0
Proceeds from borrowing 0.3 0.0
Repayment of borrowing (0.5) (475.7)
Payment of debt issuance and other deferred financing costs 0.0 (2.3)
Proceeds from stock option exercises 19.9 16.0
Tax withholding payment related to net settlement of equity awards (8.9) (6.1)
All other financing activities 0.0 0.7
Net cash provided by (used in) financing activities 80.8 (467.4)
Effect of exchange rate changes on cash and cash equivalents (2.1) 17.6
Net change in cash and cash equivalents (505.1) (250.1)
Beginning balance of cash and cash equivalents 1,073.6 888.9
Ending balance of cash and cash equivalents 568.5 638.8
Supplemental data:    
Cash paid for interest 21.1 26.1
Cash paid for taxes 80.2 65.6
ROU assets obtained in exchange for operating lease obligations $ 29.6 $ 24.9
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business And Basis Of Presentation
 9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business and Basis of Presentation BUSINESS AND BASIS OF PRESENTATION
Business Overview

The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services and is dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity.

The Company operates in two business segments: Specialty Products & Technologies and Equipment & Consumables.
The Company’s Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Company’s Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Basis of Presentation
All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the financial statements. All significant intercompany accounts and transactions between the businesses comprising the Company have been eliminated in the accompanying Condensed Consolidated Financial Statements.

The Condensed Consolidated Financial Statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The accompanying Condensed Consolidated Financial Statements contain all adjustments (consisting of only normal recurring adjustments and reclassifications to conform to current year presentation) necessary to present fairly the financial position of the Company as of September 30, 2022 and December 31, 2021, and its results of operations for the three and nine month periods ended September 30, 2022 and October 1, 2021 and cash flows for the nine month periods ended September 30, 2022 and October 1, 2021. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Consolidated and Combined Financial Statements and accompanying notes for the three years ended December 31, 2021, included in the Annual Report on Form 10-K filed by the Company with the SEC on February 24, 2022.

As discussed in Note 3, Discontinued Operations, on December 31, 2021, the Company completed the sale of its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.

Risks and Uncertainties

The Company is subject to risks and uncertainties as a result of the novel coronavirus (“COVID-19”) pandemic.

During the three and nine months ended September 30, 2022, notwithstanding improvement in many markets in which the Company operates due to a return to more normalized business operations, certain markets continue to be adversely impacted either directly attributable to COVID-19 or as a result of prior COVID-19 influenced policies. Late in the first quarter of 2022, the Chinese authorities instituted COVID-19-related lockdowns, shut-downs and restrictions in certain parts of China, specifically the Shanghai area, which impacted the Company’s operations in China. These restrictions were lifted in early June 2022, but the extent to which continuing effects from these restrictions, current localized restrictions throughout China under its zero-COVID policy, and any future restrictions may impact our operations remains uncertain.
The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the scope and duration of the pandemic, the rise of new variants, the extent and severity of the impact on the Company's customers, the measures that have been and may be taken to contain the virus (including its various mutations) and mitigate its impact, U.S. and foreign government actions to respond to the reduction in global economic activity, the ability of the Company to continue to manufacture and source its products and to find suitable alternative products at reasonable prices, the Company’s ability to continue to ship and deliver its products in a cost-effective and timely manner, uncertain demand, staffing shortages, the impact of the pandemic and associated economic downturn on the Company’s ability to access capital if and when needed and how quickly and to what extent normal economic and operating conditions can resume, all of which are uncertain and cannot be predicted. Even after the COVID-19 pandemic has further subsided, the Company may continue to experience materially adverse impacts on the Company’s financial condition and results of operations.

In addition, Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on the Company’s business, including impacting the Company’s ability to market and sell products in the affected regions, impacting its ability to enforce its intellectual property rights in Russia, creating disruptions in the global supply chain, and by potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise.

Accounting Standards Recently Adopted
In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. The ASU is effective for public entities through December 31, 2022 and the adoption did not have an impact on the Company’s Condensed Consolidated Financial Statements.
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisitions
 9 Months Ended
Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]  
Acquisitions ACQUISITIONS
The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into new and attractive business areas. The Company has completed a number of acquisitions that have been accounted for as business combinations and have resulted in the recognition of goodwill in the Company’s Condensed Consolidated Financial Statements. Among other things, goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.

The Company makes an initial allocation of the purchase price at the date of acquisition based upon its understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains this information during due diligence and through other sources. For those assets and liabilities that were accounted for on a preliminary basis, the Company may up to 12 months after closing, refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The finalization of the acquisition valuation assessment, for the acquisitions listed below, may result in a change in the valuation of deferred taxes and goodwill, which could have a material impact on the Company’s financial statements.

During the nine months ended September 30, 2022, the Company completed the following acquisitions:

Osteogenics Biomedical Inc., Allotech LLC and OBI Biologics, Inc.
On July 5, 2022, the Company acquired all of the equity of Osteogenics Biomedical Inc., Allotech LLC and OBI Biologics, Inc. (together "Osteogenics") for total consideration of approximately $128.2 million, subject to certain customary adjustments as provided in the definitive agreement dated May 17, 2022. Osteogenics develops innovative regenerative solutions for periodontists, oral and maxillofacial surgeons, and clinicians involved in implant dentistry throughout the world, and is part of the Company’s Specialty Products & Technologies segment.
Carestream Dental Technology Parent Limited’s Intraoral Scanner Business
On April 20, 2022, the Company completed the acquisition of Carestream Dental Technology Parent Limited’s (“Carestream Dental”) intraoral scanner business (the “Intraoral Scanner Business”) for total consideration of $580.3 million, including contingent consideration of $7.5 million, and subject to certain customary adjustments as provided in the Stock and Asset Purchase Agreement dated December 21, 2021 and as subsequently amended by the closing agreement dated as of April 20, 2022. The Intraoral Scanner Business manufactures, markets, sells, commercializes, distributes, services, trains, supports, and maintains operations of intraoral scanners and software, and is part of the Company’s Equipment & Consumables segment. The Company purchased the Intraoral Scanner Business through the acquisition of certain assets and the assumption of certain liabilities as well as the acquisition of all of the equity of certain subsidiaries of Carestream Dental.

The following table summarizes the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates ($ in millions):

Osteogenics
July 5, 2022		Intraoral Scanner Business
April 20, 2022
Assets acquired:
   Cash$2.1 $2.7 
   Accounts receivable2.5 0.1 
   Inventories13.3 6.1 
   Intangible assets53.0 129.8 
   Property, plant and equipment— 0.3 
   Prepaids and Other Current Assets1.3 — 
   Goodwill77.5 370.6 
   Non-current deferred tax asset— 98.5 
   Operating lease right-of-use assets2.6 0.9 
   Other long-term assets4.9 0.2 
       Total assets acquired157.2 609.2 
Liabilities assumed:
   Accounts payable (4.1)(0.5)
   Accrued expenses and other liabilities (2.6)(27.9)
   Non-current deferred tax liability(14.4)— 
   Other long-term liabilities(5.8)— 
   Operating lease liabilities(2.1)(0.5)
       Total liabilities assumed(29.0)(28.9)
Total net assets acquired$128.2 $580.3 

The intangible assets acquired consist of trade name, developed technology, and customer relationships. The weighted average amortization period of the acquired intangible assets in the aggregate is 8 and 10 years for the Intraoral Scanner Business and Osteogenics, respectively.

The excess of the purchase price over the fair value assigned to the assets acquired and liabilities assumed represents the goodwill resulting from the acquisitions. Goodwill attributable to the acquisitions has been recorded as a non-current asset and is not amortized, but is subject to review at least on an annual basis for impairment. Goodwill recognized was primarily attributable to expected operating efficiencies and expansion opportunities in the businesses acquired. Goodwill is not deductible for income tax purposes. The pro forma impact of the acquisitions is not presented as the acquisitions were not considered material to the Company's Condensed Consolidated Financial Statements.

For the three and nine months ended September 30, 2022, legal, accounting, and other professional service costs associated with the acquisitions were $1.5 million and $13.4 million, respectively, and have been recorded as selling, general and administrative expense in the Condensed Consolidated Statements of Income.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Discontinued Operations
 9 Months Ended
Sep. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations DISCONTINUED OPERATIONS
On December 31, 2021, the Company completed the sale of substantially all of the KaVo Treatment Unit and Instrument Business (the “Divestiture”) to planmeca Verwaltungs Gmbh, Germany (“Planmeca”), pursuant to the master sale and purchase agreement (the “Purchase Agreement”) among the Company, Planmeca, and Planmeca Oy, as guarantor. In accordance with the terms of the Purchase Agreement, the Company received cash consideration of $317.3 million upon closing on December 31, 2021. During the nine months ended September 30, 2022, the Company has received an additional $59.8 million related to an earnout payment and certain working capital adjustments.

On December 30, 2021, the Company entered into an amendment to the Purchase Agreement (the "Amendment"), providing that the transfer of net assets in Russia, China and Brazil (the "Relevant Jurisdictions") would be deferred until the purchaser had formed entities for such transfer of assets in each such Relevant Jurisdiction and the applicable asset transfer agreement could be executed and consummated (each such asset transfer, a "Deferred Local Closing"). Except for the implementation of the Deferred Local Closings and related matters regarding the assets in the Relevant Jurisdictions, the provisions, terms and conditions of the Purchase Agreement were not materially amended by the Amendment. The Amendment did not alter the preliminary purchase price that Planmeca paid to the Company upon the closing of the Divestiture and the Company recognized the applicable gain or loss at the time of each Relevant Jurisdiction’s applicable closing. At December 31, 2021, the Company recorded a liability of $10.8 million for the proceeds related to the Relevant Jurisdictions. All three Relevant Jurisdictions have closed as of September 30, 2022 and the related liability associated with the proceeds released.

The Company recognized a loss of $1.6 million and a gain of $5.7 million on the Divestiture during the three and nine months ended September 30, 2022, respectively, primarily related to the recognition of certain purchase price adjustments and the closing of the Relevant Jurisdictions.

In conjunction with the Divestiture, the Company entered into a customary transition services agreement, which requires support transition services to Planmeca throughout the applicable transition period.

For the three and nine months ended September 30, 2022, the Divestiture continued to meet the criteria to be classified as held for sale and to be presented as a discontinued operation. Accordingly, the Company reclassified the results of operations and financial position of the Divestiture to discontinued operations in its accompanying Condensed Consolidated Statements of Income and Condensed Consolidated Balance Sheets for all periods presented. The Company’s Condensed Consolidated Statements of Cash Flows for all periods presented include the financial results of the KaVo Treatment Unit and Instrument Business.

For the nine months ended October 1, 2021, balances represent activity for the entire Divestiture, while balances for the nine months ended September 30, 2022, represent activity for the remaining Relevant Jurisdictions.

The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):
December 31, 2021
ASSETS
Current assets:
Assets for relevant jurisdictions$12.2 
Current assets held for sale$12.2 
LIABILITIES AND EQUITY
Current liabilities:
Liabilities for relevant jurisdictions$4.0 
Current liabilities held for sale$4.0 
The operating results of the Divestiture are reflected in the Condensed Consolidated Statements of Income within income from discontinued operations, net of tax as follows ($ in millions):
 Three Months EndedNine Months Ended
 September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Sales$2.8 $102.5 $11.7 $302.0 
Cost of sales2.1 57.2 9.1 174.4 
Gross profit0.7 45.3 2.6 127.6 
Operating expenses:
Selling, general and administrative1.1 25.2 3.2 70.4 
Research and development— 3.8 — 12.5 
Operating (loss) profit(0.4)16.3 (0.6)44.7 
Income tax expense— 3.6 — 11.0 
(Loss) income from discontinued operations(0.4)12.7 (0.6)33.7 
(Loss) gain on sale of discontinued operations, net of tax(1.6)— 5.7 — 
Net (loss) income from discontinued operations$(2.0)$12.7 $5.1 $33.7 

Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):
Nine Months Ended
September 30, 2022October 1, 2021
Cash flows from operating activities
Depreciation and amortization1
$— $5.6 
Cash flows from investing activities:
Capital expenditures$— $4.2 
1 Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Credit Losses
 9 Months Ended
Sep. 30, 2022
Credit Loss [Abstract]  
Credit Losses CREDIT LOSSES
The allowance for credit losses is a valuation account deducted from accounts receivable to present the net amount expected to be collected. Accounts receivable are charged off against the allowance when management believes the uncollectibility of an accounts receivable balance is confirmed.

Management estimates the adequacy of the allowance by using relevant available information, from internal and external sources, relating to past events, current conditions and forecasts. Historical credit loss experience provides the basis for estimation of expected credit losses and is adjusted as necessary using the relevant information available. The allowance for credit losses is measured on a collective basis when similar risk characteristics exist. The Company has identified one portfolio segment based on the following risk characteristics: geographic regions, product lines, default rates and customer specific factors.

The factors used by management in its credit loss analysis are inherently subject to uncertainty. If actual results are not consistent with management’s estimates and assumptions, the allowance for credit losses may be overstated or understated and a charge or credit to net income (loss) may be required.
The rollforward of the allowance for credit losses is summarized as follows ($ in millions):

Balance at December 31, 2021$20.7 
Foreign currency translation(1.5)
Provision for credit losses3.8 
Write-offs charged against the allowance(3.3)
Recoveries(2.9)
Balance at September 30, 2022$16.8 
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Inventories
 9 Months Ended
Sep. 30, 2022
Inventory Disclosure [Abstract]  
Inventories INVENTORIES
The classes of inventory are summarized as follows ($ in millions):
September 30, 2022December 31, 2021
Finished goods$234.9 $214.3 
Work in process26.7 22.0 
Raw materials87.3 88.3 
Reserve for inventory obsolescence(57.6)(60.8)
Total$291.3 $263.8 
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property, Plant And Equipment
 9 Months Ended
Sep. 30, 2022
Property, Plant and Equipment [Abstract]  
Property, Plant And Equipment PROPERTY, PLANT AND EQUIPMENT
The classes of property, plant and equipment are summarized as follows ($ in millions):
September 30, 2022December 31, 2021
Land and improvements$10.4 $10.7 
Buildings and improvements155.2 168.7 
Machinery, equipment and other assets353.2 354.5 
Construction in progress69.3 45.6 
Gross property, plant and equipment588.1 579.5 
Less: accumulated depreciation(310.9)(315.4)
Property, plant and equipment, net$277.2 $264.1 
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Goodwill
 9 Months Ended
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill GOODWILL
The following is a rollforward of the Company’s goodwill by segment ($ in millions):
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Balance at December 31, 2021$2,029.7 $1,102.3 $3,132.0 
Acquisitions77.5 370.6 448.1 
Foreign currency translation(126.2)(54.3)(180.5)
Balance at September 30, 2022$1,981.0 $1,418.6 $3,399.6 
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accrued Expenses And Other Liabilities
 9 Months Ended
Sep. 30, 2022
Accrued expenses and other [Abstract]  
Accrued expenses and other liabilities ACCRUED EXPENSES AND OTHER LIABILITIES
Accrued expenses and other liabilities were as follows ($ in millions):
September 30, 2022December 31, 2021
CurrentNoncurrentCurrentNoncurrent
Compensation and benefits$145.1 $16.2 $188.9 $17.9 
Restructuring-related employee severance, benefits and other17.6 — 21.9 — 
Pension benefits5.6 37.3 5.6 41.7 
Taxes, income and other30.4 116.6 48.1 201.4 
Contract liabilities71.4 8.9 60.1 5.1 
Sales and product allowances81.9 1.1 75.4 1.2 
Loss contingencies8.0 29.1 8.4 30.3 
Derivative financial instruments— — 19.6 — 
Other102.5 11.5 134.3 6.6 
Total$462.5 $220.7 $562.3 $304.2 
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Hedging Transactions And Derivative Financial Instruments
 9 Months Ended
Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Hedging Transactions and Derivative Financial Instruments HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The Company has foreign currency denominated long-term debt in the amount of €208.0 million. This senior unsecured term loan facility represents a partial hedge of the Company’s net investment in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The euro senior unsecured term loan facility is designated and qualifies as a non-derivative hedging instrument. Accordingly, the foreign currency translation of the euro senior unsecured term loan facility is recorded in accumulated other comprehensive loss in equity in the accompanying Condensed Consolidated Balance Sheets, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive loss in equity (see Note 14). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The euro senior unsecured term loan facility matures in September 2024. Refer to Note 13 for a further discussion of the above loan facility.

The Company has used cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts were agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. The Company maintained cross-currency swap derivative contracts with respect to its $650.0 million senior unsecured term loan facility. These contracts effectively converted the $650.0 million senior unsecured term loan facility to an obligation denominated in euros and partially offset the impact of changes in currency rates on foreign currency denominated net investments. During the three months ended September 30, 2022, the Company settled all of its cross-currency swap derivative contracts and as of September 30, 2022 did not have any cross-currency swap derivative contracts outstanding. The changes in the fair value of these instruments were recorded in accumulated other comprehensive loss in equity, in the accompanying Condensed Consolidated Balance Sheets, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that was also recorded in accumulated other comprehensive loss as reflected in Note 14. Any ineffective portions of net investment hedges were reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps was recorded in interest expense, net in the Company’s Condensed Consolidated Statements of Income consistent with the classification of interest expense attributable to the underlying debt.

The Company has also used interest rate swap derivative contracts to reduce its variability of cash flows related to interest payments with respect to its senior unsecured term loans. The interest rate swap contracts exchanged interest payments based on variable rates for interest payments based on fixed rates. During the three months ended September 30, 2022, the existing interest rate swap matured. As of September 30, 2022, the Company did not have any outstanding interest rate swap contracts. The changes in the fair value of these instruments were recorded in accumulated other comprehensive loss in equity (see Note 14). Any ineffective portions of the cash flow hedges were reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps was recorded in interest expense in the Company’s Condensed Consolidated Statements of Income consistent with the classification of interest expense attributable to the underlying debt.
The following table summarizes the notional values as of September 30, 2022 and October 1, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three and nine months ended September 30, 2022 and October 1, 2021 ($ in millions):

Three Months Ended
September 30, 2022		Three Months Ended
October 1, 2021
Notional AmountGain (Loss) Recognized in OCINotional AmountGain Recognized in OCI
Foreign currency denominated debt$203.9 $12.8 $241.2 $5.6 
Interest rate contract— (0.3)250.01.5
Foreign currency contracts— 14.4 650.0 14.1 
Total$203.9 $26.9 $1,141.2 $21.2 
Nine Months Ended
September 30, 2022		Nine Months Ended
October 1, 2021
Notional AmountGain Recognized in OCINotional AmountGain Recognized in OCI
Foreign currency denominated debt$203.9 $32.7 $241.2 $19.7 
Interest rate contracts— 2.2 250.0 4.8 
Foreign currency contracts— 68.5 650.0 33.1 
Total$203.9 $103.4 $1,141.2 $57.6 

Gains or losses related to the foreign currency contracts and foreign currency denominated debt were classified as foreign currency translation adjustments in the schedule of changes in OCI in Note 14, as these items were attributable to the Company’s hedges of its net investment in foreign operations. Gains or losses related to the interest rate contracts were classified as cash flow hedge adjustments in the schedule of changes in OCI in Note 14. The Company did not reclassify any deferred gains or losses related to net investment and cash flow hedges from accumulated other comprehensive loss to income during the three and nine months ended September 30, 2022 and October 1, 2021. In addition, the Company did not have any ineffectiveness related to net investment and cash flow hedges during the three and nine months ended September 30, 2022 and October 1, 2021. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in investing activities in the accompanying Condensed Consolidated Statements of Cash Flows.

The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified in the Company’s Condensed Consolidated Balance Sheets as follows ($ in millions):
September 30, 2022December 31, 2021
Derivative liabilities:
Accrued expenses and other liabilities$— $19.6 
Nonderivative hedging instruments:
Long-term debt$203.9 $236.5 
Amounts related to the Company’s derivatives expected to be reclassified from accumulated other comprehensive loss to net income during the next 12 months are not significant.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements
 9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements FAIR VALUE MEASUREMENTS
Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows: Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation; and Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
September 30, 2022:
Liabilities:
Deferred compensation plans$— $14.8 $— $14.8 
Contingent consideration$— $— $6.0 $6.0 
December 31, 2021:
Liabilities:
Interest rate swap derivative contracts$— $2.2 $— $2.2 
Cross-currency swap derivative contracts$— $17.4 $— $17.4 
Deferred compensation plans$— $16.5 $— $16.5 
Derivative Instruments
The cross-currency swap derivative contracts were classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates and foreign currency current exchange rates and forward curves as inputs. The interest rate swap derivative contracts were classified as Level 2 in the fair value hierarchy as they were measured using the income approach with the relevant interest rates and forward curves as inputs. Refer to Note 9 for additional information.
Deferred Compensation Plans
Certain management employees of the Company participate in nonqualified deferred compensation programs that permit such employees to defer a portion of their compensation, on a pretax basis. All amounts deferred under this plan are unfunded, unsecured obligations and are presented as a component of the Company’s compensation and benefits accrual included in accrued expenses in the accompanying Condensed Consolidated Balance Sheets (refer to Note 8). Participants may choose among alternative earnings rates for the amounts they defer, which are primarily based on investment options within the Company’s 401(k) program. Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates on investment options within the Company’s 401(k) program. Amounts voluntarily deferred by employees into the Company stock fund and amounts contributed to participant accounts by the Company are deemed invested in the Company’s common stock and future distributions of such contributions will be made solely in shares of Company common stock, and therefore are not reflected in the above amounts.
Contingent Consideration
Contingent consideration represents a cash hold back intended to be used for certain liabilities related to the Company’s newly acquired Intraoral Scanner Business (as further discussed in Note 2). Contingent consideration was classified as Level 3 in the fair value hierarchy as the estimated fair value was measured using a probability weighted discounted cash flow model.
Fair Value of Financial Instruments
The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):
September 30, 2022December 31, 2021
 Carrying AmountFair ValueCarrying AmountFair Value
Liabilities:
Contingent consideration$6.0 $6.0 $— $— 
Interest rate swap derivative contracts$— $— $2.2 $2.2 
Cross-currency swap derivative contracts$— $— $17.4 $17.4 
Convertible senior notes due 2025$509.3 $854.5 $432.1 $1,162.5 
Long-term debt$851.6 $851.6 $883.4 $883.4 
The fair value of long-term debt approximates the carrying value as these borrowings are based on variable market rates. The fair value of the convertible senior notes due 2025 was determined based on the quoted bid price of the convertible senior notes in an over-the-counter market on September 30, 2022 and December 31, 2021. The convertible senior notes are considered as Level 2 of the fair value hierarchy. The fair values of cash and cash equivalents, which consist primarily of money market funds, time and demand deposits, trade accounts receivable, net and trade accounts payable approximate their carrying amounts due to the short-term maturities of these instruments.
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Warranty
 9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Warranty WARRANTY
The Company generally accrues estimated warranty costs at the time of sale. In general, manufactured products are warranted against defects in material and workmanship when properly used for their intended purpose, installed correctly and appropriately maintained. Warranty periods depend on the nature of the product and range from 90 days up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known.
The following is a rollforward of the Company’s accrued warranty liability ($ in millions):
Balance at December 31, 2021$9.4 
Accruals for warranties issued during the year11.0 
Settlements made(11.3)
Effect of foreign currency translation(0.8)
Balance at September 30, 2022$8.3 
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
Litigation And Contingencies
 9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Litigation And Contingencies LITIGATION AND CONTINGENCIES The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated. The Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated and has accrued $37.1 million and $38.7 million as of September 30, 2022 and December 31, 2021, respectively, which are included in accrued liabilities in the Condensed Consolidated Balance Sheets. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated. In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's Condensed Consolidated Balance Sheets, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company’s results of operations and cash flows for that period.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt And Credit Facilities
 9 Months Ended
Sep. 30, 2022
Debt Disclosure [Abstract]  
Debt And Credit Facilities DEBT AND CREDIT FACILITIES
The components of the Company’s debt were as follows ($ in millions):
September 30, 2022December 31, 2021
Senior term loan facility due 2024 ($650.0 aggregate principal amount) (the “Term Loan Facility”), net of deferred debt issuance costs of $1.9 and $2.7, respectively
$648.1 $647.3 
Senior euro term loan facility due 2024 (€208.0 aggregate principal amount) (the “Euro Term Loan Facility”), net of deferred debt issuance costs of $0.3 and $0.5, respectively
203.5 236.1 
Convertible senior notes due 2025 ($517.5 aggregate principal amount), net of deferred debt issuance costs of $8.2 and $8.9, respectively, and unamortized discount of $0.0 and $76.5, respectively
509.3 432.1 
Revolving credit facility due 2024 ($750.0 aggregate borrowing capacity) (the Revolving Credit Facility)
70.0 — 
Other— 0.3 
Total debt1,430.9 1,315.8 
Less: current portion(579.3)(432.4)
Long-term debt$851.6 $883.4 
As of September 30, 2022 unamortized debt issuance costs totaled $10.4 million. As of December 31, 2021 unamortized debt issuance costs and discount totaled $88.6 million. Unamortized debt issuance costs and discount have been netted against their respective aggregate principal amounts of the related debt in the table above, and are being amortized to interest expense over the term of the respective debt.
Credit Agreement
On September 20, 2019, the Company entered into a credit agreement (the “Credit Agreement”) with a syndicate of banks under which Envista borrowed approximately $1.3 billion, consisting of the three-year $650.0 million Term Loan Facility and the three-year €600.0 million Euro Term Loan Facility (together with the Term Loan Facility, the “Term Loans”). The Credit Agreement also included the five-year, $250.0 million revolving credit facility (the “Revolving Credit Facility” and together with the Term Loans, the “Senior Credit Facilities”). Pursuant to the Separation Agreement, all of the net proceeds of the Term Loans were paid to Danaher as partial consideration for the Dental business Danaher transferred to Envista.

On February 9, 2021, in connection with an amendment to the Credit Agreement, the Company repaid $472.0 million of its Euro Term Loan Facility.
On June 15, 2021, the Company entered into an amended and restated credit agreement (the “Amended Credit Agreement”) with a syndicate of banks including Bank of America, N.A. as administrative agent (the “Administrative Agent”). The Amended Credit Agreement amends and restates the Company’s Credit Agreement, originally dated September 20, 2019 (as amended by Amendment No. 1 to Credit Agreement dated as of May 6, 2020, Amendment No. 2 to Credit Agreement dated as of May 19, 2020, and Amendment No. 3 to Credit Agreement dated as of February 9, 2021).

Under the Amended Credit Agreement: (a) the maturity date of the Company’s existing Term Loans has been extended to September 20, 2024, (b) the Revolving Credit Facility has been increased from $250.0 million to $750.0 million, (c) the Company may request further increases to the Revolving Credit Facility in an aggregate amount not to exceed $350.0 million, (d) the amount of cash and cash equivalents permitted to be netted in the definition of “Consolidated Funded Indebtedness” has been increased to up to the greater of (i) $250.0 million and (ii) 50% of Consolidated EBITDA as of the most recent measurement period, and (e) the floor on Eurocurrency rate loans applicable to the Revolving Credit Facility and the Term Loan Facility has been reduced to zero, in each case subject to and in accordance with the terms and conditions of the Amended Credit Agreement. The Company paid fees aggregating approximately $2.1 million in connection with the Amended Credit Agreement.

The Revolving Credit Facility includes an aggregate available borrowing capacity of $750.0 million with a $20.0 million sublimit for the issuance of standby letters of credit. The Revolving Credit Facility can be used for working capital and other general corporate purposes. As of September 30, 2022, the Company had $70.0 million of outstanding borrowings and $680.0 million of available aggregate undrawn borrowing capacity under the Revolving Credit Facility. At December 31, 2021 there were no borrowings outstanding under the Revolving Credit Facility. The interest rate for borrowings under the Revolving Credit Facility was 3.76% as of September 30, 2022.
Under the Senior Credit Facilities, borrowings bear interest as follows: (1) Eurocurrency Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to the London inter-bank offered (“LIBOR”) rate plus a margin of between 0.785% and 1.625%, depending on the Company’s Consolidated Leverage Ratio (as defined in the Amended Credit Agreement) as of the last day of the immediately preceding fiscal quarter; and (2) Base Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to (a) the highest of (i) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 0.50%, (ii) Bank of America’s “prime rate” as publicly announced from time to time and (iii) the Eurocurrency Rate (as defined in the Amended Credit Agreement) plus 1.0%, plus (b) a margin of between 0.00% and 0.625%, depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter. In no event will Eurocurrency Rate Loans or Base Rate Loans bear interest at a rate lower than 0.0%. In addition, the Company is required to pay a per annum facility fee of between 0.09% and 0.225% depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter and based on the aggregate commitments under the Revolving Credit Facility, whether drawn or not.
The interest rates for borrowings under the Term Loan Facility were 4.77% and 1.25% as of September 30, 2022 and December 31, 2021, respectively. The interest rate for borrowings under the Euro Term Loan Facility was 2.14% and 0.95% as of September 30, 2022 and December 31, 2021, respectively. Interest is payable quarterly for the Term Loans. The Amended Credit Agreement requires the Company to maintain a Consolidated Leverage Ratio of 3.75 to 1.00 or less and includes a provision that the maximum Consolidated Leverage Ratio will be increased to 4.25 to 1.00 for the four consecutive full fiscal quarters immediately following the consummation of any acquisition by the Company or any subsidiary of the Company in which the purchase price exceeds $100.0 million. The Amended Credit Agreement also requires the Company to maintain a Consolidated Interest Coverage Ratio (as defined in the Amended Credit Agreement) of at least 3.00 to 1.00. The Amended Credit Agreement contains customary representations, warranties, conditions precedent, events of default, indemnities and affirmative and negative covenants, including covenants that, among other things, limit or restrict the Company’s and/or the Company’s subsidiaries ability, subject to certain exceptions and qualifications, to incur liens or indebtedness, merge, consolidate or sell or otherwise transfer assets, make dividends or distributions, enter into transactions with the Company’s affiliates and use proceeds of the debt financing for other than permitted uses. The Amended Credit Agreement also contains customary events of default. Upon the occurrence and during the continuance of an event of default, the lenders may declare the outstanding advances and all other obligations under the Amended Credit Agreement immediately due and payable. The Company was in compliance with all of its debt covenants as of September 30, 2022.
Convertible Senior Notes (the “Notes”)

On May 21, 2020, the Company issued the Notes due on June 1, 2025, unless earlier repurchased, redeemed or converted. The aggregate principal amount, which includes the initial purchasers’ exercise in full of their option to purchase an additional $67.5 million principal amount of the Notes, was $517.5 million. The net proceeds from the issuance, after deducting purchasers’ discounts and estimated offering expenses, were $502.6 million. The Company used part of the net proceeds to pay for the capped call transactions (“Capped Calls”) as further described below. The Notes accrue interest at a rate of 2.375% per annum, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. The Notes have an initial conversion rate of 47.5862 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $21.01 per share of the Company’s common stock and is subject to adjustment upon the occurrence of specified events. The Notes are governed by an indenture dated as of May 21, 2020 (the “Indenture”) between the Company and Wilmington Trust, National Association, as trustee. The Indenture does not contain any financial covenants or any restrictions on the payment of dividends, the incurrence of senior debt or other indebtedness or the issuance or repurchase of the Company’s securities by the Company.

Prior to the adoption of ASU 2020-06, the Company separated the carrying amounts of the Notes and total issuance costs incurred into liability and equity components. For the Notes, the carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature, while the carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the Notes. Total issuance costs incurred were then allocated to the liability and equity components of the Notes based on their relative values.

Due to the Company’s adoption of ASU 2020-06 on January 1, 2022, the Notes and related issuance costs incurred are no longer required to be bifurcated into separate liability and equity components. This resulted in a $75.0 million increase to the carrying value of the Notes due 2025, comprised of unamortized discount of $76.5 million and deferred debt issuance costs of $1.5 million and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption of ASU 2020-06 resulted in a $21.4 million increase to retained earnings and a $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs.

As of September 30, 2022, the unamortized debt issuance costs on the Notes was $8.2 million and is being amortized over the term of the Notes.

The Notes are the Company’s senior, unsecured obligations and are (i) equal in right of payment with the Company’s existing and future senior, unsecured indebtedness; (ii) senior in right of payment to the Company’s existing and future indebtedness that is expressly subordinated to the Notes; (iii) effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and (iv) structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries.

Holders of the Notes may convert their Notes at any time on or after December 2, 2024 until the close of business on the second scheduled trading day preceding the maturity date. Holders of the Notes will also have the right to convert the Notes prior to December 2, 2024, but only upon the occurrence of specified events. In December 2021, the Company made the irrevocable election to settle all Notes conversions through combination settlement, satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash, shares of the Company’s common stock or a combination of both. If a fundamental change occurs prior to the maturity date, holders of the Notes may require the Company to repurchase all or a portion of their Notes for cash at a repurchase price equal to 100.0% of the principal amount plus any accrued and unpaid interest. In addition, if specific corporate events occur prior to the maturity date, the Company would increase the conversion rate for a holder who elects to convert its Notes in connection with such an event in certain circumstances. As of September 30, 2022 and December 31, 2021, the stock price exceeded 130% of the conversion price of $21.01 in 20 days of the final 30 trading days ended September 30, 2022 and December 31, 2021, which satisfied one of the conditions permitting early conversion by holders of the Notes, therefore, the Notes are classified as short-term debt.
The Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after June 1, 2023 and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding the redemption date, but only if the last reported sale price per share of the Company’s common stock exceeds 130.0% of the conversion price on (i) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such notice. In addition, calling any Note for redemption will constitute a “Make-Whole Fundamental Change” (as defined in the Indenture) with respect to that Note, in which case the conversion rate applicable to the conversion of that Note will be increased in certain circumstances if it is converted after it is called for redemption.

The following table sets forth total interest expense recognized related to the Notes ($ in millions):

Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Contractual interest expense
$3.1 $3.1 $9.2 $9.2 
Amortization of debt issuance costs
0.7 0.5 2.2 1.4 
Amortization of debt discount
— 4.9 — 14.2 
Total interest expense
$3.8 $8.5 $11.4 $24.8 

For the three and nine months ended September 30, 2022, the debt discount and debt issuance costs were amortized using an annual effective interest rate of 3.0%, to interest expense over the term of the Notes.

As of September 30, 2022 and December 31, 2021, the if-converted value of the Notes exceeded the outstanding principal amount by $290.5 million and $592.1 million, respectively.

Capped Call Transactions

In connection with the offering of the Notes, the Company entered into Capped Calls with certain counterparties. The Capped Calls each have an initial strike price of approximately $21.01 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have initial cap prices of $23.79 per share, subject to certain adjustments. The Capped Calls cover, subject to anti-dilution adjustments, 2.9 million shares of the Company's common stock. The Capped Calls are generally intended to reduce or offset the potential dilution from shares of common stock issued upon any conversion of the Notes with such reduction or offset, as the case may be, subject to a cap based on the cap price. As the Capped Call transactions are considered indexed to the Company's own stock and are considered equity classified, they are recorded in equity and are not accounted for as derivatives. The cost of $20.7 million incurred in connection with the Capped Calls was recorded as a reduction to additional paid-in capital.
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accumulated Other Comprehensive Loss
 9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Accumulated Other Comprehensive Loss ACCUMULATED OTHER COMPREHENSIVE LOSS The changes in accumulated other comprehensive loss by component are summarized below ($ in millions).
Foreign Currency Translation AdjustmentsUnrealized Loss on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Three Months Ended September 30, 2022
Balance, July 1, 2022$(272.1)$0.2 $(2.4)$(274.3)
Other comprehensive loss before reclassifications:
(Decrease) increase(109.9)(0.3)— (110.2)
Income tax impact(6.7)0.1 — (6.6)
Other comprehensive loss before reclassifications, net of income taxes(116.6)(0.2)— (116.8)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — (0.1)(0.1)
Income tax impact— — — — 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (0.1)(0.1)
Net current period other comprehensive loss, net of income taxes(116.6)(0.2)(0.1)(116.9)
Balance, September 30, 2022$(388.7)$— $(2.5)$(391.2)
Foreign Currency Translation AdjustmentsUnrealized Loss on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Three Months Ended October 1, 2021
Balance, July 2, 2021$(101.8)$(3.8)$(23.3)$(128.9)
Other comprehensive income before reclassifications:
(Decrease) increase(20.2)1.5 — (18.7)
Income tax impact(4.8)(0.4)— (5.2)
Other comprehensive (loss) income before reclassifications, net of income taxes(25.0)1.1 — (23.9)
Amounts reclassified from accumulated other comprehensive loss:
Decrease— — 0.2 0.2 
Income tax impact— — — — 
Amounts reclassified from accumulated other comprehensive income, net of income taxes— — 0.2 0.2 
Net current period other comprehensive (loss) income, net of income taxes(25.0)1.1 0.2 (23.7)
Balance, October 1, 2021$(126.8)$(2.7)$(23.1)$(152.6)
Foreign Currency Translation AdjustmentsUnrealized Loss on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Nine Months Ended September 30, 2022
Balance, December 31, 2021$(139.6)$(1.7)$(2.2)$(143.5)
Other comprehensive (loss) income before reclassifications:
(Decrease) increase(224.1)2.2 — (221.9)
Income tax impact(25.0)(0.5)— (25.5)
Other comprehensive (loss) income before reclassifications, net of income taxes(249.1)1.7 — (247.4)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — (0.3)(0.3)
Income tax impact— — — — 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (0.3)(0.3)
Net current period other comprehensive (loss) income, net of income taxes(249.1)1.7 (0.3)(247.7)
Balance, September 30, 2022$(388.7)$— $(2.5)$(391.2)
Foreign Currency Translation AdjustmentsUnrealized Loss on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Nine Months Ended October 1, 2021
Balance, December 31, 2020$(62.5)$(6.3)$(23.0)$(91.8)
Other comprehensive (loss) before reclassifications:
(Decrease) increase(51.2)4.8 — (46.4)
Income tax impact(13.1)(1.2)— (14.3)
Other comprehensive (loss) income before reclassifications, net of income taxes(64.3)3.6 — (60.7)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — — — 
Income tax impact— — (0.1)(0.1)
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (0.1)(0.1)
Net current period other comprehensive (loss) income, net of income taxes(64.3)3.6 (0.1)(60.8)
Balance, October 1, 2021$(126.8)$(2.7)$(23.1)$(152.6)
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue
 9 Months Ended
Sep. 30, 2022
Revenue from Contract with Customer [Abstract]  
Revenue REVENUE
The following table presents the Company’s revenues disaggregated by geographical region for the three and nine months ended September 30, 2022 and October 1, 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.
Three Months Ended September 30, 2022Three Months Ended October 1, 2021
Specialty Products & TechnologiesEquipment & ConsumablesTotalSpecialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$176.5 $163.5 $340.0 $165.4 $164.0 $329.4 
Western Europe77.7 23.6 101.3 76.7 27.0 103.7 
Other developed markets21.7 8.6 30.3 23.4 9.3 32.7 
Emerging markets119.5 40.0 159.5 97.9 43.6 141.5 
Total$395.4 $235.7 $631.1 $363.4 $243.9 $607.3 

Nine Months Ended September 30, 2022Nine Months Ended October 1, 2021
Specialty Products & TechnologiesEquipment & ConsumablesTotalSpecialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$535.3 $480.1 $1,015.4 $502.8 $491.9 $994.7 
Western Europe284.5 85.0 369.5 267.8 89.3 357.1 
Other developed markets69.1 29.2 98.3 74.2 31.1 105.3 
Emerging markets311.3 113.8 425.1 271.3 128.7 400.0 
Total$1,200.2 $708.1 $1,908.3 $1,116.1 $741.0 $1,857.1 

Sales by Major Product Group:
Three Months EndedNine Months Ended
($ in millions)September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Consumables$531.0 $493.7 $1,605.7 $1,541.6 
Equipment100.1 113.6 302.6 315.5 
Total$631.1 $607.3 $1,908.3 $1,857.1 
Consumable products include implants, regenerative solutions, prosthetics, orthodontic brackets, aligners and lab products from our Specialty Products & Technologies business segment and traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products from the Company’s Equipment & Consumables business segment. The Company’s equipment products include digital imaging systems, software and other visualization and magnification systems.

Remaining Performance Obligations
Remaining performance obligations include noncancelable purchase orders, extended warranty and service agreements and do not include revenue from contracts with customers with an original term of one year or less.
As of September 30, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $46.8 million and the Company expects to recognize revenue on the majority of this amount over the next 12 months.
Contract Liabilities
The Company often receives cash payments from customers in advance of the Company’s performance resulting in contract liabilities. These contract liabilities are classified as either current or long-term in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of September 30, 2022 and December 31, 2021, the contract liabilities were $80.3 million and $65.2 million, respectively, and are included within accrued expenses and other liabilities and other long-term liabilities in the accompanying Condensed Consolidated Balance Sheets. Revenue recognized during the nine months ended September 30, 2022 and October 1, 2021 that was included in the contract liability balance at December 31, 2021 and December 31, 2020 was $48.4 million and $34.4 million, respectively.
Significant Customers
Sales to the Company’s largest customer were 11% of sales for both the three and nine months ended September 30, 2022. Sales to the Company’s largest customer were 12% of sales for both the three and nine months ended October 1, 2021.

Seasonality

Based on historical experience, the Company generally has more sales in the second half of the calendar year than in the first half of the calendar year, with the first quarter typically having the lowest sales of the year. Based on historical customer buying patterns, the Company generally has more sales in the fourth quarter than in any other quarter of the year, driven in particular by capital spending in the Equipment & Consumables segment. As a result of this seasonality in sales, profitability in the Equipment & Consumables segment also tends to be higher in the second half of the year. There are no assurances that these historical trends will continue in the future and the ongoing COVID-19 pandemic may impact these trends.
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Restructuring Activities And Related Impairments
 9 Months Ended
Sep. 30, 2022
Restructuring and Related Activities [Abstract]  
Restructuring Activities And Related Impairments RESTRUCTURING ACTIVITIES AND RELATED IMPAIRMENTS
Restructuring Activities
The Company’s restructuring activities are undertaken as necessary to implement management’s strategy, streamline operations, take advantage of available capacity and resources, and ultimately achieve net cost reductions. These activities generally relate to the realignment of existing manufacturing capacity and closure of facilities and other exit or disposal activities, as it relates to executing the Company’s strategy, either in the normal course of business or pursuant to significant restructuring programs.
The related liability which is included in accrued liabilities in the Condensed Consolidated Balance Sheets is summarized below ($ in millions):
Employee Severance
and Related		Facility Exit
and Related		Total
Balance, December 31, 2021$21.4 $0.5 $21.9 
Costs incurred12.7 4.1 16.8 
Paid/settled(17.2)(3.9)(21.1)
Balance, September 30, 2022$16.9 $0.7 $17.6 

Restructuring related charges recorded for the three and nine months ended September 30, 2022 and October 1, 2021, by segment were as follows ($ in millions): 
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Specialty Products & Technologies$4.5 $8.2 $12.7 $15.2 
Equipment & Consumables4.2 0.1 12.6 4.5 
Other0.9 0.3 2.8 4.1 
Total$9.6 $8.6 $28.1 $23.8 
The restructuring related charges incurred during the three and nine months ended September 30, 2022 and October 1, 2021, are reflected in the following captions in the accompanying Condensed Consolidated Statements of Income ($ in millions):
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Cost of sales$3.4 $1.0 $10.0 $6.9 
Selling, general and administrative expenses6.2 7.6 18.1 16.9 
Total$9.6 $8.6 $28.1 $23.8 
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes
 9 Months Ended
Sep. 30, 2022
Income Tax Disclosure [Abstract]  
Income Taxes INCOME TAXES
The Company’s effective tax rates from continuing operations of 21.5% and 21.0% for the three and nine months ended September 30, 2022, respectively, are consistent with the U.S. federal statutory rate of 21.0%. The Company’s effective tax rates from continuing operations of (14.7)% and (1.7)% for the three and nine months ended October 1, 2021, respectively, differ from the U.S. federal statutory rate of 21.0%, primarily due to the Company’s geographical mix of earnings and certain non-recurring Swiss discrete tax benefits.

On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, the Company does not believe this legislation will have a material impact on its Condensed Consolidated Financial Statements.
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share
 9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Earnings Per Share EARNINGS PER SHARE
Earnings per share is calculated by dividing the applicable income by the weighted average number of shares of common stock outstanding for the applicable period. Diluted earnings per share is computed based on the weighted average number of common shares outstanding plus the effect of dilutive potential shares outstanding during the period using the treasury stock method. Dilutive potential common shares include employee equity options, non-vested shares and similar instruments granted by the Company and the assumed conversion impact of the Notes. The Company will settle any Notes conversions through a combination settlement by satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash or shares in the Company’s common stock or any combination thereof. As such, the Company uses the treasury stock method for the assumed conversion of the Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. As the Company will settle the principal amount of the Notes in cash upon conversion, the Notes do not have an impact on the Company's diluted earnings per share until the average share price of the Company’s common stock exceeds the conversion price of $21.01 per share in any applicable period. See the computation of earnings per share below for the dilutive impact of the Notes for the three and nine months ended September 30, 2022 and October 1, 2021.

In connection with the offering of the Notes, the Company entered into Capped Calls (see further discussion in Note 13), which are intended to reduce or offset the potential dilution from shares of common stock issued upon conversion of the Notes. However, this impact is not included when calculating potentially dilutive shares since their effect is anti-dilutive. The Capped Calls will mitigate dilution from the conversion of the Notes up to the Company’s common stock price of $23.79. If the Notes are converted at a price higher than $23.79 per share, the Capped Calls will no longer mitigate dilution from the conversion of the Notes.
The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Numerator:
Income from continuing operations, net of tax$49.6 $80.2 $164.5 $221.0 
(Loss) income from discontinued operations, net of tax$(2.0)$12.7 $5.1 $33.7 
Net income $47.6 $92.9 $169.6 $254.7 
Denominator:
Weighted-average common shares outstanding used in basic earnings (loss) per share163.1 161.5 162.7 161.1 
Incremental common shares from:
Assumed exercise of dilutive options and vesting of dilutive restricted stock units2.8 4.3 3.5 4.4 
Assumed conversion of the Notes11.0 12.3 12.2 12.0 
Weighted average common shares outstanding used in diluted earnings (loss) per share176.9 178.1 178.4 177.5 
Earnings per share:
Earnings from continuing operations - basic$0.30 $0.50 $1.01 $1.37 
Earnings from continuing operations - diluted$0.28 $0.45 $0.92 $1.25 
(Loss) earnings from discontinued operations - basic$(0.01)$0.08 $0.03 $0.21 
(Loss) earnings from discontinued operations - diluted$(0.01)$0.07 $0.03 $0.19 
Earnings - basic$0.29 $0.58 $1.04 $1.58 
Earnings - diluted$0.27 $0.52 $0.95 $1.43 *
* Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.

The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):

Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Stock-based awards1.9 1.4 1.5 1.2 
Total1.9 1.4 1.5 1.2 
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information
 9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION The Company operates and reports its results in two separate business segments, the Specialty Products & Technologies and Equipment & Consumables segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income (expense) and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Inter-segment amounts are not significant and are eliminated to arrive at consolidated totals.
The Company’s Specialty Products & Technologies products include implants, regenerative products, prosthetics, orthodontic brackets, aligners and lab products. The Company’s Equipment & Consumables products include traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products, while the Company’s equipment products include digital imaging systems, software and other visualization and magnification systems.

On December 31, 2021, the Company completed the sale of its KaVo Treatment Unit and Instrument Business, which was part of the Company’s Equipment & Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business. Refer to Note 3 for more information on the Company’s discontinued operations.

Segment related information is shown below ($ in millions):
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Sales:
Specialty Products & Technologies$395.4 $363.4 $1,200.2 $1,116.1 
Equipment & Consumables235.7 243.9 708.1 741.0 
Total$631.1 $607.3 $1,908.3 $1,857.1 
Operating profit and reconciliation to income before taxes from continuing operations:
Specialty Products & Technologies$62.3 $61.5 $206.6 $211.6 
Equipment & Consumables44.7 45.4 120.4 131.0 
Other(32.5)(25.2)(95.8)(82.5)
Operating profit74.5 81.7 231.2 260.1 
Nonoperating income (expense):
   Other income0.3 0.2 0.9 0.8 
   Interest expense, net(11.6)(12.0)(23.9)(43.6)
Income before taxes from continuing operations$63.2 $69.9 $208.2 $217.3 
Identifiable assets:September 30, 2022December 31, 2021
Specialty Products & Technologies$3,395.9 $3,498.2 
Equipment & Consumables2,424.1 1,946.1 
Held for Sale— 12.2 
Other591.9 1,117.7 
Total$6,411.9 $6,574.2 
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business And Basis Of Presentation (Policies)
 9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the financial statements. All significant intercompany accounts and transactions between the businesses comprising the Company have been eliminated in the accompanying Condensed Consolidated Financial Statements.

The Condensed Consolidated Financial Statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The accompanying Condensed Consolidated Financial Statements contain all adjustments (consisting of only normal recurring adjustments and reclassifications to conform to current year presentation) necessary to present fairly the financial position of the Company as of September 30, 2022 and December 31, 2021, and its results of operations for the three and nine month periods ended September 30, 2022 and October 1, 2021 and cash flows for the nine month periods ended September 30, 2022 and October 1, 2021. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Consolidated and Combined Financial Statements and accompanying notes for the three years ended December 31, 2021, included in the Annual Report on Form 10-K filed by the Company with the SEC on February 24, 2022.

As discussed in Note 3, Discontinued Operations, on December 31, 2021, the Company completed the sale of its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.
Accounting Standards Recently Adopted Accounting Standards Recently AdoptedIn March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. The ASU is effective for public entities through December 31, 2022 and the adoption did not have an impact on the Company’s Condensed Consolidated Financial Statements.
Acquisitions
The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into new and attractive business areas. The Company has completed a number of acquisitions that have been accounted for as business combinations and have resulted in the recognition of goodwill in the Company’s Condensed Consolidated Financial Statements. Among other things, goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.

The Company makes an initial allocation of the purchase price at the date of acquisition based upon its understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains this information during due diligence and through other sources. For those assets and liabilities that were accounted for on a preliminary basis, the Company may up to 12 months after closing, refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The finalization of the acquisition valuation assessment, for the acquisitions listed below, may result in a change in the valuation of deferred taxes and goodwill, which could have a material impact on the Company’s financial statements.
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisitions (Tables)
 9 Months Ended
Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]  
Fair Values of Assets Acquired and Liabilities Assumed
The following table summarizes the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates ($ in millions):

Osteogenics
July 5, 2022		Intraoral Scanner Business
April 20, 2022
Assets acquired:
   Cash$2.1 $2.7 
   Accounts receivable2.5 0.1 
   Inventories13.3 6.1 
   Intangible assets53.0 129.8 
   Property, plant and equipment— 0.3 
   Prepaids and Other Current Assets1.3 — 
   Goodwill77.5 370.6 
   Non-current deferred tax asset— 98.5 
   Operating lease right-of-use assets2.6 0.9 
   Other long-term assets4.9 0.2 
       Total assets acquired157.2 609.2 
Liabilities assumed:
   Accounts payable (4.1)(0.5)
   Accrued expenses and other liabilities (2.6)(27.9)
   Non-current deferred tax liability(14.4)— 
   Other long-term liabilities(5.8)— 
   Operating lease liabilities(2.1)(0.5)
       Total liabilities assumed(29.0)(28.9)
Total net assets acquired$128.2 $580.3 
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Discontinued Operations (Tables)
 9 Months Ended
Sep. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Discontinued Operations The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):
December 31, 2021
ASSETS
Current assets:
Assets for relevant jurisdictions$12.2 
Current assets held for sale$12.2 
LIABILITIES AND EQUITY
Current liabilities:
Liabilities for relevant jurisdictions$4.0 
Current liabilities held for sale$4.0 
The operating results of the Divestiture are reflected in the Condensed Consolidated Statements of Income within income from discontinued operations, net of tax as follows ($ in millions):
 Three Months EndedNine Months Ended
 September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Sales$2.8 $102.5 $11.7 $302.0 
Cost of sales2.1 57.2 9.1 174.4 
Gross profit0.7 45.3 2.6 127.6 
Operating expenses:
Selling, general and administrative1.1 25.2 3.2 70.4 
Research and development— 3.8 — 12.5 
Operating (loss) profit(0.4)16.3 (0.6)44.7 
Income tax expense— 3.6 — 11.0 
(Loss) income from discontinued operations(0.4)12.7 (0.6)33.7 
(Loss) gain on sale of discontinued operations, net of tax(1.6)— 5.7 — 
Net (loss) income from discontinued operations$(2.0)$12.7 $5.1 $33.7 

Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):
Nine Months Ended
September 30, 2022October 1, 2021
Cash flows from operating activities
Depreciation and amortization1
$— $5.6 
Cash flows from investing activities:
Capital expenditures$— $4.2 
1 Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Credit Losses (Tables)
 9 Months Ended
Sep. 30, 2022
Credit Loss [Abstract]  
Allowance for Credit Loss
The rollforward of the allowance for credit losses is summarized as follows ($ in millions):

Balance at December 31, 2021$20.7 
Foreign currency translation(1.5)
Provision for credit losses3.8 
Write-offs charged against the allowance(3.3)
Recoveries(2.9)
Balance at September 30, 2022$16.8 
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Inventories (Tables)
 9 Months Ended
Sep. 30, 2022
Inventory Disclosure [Abstract]  
Schedule of Inventory
The classes of inventory are summarized as follows ($ in millions):
September 30, 2022December 31, 2021
Finished goods$234.9 $214.3 
Work in process26.7 22.0 
Raw materials87.3 88.3 
Reserve for inventory obsolescence(57.6)(60.8)
Total$291.3 $263.8 
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property, Plant And Equipment (Tables)
 9 Months Ended
Sep. 30, 2022
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment
The classes of property, plant and equipment are summarized as follows ($ in millions):
September 30, 2022December 31, 2021
Land and improvements$10.4 $10.7 
Buildings and improvements155.2 168.7 
Machinery, equipment and other assets353.2 354.5 
Construction in progress69.3 45.6 
Gross property, plant and equipment588.1 579.5 
Less: accumulated depreciation(310.9)(315.4)
Property, plant and equipment, net$277.2 $264.1 
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Goodwill (Tables)
 9 Months Ended
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Rollforward and Carrying Value Of Goodwill
The following is a rollforward of the Company’s goodwill by segment ($ in millions):
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Balance at December 31, 2021$2,029.7 $1,102.3 $3,132.0 
Acquisitions77.5 370.6 448.1 
Foreign currency translation(126.2)(54.3)(180.5)
Balance at September 30, 2022$1,981.0 $1,418.6 $3,399.6 
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accrued Expenses And Other Liabilities (Tables)
 9 Months Ended
Sep. 30, 2022
Accrued expenses and other [Abstract]  
The components of accrued expenses and other liabilities
Accrued expenses and other liabilities were as follows ($ in millions):
September 30, 2022December 31, 2021
CurrentNoncurrentCurrentNoncurrent
Compensation and benefits$145.1 $16.2 $188.9 $17.9 
Restructuring-related employee severance, benefits and other17.6 — 21.9 — 
Pension benefits5.6 37.3 5.6 41.7 
Taxes, income and other30.4 116.6 48.1 201.4 
Contract liabilities71.4 8.9 60.1 5.1 
Sales and product allowances81.9 1.1 75.4 1.2 
Loss contingencies8.0 29.1 8.4 30.3 
Derivative financial instruments— — 19.6 — 
Other102.5 11.5 134.3 6.6 
Total$462.5 $220.7 $562.3 $304.2 
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Hedging Transactions And Derivative Financial Instruments (Tables)
 9 Months Ended
Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative instruments, gain (loss)
The following table summarizes the notional values as of September 30, 2022 and October 1, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three and nine months ended September 30, 2022 and October 1, 2021 ($ in millions):

Three Months Ended
September 30, 2022		Three Months Ended
October 1, 2021
Notional AmountGain (Loss) Recognized in OCINotional AmountGain Recognized in OCI
Foreign currency denominated debt$203.9 $12.8 $241.2 $5.6 
Interest rate contract— (0.3)250.01.5
Foreign currency contracts— 14.4 650.0 14.1 
Total$203.9 $26.9 $1,141.2 $21.2 
Nine Months Ended
September 30, 2022		Nine Months Ended
October 1, 2021
Notional AmountGain Recognized in OCINotional AmountGain Recognized in OCI
Foreign currency denominated debt$203.9 $32.7 $241.2 $19.7 
Interest rate contracts— 2.2 250.0 4.8 
Foreign currency contracts— 68.5 650.0 33.1 
Total$203.9 $103.4 $1,141.2 $57.6 
Schedule of notional amounts of outstanding derivative positions
The following table summarizes the notional values as of September 30, 2022 and October 1, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three and nine months ended September 30, 2022 and October 1, 2021 ($ in millions):

Three Months Ended
September 30, 2022		Three Months Ended
October 1, 2021
Notional AmountGain (Loss) Recognized in OCINotional AmountGain Recognized in OCI
Foreign currency denominated debt$203.9 $12.8 $241.2 $5.6 
Interest rate contract— (0.3)250.01.5
Foreign currency contracts— 14.4 650.0 14.1 
Total$203.9 $26.9 $1,141.2 $21.2 
Nine Months Ended
September 30, 2022		Nine Months Ended
October 1, 2021
Notional AmountGain Recognized in OCINotional AmountGain Recognized in OCI
Foreign currency denominated debt$203.9 $32.7 $241.2 $19.7 
Interest rate contracts— 2.2 250.0 4.8 
Foreign currency contracts— 68.5 650.0 33.1 
Total$203.9 $103.4 $1,141.2 $57.6 
Schedule of derivative instruments in statement of financial position, fair value
The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified in the Company’s Condensed Consolidated Balance Sheets as follows ($ in millions):
September 30, 2022December 31, 2021
Derivative liabilities:
Accrued expenses and other liabilities$— $19.6 
Nonderivative hedging instruments:
Long-term debt$203.9 $236.5 
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Schedule of financial assets and liabilities at carrying and fair value
A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
September 30, 2022:
Liabilities:
Deferred compensation plans$— $14.8 $— $14.8 
Contingent consideration$— $— $6.0 $6.0 
December 31, 2021:
Liabilities:
Interest rate swap derivative contracts$— $2.2 $— $2.2 
Cross-currency swap derivative contracts$— $17.4 $— $17.4 
Deferred compensation plans$— $16.5 $— $16.5 
The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):
September 30, 2022December 31, 2021
 Carrying AmountFair ValueCarrying AmountFair Value
Liabilities:
Contingent consideration$6.0 $6.0 $— $— 
Interest rate swap derivative contracts$— $— $2.2 $2.2 
Cross-currency swap derivative contracts$— $— $17.4 $17.4 
Convertible senior notes due 2025$509.3 $854.5 $432.1 $1,162.5 
Long-term debt$851.6 $851.6 $883.4 $883.4 
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
Warranty (Tables)
 9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Warranty accrual
The following is a rollforward of the Company’s accrued warranty liability ($ in millions):
Balance at December 31, 2021$9.4 
Accruals for warranties issued during the year11.0 
Settlements made(11.3)
Effect of foreign currency translation(0.8)
Balance at September 30, 2022$8.3 
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt And Credit Facilities (Tables)
 9 Months Ended
Sep. 30, 2022
Debt Disclosure [Abstract]  
Components of debt
The components of the Company’s debt were as follows ($ in millions):
September 30, 2022December 31, 2021
Senior term loan facility due 2024 ($650.0 aggregate principal amount) (the “Term Loan Facility”), net of deferred debt issuance costs of $1.9 and $2.7, respectively
$648.1 $647.3 
Senior euro term loan facility due 2024 (€208.0 aggregate principal amount) (the “Euro Term Loan Facility”), net of deferred debt issuance costs of $0.3 and $0.5, respectively
203.5 236.1 
Convertible senior notes due 2025 ($517.5 aggregate principal amount), net of deferred debt issuance costs of $8.2 and $8.9, respectively, and unamortized discount of $0.0 and $76.5, respectively
509.3 432.1 
Revolving credit facility due 2024 ($750.0 aggregate borrowing capacity) (the Revolving Credit Facility)
70.0 — 
Other— 0.3 
Total debt1,430.9 1,315.8 
Less: current portion(579.3)(432.4)
Long-term debt$851.6 $883.4 
Components of note interest expense
The following table sets forth total interest expense recognized related to the Notes ($ in millions):

Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Contractual interest expense
$3.1 $3.1 $9.2 $9.2 
Amortization of debt issuance costs
0.7 0.5 2.2 1.4 
Amortization of debt discount
— 4.9 — 14.2 
Total interest expense
$3.8 $8.5 $11.4 $24.8 
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accumulated Other Comprehensive Loss (Tables)
 9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Schedule of accumulated other comprehensive income (loss) The changes in accumulated other comprehensive loss by component are summarized below ($ in millions).
Foreign Currency Translation AdjustmentsUnrealized Loss on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Three Months Ended September 30, 2022
Balance, July 1, 2022$(272.1)$0.2 $(2.4)$(274.3)
Other comprehensive loss before reclassifications:
(Decrease) increase(109.9)(0.3)— (110.2)
Income tax impact(6.7)0.1 — (6.6)
Other comprehensive loss before reclassifications, net of income taxes(116.6)(0.2)— (116.8)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — (0.1)(0.1)
Income tax impact— — — — 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (0.1)(0.1)
Net current period other comprehensive loss, net of income taxes(116.6)(0.2)(0.1)(116.9)
Balance, September 30, 2022$(388.7)$— $(2.5)$(391.2)
Foreign Currency Translation AdjustmentsUnrealized Loss on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Three Months Ended October 1, 2021
Balance, July 2, 2021$(101.8)$(3.8)$(23.3)$(128.9)
Other comprehensive income before reclassifications:
(Decrease) increase(20.2)1.5 — (18.7)
Income tax impact(4.8)(0.4)— (5.2)
Other comprehensive (loss) income before reclassifications, net of income taxes(25.0)1.1 — (23.9)
Amounts reclassified from accumulated other comprehensive loss:
Decrease— — 0.2 0.2 
Income tax impact— — — — 
Amounts reclassified from accumulated other comprehensive income, net of income taxes— — 0.2 0.2 
Net current period other comprehensive (loss) income, net of income taxes(25.0)1.1 0.2 (23.7)
Balance, October 1, 2021$(126.8)$(2.7)$(23.1)$(152.6)
Foreign Currency Translation AdjustmentsUnrealized Loss on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Nine Months Ended September 30, 2022
Balance, December 31, 2021$(139.6)$(1.7)$(2.2)$(143.5)
Other comprehensive (loss) income before reclassifications:
(Decrease) increase(224.1)2.2 — (221.9)
Income tax impact(25.0)(0.5)— (25.5)
Other comprehensive (loss) income before reclassifications, net of income taxes(249.1)1.7 — (247.4)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — (0.3)(0.3)
Income tax impact— — — — 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (0.3)(0.3)
Net current period other comprehensive (loss) income, net of income taxes(249.1)1.7 (0.3)(247.7)
Balance, September 30, 2022$(388.7)$— $(2.5)$(391.2)
Foreign Currency Translation AdjustmentsUnrealized Loss on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Nine Months Ended October 1, 2021
Balance, December 31, 2020$(62.5)$(6.3)$(23.0)$(91.8)
Other comprehensive (loss) before reclassifications:
(Decrease) increase(51.2)4.8 — (46.4)
Income tax impact(13.1)(1.2)— (14.3)
Other comprehensive (loss) income before reclassifications, net of income taxes(64.3)3.6 — (60.7)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — — — 
Income tax impact— — (0.1)(0.1)
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (0.1)(0.1)
Net current period other comprehensive (loss) income, net of income taxes(64.3)3.6 (0.1)(60.8)
Balance, October 1, 2021$(126.8)$(2.7)$(23.1)$(152.6)
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue (Tables)
 9 Months Ended
Sep. 30, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of disaggregation of revenue by geographical region and type
The following table presents the Company’s revenues disaggregated by geographical region for the three and nine months ended September 30, 2022 and October 1, 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.
Three Months Ended September 30, 2022Three Months Ended October 1, 2021
Specialty Products & TechnologiesEquipment & ConsumablesTotalSpecialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$176.5 $163.5 $340.0 $165.4 $164.0 $329.4 
Western Europe77.7 23.6 101.3 76.7 27.0 103.7 
Other developed markets21.7 8.6 30.3 23.4 9.3 32.7 
Emerging markets119.5 40.0 159.5 97.9 43.6 141.5 
Total$395.4 $235.7 $631.1 $363.4 $243.9 $607.3 

Nine Months Ended September 30, 2022Nine Months Ended October 1, 2021
Specialty Products & TechnologiesEquipment & ConsumablesTotalSpecialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$535.3 $480.1 $1,015.4 $502.8 $491.9 $994.7 
Western Europe284.5 85.0 369.5 267.8 89.3 357.1 
Other developed markets69.1 29.2 98.3 74.2 31.1 105.3 
Emerging markets311.3 113.8 425.1 271.3 128.7 400.0 
Total$1,200.2 $708.1 $1,908.3 $1,116.1 $741.0 $1,857.1 

Sales by Major Product Group:
Three Months EndedNine Months Ended
($ in millions)September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Consumables$531.0 $493.7 $1,605.7 $1,541.6 
Equipment100.1 113.6 302.6 315.5 
Total$631.1 $607.3 $1,908.3 $1,857.1 
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Restructuring Activities And Related Impairments (Tables)
 9 Months Ended
Sep. 30, 2022
Restructuring and Related Activities [Abstract]  
Restructuring and related costs
The related liability which is included in accrued liabilities in the Condensed Consolidated Balance Sheets is summarized below ($ in millions):
Employee Severance
and Related		Facility Exit
and Related		Total
Balance, December 31, 2021$21.4 $0.5 $21.9 
Costs incurred12.7 4.1 16.8 
Paid/settled(17.2)(3.9)(21.1)
Balance, September 30, 2022$16.9 $0.7 $17.6 
Schedule of restructuring reserve by type of cost
Restructuring related charges recorded for the three and nine months ended September 30, 2022 and October 1, 2021, by segment were as follows ($ in millions): 
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Specialty Products & Technologies$4.5 $8.2 $12.7 $15.2 
Equipment & Consumables4.2 0.1 12.6 4.5 
Other0.9 0.3 2.8 4.1 
Total$9.6 $8.6 $28.1 $23.8 
The restructuring related charges incurred during the three and nine months ended September 30, 2022 and October 1, 2021, are reflected in the following captions in the accompanying Condensed Consolidated Statements of Income ($ in millions):
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Cost of sales$3.4 $1.0 $10.0 $6.9 
Selling, general and administrative expenses6.2 7.6 18.1 16.9 
Total$9.6 $8.6 $28.1 $23.8 
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share (Tables)
 9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Schedule of earnings per share, basic and diluted
The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Numerator:
Income from continuing operations, net of tax$49.6 $80.2 $164.5 $221.0 
(Loss) income from discontinued operations, net of tax$(2.0)$12.7 $5.1 $33.7 
Net income $47.6 $92.9 $169.6 $254.7 
Denominator:
Weighted-average common shares outstanding used in basic earnings (loss) per share163.1 161.5 162.7 161.1 
Incremental common shares from:
Assumed exercise of dilutive options and vesting of dilutive restricted stock units2.8 4.3 3.5 4.4 
Assumed conversion of the Notes11.0 12.3 12.2 12.0 
Weighted average common shares outstanding used in diluted earnings (loss) per share176.9 178.1 178.4 177.5 
Earnings per share:
Earnings from continuing operations - basic$0.30 $0.50 $1.01 $1.37 
Earnings from continuing operations - diluted$0.28 $0.45 $0.92 $1.25 
(Loss) earnings from discontinued operations - basic$(0.01)$0.08 $0.03 $0.21 
(Loss) earnings from discontinued operations - diluted$(0.01)$0.07 $0.03 $0.19 
Earnings - basic$0.29 $0.58 $1.04 $1.58 
Earnings - diluted$0.27 $0.52 $0.95 $1.43 *
* Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.
Schedule of antidilutive securities excluded from computation of earnings per share
The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):

Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Stock-based awards1.9 1.4 1.5 1.2 
Total1.9 1.4 1.5 1.2 
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information (Tables)
 9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Segment results
Segment related information is shown below ($ in millions):
Three Months EndedNine Months Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Sales:
Specialty Products & Technologies$395.4 $363.4 $1,200.2 $1,116.1 
Equipment & Consumables235.7 243.9 708.1 741.0 
Total$631.1 $607.3 $1,908.3 $1,857.1 
Operating profit and reconciliation to income before taxes from continuing operations:
Specialty Products & Technologies$62.3 $61.5 $206.6 $211.6 
Equipment & Consumables44.7 45.4 120.4 131.0 
Other(32.5)(25.2)(95.8)(82.5)
Operating profit74.5 81.7 231.2 260.1 
Nonoperating income (expense):
   Other income0.3 0.2 0.9 0.8 
   Interest expense, net(11.6)(12.0)(23.9)(43.6)
Income before taxes from continuing operations$63.2 $69.9 $208.2 $217.3 
Identifiable assets:September 30, 2022December 31, 2021
Specialty Products & Technologies$3,395.9 $3,498.2 
Equipment & Consumables2,424.1 1,946.1 
Held for Sale— 12.2 
Other591.9 1,117.7 
Total$6,411.9 $6,574.2 
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business And Basis Of Presentation - Narrative (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2022
USD ($)
segment
Sep. 30, 2022
USD ($)
Segment
Jul. 01, 2022
USD ($)
Apr. 01, 2022
USD ($)
Dec. 31, 2021
USD ($)
Oct. 01, 2021
USD ($)
Jul. 02, 2021
USD ($)
Apr. 02, 2021
USD ($)
Dec. 31, 2020
USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                  
Number of business segments (in segments) 2 2              
Long-term Debt $ 1,430.9 $ 1,430.9     $ 1,315.8        
Stockholders' equity (3,957.9) (3,957.9)     (4,058.0)        
Additional Paid-in Capital                  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                  
Stockholders' equity (3,689.6) (3,689.6) $ (3,678.4) $ (3,667.9) (3,732.6) $ (3,716.6) $ (3,707.6) $ (3,691.1) $ (3,684.4)
Retained Earnings                  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                  
Stockholders' equity $ (657.9) $ (657.9) $ (610.3) $ (563.2) (466.9) $ (381.1) $ (288.2) $ (198.1) $ (126.4)
Adjustment                  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                  
Net deferred tax liability         18.6        
Adjustment | Convertible Debt                  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                  
Long-term Debt         75.0        
Adjustment | Additional Paid-in Capital                  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                  
Stockholders' equity         77.8        
Adjustment | Retained Earnings                  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                  
Stockholders' equity         $ (21.4)        
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisitions - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Jul. 05, 2022
Apr. 20, 2022
Sep. 30, 2022
Sep. 30, 2022
Business Acquisition [Line Items]        
Contingent consideration     $ 6,000 $ 6,000
Osteogenics Biomedical Inc        
Business Acquisition [Line Items]        
Consideration transferred $ 128,200      
Weighted-average useful life of acquired intangible assets       10 years
Carestream Dental Technology        
Business Acquisition [Line Items]        
Consideration transferred   $ 580,300    
Contingent consideration   $ 7,500    
Weighted-average useful life of acquired intangible assets       8 years
Osteogenics Biomedical Inc & Carestream Dental Technology        
Business Acquisition [Line Items]        
Acquisition costs     $ 1,500 $ 13,400
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisitions - Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Jul. 05, 2022
Apr. 20, 2022
Dec. 31, 2021
Assets acquired:        
Goodwill $ 3,399.6     $ 3,132.0
Osteogenics Biomedical Inc        
Assets acquired:        
Cash   $ 2.1    
Accounts receivable   2.5    
Inventories   13.3    
Intangible assets   53.0    
Property, plant and equipment   0.0    
Prepaids and Other Current Assets   1.3    
Goodwill   77.5    
Non-current deferred tax asset   0.0    
Operating lease right-of-use assets   2.6    
Other long-term assets   4.9    
Total assets acquired   157.2    
Liabilities assumed:        
Accounts payable   (4.1)    
Accrued expenses and other liabilities   (2.6)    
Non-current deferred tax liability   (14.4)    
Other long-term liabilities   (5.8)    
Operating lease liabilities   (2.1)    
Total liabilities assumed   (29.0)    
Total net assets acquired   $ 128.2    
Carestream Dental Technology        
Assets acquired:        
Cash     $ 2.7  
Accounts receivable     0.1  
Inventories     6.1  
Intangible assets     129.8  
Property, plant and equipment     0.3  
Prepaids and Other Current Assets     0.0  
Goodwill     370.6  
Non-current deferred tax asset     98.5  
Operating lease right-of-use assets     0.9  
Other long-term assets     0.2  
Total assets acquired     609.2  
Liabilities assumed:        
Accounts payable     (0.5)  
Accrued expenses and other liabilities     (27.9)  
Non-current deferred tax liability     0.0  
Other long-term liabilities     0.0  
Operating lease liabilities     (0.5)  
Total liabilities assumed     (28.9)  
Total net assets acquired     $ 580.3  
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
Discontinued Operations - Narrative (Details) - Discontinued operations disposed of by sale - Plamenca - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Consideration         $ 317.3
Proceeds from sale of KaVo treatment unit and instrument business, net     $ 59.8    
Liability for proceeds related to the Relevant Jurisdictions         $ 10.8
Gain (loss) on disposal $ (1.6) $ 0.0 $ 5.7 $ 0.0  
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
Discontinued Operations - Carrying Amount of Assets and Liabilities (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Current assets held for sale $ 0.0 $ 12.2
Current liabilities:    
Current liabilities held for sale $ 0.0 4.0
Discontinued operations disposed of by sale | Plamenca    
Current assets:    
Assets for relevant jurisdictions   12.2
Current assets held for sale   12.2
Current liabilities:    
Liabilities for relevant jurisdictions   4.0
Current liabilities held for sale   $ 4.0
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
Discontinued Operations - Operating Results (Details) - Discontinued operations disposed of by sale - Plamenca - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Sales $ 2.8 $ 102.5 $ 11.7 $ 302.0
Cost of sales 2.1 57.2 9.1 174.4
Gross profit 0.7 45.3 2.6 127.6
Operating expenses:        
Selling, general and administrative 1.1 25.2 3.2 70.4
Research and development 0.0 3.8 0.0 12.5
Operating (loss) profit (0.4) 16.3 (0.6) 44.7
Income tax expense 0.0 3.6 0.0 11.0
(Loss) income from discontinued operations (0.4) 12.7 (0.6) 33.7
(Loss) gain on sale of discontinued operations, net of tax (1.6) 0.0 5.7 0.0
Net (loss) income from discontinued operations $ (2.0) $ 12.7 $ 5.1 $ 33.7
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details) - Discontinued operations disposed of by sale - Plamenca - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Cash flows from operating activities    
Depreciation and amortization $ 0.0 $ 5.6
Cash flows from investing activities:    
Capital expenditures $ 0.0 $ 4.2
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
Credit Losses - Narrative (Details)
 9 Months Ended
Sep. 30, 2022
segment
Credit Loss [Abstract]  
Number of portfolio segments (in segments) 1
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.22.2.2
Credit Losses - Allowance for Credit Losses (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2022
USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]  
Beginning balance $ 20.7
Foreign currency translation (1.5)
Provision for credit losses 3.8
Write-offs charged against the allowance (3.3)
Recoveries (2.9)
Ending balance $ 16.8
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
Inventories - Summary (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Finished goods $ 234.9 $ 214.3
Work in process 26.7 22.0
Raw materials 87.3 88.3
Reserve for inventory obsolescence (57.6) (60.8)
Total $ 291.3 $ 263.8
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property, Plant And Equipment (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment $ 588.1 $ 579.5
Less: accumulated depreciation (310.9) (315.4)
Property, plant and equipment, net 277.2 264.1
Land and improvements    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment 10.4 10.7
Buildings and improvements    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment 155.2 168.7
Machinery, equipment and other assets    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment 353.2 354.5
Construction in progress    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment $ 69.3 $ 45.6
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
Goodwill - Rollforward (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2022
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 3,132.0
Acquisitions 448.1
Foreign currency translation (180.5)
Ending balance 3,399.6
Specialty Products & Technologies  
Goodwill [Roll Forward]  
Beginning balance 2,029.7
Acquisitions 77.5
Foreign currency translation (126.2)
Ending balance 1,981.0
Equipment & Consumables  
Goodwill [Roll Forward]  
Beginning balance 1,102.3
Acquisitions 370.6
Foreign currency translation (54.3)
Ending balance $ 1,418.6
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accrued Expenses And Other Liabilities - Summary (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current    
Compensation and benefits $ 145.1 $ 188.9
Restructuring-related employee severance, benefits and other 17.6 21.9
Pension benefits 5.6 5.6
Taxes, income and other 30.4 48.1
Contract liabilities 71.4 60.1
Sales and product allowances 81.9 75.4
Loss contingencies 8.0 8.4
Derivative financial instruments 0.0 19.6
Other 102.5 134.3
Total 462.5 562.3
Noncurrent    
Compensation and benefits 16.2 17.9
Restructuring-related employee severance, benefits and other 0.0 0.0
Pension benefits 37.3 41.7
Taxes, income and other 116.6 201.4
Contract liabilities 8.9 5.1
Sales and product allowances 1.1 1.2
Loss contingencies 29.1 30.3
Derivative financial instruments 0.0 0.0
Other 11.5 6.6
Total $ 220.7 $ 304.2
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
Hedging Transactions And Derivative Financial Instruments - Narrative (Details)
Sep. 30, 2022
EUR (€)
Sep. 30, 2022
USD ($)
Dec. 31, 2021
USD ($)
Sep. 20, 2019
EUR (€)
Sep. 20, 2019
USD ($)
Derivative [Line Items]          
Total debt   $ 1,430,900,000 $ 1,315,800,000    
Euro term loan due 2024          
Derivative [Line Items]          
Term loan | € € 208,000,000.0     € 600,000,000.0  
Total debt   203,500,000 236,100,000    
US term loan due 2024          
Derivative [Line Items]          
Term loan         $ 650,000,000.0
Total debt   $ 648,100,000 $ 647,300,000   $ 650,000,000.0
XML 70 R58.htm IDEA: XBRL DOCUMENT v3.22.2.2
Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Derivative Instruments, Gain (Loss) [Line Items]        
Notional Amount $ 203.9 $ 1,141.2 $ 203.9 $ 1,141.2
Gain Recognized in OCI 26.9 21.2 103.4 57.6
Net investment hedging | Foreign currency denominated debt        
Derivative Instruments, Gain (Loss) [Line Items]        
Notional Amount 203.9 241.2 203.9 241.2
Gain Recognized in OCI 12.8 5.6 32.7 19.7
Net investment hedging | Interest rate contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Notional Amount 0.0 250.0 0.0 250.0
Gain Recognized in OCI (0.3) 1.5 2.2 4.8
Net investment hedging | Foreign currency contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Notional Amount 0.0 650.0 0.0 650.0
Gain Recognized in OCI $ 14.4 $ 14.1 $ 68.5 $ 33.1
XML 71 R59.htm IDEA: XBRL DOCUMENT v3.22.2.2
Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Derivatives, Fair Value [Line Items]    
Accrued expenses and other liabilities $ 0.0 $ 19.6
Long-term debt    
Derivatives, Fair Value [Line Items]    
Long-term debt $ 203.9 $ 236.5
XML 72 R60.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Liabilities:    
Deferred compensation plans $ 14.8 $ 16.5
Contingent consideration 6.0  
Accrued expenses and other liabilities 0.0 19.6
Quoted Prices in Active Market (Level 1)    
Liabilities:    
Deferred compensation plans 0.0 0.0
Contingent consideration 0.0  
Significant Other Observable Inputs (Level 2)    
Liabilities:    
Deferred compensation plans 14.8 16.5
Contingent consideration 0.0  
Significant Unobservable Inputs (Level 3)    
Liabilities:    
Deferred compensation plans 0.0 0.0
Contingent consideration $ 6.0  
Interest rate swap derivative contracts    
Liabilities:    
Accrued expenses and other liabilities   2.2
Interest rate swap derivative contracts | Quoted Prices in Active Market (Level 1)    
Liabilities:    
Accrued expenses and other liabilities   0.0
Interest rate swap derivative contracts | Significant Other Observable Inputs (Level 2)    
Liabilities:    
Accrued expenses and other liabilities   2.2
Interest rate swap derivative contracts | Significant Unobservable Inputs (Level 3)    
Liabilities:    
Accrued expenses and other liabilities   0.0
Cross-currency swap derivative contracts    
Liabilities:    
Accrued expenses and other liabilities   17.4
Cross-currency swap derivative contracts | Quoted Prices in Active Market (Level 1)    
Liabilities:    
Accrued expenses and other liabilities   0.0
Cross-currency swap derivative contracts | Significant Other Observable Inputs (Level 2)    
Liabilities:    
Accrued expenses and other liabilities   17.4
Cross-currency swap derivative contracts | Significant Unobservable Inputs (Level 3)    
Liabilities:    
Accrued expenses and other liabilities   $ 0.0
XML 73 R61.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements - Fair Value of Financial Instruments (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration $ 6.0  
Accrued expenses and other liabilities 0.0 $ 19.6
Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration 6.0 0.0
Convertible senior notes due 2025 509.3 432.1
Long-term debt 851.6 883.4
Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration 6.0 0.0
Convertible senior notes due 2025 854.5 1,162.5
Long-term debt 851.6 883.4
Interest rate swap derivative contracts    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Accrued expenses and other liabilities   2.2
Interest rate swap derivative contracts | Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Accrued expenses and other liabilities 0.0 2.2
Interest rate swap derivative contracts | Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Accrued expenses and other liabilities 0.0 2.2
Cross-currency swap derivative contracts    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Accrued expenses and other liabilities   17.4
Cross-currency swap derivative contracts | Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Accrued expenses and other liabilities 0.0 17.4
Cross-currency swap derivative contracts | Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Accrued expenses and other liabilities $ 0.0 $ 17.4
XML 74 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
Warranty - Narrative (Details)
 9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Product warranty period 90 days
XML 75 R63.htm IDEA: XBRL DOCUMENT v3.22.2.2
Warranty - Warranty Accrual (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2022
USD ($)
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]  
Beginning balance $ 9.4
Accruals for warranties issued during the year 11.0
Settlements made (11.3)
Effect of foreign currency translation (0.8)
Ending balance $ 8.3
XML 76 R64.htm IDEA: XBRL DOCUMENT v3.22.2.2
Litigation And Contingencies - Narrative (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
Accrual for legal matters $ 37.1 $ 38.7
XML 77 R65.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt And Credit Facilities - Components Of Debt (Details)
Sep. 30, 2022
EUR (€)
Sep. 30, 2022
USD ($)
Dec. 31, 2021
USD ($)
May 21, 2020
USD ($)
Sep. 20, 2019
EUR (€)
Sep. 20, 2019
USD ($)
Debt Instrument [Line Items]            
Total debt   $ 1,430,900,000 $ 1,315,800,000      
Less: current portion   (579,300,000) (432,400,000)      
Long-term debt   851,600,000 883,400,000      
Revolving Credit Facility            
Debt Instrument [Line Items]            
Revolving credit facility maximum borrowing capacity   750,000,000.0        
US term loan due 2024            
Debt Instrument [Line Items]            
Term loan           $ 650,000,000.0
Debt issuance costs   1,900,000 2,700,000      
Total debt   648,100,000 647,300,000     $ 650,000,000.0
Euro term loan due 2024            
Debt Instrument [Line Items]            
Term loan | € € 208,000,000.0       € 600,000,000.0  
Debt issuance costs   300,000 500,000      
Total debt   203,500,000 236,100,000      
Revolving credit facility due 2024 | Revolving Credit Facility            
Debt Instrument [Line Items]            
Total debt   70,000,000.0 0      
Other            
Debt Instrument [Line Items]            
Total debt   0 300,000      
Convertible Debt | Convertible senior notes due 2025            
Debt Instrument [Line Items]            
Term loan       $ 517,500,000    
Debt issuance costs   8,200,000 8,900,000      
Unamortized discount   0.0 76,500,000      
Total debt   $ 509,300,000 $ 432,100,000      
XML 78 R66.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt And Credit Facilities - Narrative (Details)
$ / shares in Units, shares in Millions
 9 Months Ended 12 Months Ended
Jun. 15, 2021
USD ($)
Feb. 09, 2021
USD ($)
May 21, 2020
USD ($)
tradingDay
$ / shares
shares
Sep. 20, 2019
USD ($)
Sep. 30, 2022
USD ($)
tradingDay
$ / shares
Dec. 31, 2021
USD ($)
tradingDay
$ / shares
Sep. 30, 2022
EUR (€)
Jul. 01, 2022
USD ($)
Apr. 01, 2022
USD ($)
Oct. 01, 2021
USD ($)
Jul. 02, 2021
USD ($)
Apr. 02, 2021
USD ($)
Dec. 31, 2020
USD ($)
Sep. 20, 2019
EUR (€)
Debt Instrument [Line Items]                            
Unamortized debt issuance costs and discount         $ 10,400,000 $ 88,600,000                
Total borrowings under term loan       $ 1,300,000,000                    
Senior unsecured revolving credit facility       $ 250,000,000.0                    
Rate in excess of Federal funds rate         0.0050   0.0050              
Rate in excess of Eurocurrency rate         0.010   0.010              
Leverage ratio         3.75   3.75              
Contingency provision on the ratio of indebtedness to net capital         4.25   4.25              
Contingency provision, purchase price in excess of $100 million         $ 100,000,000.0                  
Interest coverage ratio (at least)         3.00   3.00              
Conversion price (in USD per share) | $ / shares         $ 21.01 $ 21.01                
Total debt         $ 1,430,900,000 $ 1,315,800,000                
Increase (decrease) in stockholders' equity         3,957,900,000 4,058,000,000                
Additional Paid-in Capital                            
Debt Instrument [Line Items]                            
Increase (decrease) in stockholders' equity         3,689,600,000 3,732,600,000   $ 3,678,400,000 $ 3,667,900,000 $ 3,716,600,000 $ 3,707,600,000 $ 3,691,100,000 $ 3,684,400,000  
Retained Earnings                            
Debt Instrument [Line Items]                            
Increase (decrease) in stockholders' equity         657,900,000 466,900,000   $ 610,300,000 $ 563,200,000 $ 381,100,000 $ 288,200,000 $ 198,100,000 $ 126,400,000  
Adjustment                            
Debt Instrument [Line Items]                            
Net deferred tax liability           18,600,000                
Adjustment | Additional Paid-in Capital                            
Debt Instrument [Line Items]                            
Increase (decrease) in stockholders' equity           (77,800,000)                
Adjustment | Retained Earnings                            
Debt Instrument [Line Items]                            
Increase (decrease) in stockholders' equity           21,400,000                
Fair Value                            
Debt Instrument [Line Items]                            
Fair value of notes         $ 851,600,000 $ 883,400,000                
US term loan due 2024                            
Debt Instrument [Line Items]                            
Debt instrument, term       3 years                    
Term loan       $ 650,000,000.0                    
Loan facility interest rates         4.77% 1.25%                
Total debt       $ 650,000,000.0 $ 648,100,000 $ 647,300,000                
Debt issuance costs         $ 1,900,000 $ 2,700,000                
Euro term loan due 2024                            
Debt Instrument [Line Items]                            
Debt instrument, term       3 years                    
Term loan | €             € 208,000,000.0             € 600,000,000.0
Repayment of debt   $ 472,000,000.0                        
Loan facility interest rates         2.14% 0.95%                
Total debt         $ 203,500,000 $ 236,100,000                
Debt issuance costs         300,000 500,000                
Revolving Credit Facility                            
Debt Instrument [Line Items]                            
Senior unsecured revolving credit facility $ 750,000,000.0     $ 250,000,000.0                    
Increase limit of revolving credit facility 350,000,000.0                          
Cash and cash equivalent threshold $ 250,000,000.0                          
EBITDA threshold 0.50                          
Payments of debt restructuring costs $ 2,100,000                          
Revolving credit facility maximum borrowing capacity         $ 750,000,000.0                  
Line of credit facility, interest rate         3.76%   3.76%              
Line of credit facility, outstanding borrowings         $ 70,000,000.0 0                
Line of credit facility, available borrowing capacity         680,000,000.0                  
Revolving Credit Facility | Standby letters of credit                            
Debt Instrument [Line Items]                            
Revolving credit facility maximum borrowing capacity         $ 20,000,000.0                  
Minimum                            
Debt Instrument [Line Items]                            
Facility fee         0.09%                  
Maximum                            
Debt Instrument [Line Items]                            
Facility fee         0.225%                  
LIBOR | Minimum | Credit facility                            
Debt Instrument [Line Items]                            
Margin spread of variable interest rate         0.785%                  
LIBOR | Maximum | Credit facility                            
Debt Instrument [Line Items]                            
Margin spread of variable interest rate         1.625%                  
Base Rate | Minimum                            
Debt Instrument [Line Items]                            
Margin spread of variable interest rate         0.00%                  
Base Rate | Maximum                            
Debt Instrument [Line Items]                            
Margin spread of variable interest rate         0.625%                  
Revolving credit facility due 2024 | Revolving Credit Facility                            
Debt Instrument [Line Items]                            
Debt instrument, term       5 years                    
Convertible Debt | Adjustment                            
Debt Instrument [Line Items]                            
Total debt           75,000,000                
Unamortized discount (premium), net           76,500,000                
Debt issuance and deferred financing costs           1,500,000                
Convertible Debt | 2.375% convertible senior notes over allotment option                            
Debt Instrument [Line Items]                            
Term loan     $ 67,500,000                      
Convertible Debt | 2.375% convertible senior notes                            
Debt Instrument [Line Items]                            
Term loan     517,500,000                      
Proceeds from issuance of convertible senior notes     $ 502,600,000                      
Interest rate     2.375%                      
Conversion price (in USD per share) | $ / shares     $ 21.01                      
Total debt         $ 509,300,000 $ 432,100,000                
Debt issuance and deferred financing costs         $ 8,200,000                  
Redemption price     100.00%                      
Threshold percentage of stock price trigger     130.00%   130.00% 130.00%                
Convertible debt, trading days (in trading days) | tradingDay     20   20 20                
Convertible debt, consecutive trading days (in trading days) | tradingDay     30   30 30                
Debt issuance costs         $ 8,200,000 $ 8,900,000                
Effective interest rate         3.00%   3.00%              
If-converted value in excess of principal         $ 290,500,000 $ 592,100,000                
Convertible debt, conversion ratio     0.0475862                      
Convertible Debt | 2.375% convertible senior notes, capped calls                            
Debt Instrument [Line Items]                            
Conversion price (in USD per share) | $ / shares     $ 23.79                      
Convertible debt, stock price trigger (in USD per share) | $ / shares     $ 21.01                      
Convertible debt, capped calls (in shares) | shares     2.9                      
Convertible debt expense, capped calls     $ 20,700,000                      
XML 79 R67.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt And Credit Facilities - Interest Expense (Details) - Convertible Debt - 2.375% convertible senior notes - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Debt Instrument [Line Items]        
Contractual interest expense $ 3.1 $ 3.1 $ 9.2 $ 9.2
Amortization of debt issuance costs 0.7 0.5 2.2 1.4
Amortization of debt discount 0.0 4.9 0.0 14.2
Total interest expense $ 3.8 $ 8.5 $ 11.4 $ 24.8
XML 80 R68.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accumulated Other Comprehensive Loss - Rollforward (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Jul. 01, 2022
Apr. 01, 2022
Oct. 01, 2021
Jul. 02, 2021
Apr. 02, 2021
Sep. 30, 2022
Oct. 01, 2021
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]                
Balance, beginning of period     $ 4,058.0       $ 4,058.0  
Total other comprehensive loss, net of income taxes $ (116.9)     $ (23.7)     (247.7) $ (60.8)
Balance, end of period 3,957.9           3,957.9  
Accumulated Other Comprehensive Loss                
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]                
Balance, beginning of period (274.3) $ (201.8) (143.5) (128.9) $ (143.9) $ (91.8) (143.5) (91.8)
(Decrease) increase before reclassifications (110.2)     (18.7)     (221.9) (46.4)
Income tax impact (6.6)     (5.2)     (25.5) (14.3)
Other comprehensive (loss) income before reclassifications, net of income taxes (116.8)     (23.9)     (247.4) (60.7)
Increase (0.1)     0.2     (0.3) 0.0
Income tax impact 0.0     0.0     0.0 (0.1)
Amounts reclassified from accumulated other comprehensive loss, net of income taxes (0.1)     0.2     (0.3) (0.1)
Total other comprehensive loss, net of income taxes (116.9) (72.5) (58.3) (23.7) 15.0 (52.1) (247.7) (60.8)
Balance, end of period (391.2) (274.3) (201.8) (152.6) (128.9) (143.9) (391.2) (152.6)
Foreign Currency Translation Adjustments                
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]                
Balance, beginning of period (272.1)   (139.6) (101.8)   (62.5) (139.6) (62.5)
(Decrease) increase before reclassifications (109.9)     (20.2)     (224.1) (51.2)
Income tax impact (6.7)     (4.8)     (25.0) (13.1)
Other comprehensive (loss) income before reclassifications, net of income taxes (116.6)     (25.0)     (249.1) (64.3)
Increase 0.0     0.0     0.0 0.0
Income tax impact 0.0     0.0     0.0 0.0
Amounts reclassified from accumulated other comprehensive loss, net of income taxes 0.0     0.0     0.0 0.0
Total other comprehensive loss, net of income taxes (116.6)     (25.0)     (249.1) (64.3)
Balance, end of period (388.7) (272.1)   (126.8) (101.8)   (388.7) (126.8)
Unrealized Loss on Cash Flow Hedges                
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]                
Balance, beginning of period 0.2   (1.7) (3.8)   (6.3) (1.7) (6.3)
(Decrease) increase before reclassifications (0.3)     1.5     2.2 4.8
Income tax impact 0.1     (0.4)     (0.5) (1.2)
Other comprehensive (loss) income before reclassifications, net of income taxes (0.2)     1.1     1.7 3.6
Increase 0.0     0.0     0.0 0.0
Income tax impact 0.0     0.0     0.0 0.0
Amounts reclassified from accumulated other comprehensive loss, net of income taxes 0.0     0.0     0.0 0.0
Total other comprehensive loss, net of income taxes (0.2)     1.1     1.7 3.6
Balance, end of period 0.0 0.2   (2.7) (3.8)   0.0 (2.7)
Unrealized Pension Costs                
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]                
Balance, beginning of period (2.4)   $ (2.2) (23.3)   $ (23.0) (2.2) (23.0)
(Decrease) increase before reclassifications 0.0     0.0     0.0 0.0
Income tax impact 0.0     0.0     0.0 0.0
Other comprehensive (loss) income before reclassifications, net of income taxes 0.0     0.0     0.0 0.0
Increase (0.1)     0.2     (0.3) 0.0
Income tax impact 0.0     0.0     0.0 (0.1)
Amounts reclassified from accumulated other comprehensive loss, net of income taxes (0.1)     0.2     (0.3) (0.1)
Total other comprehensive loss, net of income taxes (0.1)     0.2     (0.3) (0.1)
Balance, end of period $ (2.5) $ (2.4)   $ (23.1) $ (23.3)   $ (2.5) $ (23.1)
XML 81 R69.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue - Disaggregation by Revenue Type and Geographical Region (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Disaggregation of Revenue [Line Items]        
Sales $ 631.1 $ 607.3 $ 1,908.3 $ 1,857.1
Consumables        
Disaggregation of Revenue [Line Items]        
Sales 531.0 493.7 1,605.7 1,541.6
Equipment        
Disaggregation of Revenue [Line Items]        
Sales 100.1 113.6 302.6 315.5
North America        
Disaggregation of Revenue [Line Items]        
Sales 340.0 329.4 1,015.4 994.7
Western Europe        
Disaggregation of Revenue [Line Items]        
Sales 101.3 103.7 369.5 357.1
Other developed markets        
Disaggregation of Revenue [Line Items]        
Sales 30.3 32.7 98.3 105.3
Emerging markets        
Disaggregation of Revenue [Line Items]        
Sales 159.5 141.5 425.1 400.0
Specialty Products & Technologies        
Disaggregation of Revenue [Line Items]        
Sales 395.4 363.4 1,200.2 1,116.1
Specialty Products & Technologies | North America        
Disaggregation of Revenue [Line Items]        
Sales 176.5 165.4 535.3 502.8
Specialty Products & Technologies | Western Europe        
Disaggregation of Revenue [Line Items]        
Sales 77.7 76.7 284.5 267.8
Specialty Products & Technologies | Other developed markets        
Disaggregation of Revenue [Line Items]        
Sales 21.7 23.4 69.1 74.2
Specialty Products & Technologies | Emerging markets        
Disaggregation of Revenue [Line Items]        
Sales 119.5 97.9 311.3 271.3
Equipment & Consumables        
Disaggregation of Revenue [Line Items]        
Sales 235.7 243.9 708.1 741.0
Equipment & Consumables | North America        
Disaggregation of Revenue [Line Items]        
Sales 163.5 164.0 480.1 491.9
Equipment & Consumables | Western Europe        
Disaggregation of Revenue [Line Items]        
Sales 23.6 27.0 85.0 89.3
Equipment & Consumables | Other developed markets        
Disaggregation of Revenue [Line Items]        
Sales 8.6 9.3 29.2 31.1
Equipment & Consumables | Emerging markets        
Disaggregation of Revenue [Line Items]        
Sales $ 40.0 $ 43.6 $ 113.8 $ 128.7
XML 82 R70.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue - Remaining Performance Obligations (Details)
$ in Millions
Sep. 30, 2022
USD ($)
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 46.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 12 months
XML 83 R71.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Dec. 31, 2021
Disaggregation of Revenue [Line Items]          
Contract liability $ 80.3   $ 80.3   $ 65.2
Revenue recognized     $ 48.4 $ 34.4  
Revenue Benchmark | Customer Concentration Risk | Largest customer          
Disaggregation of Revenue [Line Items]          
Concentration risk percentage 11.00% 12.00% 11.00% 12.00%  
XML 84 R72.htm IDEA: XBRL DOCUMENT v3.22.2.2
Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2022
USD ($)
Restructuring Reserve [Roll Forward]  
Balance at beginning of year $ 21.9
Costs incurred 16.8
Paid/settled (21.1)
Balance at end of year 17.6
Employee Severance and Related  
Restructuring Reserve [Roll Forward]  
Balance at beginning of year 21.4
Costs incurred 12.7
Paid/settled (17.2)
Balance at end of year 16.9
Facility Exit and Related  
Restructuring Reserve [Roll Forward]  
Balance at beginning of year 0.5
Costs incurred 4.1
Paid/settled (3.9)
Balance at end of year $ 0.7
XML 85 R73.htm IDEA: XBRL DOCUMENT v3.22.2.2
Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Restructuring Cost and Reserve [Line Items]        
Costs incurred $ 9.6 $ 8.6 $ 28.1 $ 23.8
Specialty Products & Technologies        
Restructuring Cost and Reserve [Line Items]        
Costs incurred 4.5 8.2 12.7 15.2
Equipment & Consumables        
Restructuring Cost and Reserve [Line Items]        
Costs incurred 4.2 0.1 12.6 4.5
Other        
Restructuring Cost and Reserve [Line Items]        
Costs incurred $ 0.9 $ 0.3 $ 2.8 $ 4.1
XML 86 R74.htm IDEA: XBRL DOCUMENT v3.22.2.2
Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Restructuring Cost and Reserve [Line Items]        
Costs incurred $ 9.6 $ 8.6 $ 28.1 $ 23.8
Cost of sales        
Restructuring Cost and Reserve [Line Items]        
Costs incurred 3.4 1.0 10.0 6.9
Selling, general and administrative expenses        
Restructuring Cost and Reserve [Line Items]        
Costs incurred $ 6.2 $ 7.6 $ 18.1 $ 16.9
XML 87 R75.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes - Narrative (Details)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Income Tax Disclosure [Abstract]        
Effective tax rate 21.50% (14.70%) 21.00% (1.70%)
XML 88 R76.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share - Narrative (Details) - $ / shares
Sep. 30, 2022
Dec. 31, 2021
May 21, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Conversion price (in USD per share) $ 21.01 $ 21.01  
2.375% convertible senior notes | Convertible Debt      
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Conversion price (in USD per share)     $ 21.01
Dilution threshold (in USD per share) $ 23.79    
XML 89 R77.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Numerator:        
Income from continuing operations, net of tax $ 49.6 $ 80.2 $ 164.5 $ 221.0
(Loss) income from discontinued operations, net of tax (2.0) 12.7 5.1 33.7
Net income $ 47.6 $ 92.9 $ 169.6 $ 254.7
Denominator:        
Weighted-average common shares outstanding used in basic earnings per share (in shares) 163.1 161.5 162.7 161.1
Assumed exercise of dilutive options and vesting of dilutive restricted stock units (in shares) 2.8 4.3 3.5 4.4
Assumed conversion of the Notes (in shares) 11.0 12.3 12.2 12.0
Weighted average common shares outstanding used in diluted earnings (loss) per share (in shares) 176.9 178.1 178.4 177.5
Earnings per share:        
Earnings from continuing operations - basic (in USD per share) $ 0.30 $ 0.50 $ 1.01 $ 1.37
Earnings from continuing operations - diluted (in USD per share) 0.28 0.45 0.92 1.25
(Loss) earnings from discontinued operations - basic (in USD per share) (0.01) 0.08 0.03 0.21
(Loss) earnings from discontinued operations - diluted (in USD per share) (0.01) 0.07 0.03 0.19
Earnings - basic (in USD per share) 0.29 0.58 1.04 1.58
Earnings - diluted (in USD per share) [1] $ 0.27 $ 0.52 $ 0.95 $ 1.43
[1] * Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.
XML 90 R78.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details) - shares
shares in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of diluted (loss) income per share (in shares) 1.9 1.4 1.5 1.2
Stock-based awards        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of diluted (loss) income per share (in shares) 1.9 1.4 1.5 1.2
XML 91 R79.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information - Narrative (Details) - 9 months ended Sep. 30, 2022
segment
Segment
Segment Reporting [Abstract]    
Number of reportable segments (in segments)   2
Number of operating segments (in segments) 2 2
XML 92 R80.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information - Segment Results (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Dec. 31, 2021
Segment Reporting Information [Line Items]          
Sales $ 631.1 $ 607.3 $ 1,908.3 $ 1,857.1  
Operating profit (loss) 74.5 81.7 231.2 260.1  
Other income 0.3 0.2 0.9 0.8  
Interest expense, net (11.6) (12.0) (23.9) (43.6)  
Income before income taxes 63.2 69.9 208.2 217.3  
Identifiable assets 6,411.9   6,411.9   $ 6,574.2
Other          
Segment Reporting Information [Line Items]          
Operating profit (loss) (32.5) (25.2) (95.8) (82.5)  
Identifiable assets 591.9   591.9   1,117.7
Held for sale | Discontinued operations disposed of by sale          
Segment Reporting Information [Line Items]          
Held for Sale 0.0   0.0   12.2
Specialty Products & Technologies          
Segment Reporting Information [Line Items]          
Sales 395.4 363.4 1,200.2 1,116.1  
Specialty Products & Technologies | Operating segments          
Segment Reporting Information [Line Items]          
Sales 395.4 363.4 1,200.2 1,116.1  
Operating profit (loss) 62.3 61.5 206.6 211.6  
Identifiable assets 3,395.9   3,395.9   3,498.2
Equipment & Consumables          
Segment Reporting Information [Line Items]          
Sales 235.7 243.9 708.1 741.0  
Equipment & Consumables | Operating segments          
Segment Reporting Information [Line Items]          
Sales 235.7 243.9 708.1 741.0  
Operating profit (loss) 44.7 $ 45.4 120.4 $ 131.0  
Identifiable assets $ 2,424.1   $ 2,424.1   $ 1,946.1
XML 93 nvst-20220930_htm.xml IDEA: XBRL DOCUMENT 0001757073 2022-01-01 2022-09-30 0001757073 2022-10-28 0001757073 2022-09-30 0001757073 2021-12-31 0001757073 2022-07-02 2022-09-30 0001757073 2021-07-03 2021-10-01 0001757073 2021-01-01 2021-10-01 0001757073 us-gaap:CommonStockMember 2021-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001757073 us-gaap:RetainedEarningsMember 2021-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001757073 us-gaap:ParentMember 2021-12-31 0001757073 us-gaap:NoncontrollingInterestMember 2021-12-31 0001757073 2021-01-01 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:ParentMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:CommonStockMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:RetainedEarningsMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:ParentMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:NoncontrollingInterestMember 2021-12-31 0001757073 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-04-01 0001757073 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-04-01 0001757073 us-gaap:ParentMember 2022-01-01 2022-04-01 0001757073 us-gaap:RetainedEarningsMember 2022-01-01 2022-04-01 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-04-01 0001757073 us-gaap:CommonStockMember 2022-04-01 0001757073 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 0001757073 us-gaap:RetainedEarningsMember 2022-04-01 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 0001757073 us-gaap:ParentMember 2022-04-01 0001757073 us-gaap:NoncontrollingInterestMember 2022-04-01 0001757073 us-gaap:AdditionalPaidInCapitalMember 2022-04-02 2022-07-01 0001757073 us-gaap:ParentMember 2022-04-02 2022-07-01 0001757073 us-gaap:RetainedEarningsMember 2022-04-02 2022-07-01 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-02 2022-07-01 0001757073 us-gaap:CommonStockMember 2022-07-01 0001757073 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 0001757073 us-gaap:RetainedEarningsMember 2022-07-01 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 0001757073 us-gaap:ParentMember 2022-07-01 0001757073 us-gaap:AdditionalPaidInCapitalMember 2022-07-02 2022-09-30 0001757073 us-gaap:ParentMember 2022-07-02 2022-09-30 0001757073 us-gaap:RetainedEarningsMember 2022-07-02 2022-09-30 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-02 2022-09-30 0001757073 us-gaap:CommonStockMember 2022-09-30 0001757073 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001757073 us-gaap:RetainedEarningsMember 2022-09-30 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001757073 us-gaap:ParentMember 2022-09-30 0001757073 us-gaap:CommonStockMember 2020-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001757073 us-gaap:RetainedEarningsMember 2020-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001757073 us-gaap:ParentMember 2020-12-31 0001757073 us-gaap:NoncontrollingInterestMember 2020-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-04-02 0001757073 us-gaap:ParentMember 2021-01-01 2021-04-02 0001757073 us-gaap:RetainedEarningsMember 2021-01-01 2021-04-02 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-04-02 0001757073 us-gaap:CommonStockMember 2021-04-02 0001757073 us-gaap:AdditionalPaidInCapitalMember 2021-04-02 0001757073 us-gaap:RetainedEarningsMember 2021-04-02 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-02 0001757073 us-gaap:ParentMember 2021-04-02 0001757073 us-gaap:NoncontrollingInterestMember 2021-04-02 0001757073 us-gaap:AdditionalPaidInCapitalMember 2021-04-03 2021-07-02 0001757073 us-gaap:ParentMember 2021-04-03 2021-07-02 0001757073 us-gaap:RetainedEarningsMember 2021-04-03 2021-07-02 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-03 2021-07-02 0001757073 us-gaap:CommonStockMember 2021-07-02 0001757073 us-gaap:AdditionalPaidInCapitalMember 2021-07-02 0001757073 us-gaap:RetainedEarningsMember 2021-07-02 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-02 0001757073 us-gaap:ParentMember 2021-07-02 0001757073 us-gaap:NoncontrollingInterestMember 2021-07-02 0001757073 us-gaap:AdditionalPaidInCapitalMember 2021-07-03 2021-10-01 0001757073 us-gaap:ParentMember 2021-07-03 2021-10-01 0001757073 us-gaap:RetainedEarningsMember 2021-07-03 2021-10-01 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-03 2021-10-01 0001757073 us-gaap:CommonStockMember 2021-10-01 0001757073 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 0001757073 us-gaap:RetainedEarningsMember 2021-10-01 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-01 0001757073 us-gaap:ParentMember 2021-10-01 0001757073 us-gaap:NoncontrollingInterestMember 2021-10-01 0001757073 2020-12-31 0001757073 2021-10-01 0001757073 nvst:OsteogenicsBiomedicalIncMember 2022-07-05 2022-07-05 0001757073 nvst:CarestreamDentalTechnologyMember 2022-04-20 2022-04-20 0001757073 nvst:CarestreamDentalTechnologyMember 2022-04-20 0001757073 nvst:OsteogenicsBiomedicalIncMember 2022-07-05 0001757073 nvst:CarestreamDentalTechnologyMember 2022-01-01 2022-09-30 0001757073 nvst:OsteogenicsBiomedicalIncMember 2022-01-01 2022-09-30 0001757073 nvst:OsteogenicsBiomedicalIncCarestreamDentalTechnologyMember 2022-07-02 2022-09-30 0001757073 nvst:OsteogenicsBiomedicalIncCarestreamDentalTechnologyMember 2022-01-01 2022-09-30 0001757073 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember nvst:PlamencaMember 2021-12-31 0001757073 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember nvst:PlamencaMember 2022-01-01 2022-09-30 0001757073 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember nvst:PlamencaMember 2022-07-02 2022-09-30 0001757073 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember nvst:PlamencaMember 2021-07-03 2021-10-01 0001757073 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember nvst:PlamencaMember 2021-01-01 2021-10-01 0001757073 us-gaap:LandAndLandImprovementsMember 2022-09-30 0001757073 us-gaap:LandAndLandImprovementsMember 2021-12-31 0001757073 us-gaap:BuildingAndBuildingImprovementsMember 2022-09-30 0001757073 us-gaap:BuildingAndBuildingImprovementsMember 2021-12-31 0001757073 us-gaap:MachineryAndEquipmentMember 2022-09-30 0001757073 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001757073 us-gaap:ConstructionInProgressMember 2022-09-30 0001757073 us-gaap:ConstructionInProgressMember 2021-12-31 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2021-12-31 0001757073 nvst:EquipmentandConsumablesMember 2021-12-31 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-09-30 0001757073 nvst:EquipmentandConsumablesMember 2022-01-01 2022-09-30 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2022-09-30 0001757073 nvst:EquipmentandConsumablesMember 2022-09-30 0001757073 nvst:EuroTermLoanDue2024Member 2022-09-30 0001757073 nvst:USTermLoanDue2024Member 2019-09-20 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2022-09-30 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2022-07-02 2022-09-30 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2021-10-01 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2021-07-03 2021-10-01 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2022-09-30 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2022-07-02 2022-09-30 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2021-10-01 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2021-07-03 2021-10-01 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2022-09-30 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2022-07-02 2022-09-30 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2021-10-01 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2021-07-03 2021-10-01 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-09-30 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2021-01-01 2021-10-01 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-09-30 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2021-01-01 2021-10-01 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-09-30 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2021-01-01 2021-10-01 0001757073 us-gaap:LongTermDebtMember 2022-09-30 0001757073 us-gaap:LongTermDebtMember 2021-12-31 0001757073 us-gaap:FairValueInputsLevel1Member 2022-09-30 0001757073 us-gaap:FairValueInputsLevel2Member 2022-09-30 0001757073 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001757073 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001757073 us-gaap:InterestRateSwapMember 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001757073 us-gaap:CurrencySwapMember 2021-12-31 0001757073 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001757073 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001757073 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001757073 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0001757073 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0001757073 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0001757073 us-gaap:InterestRateSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0001757073 us-gaap:InterestRateSwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0001757073 us-gaap:CurrencySwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0001757073 us-gaap:CurrencySwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0001757073 nvst:USTermLoanDue2024Member 2022-09-30 0001757073 nvst:USTermLoanDue2024Member 2021-12-31 0001757073 nvst:EuroTermLoanDue2024Member 2021-12-31 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2020-05-21 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2022-09-30 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2021-12-31 0001757073 us-gaap:RevolvingCreditFacilityMember 2022-09-30 0001757073 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-09-30 0001757073 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2021-12-31 0001757073 us-gaap:OtherDebtSecuritiesMember 2022-09-30 0001757073 us-gaap:OtherDebtSecuritiesMember 2021-12-31 0001757073 2019-09-20 2019-09-20 0001757073 nvst:USTermLoanDue2024Member 2019-09-20 2019-09-20 0001757073 nvst:EuroTermLoanDue2024Member 2019-09-20 2019-09-20 0001757073 nvst:EuroTermLoanDue2024Member 2019-09-20 0001757073 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-09-20 2019-09-20 0001757073 nvst:EuroTermLoanDue2024Member 2021-02-09 2021-02-09 0001757073 us-gaap:RevolvingCreditFacilityMember 2019-09-20 2019-09-20 0001757073 us-gaap:RevolvingCreditFacilityMember 2021-06-15 2021-06-15 0001757073 us-gaap:RevolvingCreditFacilityMember 2021-06-15 0001757073 us-gaap:RevolvingCreditFacilityMember us-gaap:StandbyLettersOfCreditMember 2022-09-30 0001757073 us-gaap:RevolvingCreditFacilityMember 2021-12-31 0001757073 srt:MinimumMember nvst:CreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2022-01-01 2022-09-30 0001757073 srt:MaximumMember nvst:CreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2022-01-01 2022-09-30 0001757073 srt:MinimumMember us-gaap:BaseRateMember 2022-01-01 2022-09-30 0001757073 srt:MaximumMember us-gaap:BaseRateMember 2022-01-01 2022-09-30 0001757073 srt:MinimumMember 2022-01-01 2022-09-30 0001757073 srt:MaximumMember 2022-01-01 2022-09-30 0001757073 nvst:USTermLoanDue2024Member 2022-01-01 2022-09-30 0001757073 nvst:USTermLoanDue2024Member 2021-01-01 2021-12-31 0001757073 nvst:EuroTermLoanDue2024Member 2022-01-01 2022-09-30 0001757073 nvst:EuroTermLoanDue2024Member 2021-01-01 2021-12-31 0001757073 nvst:A2.375ConvertibleSeniorNotesOverAllotmentOptionMember us-gaap:ConvertibleDebtMember 2020-05-21 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2020-05-21 2020-05-21 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:ConvertibleDebtMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2021-12-31 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2022-01-01 2022-09-30 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2021-01-01 2021-12-31 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2022-07-02 2022-09-30 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2021-07-03 2021-10-01 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2021-01-01 2021-10-01 0001757073 nvst:A2.375ConvertibleSeniorNotesCappedCallsMember us-gaap:ConvertibleDebtMember 2020-05-21 2020-05-21 0001757073 nvst:A2.375ConvertibleSeniorNotesCappedCallsMember us-gaap:ConvertibleDebtMember 2020-05-21 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-01 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-01 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-07-01 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-02 2022-09-30 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-02 2022-09-30 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-07-02 2022-09-30 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2022-09-30 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-09-30 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-09-30 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2021-07-02 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-07-02 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-07-02 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2021-07-03 2021-10-01 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-07-03 2021-10-01 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-07-03 2021-10-01 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2021-10-01 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-10-01 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-10-01 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-09-30 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-09-30 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-09-30 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-10-01 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-10-01 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-10-01 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-10-01 0001757073 srt:NorthAmericaMember nvst:SpecialtyProductsandTechnologiesMember 2022-07-02 2022-09-30 0001757073 srt:NorthAmericaMember nvst:EquipmentandConsumablesMember 2022-07-02 2022-09-30 0001757073 srt:NorthAmericaMember 2022-07-02 2022-09-30 0001757073 srt:NorthAmericaMember nvst:SpecialtyProductsandTechnologiesMember 2021-07-03 2021-10-01 0001757073 srt:NorthAmericaMember nvst:EquipmentandConsumablesMember 2021-07-03 2021-10-01 0001757073 srt:NorthAmericaMember 2021-07-03 2021-10-01 0001757073 nvst:WesternEuropeMember nvst:SpecialtyProductsandTechnologiesMember 2022-07-02 2022-09-30 0001757073 nvst:WesternEuropeMember nvst:EquipmentandConsumablesMember 2022-07-02 2022-09-30 0001757073 nvst:WesternEuropeMember 2022-07-02 2022-09-30 0001757073 nvst:WesternEuropeMember nvst:SpecialtyProductsandTechnologiesMember 2021-07-03 2021-10-01 0001757073 nvst:WesternEuropeMember nvst:EquipmentandConsumablesMember 2021-07-03 2021-10-01 0001757073 nvst:WesternEuropeMember 2021-07-03 2021-10-01 0001757073 nvst:OtherDevelopedMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2022-07-02 2022-09-30 0001757073 nvst:OtherDevelopedMarketsMember nvst:EquipmentandConsumablesMember 2022-07-02 2022-09-30 0001757073 nvst:OtherDevelopedMarketsMember 2022-07-02 2022-09-30 0001757073 nvst:OtherDevelopedMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2021-07-03 2021-10-01 0001757073 nvst:OtherDevelopedMarketsMember nvst:EquipmentandConsumablesMember 2021-07-03 2021-10-01 0001757073 nvst:OtherDevelopedMarketsMember 2021-07-03 2021-10-01 0001757073 nvst:HighGrowthMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2022-07-02 2022-09-30 0001757073 nvst:HighGrowthMarketsMember nvst:EquipmentandConsumablesMember 2022-07-02 2022-09-30 0001757073 nvst:HighGrowthMarketsMember 2022-07-02 2022-09-30 0001757073 nvst:HighGrowthMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2021-07-03 2021-10-01 0001757073 nvst:HighGrowthMarketsMember nvst:EquipmentandConsumablesMember 2021-07-03 2021-10-01 0001757073 nvst:HighGrowthMarketsMember 2021-07-03 2021-10-01 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2022-07-02 2022-09-30 0001757073 nvst:EquipmentandConsumablesMember 2022-07-02 2022-09-30 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2021-07-03 2021-10-01 0001757073 nvst:EquipmentandConsumablesMember 2021-07-03 2021-10-01 0001757073 srt:NorthAmericaMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-09-30 0001757073 srt:NorthAmericaMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-09-30 0001757073 srt:NorthAmericaMember 2022-01-01 2022-09-30 0001757073 srt:NorthAmericaMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-10-01 0001757073 srt:NorthAmericaMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-10-01 0001757073 srt:NorthAmericaMember 2021-01-01 2021-10-01 0001757073 nvst:WesternEuropeMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-09-30 0001757073 nvst:WesternEuropeMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-09-30 0001757073 nvst:WesternEuropeMember 2022-01-01 2022-09-30 0001757073 nvst:WesternEuropeMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-10-01 0001757073 nvst:WesternEuropeMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-10-01 0001757073 nvst:WesternEuropeMember 2021-01-01 2021-10-01 0001757073 nvst:OtherDevelopedMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-09-30 0001757073 nvst:OtherDevelopedMarketsMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-09-30 0001757073 nvst:OtherDevelopedMarketsMember 2022-01-01 2022-09-30 0001757073 nvst:OtherDevelopedMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-10-01 0001757073 nvst:OtherDevelopedMarketsMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-10-01 0001757073 nvst:OtherDevelopedMarketsMember 2021-01-01 2021-10-01 0001757073 nvst:HighGrowthMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-09-30 0001757073 nvst:HighGrowthMarketsMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-09-30 0001757073 nvst:HighGrowthMarketsMember 2022-01-01 2022-09-30 0001757073 nvst:HighGrowthMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-10-01 0001757073 nvst:HighGrowthMarketsMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-10-01 0001757073 nvst:HighGrowthMarketsMember 2021-01-01 2021-10-01 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-10-01 0001757073 nvst:EquipmentandConsumablesMember 2021-01-01 2021-10-01 0001757073 nvst:ConsumablesMember 2022-07-02 2022-09-30 0001757073 nvst:ConsumablesMember 2021-07-03 2021-10-01 0001757073 nvst:ConsumablesMember 2022-01-01 2022-09-30 0001757073 nvst:ConsumablesMember 2021-01-01 2021-10-01 0001757073 nvst:EquipmentSalesMember 2022-07-02 2022-09-30 0001757073 nvst:EquipmentSalesMember 2021-07-03 2021-10-01 0001757073 nvst:EquipmentSalesMember 2022-01-01 2022-09-30 0001757073 nvst:EquipmentSalesMember 2021-01-01 2021-10-01 0001757073 2022-10-01 2022-09-30 0001757073 nvst:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-02 2022-09-30 0001757073 nvst:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001757073 nvst:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-10-01 0001757073 nvst:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-03 2021-10-01 0001757073 us-gaap:EmployeeSeveranceMember 2021-12-31 0001757073 us-gaap:FacilityClosingMember 2021-12-31 0001757073 us-gaap:EmployeeSeveranceMember 2022-01-01 2022-09-30 0001757073 us-gaap:FacilityClosingMember 2022-01-01 2022-09-30 0001757073 us-gaap:EmployeeSeveranceMember 2022-09-30 0001757073 us-gaap:FacilityClosingMember 2022-09-30 0001757073 us-gaap:AllOtherSegmentsMember 2022-07-02 2022-09-30 0001757073 us-gaap:AllOtherSegmentsMember 2021-07-03 2021-10-01 0001757073 us-gaap:AllOtherSegmentsMember 2022-01-01 2022-09-30 0001757073 us-gaap:AllOtherSegmentsMember 2021-01-01 2021-10-01 0001757073 us-gaap:CostOfSalesMember 2022-07-02 2022-09-30 0001757073 us-gaap:CostOfSalesMember 2021-07-03 2021-10-01 0001757073 us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0001757073 us-gaap:CostOfSalesMember 2021-01-01 2021-10-01 0001757073 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-02 2022-09-30 0001757073 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-07-03 2021-10-01 0001757073 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-09-30 0001757073 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-10-01 0001757073 us-gaap:StockCompensationPlanMember 2022-07-02 2022-09-30 0001757073 us-gaap:StockCompensationPlanMember 2021-07-03 2021-10-01 0001757073 us-gaap:StockCompensationPlanMember 2022-01-01 2022-09-30 0001757073 us-gaap:StockCompensationPlanMember 2021-01-01 2021-10-01 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2022-07-02 2022-09-30 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2021-07-03 2021-10-01 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-09-30 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-10-01 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2022-07-02 2022-09-30 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2021-07-03 2021-10-01 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-09-30 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-10-01 0001757073 us-gaap:CorporateNonSegmentMember 2022-07-02 2022-09-30 0001757073 us-gaap:CorporateNonSegmentMember 2021-07-03 2021-10-01 0001757073 us-gaap:CorporateNonSegmentMember 2022-01-01 2022-09-30 0001757073 us-gaap:CorporateNonSegmentMember 2021-01-01 2021-10-01 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2022-09-30 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2021-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2022-09-30 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2021-12-31 0001757073 us-gaap:MaterialReconcilingItemsMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2022-09-30 0001757073 us-gaap:MaterialReconcilingItemsMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2021-12-31 0001757073 us-gaap:CorporateNonSegmentMember 2022-09-30 0001757073 us-gaap:CorporateNonSegmentMember 2021-12-31 shares iso4217:USD iso4217:USD shares nvst:segment iso4217:EUR pure nvst:tradingDay nvst:Segment false 2022 Q3 --12-31 0001757073 http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member 0.0475862 10-Q true 2022-09-30 false 001-39054 ENVISTA HOLDINGS CORPORATION DE 83-2206728 200 S. Kraemer Blvd., Building E 92821-6208 Brea, CA 714 817-7000 Common stock, $0.01 par value NVST NYSE Yes Yes Large Accelerated Filer false false false 163045022 568500000 1073600000 16800000 20700000 392200000 331900000 291300000 263800000 114000000.0 154300000 0 12200000 1366000000 1835800000 277200000 264100000 132100000 128100000 173200000 167800000 3399600000 3132000000 1063800000 1046400000 6411900000 6574200000 579300000 432400000 190000000.0 185800000 462500000 562300000 26500000 23700000 0 4000000.0 1258300000 1208200000 123400000 120400000 220700000 304200000 851600000 883400000 0.01 0.01 15000000 15000000 0 0 0 0 0 0 0.01 0.01 500000000 500000000 163600000 163000000 162000000 161600000 1600000 1600000 3689600000 3732600000 657900000 466900000 -391200000 -143500000 3957900000 4057600000 0 400000 3957900000 4058000000 6411900000 6574200000 631100000 607300000 1908300000 1857100000 266400000 251000000.0 799700000 773800000 364700000 356300000 1108600000 1083300000 264200000 250600000 801900000 747500000 26000000.0 24000000.0 75500000 75700000 74500000 81700000 231200000 260100000 300000 200000 900000 800000 11600000 12000000.0 23900000 43600000 63200000 69900000 208200000 217300000 13600000 -10300000 43700000 -3700000 49600000 80200000 164500000 221000000.0 -2000000.0 12700000 5100000 33700000 47600000 92900000 169600000 254700000 0.30 0.50 1.01 1.37 0.28 0.45 0.92 1.25 -0.01 0.08 0.03 0.21 -0.01 0.07 0.03 0.19 0.29 0.58 1.04 1.58 0.27 0.52 0.95 1.43 163100000 161500000 162700000 161100000 176900000 178100000 178400000 177500000 47600000 92900000 169600000 254700000 -116600000 -25000000.0 -249100000 -64300000 -200000 1100000 1700000 3600000 100000 -200000 300000 100000 -116900000 -23700000 -247700000 -60800000 -69300000 69200000 -78100000 193900000 1600000 3732600000 466900000 -143500000 4057600000 400000 -77800000 21400000 -56400000 1600000 3654800000 488300000 -143500000 4001200000 400000 -400000 13100000 13100000 74900000 74900000 -58300000 -58300000 1600000 3667900000 563200000 -201800000 4030900000 0 10500000 10500000 47100000 47100000 -72500000 -72500000 1600000 3678400000 610300000 -274300000 4016000000 11200000 11200000 47600000 47600000 -116900000 -116900000 1600000 3689600000 657900000 -391200000 3957900000 1600000 3684400000 126400000 -91800000 3720600000 400000 6700000 6700000 71700000 71700000 -52100000 -52100000 1600000 3691100000 198100000 -143900000 3746900000 400000 16500000 16500000 90100000 90100000 15000000.0 15000000.0 1600000 3707600000 288200000 -128900000 3868500000 400000 9000000.0 9000000.0 92900000 92900000 -23700000 -23700000 1600000 3716600000 381100000 -152600000 3946700000 400000 169600000 254700000 23900000 29400000 78200000 62600000 3800000 4200000 23100000 21600000 1100000 2200000 8900000 0 5500000 300000 5800000 9400000 7700000 0 17700000 21300000 3000000.0 17600000 76500000 15100000 35900000 67100000 11300000 -39900000 21700000 23400000 -109700000 -18700000 23400000 29100000 72400000 225600000 696200000 0 58800000 46000000.0 1600000 11600000 59800000 0 55900000 8500000 18500000 0 -656200000 -25900000 124000000.0 0 54000000.0 0 300000 0 500000 475700000 0 2300000 19900000 16000000.0 8900000 6100000 0 700000 80800000 -467400000 -2100000 17600000 -505100000 -250100000 1073600000 888900000 568500000 638800000 21100000 26100000 80200000 65600000 29600000 24900000 BUSINESS AND BASIS OF PRESENTATION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services and is dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in two business segments: Specialty Products &amp; Technologies and Equipment &amp; Consumables. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Specialty Products &amp; Technologies segment develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Company’s Equipment &amp; Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the financial statements. All significant intercompany accounts and transactions between the businesses comprising the Company have been eliminated in the accompanying Condensed Consolidated Financial Statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Condensed Consolidated Financial Statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The accompanying Condensed Consolidated Financial Statements contain all adjustments (consisting of only normal recurring adjustments and reclassifications to conform to current year presentation) necessary to present fairly the financial position of the Company as of September 30, 2022 and December 31, 2021, and its results of operations for the three and nine month periods ended September 30, 2022 and October 1, 2021 and cash flows for the nine month periods ended September 30, 2022 and October 1, 2021. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Consolidated and Combined Financial Statements and accompanying notes for the three years ended December 31, 2021, included in the Annual Report on Form 10-K filed by the Company with the SEC on February 24, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 3, Discontinued Operations, on December 31, 2021, the Company completed the sale of its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks and Uncertainties</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to risks and uncertainties as a result of the novel coronavirus (“COVID-19”) pandemic. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the three and nine months ended September 30, 2022, notwithstanding improvement in many markets in which the Company operates due to a return to more normalized business operations, certain markets continue to be adversely impacted either directly attributable to COVID-19 or as a result of prior COVID-19 influenced policies. Late in the first quarter of 2022, the Chinese authorities instituted COVID-19-related lockdowns, shut-downs and restrictions in certain parts of China, specifically the Shanghai area, which impacted the Company’s operations in China. These restrictions were lifted in early June 2022, but the extent to which continuing effects from these restrictions, current localized restrictions throughout China under its zero-COVID policy, and any future restrictions may impact our operations remains uncertain. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the scope and duration of the pandemic, the rise of new variants, the extent and severity of the impact on the Company's customers, the measures that have been and may be taken to contain the virus (including its various mutations) and mitigate its impact, U.S. and foreign government actions to respond to the reduction in global economic activity, the ability of the Company to continue to manufacture and source its products and to find suitable alternative products at reasonable prices, the Company’s ability to continue to ship and deliver its products in a cost-effective and timely manner, uncertain demand, staffing shortages, the impact of the pandemic and associated economic downturn on the Company’s ability to access capital if and when needed and how quickly and to what extent normal economic and operating conditions can resume, all of which are uncertain and cannot be predicted. Even after the COVID-19 pandemic has further subsided, the Company may continue to experience materially adverse impacts on the Company’s financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on the Company’s business, including impacting the Company’s ability to market and sell products in the affected regions, impacting its ability to enforce its intellectual property rights in Russia, creating disruptions in the global supply chain, and by potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Standards Recently Adopted</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span>, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. The ASU is effective for public entities through December 31, 2022 and the adoption did not have an impact on the Company’s Condensed Consolidated Financial Statements. 2 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the financial statements. All significant intercompany accounts and transactions between the businesses comprising the Company have been eliminated in the accompanying Condensed Consolidated Financial Statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Condensed Consolidated Financial Statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The accompanying Condensed Consolidated Financial Statements contain all adjustments (consisting of only normal recurring adjustments and reclassifications to conform to current year presentation) necessary to present fairly the financial position of the Company as of September 30, 2022 and December 31, 2021, and its results of operations for the three and nine month periods ended September 30, 2022 and October 1, 2021 and cash flows for the nine month periods ended September 30, 2022 and October 1, 2021. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Consolidated and Combined Financial Statements and accompanying notes for the three years ended December 31, 2021, included in the Annual Report on Form 10-K filed by the Company with the SEC on February 24, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 3, Discontinued Operations, on December 31, 2021, the Company completed the sale of its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.</span></div> Accounting Standards Recently Adopted<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span>, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. The ASU is effective for public entities through December 31, 2022 and the adoption did not have an impact on the Company’s Condensed Consolidated Financial Statements. ACQUISITIONS <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into new and attractive business areas. The Company has completed a number of acquisitions that have been accounted for as business combinations and have resulted in the recognition of goodwill in the Company’s Condensed Consolidated Financial Statements. Among other things, goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company makes an initial allocation of the purchase price at the date of acquisition based upon its understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains this information during due diligence and through other sources. For those assets and liabilities that were accounted for on a preliminary basis, the Company may up to 12 months after closing, refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The finalization of the acquisition valuation assessment, for the acquisitions listed below, may result in a change in the valuation of deferred taxes and goodwill, which could have a material impact on the Company’s financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the nine months ended September 30, 2022, the Company completed the following acquisitions:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Osteogenics Biomedical Inc., Allotech LLC and OBI Biologics, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On July 5, 2022, the Company acquired all of the equity of Osteogenics Biomedical Inc., Allotech LLC and OBI Biologics, Inc. (together "Osteogenics") for total consideration of approximately $128.2 million, subject to certain customary adjustments as provided in the definitive agreement dated May 17, 2022. Osteogenics develops innovative regenerative solutions for periodontists, oral and maxillofacial surgeons, and clinicians involved in implant dentistry throughout the world, and is part of the Company’s Specialty Products &amp; Technologies segment. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Carestream Dental Technology Parent Limited’s Intraoral Scanner Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 20, 2022, the Company completed the acquisition of Carestream Dental Technology Parent Limited’s (“Carestream Dental”) intraoral scanner business (the “Intraoral Scanner Business”) for total consideration of $580.3 million, including contingent consideration of $7.5 million, and subject to certain customary adjustments as provided in the Stock and Asset Purchase Agreement dated December 21, 2021 and as subsequently amended by the closing agreement dated as of April 20, 2022. The Intraoral Scanner Business manufactures, markets, sells, commercializes, distributes, services, trains, supports, and maintains operations of intraoral scanners and software, and is part of the Company’s Equipment &amp; Consumables segment. The Company purchased the Intraoral Scanner Business through the acquisition of certain assets and the assumption of certain liabilities as well as the acquisition of all of the equity of certain subsidiaries of Carestream Dental.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table summarizes the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates ($ in millions):</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.275%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.841%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Osteogenics<br/>July 5, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intraoral Scanner Business<br/>April 20, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Prepaids and Other Current Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Non-current deferred tax asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">       Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Accounts payable </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Accrued expenses and other liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Non-current deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">       Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The intangible assets acquired consist of trade name, developed technology, and customer relationships. The weighted average amortization period of the acquired intangible assets in the aggregate is </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">8 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">and 10 years for the Intraoral Scanner Business and Osteogenics, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The excess of the purchase price over the fair value assigned to the assets acquired and liabilities assumed represents the goodwill resulting from the acquisitions. Goodwill attributable to the acquisitions has been recorded as a non-current asset and is not amortized, but is subject to review at least on an annual basis for impairment. Goodwill recognized was primarily attributable to expected operating efficiencies and expansion opportunities in the businesses acquired. Goodwill is not deductible for income tax purposes. The pro forma impact of the acquisitions is not presented as the acquisitions were not considered material to the Company's Condensed Consolidated Financial Statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">For the three and nine months ended September 30, 2022, legal, accounting, and other professional service costs associated with the acquisitions were $1.5 million and $13.4 million, respectively, and have been recorded as selling, general and administrative expense in the Condensed Consolidated Statements of Income.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into new and attractive business areas. The Company has completed a number of acquisitions that have been accounted for as business combinations and have resulted in the recognition of goodwill in the Company’s Condensed Consolidated Financial Statements. Among other things, goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company makes an initial allocation of the purchase price at the date of acquisition based upon its understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains this information during due diligence and through other sources. For those assets and liabilities that were accounted for on a preliminary basis, the Company may up to 12 months after closing, refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The finalization of the acquisition valuation assessment, for the acquisitions listed below, may result in a change in the valuation of deferred taxes and goodwill, which could have a material impact on the Company’s financial statements.</span></div> 128200000 580300000 7500000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table summarizes the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates ($ in millions):</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.275%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.841%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Osteogenics<br/>July 5, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intraoral Scanner Business<br/>April 20, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Prepaids and Other Current Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Non-current deferred tax asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">       Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Accounts payable </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Accrued expenses and other liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Non-current deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">       Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 2100000 2700000 2500000 100000 13300000 6100000 53000000.0 129800000 0 300000 1300000 0 77500000 370600000 0 98500000 2600000 900000 4900000 200000 157200000 609200000 4100000 500000 2600000 27900000 14400000 0 5800000 0 2100000 500000 29000000.0 28900000 128200000 580300000 P8Y P10Y 1500000 13400000 DISCONTINUED OPERATIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2021, the Company completed the sale of substantially all of the KaVo Treatment Unit and Instrument Business (the “Divestiture”) to planmeca Verwaltungs Gmbh, Germany (“Planmeca”), pursuant to the master sale and purchase agreement (the “Purchase Agreement”) among the Company, Planmeca, and Planmeca Oy, as guarantor. In accordance with the terms of the Purchase Agreement, the Company received cash consideration of $317.3 million upon closing on December 31, 2021. During the nine months ended September 30, 2022, the Company has received an additional $59.8 million related to an earnout payment and certain working capital adjustments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">On December 30, 2021, the Company entered into an amendment to the Purchase Agreement (the "Amendment"), providing that the transfer of net assets in Russia, China and Brazil (the "Relevant Jurisdictions") would be deferred until the purchaser had formed entities for such transfer of assets in each such Relevant Jurisdiction and the applicable asset transfer agreement could be executed and consummated (each such asset transfer, a "Deferred Local Closing"). Except for the implementation of the Deferred Local Closings and related matters regarding the assets in the Relevant Jurisdictions, the provisions, terms and conditions of the Purchase Agreement were not materially amended by the Amendment. The Amendment did not alter the preliminary purchase price that Planmeca paid to the Company upon the closing of the Divestiture and the Company recognized the applicable gain or loss at the time of each Relevant Jurisdiction’s applicable closing. At December 31, 2021, the Company recorded a liability of $10.8 million for the proceeds related to the Relevant Jurisdictions. All three Relevant Jurisdictions have closed as of September 30, 2022 and the related liability associated with the proceeds released.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">The Company recognized a loss of $1.6 million and a gain of $5.7 million on the Divestiture during the three and nine months ended September 30, 2022, respectively, primarily related to the recognition of certain purchase price adjustments and the closing of the Relevant Jurisdictions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">In conjunction with the Divestiture, the Company entered into a customary transition services agreement, which requires support transition services to Planmeca throughout the applicable transition period. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2022, the Divestiture continued to meet the criteria to be classified as held for sale and to be presented as a discontinued operation. Accordingly, the Company reclassified the results of operations and financial position of the Divestiture to discontinued operations in its accompanying Condensed Consolidated Statements of Income and Condensed Consolidated Balance Sheets for all periods presented. The Company’s Condensed Consolidated Statements of Cash Flows for all periods presented include the financial results of the KaVo Treatment Unit and Instrument Business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended October 1, 2021, balances represent activity for the entire Divestiture, while balances for the nine months ended September 30, 2022, represent activity for the remaining Relevant Jurisdictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets for relevant jurisdictions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets held for sale</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities for relevant jurisdictions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities held for sale</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the Divestiture are reflected in the Condensed Consolidated Statements of Income within income from discontinued operations, net of tax as follows ($ in millions): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.253%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain on sale of discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.</span></div></td></tr></table></div> 317300000 59800000 10800000 -1600000 5700000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets for relevant jurisdictions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets held for sale</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities for relevant jurisdictions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities held for sale</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the Divestiture are reflected in the Condensed Consolidated Statements of Income within income from discontinued operations, net of tax as follows ($ in millions): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.253%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain on sale of discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.</span></div></td></tr></table></div> 12200000 12200000 4000000.0 4000000.0 2800000 102500000 11700000 302000000.0 2100000 57200000 9100000 174400000 700000 45300000 2600000 127600000 1100000 25200000 3200000 70400000 0 3800000 0 12500000 -400000 16300000 -600000 44700000 0 3600000 0 11000000.0 -400000 12700000 -600000 33700000 -1600000 0 5700000 0 -2000000.0 12700000 5100000 33700000 0 5600000 0 4200000 CREDIT LOSSES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses is a valuation account deducted from accounts receivable to present the net amount expected to be collected. Accounts receivable are charged off against the allowance when management believes the uncollectibility of an accounts receivable balance is confirmed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management estimates the adequacy of the allowance by using relevant available information, from internal and external sources, relating to past events, current conditions and forecasts. Historical credit loss experience provides the basis for estimation of expected credit losses and is adjusted as necessary using the relevant information available. The allowance for credit losses is measured on a collective basis when similar risk characteristics exist. The Company has identified one portfolio segment based on the following risk characteristics: geographic regions, product lines, default rates and customer specific factors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The factors used by management in its credit loss analysis are inherently subject to uncertainty. If actual results are not consistent with management’s estimates and assumptions, the allowance for credit losses may be overstated or understated and a charge or credit to net income (loss) may be required. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rollforward of the allowance for credit losses is summarized as follows ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rollforward of the allowance for credit losses is summarized as follows ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 20700000 1500000 3800000 3300000 2900000 16800000 INVENTORIES<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classes of inventory are summarized as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for inventory obsolescence</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classes of inventory are summarized as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for inventory obsolescence</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 234900000 214300000 26700000 22000000.0 87300000 88300000 57600000 60800000 291300000 263800000 PROPERTY, PLANT AND EQUIPMENT <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classes of property, plant and equipment are summarized as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classes of property, plant and equipment are summarized as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 10400000 10700000 155200000 168700000 353200000 354500000 69300000 45600000 588100000 579500000 310900000 315400000 277200000 264100000 GOODWILL<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the Company’s goodwill by segment ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,029.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,399.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the Company’s goodwill by segment ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,029.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,399.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2029700000 1102300000 3132000000 77500000 370600000 448100000 -126200000 -54300000 -180500000 1981000000 1418600000 3399600000 ACCRUED EXPENSES AND OTHER LIABILITIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities were as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncurrent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncurrent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring-related employee severance, benefits and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes, income and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and product allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities were as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncurrent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncurrent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring-related employee severance, benefits and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes, income and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and product allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 145100000 16200000 188900000 17900000 17600000 0 21900000 0 5600000 37300000 5600000 41700000 30400000 116600000 48100000 201400000 71400000 8900000 60100000 5100000 81900000 1100000 75400000 1200000 8000000.0 29100000 8400000 30300000 0 0 19600000 0 102500000 11500000 134300000 6600000 462500000 220700000 562300000 304200000 HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has foreign currency denominated long-term debt in the amount of €208.0 million. This senior unsecured term loan facility represents a partial hedge of the Company’s net investment in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The euro senior unsecured term loan facility is designated and qualifies as a non-derivative hedging instrument. Accordingly, the foreign currency translation of the euro senior unsecured term loan facility is recorded in accumulated other comprehensive loss in equity in the accompanying Condensed Consolidated Balance Sheets, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive loss in equity (see Note 14). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The euro senior unsecured term loan facility matures in September 2024. Refer to Note 13 for a further discussion of the above loan facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has used cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts were agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. The Company maintained cross-currency swap derivative contracts with respect to its $650.0 million senior unsecured term loan facility. These contracts effectively converted the $650.0 million senior unsecured term loan facility to an obligation denominated in euros and partially offset the impact of changes in currency rates on foreign currency denominated net investments. During the three months ended September 30, 2022, the Company settled all of its cross-currency swap derivative contracts and as of September 30, 2022 did not have any cross-currency swap derivative contracts outstanding. The changes in the fair value of these instruments were recorded in accumulated other comprehensive loss in equity, in the accompanying Condensed Consolidated Balance Sheets, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that was also recorded in accumulated other comprehensive loss as reflected in Note 14. Any ineffective portions of net investment hedges were reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps was recorded in interest expense, net in the Company’s Condensed Consolidated Statements of Income consistent with the classification of interest expense attributable to the underlying debt. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also used interest rate swap derivative contracts to reduce its variability of cash flows related to interest payments with respect to its senior unsecured term loans. The interest rate swap contracts exchanged interest payments based on variable rates for interest payments based on fixed rates. During the three months ended September 30, 2022, the existing interest rate swap matured. As of September 30, 2022, the Company did not have any outstanding interest rate swap contracts. The changes in the fair value of these instruments were recorded in accumulated other comprehensive loss in equity (see Note 14). Any ineffective portions of the cash flow hedges were reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps was recorded in interest expense in the Company’s Condensed Consolidated Statements of Income consistent with the classification of interest expense attributable to the underlying debt. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the notional values as of September 30, 2022 and October 1, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three and nine months ended September 30, 2022 and October 1, 2021 ($ in millions):</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended <br/>October 1, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contract</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>October 1, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gains or losses related to the foreign currency contracts and foreign currency denominated debt were classified as foreign currency translation adjustments in the schedule of changes in OCI in Note 14, as these items were attributable to the Company’s hedges of its net investment in foreign operations. Gains or losses related to the interest rate contracts were classified as cash flow hedge adjustments in the schedule of changes in OCI in Note 14. The Company did not reclassify any deferred gains or losses related to net investment and cash flow hedges from accumulated other comprehensive loss to income during the three and nine months ended September 30, 2022 and October 1, 2021. In addition, the Company did not have any ineffectiveness related to net investment and cash flow hedges during the three and nine months ended September 30, 2022 and October 1, 2021. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in investing activities in the accompanying Condensed Consolidated Statements of Cash Flows. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified in the Company’s Condensed Consolidated Balance Sheets as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonderivative hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts related to the Company’s derivatives expected to be reclassified from accumulated other comprehensive loss to net income during the next 12 months are not significant.</span></div> 208000000.0 650000000.0 650000000.0 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the notional values as of September 30, 2022 and October 1, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three and nine months ended September 30, 2022 and October 1, 2021 ($ in millions):</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended <br/>October 1, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contract</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>October 1, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the notional values as of September 30, 2022 and October 1, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three and nine months ended September 30, 2022 and October 1, 2021 ($ in millions):</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended <br/>October 1, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contract</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>October 1, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 203900000 12800000 241200000 5600000 0 -300000 250000000.0 1500000 0 14400000 650000000.0 14100000 203900000 26900000 1141200000 21200000 203900000 32700000 241200000 19700000 0 2200000 250000000.0 4800000 0 68500000 650000000.0 33100000 203900000 103400000 1141200000 57600000 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified in the Company’s Condensed Consolidated Balance Sheets as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonderivative hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 19600000 203900000 236500000 FAIR VALUE MEASUREMENTS <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows: Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation; and Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in<br/>Active Market<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swap derivative contracts were classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates and foreign currency current exchange rates and forward curves as inputs. The interest rate swap derivative contracts were classified as Level 2 in the fair value hierarchy as they were measured using the income approach with the relevant interest rates and forward curves as inputs. Refer to Note 9 for additional information.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plans</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain management employees of the Company participate in nonqualified deferred compensation programs that permit such employees to defer a portion of their compensation, on a pretax basis. All amounts deferred under this plan are unfunded, unsecured obligations and are presented as a component of the Company’s compensation and benefits accrual included in accrued expenses in the accompanying Condensed Consolidated Balance Sheets (refer to Note 8). Participants may choose among alternative earnings rates for the amounts they defer, which are primarily based on investment options within the Company’s 401(k) program. Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates on investment options within the Company’s 401(k) program. Amounts voluntarily deferred by employees into the Company stock fund and amounts contributed to participant accounts by the Company are deemed invested in the Company’s common stock and future distributions of such contributions will be made solely in shares of Company common stock, and therefore are not reflected in the above amounts.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration represents a cash hold back intended to be used for certain liabilities related to the Company’s newly acquired Intraoral Scanner Business (as further discussed in Note 2). Contingent consideration was classified as Level 3 in the fair value hierarchy as the estimated fair value was measured using a probability weighted discounted cash flow model. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.809%"><tr><td style="width:1.0%"/><td style="width:45.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes due 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The fair value of long-term debt approximates the carrying value as these borrowings are based on variable market rates. The fair value of the convertible senior notes due 2025 was determined based on the quoted bid price of the convertible senior notes in an over-the-counter market on September 30, 2022 and December 31, 2021. The convertible senior notes are considered as Level 2 of the fair value hierarchy. The fair values of cash and cash equivalents, which consist primarily of money market funds, time and demand deposits, trade accounts receivable, net and trade accounts payable approximate their carrying amounts due to the short-term maturities of these instruments. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in<br/>Active Market<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.809%"><tr><td style="width:1.0%"/><td style="width:45.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes due 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 14800000 0 14800000 0 0 6000000.0 6000000.0 0 2200000 0 2200000 0 17400000 0 17400000 0 16500000 0 16500000 6000000.0 6000000.0 0 0 0 0 2200000 2200000 0 0 17400000 17400000 509300000 854500000 432100000 1162500000 851600000 851600000 883400000 883400000 WARRANTY<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally accrues estimated warranty costs at the time of sale. In general, manufactured products are warranted against defects in material and workmanship when properly used for their intended purpose, installed correctly and appropriately maintained. Warranty periods depend on the nature of the product and range from 90 days up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the Company’s accrued warranty liability ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties issued during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> P90D <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the Company’s accrued warranty liability ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties issued during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 9400000 11000000.0 11300000 800000 8300000 LITIGATION AND CONTINGENCIES The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated. The Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated and has accrued $37.1 million and $38.7 million as of September 30, 2022 and December 31, 2021, respectively, which are included in accrued liabilities in the Condensed Consolidated Balance Sheets. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated. In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's Condensed Consolidated Balance Sheets, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company’s results of operations and cash flows for that period. 37100000 38700000 DEBT AND CREDIT FACILITIES <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s debt were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Senior term loan facility due 2024 ($650.0 aggregate principal amount) (the “Term Loan Facility”), net of deferred debt issuance costs of $1.9 and $2.7, respectively</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior euro term loan facility due 2024 (€208.0 aggregate principal amount) (the “Euro Term Loan Facility”), net of deferred debt issuance costs of $0.3 and $0.5, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Convertible senior notes due 2025 ($517.5 aggregate principal amount), net of deferred debt issuance costs of $8.2 and $8.9, respectively, and unamortized discount of $0.0 and $76.5, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit facility due 2024 ($750.0 aggregate borrowing capacity) (the Revolving Credit Facility)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022 unamortized debt issuance costs totaled $10.4 million. As of December 31, 2021 unamortized debt issuance costs and discount totaled $88.6 million. Unamortized debt issuance costs and discount have been netted against their respective aggregate principal amounts of the related debt in the table above, and are being amortized to interest expense over the term of the respective debt.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 20, 2019, the Company entered into a credit agreement (the “Credit Agreement”) with a syndicate of banks under which Envista borrowed approximately $1.3 billion, consisting of the three-year $650.0 million Term Loan Facility and the three-year €600.0 million Euro Term Loan Facility (together with the Term Loan Facility, the “Term Loans”). The Credit Agreement also included the five-year, $250.0 million revolving credit facility (the “Revolving Credit Facility” and together with the Term Loans, the “Senior Credit Facilities”). Pursuant to the Separation Agreement, all of the net proceeds of the Term Loans were paid to Danaher as partial consideration for the Dental business Danaher transferred to Envista. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 9, 2021, in connection with an amendment to the Credit Agreement, the Company repaid $472.0 million of its Euro Term Loan Facility.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 15, 2021, the Company entered into an amended and restated credit agreement (the “Amended Credit Agreement”) with a syndicate of banks including Bank of America, N.A. as administrative agent (the “Administrative Agent”). The Amended Credit Agreement amends and restates the Company’s Credit Agreement, originally dated September 20, 2019 (as amended by Amendment No. 1 to Credit Agreement dated as of May 6, 2020, Amendment No. 2 to Credit Agreement dated as of May 19, 2020, and Amendment No. 3 to Credit Agreement dated as of February 9, 2021). </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the Amended Credit Agreement: (a) the maturity date of the Company’s existing Term Loans has been extended to September 20, 2024, (b) the Revolving Credit Facility has been increased from $250.0 million to $750.0 million, (c) the Company may request further increases to the Revolving Credit Facility in an aggregate amount not to exceed $350.0 million, (d) the amount of cash and cash equivalents permitted to be netted in the definition of “Consolidated Funded Indebtedness” has been increased to up to the greater of (i) $250.0 million and (ii) 50% of Consolidated EBITDA as of the most recent measurement period, and (e) the floor on Eurocurrency rate loans applicable to the Revolving Credit Facility and the Term Loan Facility has been reduced to zero, in each case subject to and in accordance with the terms and conditions of the Amended Credit Agreement. The Company paid fees aggregating approximately $2.1 million in connection with the Amended Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility includes an aggregate available borrowing capacity of $750.0 million with a $20.0 million sublimit for the issuance of standby letters of credit. The Revolving Credit Facility can be used for working capital and other general corporate purposes. As of September 30, 2022, the Company had $70.0 million of outstanding borrowings and $680.0 million of available aggregate undrawn borrowing capacity under the Revolving Credit Facility. At December 31, 2021 there were no borrowings outstanding under the Revolving Credit Facility. The interest rate for borrowings under the Revolving Credit Facility was 3.76% as of September 30, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Senior Credit Facilities, borrowings bear interest as follows: (1) Eurocurrency Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to the London inter-bank offered (“LIBOR”) rate plus a margin of between 0.785% and 1.625%, depending on the Company’s Consolidated Leverage Ratio (as defined in the Amended Credit Agreement) as of the last day of the immediately preceding fiscal quarter; and (2) Base Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to (a) the highest of (i) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 0.50%, (ii) Bank of America’s “prime rate” as publicly announced from time to time and (iii) the Eurocurrency Rate (as defined in the Amended Credit Agreement) plus 1.0%, plus (b) a margin of between 0.00% and 0.625%, depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter. In no event will Eurocurrency Rate Loans or Base Rate Loans bear interest at a rate lower than 0.0%. In addition, the Company is required to pay a per annum facility fee of between 0.09% and 0.225% depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter and based on the aggregate commitments under the Revolving Credit Facility, whether drawn or not. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rates for borrowings under the Term Loan Facility were 4.77% and 1.25% as of September 30, 2022 and December 31, 2021, respectively. The interest rate for borrowings under the Euro Term Loan Facility was 2.14% and 0.95% as of September 30, 2022 and December 31, 2021, respectively. Interest is payable quarterly for the Term Loans. The Amended Credit Agreement requires the Company to maintain a Consolidated Leverage Ratio of 3.75 to 1.00 or less and includes a provision that the maximum Consolidated Leverage Ratio will be increased to 4.25 to 1.00 for the four consecutive full fiscal quarters immediately following the consummation of any acquisition by the Company or any subsidiary of the Company in which the purchase price exceeds $100.0 million. The Amended Credit Agreement also requires the Company to maintain a Consolidated Interest Coverage Ratio (as defined in the Amended Credit Agreement) of at least 3.00 to 1.00. The Amended Credit Agreement contains customary representations, warranties, conditions precedent, events of default, indemnities and affirmative and negative covenants, including covenants that, among other things, limit or restrict the Company’s and/or the Company’s subsidiaries ability, subject to certain exceptions and qualifications, to incur liens or indebtedness, merge, consolidate or sell or otherwise transfer assets, make dividends or distributions, enter into transactions with the Company’s affiliates and use proceeds of the debt financing for other than permitted uses. The Amended Credit Agreement also contains customary events of default. Upon the occurrence and during the continuance of an event of default, the lenders may declare the outstanding advances and all other obligations under the Amended Credit Agreement immediately due and payable. The Company was in compliance with all of its debt covenants as of September 30, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes (the “Notes”)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 21, 2020, the Company issued the Notes due on June 1, 2025, unless earlier repurchased, redeemed or converted. The aggregate principal amount, which includes the initial purchasers’ exercise in full of their option to purchase an additional $67.5 million principal amount of the Notes, was $517.5 million. The net proceeds from the issuance, after deducting purchasers’ discounts and estimated offering expenses, were $502.6 million. The Company used part of the net proceeds to pay for the capped call transactions (“Capped Calls”) as further described below. The Notes accrue interest at a rate of 2.375% per annum, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. The Notes have an initial conversion rate of 47.5862 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $21.01 per share of the Company’s common stock and is subject to adjustment upon the occurrence of specified events. The Notes are governed by an indenture dated as of May 21, 2020 (the “Indenture”) between the Company and Wilmington Trust, National Association, as trustee. The Indenture does not contain any financial covenants or any restrictions on the payment of dividends, the incurrence of senior debt or other indebtedness or the issuance or repurchase of the Company’s securities by the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the adoption of ASU 2020-06, the Company separated the carrying amounts of the Notes and total issuance costs incurred into liability and equity components. For the Notes, the carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature, while the carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the Notes. Total issuance costs incurred were then allocated to the liability and equity components of the Notes based on their relative values.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the Company’s adoption of ASU 2020-06 on January 1, 2022, the Notes and related issuance costs incurred are no longer required to be bifurcated into separate liability and equity components. This resulted in a $75.0 million increase to the carrying value of the Notes due 2025, comprised of unamortized discount of $76.5 million and deferred debt issuance costs of $1.5 million and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption of ASU 2020-06 resulted in a $21.4 million increase to retained earnings and a $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">As of September 30, 2022, the unamortized debt issuance costs on the Notes was $8.2 million and is being amortized over the term of the Notes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes are the Company’s senior, unsecured obligations and are (i) equal in right of payment with the Company’s existing and future senior, unsecured indebtedness; (ii) senior in right of payment to the Company’s existing and future indebtedness that is expressly subordinated to the Notes; (iii) effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and (iv) structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes may convert their Notes at any time on or after December 2, 2024 until the close of business on the second scheduled trading day preceding the maturity date. Holders of the Notes will also have the right to convert the Notes prior to December 2, 2024, but only upon the occurrence of specified events. In December 2021, the Company made the irrevocable election to settle all Notes conversions through combination settlement, satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash, shares of the Company’s common stock or a combination of both. If a fundamental change occurs prior to the maturity date, holders of the Notes may require the Company to repurchase all or a portion of their Notes for cash at a repurchase price equal to 100.0% of the principal amount plus any accrued and unpaid interest. In addition, if specific corporate events occur prior to the maturity date, the Company would increase the conversion rate for a holder who elects to convert its Notes in connection with such an event in certain circumstances. As of September 30, 2022 and December 31, 2021, the stock price exceeded 130% of the conversion price of $21.01 in 20 days of the final 30 trading days ended September 30, 2022 and December 31, 2021, which satisfied one of the conditions permitting early conversion by holders of the Notes, therefore, the Notes are classified as short-term debt. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after June 1, 2023 and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding the redemption date, but only if the last reported sale price per share of the Company’s common stock exceeds 130.0% of the conversion price on (i) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such notice. In addition, calling any Note for redemption will constitute a “Make-Whole Fundamental Change” (as defined in the Indenture) with respect to that Note, in which case the conversion rate applicable to the conversion of that Note will be increased in certain circumstances if it is converted after it is called for redemption. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth total interest expense recognized related to the Notes ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">October 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contractual interest expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of debt issuance costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of debt discount</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total interest expense</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2022, the debt discount and debt issuance costs were amortized using an annual effective interest rate of 3.0%, to interest expense over the term of the Notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022 and December 31, 2021, the if-converted value of the Notes exceeded the outstanding principal amount by $290.5 million and $592.1 million, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capped Call Transactions</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the Notes, the Company entered into Capped Calls with certain counterparties. The Capped Calls each have an initial strike price of approximately $21.01 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have initial cap prices of $23.79 per share, subject to certain adjustments. The Capped Calls cover, subject to anti-dilution adjustments, 2.9 million shares of the Company's common stock. The Capped Calls are generally intended to reduce or offset the potential dilution from shares of common stock issued upon any conversion of the Notes with such reduction or offset, as the case may be, subject to a cap based on the cap price. As the Capped Call transactions are considered indexed to the Company's own stock and are considered equity classified, they are recorded in equity and are not accounted for as derivatives. The cost of $20.7 million incurred in connection with the Capped Calls was recorded as a reduction to additional paid-in capital.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s debt were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Senior term loan facility due 2024 ($650.0 aggregate principal amount) (the “Term Loan Facility”), net of deferred debt issuance costs of $1.9 and $2.7, respectively</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior euro term loan facility due 2024 (€208.0 aggregate principal amount) (the “Euro Term Loan Facility”), net of deferred debt issuance costs of $0.3 and $0.5, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Convertible senior notes due 2025 ($517.5 aggregate principal amount), net of deferred debt issuance costs of $8.2 and $8.9, respectively, and unamortized discount of $0.0 and $76.5, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit facility due 2024 ($750.0 aggregate borrowing capacity) (the Revolving Credit Facility)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 650000000.0 1900000 2700000 648100000 647300000 208000000.0 300000 500000 203500000 236100000 517500000 8200000 8900000 0.0 76500000 509300000 432100000 750000000.0 70000000.0 0 0 300000 1430900000 1315800000 579300000 432400000 851600000 883400000 10400000 88600000 1300000000 P3Y 650000000.0 P3Y 600000000.0 P5Y 250000000.0 472000000.0 250000000.0 750000000.0 350000000.0 250000000.0 0.50 2100000 750000000.0 20000000.0 70000000.0 680000000.0 0 0.0376 0.00785 0.01625 0.0050 0.010 0.0000 0.00625 0.0009 0.00225 0.0477 0.0125 0.0214 0.0095 3.75 4.25 100000000.0 3.00 67500000 517500000 502600000 0.02375 21.01 75000000 76500000 1500000 -77800000 21400000 -18600000 8200000 1.000 1.30 1.30 21.01 21.01 20 20 30 30 1.300 20 30 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth total interest expense recognized related to the Notes ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">October 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contractual interest expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of debt issuance costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of debt discount</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total interest expense</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3100000 3100000 9200000 9200000 700000 500000 2200000 1400000 0 4900000 0 14200000 3800000 8500000 11400000 24800000 0.030 290500000 592100000 21.01 23.79 2900000 20700000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCUMULATED OTHER COMPREHENSIVE LOSS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span>The changes in accumulated other comprehensive loss by component are summarized below ($ in millions).<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, July 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended October 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, July 2, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, October 1, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended October 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, October 1, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> The changes in accumulated other comprehensive loss by component are summarized below ($ in millions).<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, July 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended October 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, July 2, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, October 1, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended October 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, October 1, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -272100000 200000 -2400000 -274300000 -109900000 -300000 0 -110200000 6700000 -100000 0 6600000 -116600000 -200000 0 -116800000 0 0 100000 100000 0 0 0 0 0 0 100000 100000 -116600000 -200000 -100000 -116900000 -388700000 0 -2500000 -391200000 -101800000 -3800000 -23300000 -128900000 -20200000 1500000 0 -18700000 4800000 400000 0 5200000 -25000000.0 1100000 0 -23900000 0 0 -200000 -200000 0 0 0 0 0 0 -200000 -200000 -25000000.0 1100000 200000 -23700000 -126800000 -2700000 -23100000 -152600000 -139600000 -1700000 -2200000 -143500000 -224100000 2200000 0 -221900000 25000000.0 500000 0 25500000 -249100000 1700000 0 -247400000 0 0 300000 300000 0 0 0 0 0 0 300000 300000 -249100000 1700000 -300000 -247700000 -388700000 0 -2500000 -391200000 -62500000 -6300000 -23000000.0 -91800000 -51200000 4800000 0 -46400000 13100000 1200000 0 14300000 -64300000 3600000 0 -60700000 0 0 0 0 0 0 -100000 -100000 0 0 100000 100000 -64300000 3600000 -100000 -60800000 -126800000 -2700000 -23100000 -152600000 REVENUE <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s revenues disaggregated by geographical region for the three and nine months ended September 30, 2022 and October 1, 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended October 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographical region:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended October 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographical region:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales by Major Product Group:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.179%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Consumable products include implants, regenerative solutions, prosthetics, orthodontic brackets, aligners and lab products from our Specialty Products &amp; Technologies business segment and traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products from the Company’s Equipment &amp; Consumables business segment. The Company’s equipment products include digital imaging systems, software and other visualization and magnification systems.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations include noncancelable purchase orders, extended warranty and service agreements and do not include revenue from contracts with customers with an original term of one year or less. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $46.8 million and the Company expects to recognize revenue on the majority of this amount over the next 12 months.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company often receives cash payments from customers in advance of the Company’s performance resulting in contract liabilities. These contract liabilities are classified as either current or long-term in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of September 30, 2022 and December 31, 2021, the contract liabilities were $80.3 million and $65.2 million, respectively, and are included within accrued expenses and other liabilities and other long-term liabilities in the accompanying Condensed Consolidated Balance Sheets. Revenue recognized during the nine months ended September 30, 2022 and October 1, 2021 that was included in the contract liability balance at December 31, 2021 and December 31, 2020 was $48.4 million and $34.4 million, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Customers</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to the Company’s largest customer were 11% of sales for both the three and nine months ended September 30, 2022. Sales to the Company’s largest customer were 12% of sales for both the three and nine months ended October 1, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on historical experience, the Company generally has more sales in the second half of the calendar year than in the first half of the calendar year, with the first quarter typically having the lowest sales of the year. Based on historical customer buying patterns, the Company generally has more sales in the fourth quarter than in any other quarter of the year, driven in particular by capital spending in the Equipment &amp; Consumables segment. As a result of this seasonality in sales, profitability in the Equipment &amp; Consumables segment also tends to be higher in the second half of the year. There are no assurances that these historical trends will continue in the future and the ongoing COVID-19 pandemic may impact these trends.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s revenues disaggregated by geographical region for the three and nine months ended September 30, 2022 and October 1, 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended October 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographical region:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended October 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographical region:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales by Major Product Group:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.179%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 176500000 163500000 340000000.0 165400000 164000000.0 329400000 77700000 23600000 101300000 76700000 27000000.0 103700000 21700000 8600000 30300000 23400000 9300000 32700000 119500000 40000000.0 159500000 97900000 43600000 141500000 395400000 235700000 631100000 363400000 243900000 607300000 535300000 480100000 1015400000 502800000 491900000 994700000 284500000 85000000.0 369500000 267800000 89300000 357100000 69100000 29200000 98300000 74200000 31100000 105300000 311300000 113800000 425100000 271300000 128700000 400000000.0 1200200000 708100000 1908300000 1116100000 741000000.0 1857100000 531000000.0 493700000 1605700000 1541600000 100100000 113600000 302600000 315500000 631100000 607300000 1908300000 1857100000 46800000 P12M 80300000 65200000 48400000 34400000 0.11 0.11 0.12 0.12 RESTRUCTURING ACTIVITIES AND RELATED IMPAIRMENTS <div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Activities</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s restructuring activities are undertaken as necessary to implement management’s strategy, streamline operations, take advantage of available capacity and resources, and ultimately achieve net cost reductions. These activities generally relate to the realignment of existing manufacturing capacity and closure of facilities and other exit or disposal activities, as it relates to executing the Company’s strategy, either in the normal course of business or pursuant to significant restructuring programs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related liability which is included in accrued liabilities in the Condensed Consolidated Balance Sheets is summarized below ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Severance<br/>and Related</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Facility Exit<br/>and Related</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid/settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring related charges recorded for the three and nine months ended September 30, 2022 and October 1, 2021, by segment were as follows ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.179%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restructuring related charges incurred during the three and nine months ended September 30, 2022 and October 1, 2021, are reflected in the following captions in the accompanying Condensed Consolidated Statements of Income ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.179%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related liability which is included in accrued liabilities in the Condensed Consolidated Balance Sheets is summarized below ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Severance<br/>and Related</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Facility Exit<br/>and Related</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid/settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 21400000 500000 21900000 12700000 4100000 16800000 17200000 3900000 21100000 16900000 700000 17600000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring related charges recorded for the three and nine months ended September 30, 2022 and October 1, 2021, by segment were as follows ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.179%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restructuring related charges incurred during the three and nine months ended September 30, 2022 and October 1, 2021, are reflected in the following captions in the accompanying Condensed Consolidated Statements of Income ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.179%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 4500000 8200000 12700000 15200000 4200000 100000 12600000 4500000 900000 300000 2800000 4100000 9600000 8600000 28100000 23800000 3400000 1000000.0 10000000.0 6900000 6200000 7600000 18100000 16900000 9600000 8600000 28100000 23800000 INCOME TAXES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company’s effective tax rates from continuing operations of 21.5% and 21.0% for the three and nine months ended September 30, 2022, respectively, are consistent with the U.S. federal statutory rate of 21.0%. The Company’s effective tax rates from continuing operations of (14.7)% and (1.7)% for the three and nine months ended October 1, 2021, respectively, differ from the U.S. federal statutory rate of 21.0%, primarily due to the Company’s geographical mix of earnings and certain non-recurring Swiss discrete tax benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, the Company does not believe this legislation will have a material impact on its Condensed Consolidated Financial Statements.</span></div> 0.215 0.210 -0.147 -0.017 EARNINGS PER SHARE <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is calculated by dividing the applicable income by the weighted average number of shares of common stock outstanding for the applicable period. Diluted earnings per share is computed based on the weighted average number of common shares outstanding plus the effect of dilutive potential shares outstanding during the period using the treasury stock method. Dilutive potential common shares include employee equity options, non-vested shares and similar instruments granted by the Company and the assumed conversion impact of the Notes. The Company will settle any Notes conversions through a combination settlement by satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash or shares in the Company’s common stock or any combination thereof. As such, the Company uses the treasury stock method for the assumed conversion of the Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. As the Company will settle the principal amount of the Notes in cash upon conversion, the Notes do not have an impact on the Company's diluted earnings per share until the average share price of the Company’s common stock exceeds the conversion price of $21.01 per share in any applicable period. See the computation of earnings per share below for the dilutive impact of the Notes for the three and nine months ended September 30, 2022 and October 1, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the Notes, the Company entered into Capped Calls (see further discussion in Note 13), which are intended to reduce or offset the potential dilution from shares of common stock issued upon conversion of the Notes. However, this impact is not included when calculating potentially dilutive shares since their effect is anti-dilutive. The Capped Calls will mitigate dilution from the conversion of the Notes up to the Company’s common stock price of $23.79. If the Notes are converted at a price higher than $23.79 per share, the Capped Calls will no longer mitigate dilution from the conversion of the Notes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:46.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.147%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations, net of tax</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding used in basic earnings (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental common shares from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed exercise of dilutive options and vesting of dilutive restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed conversion of the Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding used in diluted earnings (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from continuing operations - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.01 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from continuing operations - diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings from discontinued operations - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings from discontinued operations - diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings - diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">* Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 21.01 23.79 23.79 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:46.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.147%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations, net of tax</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding used in basic earnings (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental common shares from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed exercise of dilutive options and vesting of dilutive restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed conversion of the Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding used in diluted earnings (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from continuing operations - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.01 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from continuing operations - diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings from discontinued operations - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings from discontinued operations - diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings - diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">* Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.</span></td></tr></table></div> 49600000 80200000 164500000 164500000 221000000.0 221000000.0 -2000000.0 12700000 5100000 5100000 33700000 33700000 47600000 92900000 169600000 254700000 163100000 161500000 162700000 161100000 2800000 4300000 3500000 4400000 11000000.0 12300000 12200000 12000000.0 176900000 178100000 178400000 177500000 0.30 0.50 1.01 1.37 0.28 0.45 0.92 1.25 -0.01 0.08 0.03 0.21 -0.01 0.07 0.03 0.19 0.29 0.58 1.04 1.58 0.27 0.52 0.95 1.43 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 1900000 1400000 1500000 1200000 1900000 1400000 1500000 1200000 SEGMENT INFORMATION The Company operates and reports its results in two separate business segments, the Specialty Products &amp; Technologies and Equipment &amp; Consumables segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income (expense) and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Inter-segment amounts are not significant and are eliminated to arrive at consolidated totals. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Specialty Products &amp; Technologies products include implants, regenerative products, prosthetics, orthodontic brackets, aligners and lab products. The Company’s Equipment &amp; Consumables products include traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products, while the Company’s equipment products include digital imaging systems, software and other visualization and magnification systems. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2021, the Company completed the sale of its KaVo Treatment Unit and Instrument Business, which was part of the Company’s Equipment &amp; Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business. Refer to Note 3 for more information on the Company’s discontinued operations.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment related information is shown below ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit and reconciliation to income before taxes from continuing operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonoperating income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes from continuing operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,395.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,498.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,424.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held for Sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,411.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,574.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2 2 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment related information is shown below ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit and reconciliation to income before taxes from continuing operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonoperating income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes from continuing operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,395.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,498.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,424.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held for Sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,411.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,574.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 395400000 363400000 1200200000 1116100000 235700000 243900000 708100000 741000000.0 631100000 607300000 1908300000 1857100000 62300000 61500000 206600000 211600000 44700000 45400000 120400000 131000000.0 -32500000 -25200000 -95800000 -82500000 74500000 81700000 231200000 260100000 300000 200000 900000 800000 11600000 12000000.0 23900000 43600000 63200000 69900000 208200000 217300000 3395900000 3498200000 2424100000 1946100000 0 12200000 591900000 1117700000 6411900000 6574200000 * Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding. EXCEL 94 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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̩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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 96 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 97 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 349 333 1 true 69 0 false 8 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.envistaco.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 0000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - Condensed Consolidated Statements of Income (Unaudited) Sheet http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited Condensed Consolidated Statements of Income (Unaudited) Statements 4 false false R5.htm 0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Sheet http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Statements 5 false false R6.htm 0000006 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Sheet http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 0000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 0000008 - Disclosure - Business And Basis Of Presentation Sheet http://www.envistaco.com/role/BusinessAndBasisOfPresentation Business And Basis Of Presentation Notes 8 false false R9.htm 0000009 - Disclosure - Acquisitions Sheet http://www.envistaco.com/role/Acquisitions Acquisitions Notes 9 false false R10.htm 0000010 - Disclosure - Discontinued Operations Sheet http://www.envistaco.com/role/DiscontinuedOperations Discontinued Operations Notes 10 false false R11.htm 0000011 - Disclosure - Credit Losses Sheet http://www.envistaco.com/role/CreditLosses Credit Losses Notes 11 false false R12.htm 0000012 - Disclosure - Inventories Sheet http://www.envistaco.com/role/Inventories Inventories Notes 12 false false R13.htm 0000013 - Disclosure - Property, Plant And Equipment Sheet http://www.envistaco.com/role/PropertyPlantAndEquipment Property, Plant And Equipment Notes 13 false false R14.htm 0000014 - Disclosure - Goodwill Sheet http://www.envistaco.com/role/Goodwill Goodwill Notes 14 false false R15.htm 0000015 - Disclosure - Accrued Expenses And Other Liabilities Sheet http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilities Accrued Expenses And Other Liabilities Notes 15 false false R16.htm 0000016 - Disclosure - Hedging Transactions And Derivative Financial Instruments Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstruments Hedging Transactions And Derivative Financial Instruments Notes 16 false false R17.htm 0000017 - Disclosure - Fair Value Measurements Sheet http://www.envistaco.com/role/FairValueMeasurements Fair Value Measurements Notes 17 false false R18.htm 0000018 - Disclosure - Warranty Sheet http://www.envistaco.com/role/Warranty Warranty Notes 18 false false R19.htm 0000019 - Disclosure - Litigation And Contingencies Sheet http://www.envistaco.com/role/LitigationAndContingencies Litigation And Contingencies Notes 19 false false R20.htm 0000020 - Disclosure - Debt And Credit Facilities Sheet http://www.envistaco.com/role/DebtAndCreditFacilities Debt And Credit Facilities Notes 20 false false R21.htm 0000021 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.envistaco.com/role/AccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss Notes 21 false false R22.htm 0000022 - Disclosure - Revenue Sheet http://www.envistaco.com/role/Revenue Revenue Notes 22 false false R23.htm 0000023 - Disclosure - Restructuring Activities And Related Impairments Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairments Restructuring Activities And Related Impairments Notes 23 false false R24.htm 0000024 - Disclosure - Income Taxes Sheet http://www.envistaco.com/role/IncomeTaxes Income Taxes Notes 24 false false R25.htm 0000025 - Disclosure - Earnings Per Share Sheet http://www.envistaco.com/role/EarningsPerShare Earnings Per Share Notes 25 false false R26.htm 0000026 - Disclosure - Segment Information Sheet http://www.envistaco.com/role/SegmentInformation Segment Information Notes 26 false false R27.htm 0000027 - Disclosure - Business And Basis Of Presentation (Policies) Sheet http://www.envistaco.com/role/BusinessAndBasisOfPresentationPolicies Business And Basis Of Presentation (Policies) Policies 27 false false R28.htm 0000028 - Disclosure - Acquisitions (Tables) Sheet http://www.envistaco.com/role/AcquisitionsTables Acquisitions (Tables) Tables http://www.envistaco.com/role/Acquisitions 28 false false R29.htm 0000029 - Disclosure - Discontinued Operations (Tables) Sheet http://www.envistaco.com/role/DiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://www.envistaco.com/role/DiscontinuedOperations 29 false false R30.htm 0000030 - Disclosure - Credit Losses (Tables) Sheet http://www.envistaco.com/role/CreditLossesTables Credit Losses (Tables) Tables http://www.envistaco.com/role/CreditLosses 30 false false R31.htm 0000031 - Disclosure - Inventories (Tables) Sheet http://www.envistaco.com/role/InventoriesTables Inventories (Tables) Tables http://www.envistaco.com/role/Inventories 31 false false R32.htm 0000032 - Disclosure - Property, Plant And Equipment (Tables) Sheet http://www.envistaco.com/role/PropertyPlantAndEquipmentTables Property, Plant And Equipment (Tables) Tables http://www.envistaco.com/role/PropertyPlantAndEquipment 32 false false R33.htm 0000033 - Disclosure - Goodwill (Tables) Sheet http://www.envistaco.com/role/GoodwillTables Goodwill (Tables) Tables http://www.envistaco.com/role/Goodwill 33 false false R34.htm 0000034 - Disclosure - Accrued Expenses And Other Liabilities (Tables) Sheet http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesTables Accrued Expenses And Other Liabilities (Tables) Tables http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilities 34 false false R35.htm 0000035 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Tables) Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables Hedging Transactions And Derivative Financial Instruments (Tables) Tables http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstruments 35 false false R36.htm 0000036 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.envistaco.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.envistaco.com/role/FairValueMeasurements 36 false false R37.htm 0000037 - Disclosure - Warranty (Tables) Sheet http://www.envistaco.com/role/WarrantyTables Warranty (Tables) Tables http://www.envistaco.com/role/Warranty 37 false false R38.htm 0000038 - Disclosure - Debt And Credit Facilities (Tables) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesTables Debt And Credit Facilities (Tables) Tables http://www.envistaco.com/role/DebtAndCreditFacilities 38 false false R39.htm 0000039 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) Tables http://www.envistaco.com/role/AccumulatedOtherComprehensiveLoss 39 false false R40.htm 0000040 - Disclosure - Revenue (Tables) Sheet http://www.envistaco.com/role/RevenueTables Revenue (Tables) Tables http://www.envistaco.com/role/Revenue 40 false false R41.htm 0000041 - Disclosure - Restructuring Activities And Related Impairments (Tables) Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsTables Restructuring Activities And Related Impairments (Tables) Tables http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairments 41 false false R42.htm 0000042 - Disclosure - Earnings Per Share (Tables) Sheet http://www.envistaco.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.envistaco.com/role/EarningsPerShare 42 false false R43.htm 0000043 - Disclosure - Segment Information (Tables) Sheet http://www.envistaco.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.envistaco.com/role/SegmentInformation 43 false false R44.htm 0000044 - Disclosure - Business And Basis Of Presentation - Narrative (Details) Sheet http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails Business And Basis Of Presentation - Narrative (Details) Details 44 false false R45.htm 0000045 - Disclosure - Acquisitions - Narrative (Details) Sheet http://www.envistaco.com/role/AcquisitionsNarrativeDetails Acquisitions - Narrative (Details) Details 45 false false R46.htm 0000046 - Disclosure - Acquisitions - Fair Values of Assets Acquired and Liabilities Assumed (Details) Sheet http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails Acquisitions - Fair Values of Assets Acquired and Liabilities Assumed (Details) Details 46 false false R47.htm 0000047 - Disclosure - Discontinued Operations - Narrative (Details) Sheet http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails Discontinued Operations - Narrative (Details) Details 47 false false R48.htm 0000048 - Disclosure - Discontinued Operations - Carrying Amount of Assets and Liabilities (Details) Sheet http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails Discontinued Operations - Carrying Amount of Assets and Liabilities (Details) Details 48 false false R49.htm 0000049 - Disclosure - Discontinued Operations - Operating Results (Details) Sheet http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails Discontinued Operations - Operating Results (Details) Details 49 false false R50.htm 0000050 - Disclosure - Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details) Sheet http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details) Details 50 false false R51.htm 0000051 - Disclosure - Credit Losses - Narrative (Details) Sheet http://www.envistaco.com/role/CreditLossesNarrativeDetails Credit Losses - Narrative (Details) Details 51 false false R52.htm 0000052 - Disclosure - Credit Losses - Allowance for Credit Losses (Details) Sheet http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails Credit Losses - Allowance for Credit Losses (Details) Details 52 false false R53.htm 0000053 - Disclosure - Inventories - Summary (Details) Sheet http://www.envistaco.com/role/InventoriesSummaryDetails Inventories - Summary (Details) Details 53 false false R54.htm 0000054 - Disclosure - Property, Plant And Equipment (Details) Sheet http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails Property, Plant And Equipment (Details) Details http://www.envistaco.com/role/PropertyPlantAndEquipmentTables 54 false false R55.htm 0000055 - Disclosure - Goodwill - Rollforward (Details) Sheet http://www.envistaco.com/role/GoodwillRollforwardDetails Goodwill - Rollforward (Details) Details 55 false false R56.htm 0000056 - Disclosure - Accrued Expenses And Other Liabilities - Summary (Details) Sheet http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails Accrued Expenses And Other Liabilities - Summary (Details) Details 56 false false R57.htm 0000057 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Narrative (Details) Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails Hedging Transactions And Derivative Financial Instruments - Narrative (Details) Details http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables 57 false false R58.htm 0000058 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details) Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details) Details 58 false false R59.htm 0000059 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details) Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details) Details 59 false false R60.htm 0000060 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details) Sheet http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details) Details 60 false false R61.htm 0000061 - Disclosure - Fair Value Measurements - Fair Value of Financial Instruments (Details) Sheet http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails Fair Value Measurements - Fair Value of Financial Instruments (Details) Details 61 false false R62.htm 0000062 - Disclosure - Warranty - Narrative (Details) Sheet http://www.envistaco.com/role/WarrantyNarrativeDetails Warranty - Narrative (Details) Details 62 false false R63.htm 0000063 - Disclosure - Warranty - Warranty Accrual (Details) Sheet http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails Warranty - Warranty Accrual (Details) Details 63 false false R64.htm 0000064 - Disclosure - Litigation And Contingencies - Narrative (Details) Sheet http://www.envistaco.com/role/LitigationAndContingenciesNarrativeDetails Litigation And Contingencies - Narrative (Details) Details 64 false false R65.htm 0000065 - Disclosure - Debt And Credit Facilities - Components Of Debt (Details) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails Debt And Credit Facilities - Components Of Debt (Details) Details 65 false false R66.htm 0000066 - Disclosure - Debt And Credit Facilities - Narrative (Details) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails Debt And Credit Facilities - Narrative (Details) Details 66 false false R67.htm 0000067 - Disclosure - Debt And Credit Facilities - Interest Expense (Details) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails Debt And Credit Facilities - Interest Expense (Details) Details 67 false false R68.htm 0000068 - Disclosure - Accumulated Other Comprehensive Loss - Rollforward (Details) Sheet http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails Accumulated Other Comprehensive Loss - Rollforward (Details) Details 68 false false R69.htm 0000069 - Disclosure - Revenue - Disaggregation by Revenue Type and Geographical Region (Details) Sheet http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails Revenue - Disaggregation by Revenue Type and Geographical Region (Details) Details 69 false false R70.htm 0000070 - Disclosure - Revenue - Remaining Performance Obligations (Details) Sheet http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails Revenue - Remaining Performance Obligations (Details) Details 70 false false R71.htm 0000071 - Disclosure - Revenue - Narrative (Details) Sheet http://www.envistaco.com/role/RevenueNarrativeDetails Revenue - Narrative (Details) Details 71 false false R72.htm 0000072 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details) Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details) Details 72 false false R73.htm 0000073 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details) Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details) Details 73 false false R74.htm 0000074 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details) Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details) Details 74 false false R75.htm 0000075 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.envistaco.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 75 false false R76.htm 0000076 - Disclosure - Earnings Per Share - Narrative (Details) Sheet http://www.envistaco.com/role/EarningsPerShareNarrativeDetails Earnings Per Share - Narrative (Details) Details 76 false false R77.htm 0000077 - Disclosure - Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details) Sheet http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details) Details 77 false false R78.htm 0000078 - Disclosure - Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details) Sheet http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details) Details 78 false false R79.htm 0000079 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.envistaco.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 79 false false R80.htm 0000080 - Disclosure - Segment Information - Segment Results (Details) Sheet http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails Segment Information - Segment Results (Details) Details 80 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:DebtInstrumentConvertibleConversionRatio1 - nvst-20220930.htm 4 nvst-20220930.htm ace-fourthspaamendmentrecl.htm ace-thirdsapaamendmentexec.htm exhibit3119302022.htm exhibit3129302022.htm exhibit3219302022.htm nvst-20220930.xsd nvst-20220930_cal.xml nvst-20220930_def.xml nvst-20220930_lab.xml nvst-20220930_pre.xml nvst-20220930_g1.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 100 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nvst-20220930.htm": { "axisCustom": 0, "axisStandard": 27, "contextCount": 349, "dts": { "calculationLink": { "local": [ "nvst-20220930_cal.xml" ] }, "definitionLink": { "local": [ "nvst-20220930_def.xml" ] }, "inline": { "local": [ "nvst-20220930.htm" ] }, "labelLink": { "local": [ "nvst-20220930_lab.xml" ] }, "presentationLink": { "local": [ "nvst-20220930_pre.xml" ] }, "schema": { "local": [ "nvst-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 548, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 2, "http://xbrl.sec.gov/dei/2022": 5, "total": 7 }, "keyCustom": 24, "keyStandard": 309, "memberCustom": 19, "memberStandard": 49, "nsprefix": "nvst", "nsuri": "http://www.envistaco.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "role": "http://www.envistaco.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Discontinued Operations", "role": "http://www.envistaco.com/role/DiscontinuedOperations", "shortName": "Discontinued Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CreditLossFinancialInstrumentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Credit Losses", "role": "http://www.envistaco.com/role/CreditLosses", "shortName": "Credit Losses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CreditLossFinancialInstrumentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Inventories", "role": "http://www.envistaco.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Property, Plant And Equipment", "role": "http://www.envistaco.com/role/PropertyPlantAndEquipment", "shortName": "Property, Plant And Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Goodwill", "role": "http://www.envistaco.com/role/Goodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Accrued Expenses And Other Liabilities", "role": "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilities", "shortName": "Accrued Expenses And Other Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Hedging Transactions And Derivative Financial Instruments", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstruments", "shortName": "Hedging Transactions And Derivative Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Fair Value Measurements", "role": "http://www.envistaco.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Warranty", "role": "http://www.envistaco.com/role/Warranty", "shortName": "Warranty", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Litigation And Contingencies", "role": "http://www.envistaco.com/role/LitigationAndContingencies", "shortName": "Litigation And Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)", "role": "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "shortName": "Condensed Consolidated Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Debt And Credit Facilities", "role": "http://www.envistaco.com/role/DebtAndCreditFacilities", "shortName": "Debt And Credit Facilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Accumulated Other Comprehensive Loss", "role": "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLoss", "shortName": "Accumulated Other Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Revenue", "role": "http://www.envistaco.com/role/Revenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Restructuring Activities And Related Impairments", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairments", "shortName": "Restructuring Activities And Related Impairments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Income Taxes", "role": "http://www.envistaco.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Earnings Per Share", "role": "http://www.envistaco.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Segment Information", "role": "http://www.envistaco.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Business And Basis Of Presentation (Policies)", "role": "http://www.envistaco.com/role/BusinessAndBasisOfPresentationPolicies", "shortName": "Business And Basis Of Presentation (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Acquisitions (Tables)", "role": "http://www.envistaco.com/role/AcquisitionsTables", "shortName": "Acquisitions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Discontinued Operations (Tables)", "role": "http://www.envistaco.com/role/DiscontinuedOperationsTables", "shortName": "Discontinued Operations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "role": "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Credit Losses (Tables)", "role": "http://www.envistaco.com/role/CreditLossesTables", "shortName": "Credit Losses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Inventories (Tables)", "role": "http://www.envistaco.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - Property, Plant And Equipment (Tables)", "role": "http://www.envistaco.com/role/PropertyPlantAndEquipmentTables", "shortName": "Property, Plant And Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - Goodwill (Tables)", "role": "http://www.envistaco.com/role/GoodwillTables", "shortName": "Goodwill (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - Accrued Expenses And Other Liabilities (Tables)", "role": "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesTables", "shortName": "Accrued Expenses And Other Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Tables)", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables", "shortName": "Hedging Transactions And Derivative Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.envistaco.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - Warranty (Tables)", "role": "http://www.envistaco.com/role/WarrantyTables", "shortName": "Warranty (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - Debt And Credit Facilities (Tables)", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesTables", "shortName": "Debt And Credit Facilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - Accumulated Other Comprehensive Loss (Tables)", "role": "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossTables", "shortName": "Accumulated Other Comprehensive Loss (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - Condensed Consolidated Statements of Income (Unaudited)", "role": "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "shortName": "Condensed Consolidated Statements of Income (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - Revenue (Tables)", "role": "http://www.envistaco.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - Restructuring Activities And Related Impairments (Tables)", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsTables", "shortName": "Restructuring Activities And Related Impairments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.envistaco.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - Segment Information (Tables)", "role": "http://www.envistaco.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - Business And Basis Of Presentation - Narrative (Details)", "role": "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "shortName": "Business And Basis Of Presentation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - Acquisitions - Narrative (Details)", "role": "http://www.envistaco.com/role/AcquisitionsNarrativeDetails", "shortName": "Acquisitions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "if9c39de36f8a428189585f303e45ba27_D20220705-20220705", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - Acquisitions - Fair Values of Assets Acquired and Liabilities Assumed (Details)", "role": "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "shortName": "Acquisitions - Fair Values of Assets Acquired and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "ibfc5f208a0024dc6ac70c0a22def4e4c_I20220705", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "ic0db70c44f2f44b4a54681302d92e36f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - Discontinued Operations - Narrative (Details)", "role": "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "shortName": "Discontinued Operations - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "ic0db70c44f2f44b4a54681302d92e36f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000048 - Disclosure - Discontinued Operations - Carrying Amount of Assets and Liabilities (Details)", "role": "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "shortName": "Discontinued Operations - Carrying Amount of Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "ic0db70c44f2f44b4a54681302d92e36f_I20211231", "decimals": "-5", "lang": "en-US", "name": "nvst:DisposalGroupIncludingDiscontinuedOperationAssetForRelevantJurisdictionProceedsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i46cc84fab3b141bf98e1b27748a96ce1_D20220702-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - Discontinued Operations - Operating Results (Details)", "role": "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "shortName": "Discontinued Operations - Operating Results (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i46cc84fab3b141bf98e1b27748a96ce1_D20220702-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)", "role": "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited", "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "ie1c8695b52e443b0ac8e17d98b238c55_D20220101-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details)", "role": "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "shortName": "Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "ie1c8695b52e443b0ac8e17d98b238c55_D20220101-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "nvst:NumberOfPortfolioSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000051 - Disclosure - Credit Losses - Narrative (Details)", "role": "http://www.envistaco.com/role/CreditLossesNarrativeDetails", "shortName": "Credit Losses - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "nvst:NumberOfPortfolioSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i405eee55380043d9ae585a9774b5124d_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000052 - Disclosure - Credit Losses - Allowance for Credit Losses (Details)", "role": "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails", "shortName": "Credit Losses - Allowance for Credit Losses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000053 - Disclosure - Inventories - Summary (Details)", "role": "http://www.envistaco.com/role/InventoriesSummaryDetails", "shortName": "Inventories - Summary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000054 - Disclosure - Property, Plant And Equipment (Details)", "role": "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails", "shortName": "Property, Plant And Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i405eee55380043d9ae585a9774b5124d_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000055 - Disclosure - Goodwill - Rollforward (Details)", "role": "http://www.envistaco.com/role/GoodwillRollforwardDetails", "shortName": "Goodwill - Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000056 - Disclosure - Accrued Expenses And Other Liabilities - Summary (Details)", "role": "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails", "shortName": "Accrued Expenses And Other Liabilities - Summary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000057 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Narrative (Details)", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "shortName": "Hedging Transactions And Derivative Financial Instruments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000058 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details)", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails", "shortName": "Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000059 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details)", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails", "shortName": "Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i4e4e3f1350ad4528bbd4d12fddb92cfd_I20220930", "decimals": "-5", "lang": "en-US", "name": "nvst:NonderivativeHedgingInstruments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icbfca68d4acf420cae01bb41ea9dd62a_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "role": "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i4bf03b28a111493eab0f25ac55729cf4_D20210101-20210402", "decimals": "-5", "lang": "en-US", "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000060 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details)", "role": "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "shortName": "Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000061 - Disclosure - Fair Value Measurements - Fair Value of Financial Instruments (Details)", "role": "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "shortName": "Fair Value Measurements - Fair Value of Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i0d7fa7cfce2543d3874f0f0dcdbf6383_I20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "nvst:ProductWarrantyPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000062 - Disclosure - Warranty - Narrative (Details)", "role": "http://www.envistaco.com/role/WarrantyNarrativeDetails", "shortName": "Warranty - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "nvst:ProductWarrantyPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i405eee55380043d9ae585a9774b5124d_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000063 - Disclosure - Warranty - Warranty Accrual (Details)", "role": "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails", "shortName": "Warranty - Warranty Accrual (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i405eee55380043d9ae585a9774b5124d_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000064 - Disclosure - Litigation And Contingencies - Narrative (Details)", "role": "http://www.envistaco.com/role/LitigationAndContingenciesNarrativeDetails", "shortName": "Litigation And Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000065 - Disclosure - Debt And Credit Facilities - Components Of Debt (Details)", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "shortName": "Debt And Credit Facilities - Components Of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DebtCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000066 - Disclosure - Debt And Credit Facilities - Narrative (Details)", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "shortName": "Debt And Credit Facilities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "iee3d6e7fc35c4cbf976305997076bf8b_D20220702-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000067 - Disclosure - Debt And Credit Facilities - Interest Expense (Details)", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "shortName": "Debt And Credit Facilities - Interest Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "iee3d6e7fc35c4cbf976305997076bf8b_D20220702-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i405eee55380043d9ae585a9774b5124d_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000068 - Disclosure - Accumulated Other Comprehensive Loss - Rollforward (Details)", "role": "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "shortName": "Accumulated Other Comprehensive Loss - Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i4c990bd0c0d940f891c6a061eee9e85c_D20220702-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000069 - Disclosure - Revenue - Disaggregation by Revenue Type and Geographical Region (Details)", "role": "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "shortName": "Revenue - Disaggregation by Revenue Type and Geographical Region (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i0e4e2cf75ddd46e58182268a5a5e25f0_D20220702-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000070 - Disclosure - Revenue - Remaining Performance Obligations (Details)", "role": "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails", "shortName": "Revenue - Remaining Performance Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000071 - Disclosure - Revenue - Narrative (Details)", "role": "http://www.envistaco.com/role/RevenueNarrativeDetails", "shortName": "Revenue - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i405eee55380043d9ae585a9774b5124d_I20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i405eee55380043d9ae585a9774b5124d_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000072 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details)", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails", "shortName": "Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i405eee55380043d9ae585a9774b5124d_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000073 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details)", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "shortName": "Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i2243899c0c0c4e0285ec43da7f77071c_D20220702-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000074 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details)", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails", "shortName": "Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i002cfcb3dd134ba3a570b939d117fa14_D20220702-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000075 - Disclosure - Income Taxes - Narrative (Details)", "role": "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "us-gaap:DebtInstrumentConvertibleConversionPrice1", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "icefdcd03e5b04c38b08e42ea316554a2_I20220930", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000076 - Disclosure - Earnings Per Share - Narrative (Details)", "role": "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails", "shortName": "Earnings Per Share - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "ib79b95eb04b54327aa05373016eaf7ef_I20220930", "decimals": "INF", "lang": "en-US", "name": "nvst:DerivativeCapPriceDilutionThreshold", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperations", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000077 - Disclosure - Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details)", "role": "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails", "shortName": "Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000078 - Disclosure - Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details)", "role": "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails", "shortName": "Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "us-gaap:NumberOfOperatingSegments", "ix:continuation", "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment2", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000079 - Disclosure - Segment Information - Narrative (Details)", "role": "http://www.envistaco.com/role/SegmentInformationNarrativeDetails", "shortName": "Segment Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:NumberOfOperatingSegments", "ix:continuation", "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment2", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000008 - Disclosure - Business And Basis Of Presentation", "role": "http://www.envistaco.com/role/BusinessAndBasisOfPresentation", "shortName": "Business And Basis Of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i53aba7d2f7494502a44f1c86c0922af0_D20220702-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000080 - Disclosure - Segment Information - Segment Results (Details)", "role": "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails", "shortName": "Segment Information - Segment Results (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i9928c1c128c94dd1b99f3fa5b8bee3ab_D20220702-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - Acquisitions", "role": "http://www.envistaco.com/role/Acquisitions", "shortName": "Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220930.htm", "contextRef": "i322d0f81c7a84aae99a92e341c05f464_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 69, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r689" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r690" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r691" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r686" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r688" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "nvst_A2.375ConvertibleSeniorNotesCappedCallsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.375% Convertible Senior Notes, Capped Calls [Member]", "label": "2.375% Convertible Senior Notes, Capped Calls [Member]", "terseLabel": "2.375% convertible senior notes, capped calls" } } }, "localname": "A2.375ConvertibleSeniorNotesCappedCallsMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_A2.375ConvertibleSeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.375% Convertible Senior Notes [Member]", "label": "2.375% Convertible Senior Notes [Member]", "terseLabel": "2.375% convertible senior notes", "verboseLabel": "Convertible senior notes due 2025" } } }, "localname": "A2.375ConvertibleSeniorNotesMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_A2.375ConvertibleSeniorNotesOverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.375% Convertible Senior Notes Over Allotment Option [Member]", "label": "2.375% Convertible Senior Notes Over Allotment Option [Member]", "terseLabel": "2.375% convertible senior notes over allotment option" } } }, "localname": "A2.375ConvertibleSeniorNotesOverAllotmentOptionMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_AccountsReceivableCreditLossExpenseReversalAdjustedForDiscontinuedOperations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accounts Receivable, Credit Loss Expense (Reversal), Adjusted for Discontinued Operations", "label": "Accounts Receivable, Credit Loss Expense (Reversal), Adjusted for Discontinued Operations", "verboseLabel": "Provision for credit losses" } } }, "localname": "AccountsReceivableCreditLossExpenseReversalAdjustedForDiscontinuedOperations", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "nvst_AccruedexpensesandotherAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued expenses and other [Abstract]", "label": "Accrued expenses and other [Abstract]", "terseLabel": "Accrued expenses and other [Abstract]" } } }, "localname": "AccruedexpensesandotherAbstract", "nsuri": "http://www.envistaco.com/20220930", "xbrltype": "stringItemType" }, "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 9.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right Of Use Asset", "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right Of Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "nvst_CarestreamDentalTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carestream Dental Technology", "label": "Carestream Dental Technology [Member]", "terseLabel": "Carestream Dental Technology" } } }, "localname": "CarestreamDentalTechnologyMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_ConsumablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumables [Member]", "label": "Consumables [Member]", "terseLabel": "Consumables" } } }, "localname": "ConsumablesMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "nvst_ContingencyProvisionPurchasePriceinExcessof100million": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contingency Provision, Purchase Price in Excess of $100 million", "label": "Contingency Provision, Purchase Price in Excess of $100 million", "terseLabel": "Contingency provision, purchase price in excess of $100 million" } } }, "localname": "ContingencyProvisionPurchasePriceinExcessof100million", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_CreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Facility [Member]", "label": "Credit Facility [Member]", "terseLabel": "Credit facility" } } }, "localname": "CreditFacilityMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_DebtInstrumentAccordionFeatureIncreaseLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Accordion Feature, Increase Limit", "label": "Debt Instrument, Accordion Feature, Increase Limit", "terseLabel": "Increase limit of revolving credit facility" } } }, "localname": "DebtInstrumentAccordionFeatureIncreaseLimit", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DebtInstrumentConvertibleCappedCallsExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Capped Calls, Expense", "label": "Debt Instrument, Convertible, Capped Calls, Expense", "terseLabel": "Convertible debt expense, capped calls" } } }, "localname": "DebtInstrumentConvertibleCappedCallsExpense", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DebtInstrumentConvertibleCappedCallsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Capped Calls, Shares", "label": "Debt Instrument, Convertible, Capped Calls, Shares", "terseLabel": "Convertible debt, capped calls (in shares)" } } }, "localname": "DebtInstrumentConvertibleCappedCallsShares", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "sharesItemType" }, "nvst_DebtInstrumentCovenantCashAndCashEquivalentThreshold": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant, Cash and Cash Equivalent Threshold", "label": "Debt Instrument, Covenant, Cash and Cash Equivalent Threshold", "terseLabel": "Cash and cash equivalent threshold" } } }, "localname": "DebtInstrumentCovenantCashAndCashEquivalentThreshold", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DebtInstrumentCovenantPercentageOfEarningsBeforeTaxesThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant, Percentage Of Earnings Before Taxes, Threshold", "label": "Debt Instrument, Covenant, Percentage Of Earnings Before Taxes, Threshold", "terseLabel": "EBITDA threshold" } } }, "localname": "DebtInstrumentCovenantPercentageOfEarningsBeforeTaxesThreshold", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_DerivativeCapPriceDilutionThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative, Cap Price, Dilution Threshold", "label": "Derivative, Cap Price, Dilution Threshold", "terseLabel": "Dilution threshold (in USD per share)" } } }, "localname": "DerivativeCapPriceDilutionThreshold", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "perShareItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationAssetForRelevantJurisdictionProceedsCurrent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Asset For Relevant Jurisdiction Proceeds, Current", "label": "Disposal Group, Including Discontinued Operation, Asset For Relevant Jurisdiction Proceeds, Current", "terseLabel": "Assets for relevant jurisdictions" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAssetForRelevantJurisdictionProceedsCurrent", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationCashFlowsFromDiscontinuedOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Cash Flows from Discontinued Operations", "label": "Disposal Group, Including Discontinued Operation, Cash Flows from Discontinued Operations [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashFlowsFromDiscontinuedOperationsAbstract", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationCashFlowsFromInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Cash Flows From Investing Activities", "label": "Disposal Group, Including Discontinued Operation, Cash Flows From Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashFlowsFromInvestingActivitiesAbstract", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationOperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Expenses", "label": "Disposal Group, Including Discontinued Operation, Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpensesAbstract", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "stringItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 3.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Research And Development Expense", "label": "Disposal Group, Including Discontinued Operation, Research And Development Expense", "terseLabel": "Research and development" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationsLiabilityForRelevantJurisdictionProceedsCurrent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operations, Liability For Relevant Jurisdiction Proceeds, Current", "label": "Disposal Group, Including Discontinued Operations, Liability For Relevant Jurisdiction Proceeds, Current", "terseLabel": "Liabilities for relevant jurisdictions" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationsLiabilityForRelevantJurisdictionProceedsCurrent", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nvst_EquipmentSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment Sales [Member]", "label": "Equipment Sales [Member]", "terseLabel": "Equipment" } } }, "localname": "EquipmentSalesMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "nvst_EquipmentandConsumablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment and Consumables", "label": "Equipment and Consumables [Member]", "terseLabel": "Equipment & Consumables" } } }, "localname": "EquipmentandConsumablesMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "nvst_EuroTermLoanDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Euro Term Loan Due 2024", "label": "Euro Term Loan Due 2024 [Member]", "verboseLabel": "Euro term loan due 2024" } } }, "localname": "EuroTermLoanDue2024Member", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_ForeignCurrencyDenominatedDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Denominated debt [Member]", "label": "Foreign Currency Denominated Debt [Member]", "terseLabel": "Foreign currency denominated debt" } } }, "localname": "ForeignCurrencyDenominatedDebtMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "nvst_HighGrowthMarketsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which includes Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia).", "label": "High-Growth Markets [Member]", "terseLabel": "Emerging markets" } } }, "localname": "HighGrowthMarketsMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "nvst_InterestCoverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Coverage Ratio", "label": "Interest Coverage Ratio", "terseLabel": "Interest coverage ratio (at least)" } } }, "localname": "InterestCoverageRatio", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_LargestCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Largest Customer", "label": "Largest Customer [Member]", "terseLabel": "Largest customer" } } }, "localname": "LargestCustomerMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_NonderivativeHedgingInstruments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Nonderivative Hedging Instruments", "label": "Nonderivative Hedging Instruments", "terseLabel": "Long-term debt" } } }, "localname": "NonderivativeHedgingInstruments", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "nvst_NumberOfPortfolioSegments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Portfolio Segments", "label": "Number Of Portfolio Segments", "terseLabel": "Number of portfolio segments (in segments)" } } }, "localname": "NumberOfPortfolioSegments", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/CreditLossesNarrativeDetails" ], "xbrltype": "integerItemType" }, "nvst_OsteogenicsBiomedicalIncCarestreamDentalTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Osteogenics Biomedical Inc & Carestream Dental Technology", "label": "Osteogenics Biomedical Inc & Carestream Dental Technology [Member]", "terseLabel": "Osteogenics Biomedical Inc & Carestream Dental Technology" } } }, "localname": "OsteogenicsBiomedicalIncCarestreamDentalTechnologyMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_OsteogenicsBiomedicalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Osteogenics Biomedical Inc", "label": "Osteogenics Biomedical Inc [Member]", "terseLabel": "Osteogenics Biomedical Inc" } } }, "localname": "OsteogenicsBiomedicalIncMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_OtherDevelopedMarketsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other developed markets [Member]", "label": "Other Developed Markets [Member]", "terseLabel": "Other developed markets" } } }, "localname": "OtherDevelopedMarketsMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "nvst_PlamencaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plamenca", "label": "Plamenca [Member]", "terseLabel": "Plamenca" } } }, "localname": "PlamencaMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "domainItemType" }, "nvst_PrimeRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prime Rate", "label": "Prime Rate", "terseLabel": "Rate in excess of Federal funds rate" } } }, "localname": "PrimeRate", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_ProductWarrantyPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product Warranty Period", "label": "Product Warranty Period", "terseLabel": "Product warranty period" } } }, "localname": "ProductWarrantyPeriod", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/WarrantyNarrativeDetails" ], "xbrltype": "durationItemType" }, "nvst_RateinexcessofEurocurrencyrate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rate in excess of Eurocurrency rate", "label": "Rate in excess of Eurocurrency rate", "terseLabel": "Rate in excess of Eurocurrency rate" } } }, "localname": "RateinexcessofEurocurrencyrate", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_RatioofIndebtednesstoNetCapitalContingencyProvision": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ratio of Indebtedness to Net Capital, Contingency Provision", "label": "Ratio of Indebtedness to Net Capital, Contingency Provision", "terseLabel": "Contingency provision on the ratio of indebtedness to net capital" } } }, "localname": "RatioofIndebtednesstoNetCapitalContingencyProvision", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_SalesAndProductAllowancesCurrent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sales And Product Allowances, Current", "label": "Sales And Product Allowances, Current", "terseLabel": "Sales and product allowances" } } }, "localname": "SalesAndProductAllowancesCurrent", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "nvst_SalesAndProductAllowancesNoncurrent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sales And Product Allowances, Noncurrent", "label": "Sales And Product Allowances, Noncurrent", "terseLabel": "Sales and product allowances" } } }, "localname": "SalesAndProductAllowancesNoncurrent", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "nvst_SeniorUnsecuredRevolvingCreditFacility": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Revolving Credit Facility", "label": "Senior Unsecured Revolving Credit Facility", "terseLabel": "Senior unsecured revolving credit facility" } } }, "localname": "SeniorUnsecuredRevolvingCreditFacility", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_SpecialtyProductsandTechnologiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specialty Products and Technologies", "label": "Specialty Products and Technologies [Member]", "terseLabel": "Specialty Products & Technologies" } } }, "localname": "SpecialtyProductsandTechnologiesMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "nvst_TotalBorrowingsunderTermLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total Borrowings under Term Loan", "label": "Total Borrowings under Term Loan", "terseLabel": "Total borrowings under term loan" } } }, "localname": "TotalBorrowingsunderTermLoan", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_USTermLoanDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "US Term Loan Due 2024", "label": "US Term Loan Due 2024 [Member]", "verboseLabel": "US term loan due 2024" } } }, "localname": "USTermLoanDue2024Member", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_WesternEuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Western Europe [Member]", "label": "Western Europe [Member]", "terseLabel": "Western Europe" } } }, "localname": "WesternEuropeMember", "nsuri": "http://www.envistaco.com/20220930", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r152", "r198", "r211", "r212", "r213", "r214", "r216", "r218", "r222", "r329", "r330", "r331", "r332", "r333", "r334", "r336", "r337", "r339", "r341", "r342" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r152", "r198", "r211", "r212", "r213", "r214", "r216", "r218", "r222", "r329", "r330", "r331", "r332", "r333", "r334", "r336", "r337", "r339", "r341", "r342" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": { "auth_ref": [ "r2", "r156", "r164", "r242", "r440", "r441", "r442", "r455", "r456", "r526", "r531", "r532", "r586" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]", "terseLabel": "Adjusted balance" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r2", "r156", "r164", "r170", "r242", "r440", "r441", "r442", "r455", "r456", "r526", "r529", "r531", "r532", "r586" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r2", "r156", "r164", "r170", "r242", "r440", "r441", "r442", "r455", "r456", "r526", "r529", "r531", "r532", "r586" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r2", "r156", "r164", "r170", "r242", "r440", "r441", "r442", "r455", "r456", "r526", "r529", "r531", "r532", "r586" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r229", "r406", "r412", "r653" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r314", "r315", "r316", "r317", "r348", "r385", "r431", "r433", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r650", "r654", "r683", "r684" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r314", "r315", "r316", "r317", "r348", "r385", "r431", "r433", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r650", "r654", "r683", "r684" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r229", "r406", "r412", "r653" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r225", "r315", "r316", "r406", "r410", "r604", "r649", "r651" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r225", "r315", "r316", "r406", "r410", "r604", "r649", "r651" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r293", "r314", "r315", "r316", "r317", "r348", "r385", "r421", "r431", "r433", "r436", "r437", "r438", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r650", "r654", "r683", "r684" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r293", "r314", "r315", "r316", "r317", "r348", "r385", "r421", "r431", "r433", "r436", "r437", "r438", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r650", "r654", "r683", "r684" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r226", "r227", "r406", "r411", "r652", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r226", "r227", "r406", "r411", "r652", "r669", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r157", "r158", "r159", "r160", "r235", "r236", "r239", "r240", "r241", "r242", "r243", "r244", "r440", "r441", "r442", "r455", "r456", "r476", "r477", "r478", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r564", "r565", "r573", "r574", "r575", "r583", "r584", "r585", "r586", "r587", "r588", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666" ], "lang": { "en-us": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible Enumeration]", "terseLabel": "Accounting Standards Update [Extensible List]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r36", "r67" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Trade accounts payable" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Allowance for Credit Loss" } } }, "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CreditLossesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r231", "r232" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade accounts receivable, less allowance for credit losses of $16.8 and $20.7, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r46", "r612", "r632" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Taxes, income and other" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesNoncurrent": { "auth_ref": [ "r49", "r612", "r632" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.", "label": "Accrued Income Taxes, Noncurrent", "terseLabel": "Taxes, income and other" } } }, "localname": "AccruedIncomeTaxesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r86", "r92", "r100", "r101", "r102", "r494" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Unrealized Pension Costs" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r40", "r285" ], "calculation": { "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r92", "r100", "r101", "r102", "r103", "r493" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "verboseLabel": "Unrealized Loss on Cash Flow Hedges" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r54", "r89", "r91", "r92", "r635", "r662", "r666" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r100", "r101", "r557", "r558", "r559", "r560", "r561", "r563" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r88", "r92", "r100", "r101", "r102", "r153", "r154", "r155", "r494", "r588", "r657", "r658" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r85", "r92", "r100", "r101", "r102", "r494", "r558", "r559", "r560", "r561", "r563" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Adjustments" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Weighted-average useful life of acquired intangible assets" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r52", "r592" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r153", "r154", "r155", "r440", "r441", "r442", "r531" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Noncash items:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r434", "r443", "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Common stock-based award activity" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllOtherSegmentsMember": { "auth_ref": [ "r193", "r211", "r212", "r213", "r214", "r216" ], "lang": { "en-us": { "role": { "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.", "label": "Other Segments [Member]", "terseLabel": "Other" } } }, "localname": "AllOtherSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r58", "r233", "r245", "r247", "r251" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Allowance for credit losses" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": { "auth_ref": [ "r250" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery.", "label": "Accounts Receivable, Allowance for Credit Loss, Recovery", "negatedTerseLabel": "Recoveries" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r249" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "negatedLabel": "Write-offs charged against the allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r118", "r142", "r368", "r567" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r112", "r142", "r368", "r569" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r142", "r368", "r381", "r382", "r569" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of debt discount and issuance costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of diluted (loss) income per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r43", "r149", "r206", "r213", "r220", "r238", "r329", "r330", "r331", "r333", "r334", "r335", "r336", "r338", "r340", "r342", "r343", "r491", "r496", "r547", "r590", "r592", "r610", "r631" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets", "verboseLabel": "Identifiable assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r34", "r66", "r149", "r238", "r329", "r330", "r331", "r333", "r334", "r335", "r336", "r338", "r340", "r342", "r343", "r491", "r496", "r547", "r590", "r592" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r5", "r6", "r23", "r25", "r29", "r288" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Assets", "terseLabel": "Held for Sale" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r5", "r6", "r23", "r25", "r29", "r282", "r288" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "terseLabel": "Assets held for sale", "totalLabel": "Current assets held for sale" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r507", "r510" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Building and Building Improvements [Member]", "terseLabel": "Buildings and improvements" } } }, "localname": "BuildingAndBuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r430", "r432", "r474" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r430", "r432", "r468", "r469", "r474" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r467" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r480", "r481", "r483" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Consideration transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r479", "r482", "r484" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r475", "r485" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "verboseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory": { "auth_ref": [ "r473" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory", "terseLabel": "Fair value of acquisition-related inventory" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]", "terseLabel": "Assets acquired:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": { "auth_ref": [ "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lease obligation assumed in business combination.", "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation", "negatedTerseLabel": "Operating lease liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 7.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "terseLabel": "Prepaids and Other Current Assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Accounts receivable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "negatedTerseLabel": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "negatedTerseLabel": "Accrued expenses and other liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": { "auth_ref": [ "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets", "terseLabel": "Non-current deferred tax asset" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "negatedTerseLabel": "Non-current deferred tax liability" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r470", "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 10.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedTotalLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]", "terseLabel": "Liabilities assumed:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r470", "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "totalLabel": "Total net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "negatedTerseLabel": "Other long-term liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [ "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 8.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other long-term assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r470", "r471" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property, plant and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpenditureDiscontinuedOperations": { "auth_ref": [ "r22" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of capital expenditure attributable to discontinued operations.", "label": "Capital Expenditure, Discontinued Operations", "terseLabel": "Capital expenditures" } } }, "localname": "CapitalExpenditureDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r543", "r544" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Amount" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r32", "r38", "r144" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r137", "r144", "r146" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Ending balance of cash and cash equivalents", "periodStartLabel": "Beginning balance of cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r137", "r556" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r77", "r617", "r640" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock": { "auth_ref": [ "r311", "r318", "r327" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments, contingencies, and guarantees.", "label": "Commitments Contingencies and Guarantees [Text Block]", "terseLabel": "Litigation And Contingencies" } } }, "localname": "CommitmentsContingenciesAndGuaranteesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LitigationAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r153", "r154", "r531" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in USD per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r51", "r386" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r51", "r592" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock - $0.01 par value, 500.0 million shares authorized; 163.6 million shares issued and 163.0 million shares outstanding at September 30, 2022; 162.0 million shares issued and 161.6 million outstanding at December 31, 2021" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r96", "r98", "r99", "r109", "r623", "r645" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive (loss) income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r108", "r121", "r622", "r644" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r191", "r192", "r229", "r545", "r546", "r670" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r191", "r192", "r229", "r545", "r546", "r667", "r670" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r191", "r192", "r229", "r545", "r546", "r667", "r670" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r191", "r192", "r229", "r545", "r546" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r191", "r192", "r229", "r545", "r546", "r670" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r393", "r394", "r407" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Contract liability" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r393", "r394", "r407" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r393", "r394", "r407" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtFairValueDisclosures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt, Fair Value Disclosures", "verboseLabel": "Convertible senior notes due 2025" } } }, "localname": "ConvertibleDebtFairValueDisclosures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r344", "r345", "r346", "r348", "r358", "r359", "r360", "r364", "r365", "r366", "r367", "r368", "r379", "r380", "r381", "r382" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Components of note interest expense" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r211", "r212", "r213", "r214", "r216", "r222", "r224" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Other" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r115", "r604" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Credit Loss [Abstract]" } } }, "localname": "CreditLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CreditLossFinancialInstrumentTextBlock": { "auth_ref": [ "r246", "r253", "r254", "r255", "r256", "r258", "r259" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security.", "label": "Credit Loss, Financial Instrument [Text Block]", "terseLabel": "Credit Losses" } } }, "localname": "CreditLossFinancialInstrumentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CreditLosses" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.", "label": "Currency Swap [Member]", "terseLabel": "Cross-currency swap derivative contracts", "verboseLabel": "Cross-currency swap derivative contracts" } } }, "localname": "CurrencySwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r190", "r229" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of debt and lease obligation, classified as current.", "label": "Debt, Current", "negatedLabel": "Less: current portion" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r147", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r362", "r369", "r370", "r372", "r383" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Debt And Credit Facilities" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r45", "r46", "r48", "r148", "r152", "r345", "r346", "r347", "r348", "r349", "r350", "r352", "r358", "r359", "r360", "r361", "r363", "r364", "r365", "r366", "r367", "r368", "r379", "r380", "r381", "r382", "r571", "r611", "r613", "r630" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Margin spread of variable interest rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r347", "r375" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price (in USD per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r73", "r347", "r387", "r388", "r390" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "Debt Instrument, Convertible, Conversion Ratio", "terseLabel": "Convertible debt, conversion ratio" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal": { "auth_ref": [ "r376" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.", "label": "Debt Instrument, Convertible, If-converted Value in Excess of Principal", "terseLabel": "If-converted value in excess of principal" } } }, "localname": "DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of the entity's common stock which would be required to be attained for the conversion feature embedded in the debt instrument to become effective.", "label": "Debt Instrument, Convertible, Stock Price Trigger", "terseLabel": "Convertible debt, stock price trigger (in USD per share)" } } }, "localname": "DebtInstrumentConvertibleStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Convertible debt, consecutive trading days (in trading days)" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "terseLabel": "Threshold percentage of stock price trigger" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Convertible debt, trading days (in trading days)" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r345", "r379", "r380", "r568", "r571", "r572" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Term loan" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r72", "r365", "r568" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument, Interest Rate During Period", "terseLabel": "Loan facility interest rates" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r72", "r377", "r568", "r571" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r72", "r346" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r74", "r148", "r152", "r345", "r346", "r347", "r348", "r349", "r350", "r352", "r358", "r359", "r360", "r361", "r363", "r364", "r365", "r366", "r367", "r368", "r379", "r380", "r381", "r382", "r571" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Redemption price" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r74", "r148", "r152", "r345", "r346", "r347", "r348", "r349", "r350", "r352", "r358", "r359", "r360", "r361", "r363", "r364", "r365", "r366", "r367", "r368", "r371", "r379", "r380", "r381", "r382", "r387", "r389", "r390", "r391", "r567", "r568", "r571", "r572", "r629" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r358", "r567", "r572" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Unamortized discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r358", "r373", "r379", "r380", "r569" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "terseLabel": "Unamortized debt issuance costs and discount" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": { "auth_ref": [ "r358", "r567", "r568", "r569", "r570", "r572" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount (premium).", "label": "Debt Instrument, Unamortized Discount (Premium), Net", "terseLabel": "Unamortized discount (premium), net" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).", "label": "Deferred Compensation Liability, Classified, Noncurrent", "terseLabel": "Deferred compensation plans" } } }, "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r569" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r358", "r569" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "terseLabel": "Debt issuance and deferred financing costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r446", "r447" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "negatedLabel": "Net deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r142", "r283" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortizationDiscontinuedOperations": { "auth_ref": [ "r22", "r142" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations.", "label": "Depreciation and Amortization, Discontinued Operations", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortizationDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r83", "r508", "r509", "r513", "r516" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r522", "r535" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Hedging Transactions and Derivative Financial Instruments" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r505", "r508", "r513" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r505", "r508", "r513", "r516", "r517", "r520", "r521" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r81", "r82", "r83", "r542" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Accrued expenses and other liabilities" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r81" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 8.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative financial instruments" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r81" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 8.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Noncurrent", "terseLabel": "Derivative financial instruments" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r501", "r503" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "verboseLabel": "Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r500", "r502", "r503", "r505", "r506", "r511", "r513", "r518", "r519", "r521", "r522" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r406", "r410", "r411", "r412", "r413", "r414", "r415", "r416" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of disaggregation of revenue by geographical region and type" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": { "auth_ref": [ "r8", "r10", "r12", "r26" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.", "label": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax", "terseLabel": "Gain (loss) on disposal", "verboseLabel": "(Loss) gain on sale of discontinued operations, net of tax" } } }, "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax": { "auth_ref": [ "r8", "r9", "r26" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax", "totalLabel": "(Loss) income from discontinued operations" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share", "terseLabel": "(Loss) earnings from discontinued operations - basic (in USD per share)" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "terseLabel": "(Loss) earnings from discontinued operations - diluted (in USD per share)" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "auth_ref": [ "r9", "r10", "r11", "r12", "r20", "r26", "r448", "r458", "r461" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 1.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.", "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "terseLabel": "Income tax expense" } } }, "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]", "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.", "label": "Discontinued Operations, Disposed of by Sale [Member]", "terseLabel": "Discontinued operations disposed of by sale" } } }, "localname": "DiscontinuedOperationsDisposedOfBySaleMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Consideration", "terseLabel": "Consideration" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "auth_ref": [ "r21", "r29" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 1.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "terseLabel": "Cost of sales" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": { "auth_ref": [ "r21" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 2.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": { "auth_ref": [ "r21", "r29" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 1.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)", "totalLabel": "Gross profit" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": { "auth_ref": [ "r21" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 2.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)", "totalLabel": "Operating (loss) profit" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "auth_ref": [ "r21", "r29" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 2.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Revenue", "terseLabel": "Sales" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "auth_ref": [ "r30", "r292" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Discontinued Operations" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r430", "r432" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DueToEmployeesNoncurrent": { "auth_ref": [ "r75", "r589" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts due to Employee, not to include stockholders or officers, which are due after one year (or one business cycle).", "label": "Due to Employees, Noncurrent", "terseLabel": "Compensation and benefits" } } }, "localname": "DueToEmployeesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r110", "r162", "r163", "r164", "r165", "r166", "r171", "r173", "r180", "r181", "r182", "r186", "r187", "r532", "r533", "r624", "r646" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Earnings - basic (in USD per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r110", "r162", "r163", "r164", "r165", "r166", "r173", "r180", "r181", "r182", "r186", "r187", "r532", "r533", "r624", "r646" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Earnings - diluted (in USD per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share Reconciliation [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "EarningsPerShareReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r183", "r184", "r185", "r188" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r556" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r449" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r69" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Compensation and benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Employee Severance and Related" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r2", "r100", "r101", "r102", "r153", "r154", "r155", "r158", "r167", "r169", "r189", "r242", "r386", "r392", "r440", "r441", "r442", "r455", "r456", "r531", "r557", "r558", "r559", "r560", "r561", "r563", "r588", "r657", "r658", "r659" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r360", "r379", "r380", "r542" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Fair\u00a0Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FacilityClosingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Facility Closing [Member]", "terseLabel": "Facility Exit and Related" } } }, "localname": "FacilityClosingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r536", "r537", "r539" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]", "verboseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r360", "r379", "r380", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r537", "r593", "r594", "r595" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r360", "r379", "r380", "r536", "r540" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [ "r360", "r379", "r380" ], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r538" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r360", "r422", "r423", "r428", "r429", "r537", "r593" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "verboseLabel": "Quoted\u00a0Prices\u00a0in Active Market (Level 1)" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r360", "r379", "r380", "r422", "r423", "r428", "r429", "r537", "r594" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Significant\u00a0Other Observable\u00a0Inputs (Level 2)" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r360", "r379", "r380", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r537", "r595" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Significant Unobservable Inputs (Level 3)" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r360", "r379", "r380", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r593", "r594", "r595" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r507", "r511", "r520" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation": { "auth_ref": [ "r252" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) allowance for credit loss on financing receivable. Excludes net investment in lease.", "label": "Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation", "negatedLabel": "Foreign currency translation" } } }, "localname": "FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r83", "r422", "r515" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign currency contracts" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfBusiness": { "auth_ref": [ "r142", "r495" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.", "label": "Gain (Loss) on Disposition of Business", "negatedTerseLabel": "Gain on sale of KaVo treatment unit and instrument business" } } }, "localname": "GainLossOnSaleOfBusiness", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r142" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedTerseLabel": "Gain on sale of property, plant and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r41", "r263", "r264", "r271", "r276", "r592", "r609" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 }, "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/GoodwillRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r265", "r276" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Acquisitions" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r272", "r274", "r276", "r277" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r269" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "verboseLabel": "Foreign currency translation" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r113", "r149", "r206", "r212", "r216", "r219", "r222", "r238", "r329", "r330", "r331", "r334", "r335", "r336", "r338", "r340", "r342", "r343", "r547" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r142", "r281" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment of Intangible Assets, Finite-Lived", "terseLabel": "Impairment charges" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r114", "r143", "r162", "r163", "r164", "r165", "r179", "r182", "r489" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "terseLabel": "Income from continuing operations, net of tax", "totalLabel": "Income from continuing operations, net of tax" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r106", "r206", "r212", "r216", "r219", "r222", "r608", "r619", "r626", "r647" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r104", "r110", "r157", "r162", "r163", "r164", "r165", "r173", "r180", "r181", "r533", "r618", "r620", "r624", "r641" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Earnings from continuing operations - basic (in USD per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r104", "r110", "r157", "r162", "r163", "r164", "r165", "r173", "r180", "r181", "r182", "r533", "r624", "r641", "r644", "r646" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Earnings from continuing operations - diluted (in USD per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "auth_ref": [ "r8", "r9", "r10", "r11", "r12", "r26", "r29", "r462", "r642" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Net (loss) income from discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "auth_ref": [ "r8", "r9", "r10", "r11", "r12", "r20", "r26", "r490" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent", "terseLabel": "(Loss) income from discontinued operations, net of tax", "verboseLabel": "(Loss) income from discontinued operations, net of tax (Note 3)" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r430", "r432" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r6", "r14", "r15", "r16", "r17", "r18", "r19", "r24", "r27", "r28", "r29", "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r287", "r298" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r150", "r450", "r451", "r452", "r457", "r459", "r463", "r464", "r465" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r151", "r168", "r169", "r204", "r448", "r458", "r460", "r648" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax expense (benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r139", "r145" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r141" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Change in trade accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r141" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Change in trade accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1": { "auth_ref": [ "r508", "r512" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) related to the fair value of interest rate derivatives designated as fair value hedging instruments, as offset by the gain (loss) on the hedged item to the extent that the fair value hedge is determined to be effective.", "label": "Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments", "terseLabel": "Gain Recognized in OCI" } } }, "localname": "IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r141" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Change in inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r141" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "terseLabel": "Change in accrued expenses and other liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r141" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Change in prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "auth_ref": [ "r177", "r178", "r182" ], "calculation": { "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails": { "order": 3.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities", "terseLabel": "Assumed conversion of the Notes (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r174", "r175", "r176", "r182", "r435" ], "calculation": { "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Assumed exercise of dilutive options and vesting of dilutive restricted stock units (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r278", "r280" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r105", "r200", "r566", "r569", "r625" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest expense, net" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r118", "r366", "r378", "r381", "r382" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "totalLabel": "Total interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r120", "r367", "r381", "r382" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Contractual interest expense" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r135", "r138", "r145" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateContractMember": { "auth_ref": [ "r83", "r422", "r514" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.", "label": "Interest Rate Contract [Member]", "terseLabel": "Interest rate contracts" } } }, "localname": "InterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest rate swap derivative contracts", "verboseLabel": "Interest rate swap derivative contracts" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r59" ], "calculation": { "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r33", "r65", "r592" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r61" ], "calculation": { "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Raw Materials, Gross", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r65", "r261" ], "calculation": { "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": 4.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedTerseLabel": "Reserve for inventory obsolescence" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r60" ], "calculation": { "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory, Work in Process, Gross", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r260" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Restructuring charges" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandAndLandImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate held and assets that are an addition or improvement to real estate held.", "label": "Land and Land Improvements [Member]", "terseLabel": "Land and improvements" } } }, "localname": "LandAndLandImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r57", "r149", "r238", "r547", "r592", "r615", "r638" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r35", "r71", "r149", "r238", "r329", "r330", "r331", "r334", "r335", "r336", "r338", "r340", "r342", "r343", "r492", "r496", "r497", "r547", "r590", "r591", "r592" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r5", "r6", "r23", "r25", "r29", "r288" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "terseLabel": "Liability for proceeds related to the Relevant Jurisdictions" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r5", "r6", "r23", "r25", "r29", "r282", "r288" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "terseLabel": "Liabilities held for sale", "totalLabel": "Current liabilities held for sale" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r48", "r613", "r630" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "terseLabel": "Line of credit facility, outstanding borrowings" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Facility fee" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": { "auth_ref": [ "r68" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Current Borrowing Capacity", "terseLabel": "Line of credit facility, available borrowing capacity" } } }, "localname": "LineOfCreditFacilityCurrentBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate at the end of the reporting period.", "label": "Line of Credit Facility, Interest Rate at Period End", "terseLabel": "Line of credit facility, interest rate" } } }, "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r68" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Revolving credit facility maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Revolving credit facility due 2024" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r48", "r359", "r374", "r379", "r380", "r613", "r634" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "terseLabel": "Long-term Debt", "totalLabel": "Total debt", "verboseLabel": "Total debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-Term Debt, Fair Value", "terseLabel": "Long-term debt", "verboseLabel": "Fair value of notes" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long-Term Debt [Member]", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt", "verboseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r74", "r328" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r312", "r313" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual", "terseLabel": "Accrual for legal matters" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LitigationAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "auth_ref": [ "r312" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Current", "terseLabel": "Loss contingencies" } } }, "localname": "LossContingencyAccrualCarryingValueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": { "auth_ref": [ "r312" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Noncurrent", "terseLabel": "Loss contingencies" } } }, "localname": "LossContingencyAccrualCarryingValueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery, equipment and other assets" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MaterialReconcilingItemsMember": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.", "label": "Segment Reconciling Items [Member]", "terseLabel": "Held for sale" } } }, "localname": "MaterialReconcilingItemsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r79", "r149", "r238", "r329", "r334", "r335", "r336", "r342", "r343", "r547", "r614", "r637" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestPeriodIncreaseDecrease": { "auth_ref": [ "r488" ], "lang": { "en-us": { "role": { "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.", "label": "Noncontrolling Interest, Period Increase (Decrease)", "terseLabel": "Change in noncontrolling interest" } } }, "localname": "MinorityInterestPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]", "terseLabel": "Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]" } } }, "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r137" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r137" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r137", "r140", "r143" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r29", "r94", "r97", "r102", "r107", "r143", "r149", "r157", "r162", "r163", "r164", "r165", "r168", "r169", "r179", "r206", "r212", "r216", "r219", "r222", "r238", "r329", "r330", "r331", "r334", "r335", "r336", "r338", "r340", "r342", "r343", "r533", "r547", "r621", "r643" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r504" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net investment hedging" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r156", "r157", "r158", "r159", "r160", "r161", "r164", "r170", "r186", "r235", "r236", "r239", "r240", "r241", "r242", "r243", "r244", "r440", "r441", "r442", "r453", "r454", "r455", "r456", "r476", "r477", "r478", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r564", "r565", "r573", "r574", "r575", "r576", "r583", "r584", "r585", "r586", "r587", "r588", "r605", "r606", "r607", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "Accounting Standards Update and Change in Accounting Principle [Table]", "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Accounting Standards Recently Adopted" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r153", "r154", "r155", "r392", "r487" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Nonoperating income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of business segments (in segments)", "verboseLabel": "Number of operating segments (in segments)" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments (in segments)" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r206", "r212", "r216", "r219", "r222" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating profit (loss)", "totalLabel": "Operating profit" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r578" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r578" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r579", "r580" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "negatedLabel": "Change in operating lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r577" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r142" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Amortization of right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r211", "r212", "r213", "r214", "r216", "r222" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r31", "r499" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "verboseLabel": "Business and Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r69" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 9.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesNoncurrent": { "auth_ref": [ "r76" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 9.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Noncurrent", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAmortizationOfDeferredCharges": { "auth_ref": [ "r116", "r142" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization of other deferred costs recognized in the income statement.", "label": "Amortization of Other Deferred Charges", "terseLabel": "Amortization" } } }, "localname": "OtherAmortizationOfDeferredCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r42" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other long-term assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r92", "r100", "r101", "r557", "r559", "r563" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "terseLabel": "(Decrease) increase before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r92", "r100", "r101", "r103", "r557", "r559", "r563" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "totalLabel": "Other comprehensive (loss) income before reclassifications, net of income taxes" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": { "auth_ref": [ "r90", "r100" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax", "negatedLabel": "Income tax impact" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": { "auth_ref": [ "r89" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent", "verboseLabel": "Cash flow hedge adjustments" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r84" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "verboseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r95", "r98", "r100", "r101", "r103", "r108", "r386", "r557", "r562", "r563", "r622", "r644" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive loss", "totalLabel": "Total other comprehensive loss, net of income taxes" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive (loss) income, net of income taxes:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r87", "r89" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Pension plan adjustments" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherDebtSecuritiesMember": { "auth_ref": [ "r237", "r257", "r422", "r538" ], "lang": { "en-us": { "role": { "documentation": "Investments in debt securities classified as other.", "label": "Other Debt Obligations [Member]", "terseLabel": "Other" } } }, "localname": "OtherDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r69", "r592" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Accrued expenses and other liabilities", "totalLabel": "Total" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails", "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities, Current [Abstract]", "terseLabel": "Current" } } }, "localname": "OtherLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "Other Liabilities Disclosure [Text Block]", "terseLabel": "Accrued expenses and other liabilities" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r76" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities", "totalLabel": "Total" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails", "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities, Noncurrent [Abstract]", "terseLabel": "Noncurrent" } } }, "localname": "OtherLiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other liabilities.", "label": "Other Liabilities [Table Text Block]", "terseLabel": "The components of accrued expenses and other liabilities" } } }, "localname": "OtherLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r119" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total Envista Equity" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r124", "r127" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedTerseLabel": "All other investing activities, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r136", "r297" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedTerseLabel": "Paid/settled" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r133" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Payment of debt issuance and other deferred financing costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtRestructuringCosts": { "auth_ref": [ "r134" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.", "label": "Payments of Debt Restructuring Costs", "terseLabel": "Payments of debt restructuring costs" } } }, "localname": "PaymentsOfDebtRestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r131" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedTerseLabel": "Tax withholding payment related to net settlement of equity awards" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r125" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Acquisition, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r126" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Payments for additions to property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent": { "auth_ref": [ "r46", "r418", "r419", "r420" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current.", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Current", "terseLabel": "Pension benefits" } } }, "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r49", "r418", "r419", "r420" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as noncurrent.", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent", "terseLabel": "Pension benefits" } } }, "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r541" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r50", "r384" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in USD per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r50", "r384" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r50", "r592" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at September 30, 2022 and December 31, 2021" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r66" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from issuance of convertible senior notes" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities": { "auth_ref": [ "r124" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.", "label": "Proceeds from Derivative Instrument, Investing Activities", "terseLabel": "Proceeds from the settlement of derivative financial instruments" } } }, "localname": "ProceedsFromDerivativeInstrumentInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "auth_ref": [ "r122" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.", "label": "Proceeds from Divestiture of Businesses", "terseLabel": "Proceeds from sale of KaVo treatment unit and instrument business, net" } } }, "localname": "ProceedsFromDivestitureOfBusinesses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": { "auth_ref": [ "r122" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.", "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested", "terseLabel": "Proceeds from sale of KaVo treatment unit and instrument business, net" } } }, "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "auth_ref": [ "r129" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Proceeds from Long-Term Lines of Credit", "terseLabel": "Proceeds from revolving line of credit" } } }, "localname": "ProceedsFromLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r130", "r134" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "All other financing activities" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r123" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from sales of property, plant and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromShortTermDebtMaturingInThreeMonthsOrLess": { "auth_ref": [ "r129" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing having initial term of repayment within three months.", "label": "Proceeds from Short-Term Debt, Maturing in Three Months or Less", "terseLabel": "Proceeds from borrowing" } } }, "localname": "ProceedsFromShortTermDebtMaturingInThreeMonthsOrLess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r128", "r439" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from stock option exercises" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrual": { "auth_ref": [ "r323", "r324", "r616" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Standard and Extended Product Warranty Accrual", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "ProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r320" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Settlements made" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Accruals for warranties issued during the year" } } }, "localname": "ProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyDisclosureTextBlock": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.", "label": "Product Warranty Disclosure [Text Block]", "terseLabel": "Warranty" } } }, "localname": "ProductWarrantyDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/Warranty" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r292", "r671", "r672", "r673" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property, Plant And Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r39", "r284" ], "calculation": { "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Gross property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r286", "r592", "r627", "r639" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "verboseLabel": "Schedule of Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r111", "r248" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Allowance for credit losses" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RatioOfIndebtednessToNetCapital1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indebtedness divided by net capital.", "label": "Ratio of Indebtedness to Net Capital", "terseLabel": "Leverage ratio" } } }, "localname": "RatioOfIndebtednessToNetCapital1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]", "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r92", "r100", "r101", "r557", "r561", "r563" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 1.0, "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "negatedLabel": "Increase" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r92", "r100", "r101", "r103", "r557", "r561", "r563" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTotalLabel": "Amounts reclassified from accumulated other comprehensive loss, net of income taxes" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "auth_ref": [ "r90", "r93", "r100" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 2.0, "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Reclassification from AOCI, Current Period, Tax", "terseLabel": "Income tax impact" } } }, "localname": "ReclassificationFromAociCurrentPeriodTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r132" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "terseLabel": "Repayment of debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "auth_ref": [ "r132" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Repayments of Long-Term Lines of Credit", "negatedTerseLabel": "Repayment of revolving line of credit" } } }, "localname": "RepaymentsOfLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "auth_ref": [ "r132" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from a repayment of a borrowing having initial term of repayment within three months.", "label": "Repayments of Short-Term Debt, Maturing in Three Months or Less", "negatedTerseLabel": "Repayment of borrowing" } } }, "localname": "RepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r445", "r603", "r685" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r295", "r297", "r300", "r309", "r310" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring Activities And Related Impairments" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairments" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r142", "r294", "r303", "r306" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "terseLabel": "Costs incurred" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r296", "r297", "r306", "r307" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostsAndAssetImpairmentCharges": { "auth_ref": [ "r142" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.", "label": "Restructuring Costs and Asset Impairment Charges", "terseLabel": "Costs incurred" } } }, "localname": "RestructuringCostsAndAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r297", "r304" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Balance at end of year", "periodStartLabel": "Balance at beginning of year" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r46", "r297", "r307" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "terseLabel": "Restructuring-related employee severance, benefits and other" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveNoncurrent": { "auth_ref": [ "r80", "r297", "r307" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Noncurrent", "terseLabel": "Restructuring-related employee severance, benefits and other" } } }, "localname": "RestructuringReserveNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r53", "r392", "r592", "r636", "r661", "r666" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r2", "r153", "r154", "r155", "r158", "r167", "r169", "r242", "r440", "r441", "r442", "r455", "r456", "r531", "r657", "r659" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r197", "r198", "r211", "r217", "r218", "r225", "r226", "r229", "r405", "r406", "r604" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r395", "r396", "r397", "r398", "r399", "r400", "r403", "r404", "r409", "r417" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r401" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Remaining performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Expected timing of satisfaction" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r581", "r582" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "ROU assets obtained in exchange for operating lease obligations" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r191", "r229" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r92", "r562", "r563" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of accumulated other comprehensive income (loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of antidilutive securities excluded from computation of earnings per share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r468", "r469", "r474" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r74", "r152", "r379", "r381", "r387", "r389", "r390", "r391", "r567", "r568", "r572", "r629" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "terseLabel": "Components of debt" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r508", "r513", "r517" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Derivative instruments, gain (loss)" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r511" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of derivative instruments in statement of financial position, fair value" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r6", "r14", "r15", "r16", "r17", "r18", "r19", "r24", "r27", "r28", "r29", "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Schedule of Discontinued Operations" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r182" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of earnings per share, basic and diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r536", "r537" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of financial assets and liabilities at carrying and fair value" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r275", "r276" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r275", "r276" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Rollforward and Carrying Value Of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r37", "r62", "r63", "r64" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r501" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of notional amounts of outstanding derivative positions" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r325" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Warranty accrual" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/WarrantyTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Fair Values of Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r296", "r297", "r298", "r299", "r306", "r307", "r308" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r301", "r302", "r305" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Restructuring and related costs" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r297", "r307" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of restructuring reserve by type of cost" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r206", "r209", "r215", "r272" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r206", "r209", "r215", "r272" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Segment results" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r193", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r211", "r212", "r213", "r214", "r216", "r217", "r218", "r219", "r220", "r222", "r229", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r276", "r299", "r308", "r649" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r193", "r195", "r196", "r206", "r210", "r216", "r220", "r221", "r222", "r223", "r225", "r228", "r229", "r230" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r117" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r141" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r44", "r592", "r611", "r633" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short-Term Debt", "verboseLabel": "Short-term debt" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r322" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the standard and extended product warranty accrual.", "label": "Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss)", "negatedLabel": "Effect of foreign currency translation" } } }, "localname": "StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandbyLettersOfCreditMember": { "auth_ref": [ "r319", "r326", "r486", "r668" ], "lang": { "en-us": { "role": { "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.", "label": "Standby Letters of Credit [Member]", "terseLabel": "Standby letters of credit" } } }, "localname": "StandbyLettersOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r13", "r193", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r211", "r212", "r213", "r214", "r216", "r217", "r218", "r219", "r220", "r222", "r229", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r276", "r289", "r299", "r308", "r649" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r2", "r78", "r100", "r101", "r102", "r153", "r154", "r155", "r158", "r167", "r169", "r189", "r242", "r386", "r392", "r440", "r441", "r442", "r455", "r456", "r531", "r557", "r558", "r559", "r560", "r561", "r563", "r588", "r657", "r658", "r659" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r153", "r154", "r155", "r189", "r604" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockCompensationPlanMember": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.", "label": "Share-Based Payment Arrangement [Member]", "terseLabel": "Stock-based awards" } } }, "localname": "StockCompensationPlanMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r51", "r55", "r56", "r149", "r234", "r238", "r547", "r592" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Envista stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r2", "r3", "r101", "r149", "r153", "r154", "r155", "r158", "r167", "r238", "r242", "r392", "r440", "r441", "r442", "r455", "r456", "r487", "r488", "r498", "r531", "r547", "r557", "r558", "r563", "r588", "r658", "r659" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "negatedLabel": "Stockholders' equity", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period", "terseLabel": "Increase (decrease) in stockholders' equity", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental data:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r296", "r297", "r306", "r307" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r172", "r182" ], "calculation": { "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average common shares outstanding used in diluted earnings (loss) per share (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Average common stock and common equivalent shares outstanding:", "verboseLabel": "Denominator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r171", "r182" ], "calculation": { "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted-average common shares outstanding used in basic earnings per share (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r121": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "https://asc.fasb.org/topic&trid=2134417" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r188": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r230": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919269-210447" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919272-210447" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919236-210447" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r262": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r277": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r292": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r30": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(e))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r31": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r310": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "https://asc.fasb.org/topic&trid=2175745" }, "r311": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r318": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e12803-110250" }, "r327": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "460", "URI": "https://asc.fasb.org/topic&trid=2155896" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r383": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r417": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r465": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(21))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r485": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r499": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011" }, "r535": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r686": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r687": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r688": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r689": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r690": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r691": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "210-10-S99-1(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580" } }, "version": "2.1" } ZIP 101 0001757073-22-000091-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001757073-22-000091-xbrl.zip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